<!-- cope.cgi version 31.4.18, revision Oct 4, 2013. (c) JI. Powered by Perl 5.010001 [b=3] --><!-- Top of ./topictop.htm --><html><head><title>macrophages (Cytokines &amp; Cells Encyclopedia - COPE) </title><link href="cope.css" rel="stylesheet" type="text/css"/><meta content="text/html; charset=utf-8" http-equiv="content-type"/><!-- meta http-equiv="content-type" content="text/html; charset=ISO-8859-1" --><meta content="Cytokines &amp; Cells Online Pathfinder Encyclopedia" name="description"/><meta content="Horst Ibelgaufts" name="author"/><meta content=" cytokines, growth factors, eukaryotic cell types, angiogenesis, apoptosis, bioassays, CD antigens, cell lines, chemokines, endocrinology, hematology, hormones, immune system, innate immunity, immunology, interferons, interleukins, lymphokines, metalloproteinases, modulins, antimicrobial peptides, neuroimmunology, neurotrophic factors, protein domains, regulatory peptide factors, signal transduction, viroceptors, virokines, virulence factors, encyclopedia, dictionary, glossary" name="keywords"/><meta content="Cytokines &amp; Cells Encyclopedia" name="description"/></head><body alink="red" bgcolor="#FFFFCC" link="blue" text="black" vlink="purple">
<a name="TOP_OF_PAGE"></a>
<center>
<a href="COPE_Media_Kit.pdf"><img alt="COPE Advertising options" src="copetopbanner.gif"/></a>
<p>
<!--
<a href="cope.cgi?key=HELP REQUEST"><B> <P>COPE needs your support to remain a free research/educational tool!</B></a>
<BR><B>Make a donation through PayPal</B>
-->
</p></center>
<hr size="5"/>
<center>
<table border="0">
<tr>
<td> <a href="cope.cgi?key=COPE Contact Information" target="_new"><img alt="COGITO ERGO COPE ADVERTISING SPACE" height="60" src="selfad1.jpg" width="234"/></a> </td>
<td> <a href="cope.cgi?key=COPE Contact Information" target="_new"><img alt="COGITO ERGO COPE ADVERTISING SPACE" height="60" src="selfad2.jpg" width="234"/></a> </td>
<td> <a href="cellgenix_forward.html" target="_new"><img alt="http://www.cellgenix.com/products/product-lines/cellgror-cytokines/gmp-grade-for-clinical-ex-vivo-use.html" height="60" src="2013-06-07_CellGenix_banner.gif" width="234"/></a> </td>
</tr>
<tr>
<td> <a href="Promokine2013_forward.html" target="_new"><img alt="http://www.promokine.info/products/special-offers/" height="60" src="PromoKine_new_2013.gif" width="234"/></a> </td>
<td> <a href="cope.cgi?key=COPE Contact Information" target="_new"><img alt="COGITO ERGO COPE ADVERTISING SPACE" height="60" src="selfad1.jpg" width="234"/></a> </td>
<td> <a href="cope.cgi?key=COPE Contact Information" target="_new"><img alt="COGITO ERGO COPE ADVERTISING SPACE" height="60" src="selfad2.jpg" width="234"/></a> </td>
</tr>
</table>
</center>
<!-- Bottom of ./topictop.htm -->
<hr/>
<center>
<table border="" cellpadding="2" cellspacing="0">
<tr>
<td><a href="cope.cgi"> COPE Homepage</a></td>
<td><a href="#END_OF_PAGE">Bottom of page</a></td>
<td>Previous entry:<br/><a href="cope.cgi?key=Macrophage%2dreleased%20neutrophil%20chemotactic%20factor">Macrophage-released neutrophil chemotactic factor</a></td>
<td>Next entry:<br/><a href="cope.cgi?key=macrophage%20scavenger%20receptor">macrophage scavenger receptor</a></td>
<td>Random entry:<br/><a href="cope.cgi?key=VASH1"> VASH1</a></td>
</tr>
<td colspan="5"><form action="cope.cgi" method="get"><b>Search COPE: </b><input name="pattern" size="50" type="text"/><input type="submit" value="Search"/></form></td></table>
</center>
<br/>
<center><table cellpadding="5" cellspacing="0">
<tr>
<th rowspan="2"><p></p><center><img alt="Please donate" src="shutdownzero.jpg"/></center></th>
<td><center><!-- Top of paypalbutton.htm -->
<form action="https://www.paypal.com/cgi-bin/webscr" method="post">
<input name="cmd" type="hidden" value="_s-xclick"/>
<input name="encrypted" type="hidden" value="-----BEGIN PKCS7-----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-----END PKCS7----- 
"/>
<input alt="PayPal - The safer, easier way to pay online!" border="0" name="submit" src="https://www.paypalobjects.com/en_US/i/btn/btn_donateCC_LG.gif" type="image"/>
<img alt="" border="" bottom="" of="" paypalbutton.htm=""/>
</form></center></td>
</tr>
<tr>
<td><center><b>COPEing Friends<br/>for COPE Fund</b></center></td>
</tr>
</table></center><br/>
<h1>macrophages</h1>
<p> </p><p>abbr. in texts frequently: <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Mphi">Mphi</a></b>. </p><p>Macrophages are <a href="cope.cgi?key=cell%20types">cells</a> derived from bone marrow-derived <a href="cope.cgi?key=mononuclear%20cells">mononuclear cells</a> (<a href="cope.cgi?key=BMM">bone marrow-derived macrophages</a>, abbr. <a href="cope.cgi?key=BMM">BMM</a>; <a href="cope.cgi?key=monocyte%2dderived%20macrophages">monocyte-derived macrophages</a>, abbr. <a href="cope.cgi?key=MDM">MDM</a>) (Gordon and Taylor, 2005) that circulate in the blood or have homed in to tissues in the steady state or in response to <a href="cope.cgi?key=inflammation">inflammation</a>. The <a href="cope.cgi?key=myeloid%20progenitor%20cells">myeloid progenitor cell</a> in the bone marrow that gives rise to circulating <a href="cope.cgi?key=peripheral%20blood%20mononuclear%20cells">peripheral blood mononuclear cells</a> also is the precursor of many different <a href="cope.cgi?key=cell%20types">cell types</a> such as <a href="cope.cgi?key=neutrophils">neutrophils</a>, <a href="cope.cgi?key=eosinophils">eosinophils</a>, <a href="cope.cgi?key=basophils">basophils</a>, macrophages, <a href="cope.cgi?key=dendritic%20cells">dendritic cells</a> and <a href="cope.cgi?key=mast%20cells">mast cells</a> (see also: <a href="cope.cgi?key=Hematopoiesis">hematopoiesis</a>). </p><p>The <a href="cope.cgi?key=differentiation">differentiation</a> of macrophages from unipotential <a href="cope.cgi?key=progenitor%20cells">progenitor cells</a> and bipotential <a href="cope.cgi?key=progenitor%20cells">progenitor cells</a> in the bone marrow is controlled by a variety of <a href="cope.cgi?key=cytokines">cytokines</a>. Hashimoto et al (1999) have reported the analysis of <a href="cope.cgi?key=Gene%20expression">gene expression</a> during this process and describe 35,037 different transcripts expressed in <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a> blood <a href="cope.cgi?key=monocytes">monocytes</a> and macrophages induced by <a href="cope.cgi?key=GM%2dCSF">GM-CSF</a> or <a href="cope.cgi?key=M%2dCSF">M-CSF</a>. </p><p>Blood <a href="cope.cgi?key=monocytes">monocytes</a>, which can engage in pinocytic and <a href="cope.cgi?key=phagocytes">phagocytic</a> activities, migrate in response to various <a href="cope.cgi?key=chemotaxis">chemotactic</a> factors, and express Fc-gamma receptors and iC3b complement, have been considered to be immature forms of tissue-resident macrophages but can be seen also as a population of circulating macrophages (see also: <a href="cope.cgi?key=histiomonocytes">histiomonocytes</a>). Further <a href="cope.cgi?key=differentiation">differentiation</a> takes place in tissues and the resulting macrophage populations are being referred to as <a href="cope.cgi?key=resident%20macrophages">resident macrophages</a>. </p><p>Leenen et al (1994) have reviewed a variety of immunological markers recognized by a selected panel of monoclonal antibodies that are characteristic of: macrophage precursors and immature macrophages (<a href="cope.cgi?key=ER%2dMP12">ER-MP12</a>, ER-MP20, ER-MP54, ER-MP58), mature macrophages in general (<a href="cope.cgi?key=F4%2f80">F4/80</a>, <a href="cope.cgi?key=BM8">BM8</a>, <a href="cope.cgi?key=Mac%2d1">Mac-1</a>, <a href="cope.cgi?key=Mac%2d2">Mac-2</a>, ER-BMDM1), macrophage subsets (ER-HR3, ER-MP23, ER-TR9, Forssman antigen, <a href="cope.cgi?key=MOMA%2d1">MOMA-1</a>, MOMA-2, Monts-4, SER-4), and IFN-gamma-stimulated macrophages (H-2Ia, <a href="cope.cgi?key=LFA%2d1">LFA-1</a>, <a href="cope.cgi?key=ICAM%2d1">ICAM-1</a>, 158.2, MBR-2, TM-2, TM-4, and TM-5). </p><p>Normal macrophages (<b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=resident%20macrophages">resident macrophages</a></b> or <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=tissue%20macrophages">tissue macrophages</a></b>; sometimes also referred to as <a href="cope.cgi?key=trophic%20macrophages">trophic macrophages</a>) can be found in many tissues, including connective tissues, liver, lung, lymph nodes, spleen, bone marrow, serous fluids, skin, and others (for <a href="cope.cgi?key=resident%20macrophages">resident macrophages</a> in the heart see: <a href="cope.cgi?key=cardiac%20tissue%20macrophages">Cardiac tissue macrophages</a>; for specialized germinal center macrophages see: <a href="cope.cgi?key=tingible%20body%20macrophages">tingible body macrophages</a>; for <a href="cope.cgi?key=resident%20macrophages">resident macrophages</a> in adipose tissues see: <a href="cope.cgi?key=Adipose%20tissue%20macrophages">adipose tissue macrophages</a> (abbr. often <a href="cope.cgi?key=ATM">ATMs</a>)). <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=foam%20cells">Foam cells</a></b> are lipid-laden macrophages, called also <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=lipophages">lipophages</a></b>, associated with atherosclerotic plaques. <a href="cope.cgi?key=siderophages">Siderophages</a> are iron-laden macrophages. <a href="cope.cgi?key=smoker%20cells">Smoker cells</a> are <a href="cope.cgi?key=tissue%20macrophages">tissue macrophages</a> found in the lungs of smokers. </p><p><b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=multinucleated%20giant%20cells">Multinucleated giant cells</a></b> are derived by fusion of macrophages. They have the capacity to function like macrophages in host defense against infection and are engaged in the removal of large foreign objects. </p><p>Local populations of macrophages are maintained by proliferation of <a href="cope.cgi?key=resident%20cells">resident</a> <a href="cope.cgi?key=progenitor%20cells">progenitor cells</a> and influx of <a href="cope.cgi?key=monocytes">monocytes</a> from blood. Some types of macrophages have special <a href="cope.cgi?key=nomenclature">names</a>, depending on where they reside. Macrophages in connective tissue and the skin are often being referred to as <a href="cope.cgi?key=histiocytes">histiocytes</a>. One type of macrophages in the skin is known as <a href="cope.cgi?key=Langerhans%20cells">Langerhans cells</a>. Kupffers <a href="cope.cgi?key=cell%20types">cells</a> are macrophages in the liver sinusoids. <a href="cope.cgi?key=osteoclasts">Osteoclasts</a> are macrophages in the bone. Macrophages in the brain are <a href="cope.cgi?key=microglial%20cells">microglial cells</a>. <a href="cope.cgi?key=placental%20macrophages">Placental macrophages</a> are frequently being referred to as <a href="cope.cgi?key=Hofbauer%20cells">Hofbauer cells</a>. Macrophage-like <a href="cope.cgi?key=cell%20types">cells</a> in the synovium of <a href="cope.cgi?key=cell%20types">cells</a> are <a href="cope.cgi?key=synoviomacrophages">synoviomacrophages</a> (called also <a href="cope.cgi?key=A%2dsynoviocytes">A-synoviocytes</a>). The term <a href="cope.cgi?key=neuronophages">neuronophages</a> has been used for <a href="cope.cgi?key=Antigen%2dpresenting%20cells">antigen-presenting cells</a> of the brain that are capable of taking up dead <a href="cope.cgi?key=neurons">neurons</a> by phagocytosis. </p><p><br/> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=inflammatory%20macrophages">Inflammatory macrophages</a> </b>are derived exclusively from <a href="cope.cgi?key=monocytes">monocytes</a>, have similar properties, and are present in various exudates. Some types of macrophages, identified either bei expression of distinct surface markers or by discrete secretion products, may be associated with distinct disease states. </p><p><br/> Macrophage populations have been shown to comprise distinct subpopulations that are being referred to generally as <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=polarized%20macrophages">polarized macrophages</a></b>. The term <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=classically%20activated%20macrophages">classically activated macrophages</a></b> (abbr. sometimes <a href="cope.cgi?key=CAMPhi">CAMPhi</a>; called also <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a></b>; abbr. <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Mphi1">Mphi1</a></b>) refers to macrophages having undergone <a href="cope.cgi?key=Cell%20activation">cell activation</a> in response to <a href="cope.cgi?key=LPS">LPS</a> or <a href="cope.cgi?key=IFN%2dgamma">IFN-gamma</a>. Classical <a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a> have a <a href="cope.cgi?key=inflammation">pro-inflammatory</a> phenotype and are characterized by high expression of pro-inßammatory <a href="cope.cgi?key=cytokines">cytokines</a>, iNOS expression, and production of reactive oxygen <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">species</a> (Gordon, 2003; Gordon S and Taylor PR, 2005; Martinez et al, 2008). More generally speaking, <a href="cope.cgi?key=Cell%20activation">cell activation</a> of macrophages by <a href="cope.cgi?key=Th1%20cytokines">Th1 cytokines</a> (which includes <a href="cope.cgi?key=IFN%2dgamma">IFN-gamma</a> and <a href="cope.cgi?key=TNF%2dalpha">TNF-alpha</a>) is referred to as <b style="mso-bidi-font-weight:normal">type 1 activation</b> (Ma et al, 2003). The <a href="cope.cgi?key=cytokines">cytokines</a> expressed by <a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a> such as <a href="cope.cgi?key=IL1%2dbeta">IL1-beta</a>, <a href="cope.cgi?key=TNF%2dalpha">TNF-alpha</a>, <a href="cope.cgi?key=IL12">IL12</a>, <a href="cope.cgi?key=IL6">IL6</a> are being referred to sometimes as <a href="cope.cgi?key=M1%20cytokines">M1 cytokines</a>.<br/> The term <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=alternatively%20activated%20macrophages">alternatively activated macrophages</a></b> (abbr. sometimes <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=AAMPhi">AAMPhi</a></b> or <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=aaMF">aaMF</a></b> or <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=AAMs">AAMs</a></b>; called also <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a></b>; abbr. <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Mphi2">Mphi2</a></b>) refers to macrophages having undergone <a href="cope.cgi?key=Cell%20activation">cell activation</a> in response to <a href="cope.cgi?key=IL4">IL4</a> or glucocorticoids (Gordon, 2003; Martinez et al, 2008; Gordon and Martinez, 2010). These <a href="cope.cgi?key=cell%20types">cells</a> have an <a href="cope.cgi?key=inflammation">anti-inflammatory</a> phenotype (for <a href="cope.cgi?key=cell%20types">cells</a> with an M2 phenotype see also: <a href="cope.cgi?key=Adipose%20tissue%20macrophages">adipose tissue macrophages</a>; for an imbalance between <a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a> and <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> involved in metabolic syndromes see also: <a href="cope.cgi?key=metainflammation">metainflammation</a>). More generally speaking, <a href="cope.cgi?key=Cell%20activation">cell activation</a> of macrophages by <a href="cope.cgi?key=Th2%20cytokines">Th2 cytokines</a> (which includes <a href="cope.cgi?key=IL4">IL4</a> and <a href="cope.cgi?key=IL13">IL13</a>) is referred to as <b style="mso-bidi-font-weight:normal">type 2 activation</b> (Ma et al, 2003). <a href="cope.cgi?key=alternatively%20activated%20macrophages">Alternatively activated macrophages</a> generated in vivo have a <a href="cope.cgi?key=Gene%20expression">gene expression</a> profile distinct from other macrophage populations (Loke et al, 2002). The <a href="cope.cgi?key=cytokines">cytokines</a> expressed by <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> such as <a href="cope.cgi?key=IL10">IL10</a>, <a href="cope.cgi?key=IL1ra">IL1ra</a>, <a href="cope.cgi?key=TGF%2dbeta">TGF-beta</a> are being referred to sometimes as <a href="cope.cgi?key=M2%20cytokines">M2 cytokines</a>. </p><p><a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a> and <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> are thought to represent two extremes of a spectrum of macrophage activation states (Mosser and Edwards, 2008; Murray and Wynn, 2011; Gordon and Martinez, 2010). <a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a> are characterized by high expression of <a href="cope.cgi?key=IL12">IL12</a> and <a href="cope.cgi?key=IL23">IL23</a>, and low expression of <a href="cope.cgi?key=IL10">IL10</a> and generally have immunostimulatory properties oriented towards <a href="cope.cgi?key=Th1%20cells">Th1 cell</a> activation. They kill intracellular pathogens, and have antitumoral activity. <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> express love levels of <a href="cope.cgi?key=IL12">IL12</a> and IL-23, and express high levels of <a href="cope.cgi?key=IL10">IL10</a> and <a href="cope.cgi?key=CD206">CD206</a> as well as scavenger receptors. <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> have poor antigen-presenting capacity, promote <a href="cope.cgi?key=Angiogenesis">angiogenesis</a>, tissue remodelling and repair; and suppress immunity involving <a href="cope.cgi?key=Th1%20cells">Th1 cells</a>. They support <a href="cope.cgi?key=Th2%20cells">Th2 cell</a> responses necessary for killing and encapsulation of parasites (Martinez FO et al, 2008; Martinez FO et al, 2009).  </p><p>Both types of <a href="cope.cgi?key=activated%20cells">activated cells</a> can co-exist and show differences in their capacity to secrete mediators and to express receptors (see, for example, Kordelja et al, 1997; Mosser and Edwards, 2008; Martinez FO et al, 2006). Thus, these <a href="cope.cgi?key=cell%20types">cells</a> participate to different extents in <a href="cope.cgi?key=inflammation">pro-inflammatory</a> and <a href="cope.cgi?key=inflammation">anti-inflammatory</a> immune reactions. Particle-mediated <a href="cope.cgi?key=Cell%20activation">cell activation</a> of macrophages also differs from type 1 or type <a href="cope.cgi?key=activated%20cells">activated cells</a> in <a href="cope.cgi?key=Gene%20expression">gene expression</a> patterns (Ma et al, 2003). <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> express high levels of <a href="cope.cgi?key=mannose%20receptor">mannose receptor</a>, <a href="cope.cgi?key=Dectin%2d1">dectin-1</a>, and <a href="cope.cgi?key=Arginase">arginase</a>. M2 subsets have been characterized (Gordon and Taylor, 2005) and include <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> activated by <a href="cope.cgi?key=IL4">IL4</a> or <a href="cope.cgi?key=IL13">IL13</a> (referred to also as <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=M2a%20macrophages">M2a macrophages</a></b> (Martinez et al, 2008), macrophages activated by immune complexes (referred to also as <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M2b%20macrophages">M2b macrophages</a></b>), and macrophages <a href="cope.cgi?key=polarized%20cells">polarized</a> with glucocorticoids or <a href="cope.cgi?key=IL10">IL10</a> (<b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M2c%20macrophages">M2c macrophages</a></b>) (Martinez et al, 2008). </p><p>The term <b style="mso-bidi-font-weight:normal">macrophage deactivation</b> refers to a reversal of the activated state. This process requires the presence of a variety of mediators. </p><p><b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M4%20macrophages">M4 macrophages</a></b> define a macrophage <a href="cope.cgi?key=differentiation">differentiation</a> step that differs from <a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a> and <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a> (Gleissner et al, 2010). <a href="cope.cgi?key=M4%20macrophages">M4 macrophages</a> are induced by the <a href="cope.cgi?key=Chemokines">chemokine</a> <a href="cope.cgi?key=CXCL4">CXCL4</a> derived from <a href="cope.cgi?key=platelets">platelets</a>, and their transcriptome differs markedly from the other two <a href="cope.cgi?key=differentiation">differentiation</a> types. </p><p>The different types of macrophages constitute a heterogeneous population of <a href="cope.cgi?key=cell%20types">cells</a> that differ in their origin and <a href="cope.cgi?key=differentiation">differentiation</a> stage and may have been subject to different tissue-specific micro-environmental influences. These <a href="cope.cgi?key=cell%20types">cells</a> thus can display a range of functional and morphological phenotypes (expression of membrane-bound and secretory products). Mosser and Edwards (2008) have reviewed the biology of different subpopulations of macrophages and have suggested a macrophage classification scheme based on the fundamental macrophage functions that are involved in maintaining homeostasis. <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=host%20defence%20macrophages">Host defence macrophages</a></b> correspond to <a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a>. In addition, a distinction is made between <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=wound%20healing%20macrophages">wound healing macrophages</a></b> and <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=regulatory%20macrophages">regulatory macrophages</a></b> engaged in immune regulation. Macrophages can evolve to exhibit characteristics that are shared by more than one macrophage population and probably constitute a spectrum of <a href="cope.cgi?key=cell%20types">cell types</a> with shared or specific activities. The term <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=regulatory%20macrophages">regulatory macrophages</a></b> has been used to describe a population of macrophages that produces high levels of <a href="cope.cgi?key=IL10">IL10</a> and low levels of <a href="cope.cgi?key=IL12">IL12</a> and <a href="cope.cgi?key=IL23">IL23</a>. These macrophages also produce <a href="cope.cgi?key=HB%2dEGF">HB-EGF</a> (Edwards et al, 2009). </p><p><b style="mso-bidi-font-weight:normal"><br/> <a href="cope.cgi?key=CD4%28%2b%29%20CD8%28%2b%29%20macrophages">CD4(+) CD8(+) macrophages</a></b> have been shown to constitute a unique subpopulation of cytotoxic macrophages that kill tumor <a href="cope.cgi?key=cell%20types">cells</a> by mechanisms involving <a href="cope.cgi?key=NKG2D">NKG2D</a> receptors, <a href="cope.cgi?key=Granzymes">granzymes</a> and <a href="cope.cgi?key=Perforin">perforin</a> (Baba et al, 2008).<br/> <br/> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=tumor%2dassociated%20macrophages">Tumor-associated macrophages</a></b> (abbr. <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TAM">TAM</a></b>) are highly active <a href="cope.cgi?key=resident%20cells">resident</a> immune effector <a href="cope.cgi?key=cell%20types">cells</a> found in the stroma of tumors. They may either positively or negatively regulate the growth of various malignant <a href="cope.cgi?key=cell%20types">cells</a> (see also: <a href="cope.cgi?key=TIL">TIL</a> [<a href="cope.cgi?key=tumor%20infiltrating%20lymphocytes">tumor infiltrating lymphocytes</a>]) (Ohno et al, 2003; Mantovani et al, 2002; Sica et al, 2002). Resting <a href="cope.cgi?key=TAM">TAMs</a> have been shown to express the immunosuppressive <a href="cope.cgi?key=cytokines">cytokine</a> <a href="cope.cgi?key=IL10">IL10</a>, phagocytosis-related receptors/molecules (Msr2 and <a href="cope.cgi?key=C1q">C1q</a>), <a href="cope.cgi?key=inflammatory%20chemokines">inflammatory chemokines</a> (<a href="cope.cgi?key=CCL2">CCL2</a> and <a href="cope.cgi?key=CCL5">CCL5</a>) and <a href="cope.cgi?key=Chemokines">chemokines</a> (<a href="cope.cgi?key=CXCL9">CXCL9</a>, <a href="cope.cgi?key=CXCL10">CXCL10</a>, <a href="cope.cgi?key=CXCL16">CXCL16</a>), the expression of which is inducible by <a href="cope.cgi?key=Interferons">interferons</a>. <a href="cope.cgi?key=Cell%20activation">Cell activation</a> of <a href="cope.cgi?key=TAM">TAMs</a> by <a href="cope.cgi?key=Lipopolysaccharides">lipopolysaccharides</a> interferes with the expression of several <a href="cope.cgi?key=pro%2dinflammatory%20cytokines">pro-inflammatory cytokines</a> (<a href="cope.cgi?key=IL1%2dbeta">IL1-beta</a>, <a href="cope.cgi?key=IL6">IL6</a>, <a href="cope.cgi?key=TNF%2dalpha">TNF-alpha</a>) and <a href="cope.cgi?key=Chemokines">chemokines</a> (<a href="cope.cgi?key=CCL3">CCL3</a>), but upregulates the expression of immunosuppressive <a href="cope.cgi?key=cytokines">cytokines</a> (<a href="cope.cgi?key=IL10">IL10</a>, <a href="cope.cgi?key=TGF%2dbeta">TGF-beta</a>) and <a href="cope.cgi?key=IFN">IFN</a> inducible <a href="cope.cgi?key=Chemokines">chemokines</a> (<a href="cope.cgi?key=CCL5">CCL5</a>, <a href="cope.cgi?key=CXCL9">CXCL9</a>, <a href="cope.cgi?key=CXCL10">CXCL10</a>, <a href="cope.cgi?key=CXCL16">CXCL16</a>) (Biswas et al, 2006). Duff et al (2007) have reported <a href="cope.cgi?key=Gene%20expression">gene expression</a> patterns of <a href="cope.cgi?key=TAM">TAMs</a>, which reveal that these <a href="cope.cgi?key=cell%20types">cells</a> are distinct from both wound and peritoneal macrophages. </p><p><a href="cope.cgi?key=resident%20macrophages">Resident macrophages</a> retain some proliferative capacity, can engage in phagocytosis, can respond to various stimuli, but are otherwise relative quiescent with respect to immunological and secretory functions. </p><p>Macrophages participate in all phases of the immune response as <a href="cope.cgi?key=phagocytes">phagocytic</a> <a href="cope.cgi?key=cell%20types">cells</a>, and functionally distinct macrophage populations provide for very flexible immune responses. They play a key role in host defences against intracellular parasitic <a href="cope.cgi?key=Modulins">micro-organisms</a> and tumor <a href="cope.cgi?key=cell%20types">cells</a>. Macrophages, through their secretory products, control <a href="cope.cgi?key=inflammation">inflammation</a>, changes in the composition of the <a href="cope.cgi?key=extracellular%20matrix">extracellular matrix</a>, <a href="cope.cgi?key=Wound%20healing">tissue reorganization</a>, <a href="cope.cgi?key=Angiogenesis">angiogenesis</a>, and other processes. These <a href="cope.cgi?key=cell%20types">cells</a> can be cytotoxic for other <a href="cope.cgi?key=cell%20types">cells</a> (<a href="cope.cgi?key=K%20cells">K cells</a>) and can kill or damage extracellular targets by means of <a href="cope.cgi?key=antibody%2ddependent%20cell%2dmediated%20cytotoxicity">antibody-dependent cell-mediated cytotoxicity</a>. Macrophages constitute an important link between the innate and adaptive immune systems through presentation of antigens to <a href="cope.cgi?key=T%2dcells">T-cells</a> and production of <a href="cope.cgi?key=cytokines">cytokines</a> and <a href="cope.cgi?key=Chemokines">chemokines</a>. The capacity of macrophages to participate in these and other processes by directly or indirectly influencing the bioactivities of other <a href="cope.cgi?key=cell%20types">cells</a> may depend on the developmental stage and also depends largely on <a href="cope.cgi?key=Cell%20activation">cell activation</a>. <a href="cope.cgi?key=tissue%20macrophages">Tissue macrophages</a> play a critical role in <a href="cope.cgi?key=Wound%20healing">wound healing</a> by producing <a href="cope.cgi?key=chemoattractants">chemoattractants</a> recruiting and activating additional macrophages, <a href="cope.cgi?key=Growth%20factors">growth factors</a> promoting cellular proliferation, proteases and <a href="cope.cgi?key=extracellular%20matrix">extracellular matrix</a> molecules, and factors restraining tissue growth once repair is completed. For macrophages that antagonize immune responses see: <a href="cope.cgi?key=suppressor%20macrophages">suppressor macrophages</a>. </p><p>Macrophages have the capacity to secrete a plethora of <a href="cope.cgi?key=cytokines">cytokines</a>, <a href="cope.cgi?key=Growth%20factors">growth factors</a>, and other mediators (Nathan, 1987), which may be engaged in <a href="cope.cgi?key=Autocrine">autocrine</a>, <a href="cope.cgi?key=Paracrine">paracrine</a> or endocrine interactions that can affect many other <a href="cope.cgi?key=cell%20types">cell types</a>. Some mediators are produced constitutively, others are produced only after <a href="cope.cgi?key=Cell%20activation">cell activation</a>. The <a href="cope.cgi?key=cell%20types">cells</a> are said to have become 'stimulated', 'activated', 'induced', 'elicited', etc, and these terms are often used interchangeably. Frequently, any distinctions made to describe degrees of <a href="cope.cgi?key=Cell%20activation">cell activation</a> are more or less arbitrary. Depending in large part on the nature of the stimuli, macrophages may be primed only for selected functions and may not attain the full spectrum of functional capacities. Distinct subpopulations of macrophages or differently activated macrophages display various functions in immune reactions and this may be reflected by differences in the factors they produce, and the mediators they respond to, under various circumstances. </p><p>Numerous studies have been carried out to identify genes expressed or repressed specifically in macrophages in response to a variety of stimuli. Chaussabel et al (2003) have compared <a href="cope.cgi?key=Gene%20expression">gene expression</a> profiles in <a href="cope.cgi?key=monocyte%2dderived%20dendritic%20cells">monocyte-derived dendritic cells</a> and macrophages generated in vitro from the same individual blood donors and exposed to 5 different pathogens. These analyses demonstrate <a href="cope.cgi?key=dendritic%20cells">dendritic cells</a> and macrophages constitutively express approximately 4000 genes, 96 % of which are shared between the 2 <a href="cope.cgi?key=cell%20types">cell types</a>. Unique expression patterns are found in response to each pathogen. Li et al (2004) have reported the results of a <a href="cope.cgi?key=Gene%20expression">gene expression</a> profiling study aimed at identifying genes expressed or repressed specifically in response to <a href="cope.cgi?key=endotoxins">bacterial lipopolysaccharides</a>. <a href="cope.cgi?key=Gene%20expression">Gene expression</a> profiling of <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">bovine</a> macrophages in response to <a href="cope.cgi?key=Escherichia%20coli">Escherichia coli</a> O157:H7 lipopolysaccharide has been reported by Chitko-McKown et al (2004). Kohro et al (2004) have reported a comparison of the differences in <a href="cope.cgi?key=Gene%20expression">gene expression</a> profiles of <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a> <a href="cope.cgi?key=monocyte%2dderived%20macrophages">monocyte-derived macrophages</a> and THP-1 <a href="cope.cgi?key=cell%20types">cells</a> differentiated in response to <a href="cope.cgi?key=phorbol%2012%2dmyristate%2013%2dacetate">phorbol 12-myristate 13-acetate</a>. Rodriguez et al (2004) have compared <a href="cope.cgi?key=Gene%20expression">gene expression</a> patterns in macrophages after phagocytosis of Leishmania chagasi with those observed after treatment with <a href="cope.cgi?key=Lipopolysaccharides">lipopolysaccharides</a> and <a href="cope.cgi?key=IFN%2dgamma">IFN-gamma</a>. Chaussabel et al (2003) have compared <a href="cope.cgi?key=Gene%20expression">gene expression</a> patterns in <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a> macrophages and <a href="cope.cgi?key=dendritic%20cells">dendritic cells</a>. In the absence of microbial stimulation, <a href="cope.cgi?key=dendritic%20cells">dendritic cells</a> and macrophages constitutively express approximately 4000 genes, 96 % of which are shared between the 2 <a href="cope.cgi?key=cell%20types">cell types</a>. The genes altered transcriptionally in both <a href="cope.cgi?key=cell%20types">cell types</a> following pathogen exposure are largely cell specific. Ragno et al (2001) have reported changes in <a href="cope.cgi?key=Gene%20expression">gene expression</a> that occur in the <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a> macrophage <a href="cope.cgi?key=Cell%20lines%20in%20Cytokine%20Research">cell line</a>, THP1 following infection with Mycobacterium tuberculosis. Gustafsson et al (2008) have used micro-arrays comprising approximately 14,000 genes and compare the <a href="cope.cgi?key=Gene%20expression">gene expression</a> patterns of <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a> first trimester decidual <a href="cope.cgi?key=CD14">CD14(+)</a> <a href="cope.cgi?key=monocytes">monocytes</a> / macrophages with the <a href="cope.cgi?key=Cytokine%20expression%20profiles">expression profile</a> of the corresponding <a href="cope.cgi?key=cell%20types">cells</a> in blood. Guerfali et al (2008) have reported the <a href="cope.cgi?key=Gene%20expression">gene expression</a> profile of <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a> macrophages infected with Leishmania major parasites. Edwards et al (2006) have reported <a href="cope.cgi?key=Cytokine%20expression%20profiles">expression profiles</a> and gene signatures for <a href="cope.cgi?key=M1%20macrophages">M1 macrophages</a>, <a href="cope.cgi?key=M2%20macrophages">M2 macrophages</a>, and type 2 activation.  </p><p><br/> Macrophages have been shown to possess the capacity to express the proteins listed below. Please note the following general observations, which practically apply to all <a href="cope.cgi?key=cell%20types">cell types</a>: expression may be influenced by tissue localization, may occur only in discrete subpopulations of <a href="cope.cgi?key=cell%20types">cells</a>, may vary between <a href="cope.cgi?key=established%20cell%20line">established cell lines</a>, <a href="cope.cgi?key=primary%20cells">primary cells</a>, embryonic <a href="cope.cgi?key=cell%20types">cells</a>, mature <a href="cope.cgi?key=cell%20types">cells</a>, fully <a href="cope.cgi?key=differentiated%20cells">differentiated cells</a>, <a href="cope.cgi?key=activated%20cells">activated cells</a>, non-activated <a href="cope.cgi?key=cell%20types">cells</a> or growth conditions (confluent vs. sparse cultures), may be influenced by various disease states (including cancer environment), and may differ between <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">species</a>.<br/> Note also: <a href="cope.cgi?key=Cytokine%20expression%20profiles">expression profile</a> information lists entities only for which there is an entry in <a href="cope.cgi?key=COPE">COPE</a> or one of its <a href="cope.cgi?key=MiniCOPE%20Dictionaries">subdictionaries</a>. </p>The meaning of <b style="mso-bidi-font-weight:normal">¥</b> and <b style="mso-bidi-font-weight: normal">¥¥</b> is as follows: <b style="mso-bidi-font-weight:normal">¥ </b>factor/protein is expressed; <b style="mso-bidi-font-weight: normal">¥¥ </b>receptor (or, in some instances, binding sites) for this factor/protein is expressed. For further explanations concerning format, "hidden" information, and/or ambiguities see my remarks in the entry <a href="cope.cgi?key=cell%20types">cell types</a>. <br/><br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=4%2d1BB">4-1BB</a></b> (<a href="cope.cgi?key=CD137">CD137</a>, <a href="cope.cgi?key=CDw137">CDw137</a>, <a href="cope.cgi?key=Ly63">Ly63</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%2063">lymphocyte antigen 63</a>, <a href="cope.cgi?key=ILA">ILA</a>, <a href="cope.cgi?key=induced%20by%20lymphocyte%20activation">induced by lymphocyte activation</a>, <a href="cope.cgi?key=TNFRSF9">TNFRSF9</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%209">TNF receptor superfamily member 9</a>) (Setareh et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=4%2d1BB%20ligand">4-1BB ligand</a></b> (<a href="cope.cgi?key=4%2d1BBL">4-1BBL</a>, <a href="cope.cgi?key=TNFSF9">TNFSF9</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%209">TNF ligand superfamily member 9</a>, <a href="cope.cgi?key=CD137L">CD137L</a>, <a href="cope.cgi?key=CD137%20ligand">CD137 ligand</a>, <a href="cope.cgi?key=Ly63%20ligand">Ly63 ligand</a>) (Philipps et al, 2001; Futagawa et al, 2002; Kim DK et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=14%2d3%2d3%2dzeta">14-3-3-zeta</a></b> (<a href="cope.cgi?key=YWHAZ">YWHAZ</a>, <a href="cope.cgi?key=tyrosine%203%2dMonooxygenase%2fTryptophan%205%2dMonooxygenase%20Activation%20Protein%2dzeta">Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein-zeta</a>, <a href="cope.cgi?key=14%2d3%2d3%2ddelta">14-3-3-delta</a>, <a href="cope.cgi?key=Exo1">Exo1</a>, <a href="cope.cgi?key=FAS">FAS</a>, <a href="cope.cgi?key=factor%20activating%20ExoS">factor activating ExoS</a>) (Kobayashi et al, 2009)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=A20">A20</a></b> (<a href="cope.cgi?key=TNFAIP3">TNFAIP3</a> [<a href="cope.cgi?key=TNF%2dalpha%2dinduced%20protein%203">TNF-alpha-induced protein 3</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%2dalpha%2dinduced%20protein%203">tumor necrosis factor-alpha-induced protein 3</a>, <a href="cope.cgi?key=Zinc%20finger%20protein%20A20">Zinc finger protein A20</a>, <a href="cope.cgi?key=OTUD7C">OTUD7C</a>, <a href="cope.cgi?key=OTU%20domain%2dcontaining%20protein%207C">OTU domain-containing protein 7C</a>) (Folco et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ABIN%2d3">ABIN-3</a> </b>(<a href="cope.cgi?key=A20%2dbinding%20inhibitor%20of%20NF%2dkappa%2dB%20activation%2d3">A20-binding inhibitor of NF-kappa-B activation-3</a>, <a href="cope.cgi?key=LIND">LIND</a>, <a href="cope.cgi?key=Listeria%20induced">Listeria induced</a>, <a href="cope.cgi?key=TNIP3">TNIP3</a>, <a href="cope.cgi?key=TNFAIP3%20interacting%20protein%203">TNFAIP3 interacting protein 3</a>) (Staege et al, 2001; Folco et al 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=AcSDKP">AcSDKP</a></b> (<a href="cope.cgi?key=N%2dacetyl%2dseryl%2daspartyl%2dlysyl%2dproline">N-acetyl-seryl-aspartyl-lysyl-proline</a>, <a href="cope.cgi?key=Acetyl%2dN%2dSer%2dAsp%2dLys%2dPro">acetyl-N-Ser-Asp-Lys-Pro</a>, <a href="cope.cgi?key=Seraspenide">Seraspenide</a>, <a href="cope.cgi?key=Goralatide">Goralatide</a>, <a href="cope.cgi?key=Thymosin%2dbeta%2d4">thymosin-beta-4</a>) (Li et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ACTH">ACTH</a></b> (<a href="cope.cgi?key=Adrenocorticotropic%20hormone">adrenocorticotropic hormone</a>, <a href="cope.cgi?key=Corticotropin">corticotropin</a>, <a href="cope.cgi?key=POMC">POMC</a>, <a href="cope.cgi?key=Proopiomelanocortin">proopiomelanocortin</a>) (Lolait et al, 1986)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ACTH">ACTH</a> </b>(<a href="cope.cgi?key=Adrenocorticotropic%20hormone">adrenocorticotropic hormone</a>, <a href="cope.cgi?key=Corticotropin">corticotropin</a>, <a href="cope.cgi?key=POMC">POMC</a>, <a href="cope.cgi?key=Proopiomelanocortin">proopiomelanocortin</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (melanocortin receptors) (Kaur et al, 2002; Luger et al, 2000; Johnson et al, 2001; Getting et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Activin%20A">Activin A</a> </b>(<a href="cope.cgi?key=EDF">EDF</a>, <a href="cope.cgi?key=Erythroid%20differentiation%20factor">erythroid differentiation factor</a>, <a href="cope.cgi?key=FRP">FRP</a>, <a href="cope.cgi?key=Follicle%20stimulating%20hormone%20releasing%20protein">Follicle stimulating hormone releasing protein</a>, <a href="cope.cgi?key=Restrictin%2dP">Restrictin-P</a>, <a href="cope.cgi?key=WEHI%2dMIF">WEHI-MIF</a>, <a href="cope.cgi?key=WEHI%20mesoderm%20inducing%20factor">WEHI mesoderm inducing factor</a>, <a href="cope.cgi?key=activin%2dbeta%2dA">activin-beta-A</a>, <a href="cope.cgi?key=INHA">INHA</a>, <a href="cope.cgi?key=Inhibin%2dalpha">inhibin-alpha</a>, <a href="cope.cgi?key=Inhibin%2dbeta%2dA">Inhibin-beta-A</a>, <a href="cope.cgi?key=INHBA">INHBA</a> ) (Ogawa et al, 2000; Eto et al, 1987; Murata et al, 1988; Ebert et al, 2007; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Activin%20A">Activin A</a> </b>(<a href="cope.cgi?key=EDF">EDF</a>, <a href="cope.cgi?key=Erythroid%20differentiation%20factor">erythroid differentiation factor</a>, <a href="cope.cgi?key=FRP">FRP</a>, <a href="cope.cgi?key=Follicle%20stimulating%20hormone%20releasing%20protein">Follicle stimulating hormone releasing protein</a>, <a href="cope.cgi?key=Restrictin%2dP">Restrictin-P</a>, <a href="cope.cgi?key=WEHI%2dMIF">WEHI-MIF</a>, <a href="cope.cgi?key=WEHI%20mesoderm%20inducing%20factor">WEHI mesoderm inducing factor</a>, <a href="cope.cgi?key=activin%2dbeta%2dA">activin-beta-A</a>, <a href="cope.cgi?key=INHA">INHA</a>, <a href="cope.cgi?key=Inhibin%2dalpha">inhibin-alpha</a>, <a href="cope.cgi?key=Inhibin%2dbeta%2dA">Inhibin-beta-A</a>, <a href="cope.cgi?key=INHBA">INHBA</a> ) <b style="mso-bidi-font-weight:normal">receptors</b> (ActRI, ActRIB, ActRII, and ActRIIB) (Ogawa et al, 2000; Funaba et al, 2003; Ota et al, 2003; Nusing and Barsig, 1999; Nishihara et al, 1995; Zhou et al, 2009; Lee HJ et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAM8">ADAM8</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloprotease%20domain%208">disintegrin and metalloprotease domain 8</a>, <a href="cope.cgi?key=MS2">MS2</a>, <a href="cope.cgi?key=CD156">CD156</a>) (Hodgkinson and Ye, 2003, Yoshiyama et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAM9">ADAM9</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloprotease%20domain%209">disintegrin and metalloprotease domain 9</a>, <a href="cope.cgi?key=Meltrin%2dgamma">Meltrin-gamma</a>, <a href="cope.cgi?key=MLTNG">MLTNG</a>, <a href="cope.cgi?key=Myeloma%20Cell%20Metalloproteinase">Myeloma Cell Metalloproteinase</a>, <a href="cope.cgi?key=MCMP">MCMP</a>, <a href="cope.cgi?key=MDC%2d9">MDC-9</a>, <a href="cope.cgi?key=KIAA0021">KIAA0021</a>) (Oksala et al, 2009<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAM15">ADAM15</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloprotease%20domain%2015">disintegrin and metalloprotease domain 15</a>, <a href="cope.cgi?key=Metargidin">Metargidin</a>, <a href="cope.cgi?key=MDC%2d15">MDC-15</a>, <a href="cope.cgi?key=metalloproteinase%2dlike%20disintegrin%2dlike%20cysteine%2drich%20protein%2d15">metalloproteinase-like disintegrin-like cysteine-rich protein-15</a>, <a href="cope.cgi?key=CRII%2d7">CRII-7</a>) (Oksala et al, 2009<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAM17">ADAM17</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloprotease%20domain%2017">disintegrin and metalloprotease domain 17</a>, <a href="cope.cgi?key=TACE">TACE</a>, <a href="cope.cgi?key=TNF%2dalpha%20converting%20enzyme">TNF-alpha converting enzyme</a>, <a href="cope.cgi?key=TACA">TACA</a>, <a href="cope.cgi?key=TNF%2dalpha%20converting%20activity">TNF-alpha converting activity</a>, <a href="cope.cgi?key=TNF%2dalpha%20convertase">TNF-alpha convertase</a>, <a href="cope.cgi?key=TNF%2dalpha%20sheddase">TNF-alpha sheddase</a>, <a href="cope.cgi?key=cSVP">cSVP</a>, <a href="cope.cgi?key=cellular%20snake%20venom%2dlike%20protease">cellular snake venom-like protease</a>, <a href="cope.cgi?key=CD156b">CD156b</a>) (Oksala et al, 2009<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAMTS1">ADAMTS1</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloproteinase%20with%20thrombospondin%20motif%2d1">Disintegrin and metalloproteinase with thrombospondin motif-1</a>, <a href="cope.cgi?key=METH%2d1">METH-1</a>, <a href="cope.cgi?key=KIAA1346">KIAA1346</a>) (<a href="cope.cgi?key=Lu">Lu</a> et al, 2008; Misra et al, 2008; Krampert et al, 2005; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAMTS2">ADAMTS2</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloproteinase%20with%20thrombospondin%20motif%2d2">Disintegrin and metalloproteinase with thrombospondin motif-2</a>, <a href="cope.cgi?key=ADAMTS4">ADAMTS4</a>, <a href="cope.cgi?key=KIAA0688">KIAA0688</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e14">EC3.4.24.14</a>, <a href="cope.cgi?key=PCINP">PCINP</a>, <a href="cope.cgi?key=PCPNI">PCPNI</a>, <a href="cope.cgi?key=Procollagen%20I%20N%2dproteinase">Procollagen I N-proteinase</a>, <a href="cope.cgi?key=Procollagen%20N%2dendopeptidase">Procollagen N-endopeptidase</a>, <a href="cope.cgi?key=Procollagen%20N%2dproteinase">Procollagen N-proteinase</a>, <a href="cope.cgi?key=Procollagen%20I%2fII%20amino%20propeptide%2dprocessing%20enzyme">Procollagen I/II amino propeptide-processing enzyme</a>) (Hofer et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAMTS4">ADAMTS4</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloproteinase%20with%20thrombospondin%20motif%2d4">Disintegrin and metalloproteinase with thrombospondin motif-4</a>, <a href="cope.cgi?key=Aggrecanase%2d1">Aggrecanase-1</a>, <a href="cope.cgi?key=hyalectanase">hyalectanase</a>) (Wagsater et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAMTS7">ADAMTS7</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloproteinase%20with%20thrombospondin%20motif%2d7">Disintegrin and metalloproteinase with thrombospondin motif-7</a>) (Wagsater et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAMTS8">ADAMTS8</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloproteinase%20with%20thrombospondin%20motif%2d8">Disintegrin and metalloproteinase with thrombospondin motif-8</a>, <a href="cope.cgi?key=METH%2d2">METH-2</a>) (Wagsater et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADAMTS9">ADAMTS9</a></b> (<a href="cope.cgi?key=disintegrin%20and%20metalloproteinase%20with%20thrombospondin%20motif%2d9">Disintegrin and metalloproteinase with thrombospondin motif-9</a>) (Wagsater et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> adenosine receptors (Olah and Caldwell, 2003; Nemeth et al, 2003; Fishman and Bar-Yehuda, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Adiponectin">adiponectin</a></b> (<a href="cope.cgi?key=Adpn">Adpn</a>, <a href="cope.cgi?key=Apn">Apn</a>, <a href="cope.cgi?key=ACDC">ACDC</a>, <a href="cope.cgi?key=adiponectin%2c%20C1q%20and%20collagen%20domain%20containing">adiponectin, C1q and collagen domain containing</a>, <a href="cope.cgi?key=ADIPOQ">ADIPOQ</a>, <a href="cope.cgi?key=apM1">apM1</a>, <a href="cope.cgi?key=adipose%20Most%20abundant%20gene%20transcript%2d1">adipose Most abundant gene transcript-1</a>, <a href="cope.cgi?key=GBP%2d28">GBP-28</a>, <a href="cope.cgi?key=gelatin%2dbinding%20protein%20of%2028%20kDa">gelatin-binding protein of 28 kDa</a>, <a href="cope.cgi?key=adipocyte%20complement%20related%20protein%20of%2030%20kDa">adipocyte complement related protein of 30 kDa</a>, <a href="cope.cgi?key=Acrp30">Acrp30</a>, <a href="cope.cgi?key=30%20kDa%20adipocyte%20complement%2drelated%20protein">30 kDa adipocyte complement-related protein</a>, <a href="cope.cgi?key=adipocyte%2dspecific%20secretory%20protein">adipocyte-specific secretory protein</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Okamoto et al, 2008; Zacharioudaki et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Adiponectin">adiponectin</a></b> (<a href="cope.cgi?key=Adpn">Adpn</a>, <a href="cope.cgi?key=Apn">Apn</a>, <a href="cope.cgi?key=ACDC">ACDC</a>, <a href="cope.cgi?key=adiponectin%2c%20C1q%20and%20collagen%20domain%20containing">adiponectin, C1q and collagen domain containing</a>, <a href="cope.cgi?key=ADIPOQ">ADIPOQ</a>, <a href="cope.cgi?key=apM1">apM1</a>, <a href="cope.cgi?key=adipose%20Most%20abundant%20gene%20transcript%2d1">adipose Most abundant gene transcript-1</a>, <a href="cope.cgi?key=GBP%2d28">GBP-28</a>, <a href="cope.cgi?key=gelatin%2dbinding%20protein%20of%2028%20kDa">gelatin-binding protein of 28 kDa</a>, <a href="cope.cgi?key=adipocyte%20complement%20related%20protein%20of%2030%20kDa">adipocyte complement related protein of 30 kDa</a>, <a href="cope.cgi?key=Acrp30">Acrp30</a>, <a href="cope.cgi?key=30%20kDa%20adipocyte%20complement%2drelated%20protein">30 kDa adipocyte complement-related protein</a>, <a href="cope.cgi?key=adipocyte%2dspecific%20secretory%20protein">adipocyte-specific secretory protein</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=ADIPOR1">ADIPOR1</a>, <a href="cope.cgi?key=adiponectin%20receptor%201">adiponectin receptor 1</a>, <a href="cope.cgi?key=PAQR1">PAQR1</a>, <a href="cope.cgi?key=progestin%20and%20adipoQ%20receptor%20family%20member%201">progestin and adipoQ receptor family member 1</a>, <a href="cope.cgi?key=ACDCR1">ACDCR1</a>, <a href="cope.cgi?key=TESBP1A">TESBP1A</a>, <a href="cope.cgi?key=CGI%2d45">CGI-45</a>, <a href="cope.cgi?key=AURA43">AURA43</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2043">augmented in rheumatoid arthritis 43</a>) (Awazawa et al, 2011; Chinetti et al, 2004; Li W et al, 2007; Suzuki M and Mihara M, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Adiponectin">adiponectin</a></b> (<a href="cope.cgi?key=Adpn">Adpn</a>, <a href="cope.cgi?key=Apn">Apn</a>, <a href="cope.cgi?key=ACDC">ACDC</a>, <a href="cope.cgi?key=adiponectin%2c%20C1q%20and%20collagen%20domain%20containing">adiponectin, C1q and collagen domain containing</a>, <a href="cope.cgi?key=ADIPOQ">ADIPOQ</a>, <a href="cope.cgi?key=apM1">apM1</a>, <a href="cope.cgi?key=adipose%20Most%20abundant%20gene%20transcript%2d1">adipose Most abundant gene transcript-1</a>, <a href="cope.cgi?key=GBP%2d28">GBP-28</a>, <a href="cope.cgi?key=gelatin%2dbinding%20protein%20of%2028%20kDa">gelatin-binding protein of 28 kDa</a>, <a href="cope.cgi?key=adipocyte%20complement%20related%20protein%20of%2030%20kDa">adipocyte complement related protein of 30 kDa</a>, <a href="cope.cgi?key=Acrp30">Acrp30</a>, <a href="cope.cgi?key=30%20kDa%20adipocyte%20complement%2drelated%20protein">30 kDa adipocyte complement-related protein</a>, <a href="cope.cgi?key=adipocyte%2dspecific%20secretory%20protein">adipocyte-specific secretory protein</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=ADIPOR2">ADIPOR2</a>, <a href="cope.cgi?key=adiponectin%20receptor%202">adiponectin receptor 2</a>, <a href="cope.cgi?key=PAQR2">PAQR2</a>, <a href="cope.cgi?key=progestin%20and%20adipoQ%20receptor%20family%20member%202">progestin and adipoQ receptor family member 2</a>, <a href="cope.cgi?key=ACDCR2">ACDCR2</a>) (Awazawa et al, 2011; Chinetti et al, 2004; Li W et al, 2007; Folco et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ADNP">ADNP</a></b> (<a href="cope.cgi?key=activity%2ddependent%20neuroprotective%20protein">activity-dependent neuroprotective protein</a>, <a href="cope.cgi?key=activity%2ddependent%20neuroprotector">activity-dependent neuroprotector</a>; <a href="cope.cgi?key=activity%2ddependent%20neuroprotector">activity-dependent neuroprotector</a> homeobox, <a href="cope.cgi?key=ADNP1">ADNP1</a>, <a href="cope.cgi?key=activity%2ddependent%20neuroprotective%20protein%201">activity-dependent neuroprotective protein 1</a>, <a href="cope.cgi?key=KIAA0784">KIAA0784</a>) (Quintana et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Adrenomedullin">Adrenomedullin</a></b> (<a href="cope.cgi?key=ADM">ADM</a>, <a href="cope.cgi?key=AM">AM</a>) (Cejudo-Martin et al, 2002; Zaks-Zilberman et al, 1998; Kubo et al, 1998; Nakayama et al, 1999; Ishikawa et al, 2004; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=aFGF">aFGF</a></b> (<a href="cope.cgi?key=Acidic%20fibroblast%20growth%20factor">acidic fibroblast growth factor</a>, <a href="cope.cgi?key=FGF%20acidic">FGF acidic</a>, <a href="cope.cgi?key=FGF%2d1">FGF-1</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2d1">Fibroblast growth factor-1</a>, <a href="cope.cgi?key=FGF%2dalpha">FGF-alpha</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2dalpha">Fibroblast growth factor-alpha</a>, <a href="cope.cgi?key=HBGF%2d1">HBGF-1</a>, <a href="cope.cgi?key=Heparin%20binding%20growth%20factor%2d1">heparin binding growth factor-1</a>, <a href="cope.cgi?key=ECGF%2dalpha">ECGF-alpha</a>, <a href="cope.cgi?key=Endothelial%20cell%20growth%20factor%2dalpha">Endothelial cell growth factor-alpha</a>, <a href="cope.cgi?key=ECGF%2dbeta">ECGF-beta</a>, <a href="cope.cgi?key=Endothelial%20cell%20growth%20factor%2dbeta">Endothelial cell growth factor-beta</a>) (Brogi et al, 1993; Hackshaw and Shi, 1994; Kuwabara et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=aFGF">aFGF</a></b> (<a href="cope.cgi?key=Acidic%20fibroblast%20growth%20factor">acidic fibroblast growth factor</a>, <a href="cope.cgi?key=FGF%20acidic">FGF acidic</a>, <a href="cope.cgi?key=FGF%2d1">FGF-1</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2d1">Fibroblast growth factor-1</a>, <a href="cope.cgi?key=FGF%2dalpha">FGF-alpha</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2dalpha">Fibroblast growth factor-alpha</a>, <a href="cope.cgi?key=HBGF%2d1">HBGF-1</a>, <a href="cope.cgi?key=Heparin%20binding%20growth%20factor%2d1">heparin binding growth factor-1</a>, <a href="cope.cgi?key=ECGF%2dalpha">ECGF-alpha</a>, <a href="cope.cgi?key=Endothelial%20cell%20growth%20factor%2dalpha">Endothelial cell growth factor-alpha</a>, <a href="cope.cgi?key=ECGF%2dbeta">ECGF-beta</a>, <a href="cope.cgi?key=Endothelial%20cell%20growth%20factor%2dbeta">Endothelial cell growth factor-beta</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Brogi et al, 1993; Ichinose et al, 1998; Hackshaw and Shi, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=AIF%2d1">AIF-1</a></b> (<a href="cope.cgi?key=Allograft%20inflammatory%20factor%2d1">Allograft inflammatory factor-1</a>, <a href="cope.cgi?key=daintain">daintain</a>, <a href="cope.cgi?key=MRF%2d1">MRF-1</a>, <a href="cope.cgi?key=microglial%20response%20factor%2d1">microglial response factor-1</a>, <a href="cope.cgi?key=IBA%2d1">IBA-1</a>, <a href="cope.cgi?key=ionized%20calcium%20binding%20adaptor%20molecule%2d1">ionized calcium binding adaptor molecule-1</a>, <a href="cope.cgi?key=IRT%2d1">IRT-1</a>, <a href="cope.cgi?key=interferon%20response%20transcript%201">interferon response transcript 1</a>) (Utans et al, 1995; Watano et al, 2001; Sibinga et al, 2002; Utans et al, 1996; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=AIM2">AIM2</a></b> (<a href="cope.cgi?key=absent%20in%20melanoma%202">absent in melanoma 2</a>, <a href="cope.cgi?key=PYHIN4">PYHIN4</a>, <a href="cope.cgi?key=Ifi210">Ifi210</a>, <a href="cope.cgi?key=Interferon%2dinducible%20protein%20210">Interferon-inducible protein 210</a>) (Rae et al, 2011; Sauer et al, 2010; Tsuchiya et al, 2010; Ulland et al, 2010; Wu J et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ALK2">ALK2</a></b> (<a href="cope.cgi?key=Activin%20receptor%2dlike%20kinase%202">Activin receptor-like kinase 2</a>) (Hong et al, 2009; Lee GT et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ALK3">ALK3</a></b> (<a href="cope.cgi?key=Activin%20receptor%2dlike%20kinase%203">Activin receptor-like kinase 3</a>, <a href="cope.cgi?key=BMPR1A">BMPR1A</a>, <a href="cope.cgi?key=bone%20morphogenetic%20protein%20receptor%20type%20IA">bone morphogenetic protein receptor type IA</a>, <a href="cope.cgi?key=CD292">CD292</a>) (Hong et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Alpha%2d1%2dacid%20glycoprotein%201">Alpha-1-acid glycoprotein 1</a></b> (<a href="cope.cgi?key=orosomucoid">orosomucoid</a>, <a href="cope.cgi?key=orosomucoid%201">orosomucoid 1</a>, <a href="cope.cgi?key=orosomucoid%202">orosomucoid 2</a>, <a href="cope.cgi?key=ORM">ORM</a>, <a href="cope.cgi?key=ORM1">ORM1</a>, <a href="cope.cgi?key=ORM2">ORM2</a>, <a href="cope.cgi?key=ORM1%2aF1">ORM1*F1</a>, <a href="cope.cgi?key=ORM1%2aF2">ORM1*F2</a>, <a href="cope.cgi?key=ORM1%2aS">ORM1*S</a>, <a href="cope.cgi?key=alpha%2d1%2dAGP">alpha-1-AGP</a>, <a href="cope.cgi?key=alpha%2d1%2dAGP%201">alpha-1-AGP 1</a>, <a href="cope.cgi?key=alpha%2d1%2dAGP%202">alpha-1-AGP 2</a>, <a href="cope.cgi?key=AGP">AGP</a>, <a href="cope.cgi?key=AGP1">AGP1</a>, <a href="cope.cgi?key=AGP2">AGP2</a>, <a href="cope.cgi?key=Alpha%2d1%2dacid%20glycoprotein">Alpha-1-acid glycoprotein</a>, <a href="cope.cgi?key=Alpha%2d1%2dacid%20glycoprotein%202">Alpha-1-acid glycoprotein 2</a>, <a href="cope.cgi?key=AGP%2dA">AGP-A</a>, <a href="cope.cgi?key=AGP%2dB">AGP-B</a>, <a href="cope.cgi?key=AGP%2dB%2dprime">AGP-B-prime</a>) (Fournier et al, 1999; Martinez Cordero et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Alpha%2d1%2dacid%20glycoprotein%201">Alpha-1-acid glycoprotein 1</a></b> (<a href="cope.cgi?key=orosomucoid">orosomucoid</a>, <a href="cope.cgi?key=orosomucoid%201">orosomucoid 1</a>, <a href="cope.cgi?key=orosomucoid%202">orosomucoid 2</a>, <a href="cope.cgi?key=ORM">ORM</a>, <a href="cope.cgi?key=ORM1">ORM1</a>, <a href="cope.cgi?key=ORM2">ORM2</a>, <a href="cope.cgi?key=ORM1%2aF1">ORM1*F1</a>, <a href="cope.cgi?key=ORM1%2aF2">ORM1*F2</a>, <a href="cope.cgi?key=ORM1%2aS">ORM1*S</a>, <a href="cope.cgi?key=alpha%2d1%2dAGP">alpha-1-AGP</a>, <a href="cope.cgi?key=alpha%2d1%2dAGP%201">alpha-1-AGP 1</a>, <a href="cope.cgi?key=alpha%2d1%2dAGP%202">alpha-1-AGP 2</a>, <a href="cope.cgi?key=AGP">AGP</a>, <a href="cope.cgi?key=AGP1">AGP1</a>, <a href="cope.cgi?key=AGP2">AGP2</a>, <a href="cope.cgi?key=Alpha%2d1%2dacid%20glycoprotein">Alpha-1-acid glycoprotein</a>, <a href="cope.cgi?key=Alpha%2d1%2dacid%20glycoprotein%202">Alpha-1-acid glycoprotein 2</a>, <a href="cope.cgi?key=AGP%2dA">AGP-A</a>, <a href="cope.cgi?key=AGP%2dB">AGP-B</a>, <a href="cope.cgi?key=AGP%2dB%2dprime">AGP-B-prime</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Carpentier V et al, 1993)<b style="mso-bidi-font-weight: normal"><br/> ¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Alpha%2d2%2dMacroglobulin">Alpha-2-Macroglobulin</a></b> (<a href="cope.cgi?key=Alpha%2d2MG">Alpha-2MG</a>, <a href="cope.cgi?key=Alpha%2d2M">Alpha-2M</a>, <a href="cope.cgi?key=A2M">A2M</a>) (Hussaini et al, 1990; Hovi et al, 1977; White et al, 1980; Gustafsson et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Alpha%2d2%2dMacroglobulin">Alpha-2-Macroglobulin</a></b> (<a href="cope.cgi?key=Alpha%2d2MG">Alpha-2MG</a>, <a href="cope.cgi?key=Alpha%2d2M">Alpha-2M</a>, <a href="cope.cgi?key=A2M">A2M</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=CD91">CD91</a>, <a href="cope.cgi?key=A2MR">A2MR</a>, <a href="cope.cgi?key=APOER">APOER</a>, <a href="cope.cgi?key=apolipoprotein%20E%20receptor">apolipoprotein E receptor</a>, <a href="cope.cgi?key=APR">APR</a>, <a href="cope.cgi?key=apolipoprotein%20receptor">apolipoprotein receptor</a>, <a href="cope.cgi?key=CED1">CED1</a>, <a href="cope.cgi?key=LRP">LRP</a>, <a href="cope.cgi?key=Low%20density%20lipoprotein%20receptor%2drelated%20protein">Low density lipoprotein receptor-related protein</a>, <a href="cope.cgi?key=LRP1">LRP1</a>, <a href="cope.cgi?key=lipoprotein%20receptor%2drelated%20protein">lipoprotein receptor-related protein</a>) (Misra and Pizzo, 1996; Lupu et al, 1994; Zheng et al, 1994; Bonner, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Alpha%2dMSH">alpha-MSH</a> </b>(<a href="cope.cgi?key=Melanocyte%20stimulating%20hormone%2dalpha">melanocyte stimulating hormone-alpha</a>, <a href="cope.cgi?key=Alpha%2dmelanotropin">alpha-melanotropin</a>, <a href="cope.cgi?key=Alpha%2dmelanocortin">alpha-melanocortin</a>, <a href="cope.cgi?key=Melanotropin">melanotropin</a>, <a href="cope.cgi?key=POMC">POMC</a>, <a href="cope.cgi?key=Proopiomelanocortin">proopiomelanocortin</a>) (Rajora et al, 1996; Star et al, 1995; Li et al, 1993; Taherzadeh et al, 1999; Luger et al, 2000, 2003; Neumann Andersen et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Alpha%2dMSH">alpha-MSH</a> </b>(<a href="cope.cgi?key=Melanocyte%20stimulating%20hormone%2dalpha">melanocyte stimulating hormone-alpha</a>, <a href="cope.cgi?key=Alpha%2dmelanotropin">alpha-melanotropin</a>, <a href="cope.cgi?key=Alpha%2dmelanocortin">alpha-melanocortin</a>, <a href="cope.cgi?key=Melanotropin">melanotropin</a>, <a href="cope.cgi?key=POMC">POMC</a>, <a href="cope.cgi?key=Proopiomelanocortin">proopiomelanocortin</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Star et al, 1995; Gupta et al, 2000; Taherzadeh et al, 1999; Luger et al, 2000, 2003; Sarkar et al, 2003; Neumann Andersen et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Amelogenin">Amelogenin</a></b> (<a href="cope.cgi?key=AMGY">AMGY</a>, <a href="cope.cgi?key=AMELY">AMELY</a>; <a href="cope.cgi?key=amelogenin%20Y">amelogenin Y</a>; <a href="cope.cgi?key=AMGX">AMGX</a>, <a href="cope.cgi?key=AMELX">AMELX</a>; <a href="cope.cgi?key=amelogenin%20X">amelogenin X</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Almqvist S et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Amphiregulin">amphiregulin</a></b> (<a href="cope.cgi?key=AR">AR</a>, <a href="cope.cgi?key=AMR">AMR</a>, <a href="cope.cgi?key=AREG">AREG</a>, <a href="cope.cgi?key=CRDGF">CRDGF</a>, <a href="cope.cgi?key=Colorectum%20cell%2dderived%20growth%20factor">colorectum cell-derived growth factor</a>, <a href="cope.cgi?key=KAF">KAF</a>, <a href="cope.cgi?key=Keratinocyte%2dderived%20autocrine%20factor">keratinocyte-derived autocrine factor</a>, <a href="cope.cgi?key=SDGF">SDGF</a>, <a href="cope.cgi?key=Schwannoma%2dderived%20growth%20factor">schwannoma-derived growth factor</a>, <a href="cope.cgi?key=AURA9">AURA9</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%209">augmented in rheumatoid arthritis 9</a>) (Oshima et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=AMWAP">AMWAP</a></b> (<a href="cope.cgi?key=activated%20microglia%2fmacrophage%20WAP%20domain%20protein">activated microglia/macrophage WAP domain protein</a>) (Karlstetter et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=amyloid%20P%20component">amyloid P component</a> </b>(<a href="cope.cgi?key=P%2dcomponent">P-component</a>, <a href="cope.cgi?key=9%2e5S%20alpha%2d1%2dglycoprotein">9.5S alpha-1-glycoprotein</a>, <a href="cope.cgi?key=APCS">APCS</a>, <a href="cope.cgi?key=serum%20amyloid%20P%20component">serum amyloid P component</a>; <a href="cope.cgi?key=amyloid%20P%20component%2c%20serum">amyloid P component, serum</a>, <a href="cope.cgi?key=SAP">SAP</a>, <a href="cope.cgi?key=serum%20amyloid%20P">Serum amyloid P</a>, <a href="cope.cgi?key=PTX2">PTX2</a>, <a href="cope.cgi?key=pentraxin%2d2">pentraxin-2</a>, <a href="cope.cgi?key=PRM%2d151">PRM-151</a>) (Song Z et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=ANF">ANF</a></b> (<a href="cope.cgi?key=Atrial%20natriuretic%20factor">Atrial natriuretic factor</a>, <a href="cope.cgi?key=natriuretic%20peptides">natriuretic peptide</a>, <a href="cope.cgi?key=Atrionatriuretic%20factor">atrionatriuretic factor</a>, <a href="cope.cgi?key=Alpha%2dANP">Alpha-ANP</a>, <a href="cope.cgi?key=Atrial%20natriuretic%20polypeptide">Atrial natriuretic polypeptide</a>, <a href="cope.cgi?key=ANP">ANP</a>, <a href="cope.cgi?key=Atrial%20polypeptide">Atrial polypeptide</a>, <a href="cope.cgi?key=Atriopeptin">Atriopeptin</a>, <a href="cope.cgi?key=Cardionatrin">cardionatrin</a>, <a href="cope.cgi?key=Cardionatrin%20I">cardionatrin I</a>, <a href="cope.cgi?key=NPPA">NPPA</a>)<b style="mso-bidi-font-weight: normal"> </b>(Throsby et al, 1994; Kiemer and Vollmar, 2001; Vollmar et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=ANF">ANF</a></b> (<a href="cope.cgi?key=Atrial%20natriuretic%20factor">Atrial natriuretic factor</a>, <a href="cope.cgi?key=natriuretic%20peptides">natriuretic peptide</a>, <a href="cope.cgi?key=Atrionatriuretic%20factor">atrionatriuretic factor</a>, <a href="cope.cgi?key=Alpha%2dANP">Alpha-ANP</a>, <a href="cope.cgi?key=Atrial%20natriuretic%20polypeptide">Atrial natriuretic polypeptide</a>, <a href="cope.cgi?key=ANP">ANP</a>, <a href="cope.cgi?key=Atrial%20polypeptide">Atrial polypeptide</a>, <a href="cope.cgi?key=Atriopeptin">Atriopeptin</a>, <a href="cope.cgi?key=Cardionatrin">cardionatrin</a>, <a href="cope.cgi?key=Cardionatrin%20I">cardionatrin I</a>, <a href="cope.cgi?key=NPPA">NPPA</a>)<b style="mso-bidi-font-weight: normal"> receptors </b>(Kiemer and Vollmar, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiopoietin%2d1">angiopoietin-1</a></b> (<a href="cope.cgi?key=Ang%2d1">Ang-1</a>, <a href="cope.cgi?key=ANGPT1">ANGPT1</a>, <a href="cope.cgi?key=KIAA0003">KIAA0003</a>) (Dagtekin et al, 2003; Nourhaghighi et al, 2003; Dagtekin et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiopoietin%2d2">angiopoietin-2</a></b> (<a href="cope.cgi?key=Ang%2d2">Ang-2</a>, <a href="cope.cgi?key=ANGPT2">ANGPT2</a>) (Nourhaghighi et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=angiopoietin%2dlike%2d4">angiopoietin-like-4</a></b> (<a href="cope.cgi?key=ANGPTL4">ANGPTL4</a>, <a href="cope.cgi?key=ARP%2d4">ARP-4</a>, <a href="cope.cgi?key=Angiopoietin%2drelated%20protein%2d4">angiopoietin-related protein-4</a>, <a href="cope.cgi?key=FIAF">FIAF</a>, <a href="cope.cgi?key=fasting%20induced%20adipose%20factor">fasting induced adipose factor</a>, <a href="cope.cgi?key=HFARP">HFARP</a>, <a href="cope.cgi?key=hepatic%20fibrinogen%2fangiopoietin%2drelated%20protein">hepatic fibrinogen/angiopoietin-related protein</a>, <a href="cope.cgi?key=PGAR">PGAR</a>, <a href="cope.cgi?key=peroxisome%20proliferator%2dactivated%20receptor%2dgamma%2drelated%20protein">peroxisome proliferator-activated receptor-gamma-related protein</a>) (Feingold KR et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiostatin">angiostatin</a> </b>(<a href="cope.cgi?key=Angiostatin%20K1%2d4">Angiostatin K1-4</a>, <a href="cope.cgi?key=plasminogen%20kringles%201%2d4">plasminogen kringles 1-4</a>, <a href="cope.cgi?key=PK1%2d4">PK1-4</a>, <a href="cope.cgi?key=PlgK1%2d4">PlgK1-4</a>, <a href="cope.cgi?key=AST%2d1">AST-1</a>, <a href="cope.cgi?key=angiostatin%2d1">angiostatin-1</a>, <a href="cope.cgi?key=AST%2d2">AST-2</a>, <a href="cope.cgi?key=angiostatin%2d2">angiostatin-2</a>) (Falcone et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Angiostatin">angiostatin</a> </b>(<a href="cope.cgi?key=Angiostatin%20K1%2d4">Angiostatin K1-4</a>, <a href="cope.cgi?key=plasminogen%20kringles%201%2d4">plasminogen kringles 1-4</a>, <a href="cope.cgi?key=PK1%2d4">PK1-4</a>, <a href="cope.cgi?key=PlgK1%2d4">PlgK1-4</a>, <a href="cope.cgi?key=AST%2d1">AST-1</a>, <a href="cope.cgi?key=angiostatin%2d1">angiostatin-1</a>, <a href="cope.cgi?key=AST%2d2">AST-2</a>, <a href="cope.cgi?key=angiostatin%2d2">angiostatin-2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Albini et al, 2009; Perri et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiotensin%2d1">angiotensin-1</a> </b>(<a href="cope.cgi?key=Angiotensin">angiotensin</a>) (Dezso et al, 1989; Weinstock and Blum, 1987)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiotensin%2d2">angiotensin-2</a> </b>(Okamura et al, 1998; Potter et al, 1998; Weinstock and Blum, 1987; Dezso et al, 1989)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiotensin%2d2">angiotensin-2</a> receptors</b> (Keidar et al, 2002; Yanagitani et al, 1999; Scheidegger et al, 1997; Thomas and Hoffman, 1984; Keidar et al, 1996; Simon et al, 1989)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiotensin%2d3">angiotensin-3</a></b> (<a href="cope.cgi?key=angiotensin%282%2d8%29">angiotensin(2-8)</a>, <a href="cope.cgi?key=Ang%282%2d8%29">Ang(2-8)</a>) (Dezso et al, 1989; Weinstock and Blum, 1985)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Angiotropin">Angiotropin</a></b> (<a href="cope.cgi?key=MAT">MAT</a>, <a href="cope.cgi?key=Monocyto%2dAngiotropin">Monocyto-Angiotropin</a>, <a href="cope.cgi?key=monocyte%2dderived%20angiogenic%20substance">monocyte-derived angiogenic substance</a>) (Hockel et al, 1987, 1988)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Annexin%2d1">Annexin-1</a> </b>(<a href="cope.cgi?key=Annexin%20A1">Annexin A1</a>, <a href="cope.cgi?key=ANX1">ANX1</a>, <a href="cope.cgi?key=ANXA1">ANXA1</a>, <a href="cope.cgi?key=lipocortin%2d1">lipocortin-1</a>, <a href="cope.cgi?key=LPC1">LPC1</a>, <a href="cope.cgi?key=LCT1">LCT1</a>, <a href="cope.cgi?key=LC1">LC1</a>, <a href="cope.cgi?key=Lipo1">Lipo1</a>, <a href="cope.cgi?key=macrocortin">macrocortin</a>, <a href="cope.cgi?key=renocortin">renocortin</a>, <a href="cope.cgi?key=lipomodulin">lipomodulin</a>, <a href="cope.cgi?key=GIF">GIF</a>, <a href="cope.cgi?key=Glycosylation%20inhibiting%20factor">glycosylation inhibiting factor</a>, <a href="cope.cgi?key=CB9">CB9</a>, <a href="cope.cgi?key=chromobindin%2d9">chromobindin-9</a>, <a href="cope.cgi?key=calpactin%2d2">calpactin-2</a>) (De Caterina et al, 1993; Dreier et al, 1998; Elderfield et al, 1993; Fan et al, 2004; Gold et al, 1999; Hall et al, 1999; Huitinga et al, 1998; Mayran et al, 1996; Mikuniya et al, 1998; Peters-Golden et al, 1984; Probst-Cousin et al, 2004; Sakata et al, 1992; Solito et al, 1993)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Annexin%2d1">Annexin-1</a> </b>(<a href="cope.cgi?key=Annexin%20A1">Annexin A1</a>, <a href="cope.cgi?key=ANX1">ANX1</a>, <a href="cope.cgi?key=ANXA1">ANXA1</a>, <a href="cope.cgi?key=lipocortin%2d1">lipocortin-1</a>, <a href="cope.cgi?key=LPC1">LPC1</a>, <a href="cope.cgi?key=LCT1">LCT1</a>, <a href="cope.cgi?key=LC1">LC1</a>, <a href="cope.cgi?key=Lipo1">Lipo1</a>, <a href="cope.cgi?key=macrocortin">macrocortin</a>, <a href="cope.cgi?key=renocortin">renocortin</a>, <a href="cope.cgi?key=lipomodulin">lipomodulin</a>, <a href="cope.cgi?key=GIF">GIF</a>, <a href="cope.cgi?key=Glycosylation%20inhibiting%20factor">glycosylation inhibiting factor</a>, <a href="cope.cgi?key=CB9">CB9</a>, <a href="cope.cgi?key=chromobindin%2d9">chromobindin-9</a>, <a href="cope.cgi?key=calpactin%2d2">calpactin-2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Ferlazzo et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Annexin%2d2">Annexin-2</a></b> (<a href="cope.cgi?key=Annexin%20A2">Annexin A2</a>, <a href="cope.cgi?key=ANX2">ANX2</a>, <a href="cope.cgi?key=ANXA2">ANXA2</a>, <a href="cope.cgi?key=PAP%2d4">PAP-4</a>, <a href="cope.cgi?key=placental%20anticoagulant%20protein%204">placental anticoagulant protein 4</a>, <a href="cope.cgi?key=Lipocortin%2d2">Lipocortin-2</a>, <a href="cope.cgi?key=Endonexin%2d2">Endonexin-2</a>, <a href="cope.cgi?key=Calpactin%2d1">Calpactin-1</a>) (Fan et al, 2004; Probst-Cousin et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Annexin%2d2">Annexin-2</a></b> (<a href="cope.cgi?key=Annexin%20A2">Annexin A2</a>, <a href="cope.cgi?key=ANX2">ANX2</a>, <a href="cope.cgi?key=ANXA2">ANXA2</a>, <a href="cope.cgi?key=PAP%2d4">PAP-4</a>, <a href="cope.cgi?key=placental%20anticoagulant%20protein%204">placental anticoagulant protein 4</a>, <a href="cope.cgi?key=Lipocortin%2d2">Lipocortin-2</a>, <a href="cope.cgi?key=Endonexin%2d2">Endonexin-2</a>, <a href="cope.cgi?key=Calpactin%2d1">Calpactin-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Swisher JF et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Annexin%2d5">Annexin-5</a></b> (<a href="cope.cgi?key=Annexin%20A5">Annexin A5</a>, <a href="cope.cgi?key=ANX5">ANX5</a>, <a href="cope.cgi?key=ANXA5">ANXA5</a>, <a href="cope.cgi?key=35%20kDa%20Calelectrin">35 kDa Calelectrin</a>, <a href="cope.cgi?key=35%2dgamma%20Calcimedin">35-gamma Calcimedin</a>, <a href="cope.cgi?key=Anchorin%20C2">Anchorin C2</a>, <a href="cope.cgi?key=PAP%2d1">PAP-1</a>, <a href="cope.cgi?key=placental%20anticoagulant%20protein%2d1">placental anticoagulant protein-1</a>, <a href="cope.cgi?key=CBP%2dI">CBP-I</a>, <a href="cope.cgi?key=Calphobindin%2d1">Calphobindin-1</a>, <a href="cope.cgi?key=CBP">CBP</a>, <a href="cope.cgi?key=Calphobindin">calphobindin</a>, <a href="cope.cgi?key=Endonexin%2d2">Endonexin-2</a>, <a href="cope.cgi?key=ENX2">ENX2</a>, <a href="cope.cgi?key=Lipocortin%20V">Lipocortin V</a>, <a href="cope.cgi?key=Lipocortin%2d5">Lipocortin-5</a>, <a href="cope.cgi?key=VAC%2dalpha">VAC-alpha</a>, <a href="cope.cgi?key=vascular%20anticoagulant%2dalpha">vascular anticoagulant-alpha</a>, <a href="cope.cgi?key=chromobindin%2d4">chromobindin-4</a>, <a href="cope.cgi?key=32%20kDa%20calcimedin">32 kDa calcimedin</a>, <a href="cope.cgi?key=EEP%2032%2d2">EEP 32-2</a>, <a href="cope.cgi?key=PP4">PP4</a>, <a href="cope.cgi?key=placental%20protein%2d4">placental protein-4</a>,<b style="mso-bidi-font-weight:normal"> </b><a href="cope.cgi?key=CaBP33">CaBP33</a>, <a href="cope.cgi?key=calcium%20binding%20protein%2033%20kDa">calcium binding protein 33 kDa</a>, <a href="cope.cgi?key=CaBP37">CaBP37</a>, <a href="cope.cgi?key=calcium%20binding%20protein%2037%20kDa">calcium binding protein 37 kDa</a>) (Probst-Cousin et al, 2004)<b style="mso-bidi-font-weight:normal"><br/> </b><b style="mso-bidi-font-weight:normal">¥¥ <a href="cope.cgi?key=Apelin">Apelin</a></b> (<a href="cope.cgi?key=APJ%20receptor%20ligand">APJ receptor ligand</a>, <a href="cope.cgi?key=APJ%20endogenous%20ligand">APJ endogenous ligand</a>, <a href="cope.cgi?key=APLN">APLN</a>, <a href="cope.cgi?key=APEL">APEL</a>, <a href="cope.cgi?key=Apelin%20%2842%2d77%29">Apelin (42-77)</a>, <a href="cope.cgi?key=Apelin%2d36">Apelin-36</a>, <a href="cope.cgi?key=Apelin%20%2865%2d77%29">Apelin (65-77)</a>, <a href="cope.cgi?key=Apelin%2d13">Apelin-13</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=APJ">APJ</a>, <a href="cope.cgi?key=APLNR">APLNR</a>, <a href="cope.cgi?key=APJR">APJR</a>, <a href="cope.cgi?key=Angiotensin%20Receptor%2dlike%2d1">Angiotensin Receptor-like-1</a>, <a href="cope.cgi?key=AGTRL1">AGTRL1</a>, <a href="cope.cgi?key=B78%2fapj">B78/apj</a>, <a href="cope.cgi?key=X%2dmsr">X-msr</a>, <a href="cope.cgi?key=msr%2fAPJ">msr/APJ</a>, <a href="cope.cgi?key=GPR15">GPR15</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d15">G-protein-coupled receptor-15</a>, <a href="cope.cgi?key=BOB">BOB</a>; <a href="cope.cgi?key=HG11">HG11</a>) (Leeper NJ et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=APOL1">APOL1</a></b> (<a href="cope.cgi?key=apolipoprotein%20L1">apolipoprotein L1</a>, <a href="cope.cgi?key=FSGS4">FSGS4</a>, <a href="cope.cgi?key=focal%20segmental%20glomerulosclerosis%2d4">focal segmental glomerulosclerosis-4</a>, <a href="cope.cgi?key=TLF1">TLF1</a>, <a href="cope.cgi?key=trypanosome%20lytic%20factor%201">trypanosome lytic factor 1</a>) (Martinez et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=APOL6">APOL6</a></b> (<a href="cope.cgi?key=apolipoprotein%20L6">apolipoprotein L6</a>, <a href="cope.cgi?key=APOL%2dVI">APOL-VI</a>, <a href="cope.cgi?key=apolipoprotein%20L%2dVI">apolipoprotein L-VI</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=APRIL">APRIL</a></b> (<a href="cope.cgi?key=TRDL%2d1%2dalpha">TRDL-1-alpha</a>, <a href="cope.cgi?key=TRDL%2d1%2dbeta">TRDL-1-beta</a>, <a href="cope.cgi?key=TRDL%2d1%2dgamma">TRDL-1-gamma</a>, <a href="cope.cgi?key=TNF%2drelated%20death%20ligand%2d1%2dalpha">TNF-related death ligand-1-alpha</a>, <a href="cope.cgi?key=TNFSF13">TNFSF13</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2013">TNF ligand superfamily member 13</a>, <a href="cope.cgi?key=TALL%2d2">TALL-2</a>, <a href="cope.cgi?key=TNF%20and%20ApoL%20related%20leukocyte%20expressed%20ligand%2d2">TNF and ApoL related leukocyte expressed ligand-2</a>, <a href="cope.cgi?key=CD256">CD256</a>) (Craxton A et al, 2003; Lee SM et al, 2010; Thangarajh M et al, 2006; Jang YS et al, 2009, 2011; Lee HJ et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Attractin">Attractin</a></b> (<a href="cope.cgi?key=ATRN">ATRN</a>, <a href="cope.cgi?key=mahogany">mahogany</a>, <a href="cope.cgi?key=Mgca">Mgca</a>, <a href="cope.cgi?key=Mg">Mg</a>, <a href="cope.cgi?key=zitter">zitter</a>, <a href="cope.cgi?key=zi">zi</a>, <a href="cope.cgi?key=black%20tremor">black tremor</a>, <a href="cope.cgi?key=bt">bt</a>, <a href="cope.cgi?key=myelin%20vacuolation">myelin vacuolation</a>, <a href="cope.cgi?key=mv">mv</a>, <a href="cope.cgi?key=DPPT%2dL">DPPT-L</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Duke-Cohan et al, 1998, 2000)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=B7%2dH3">B7-H3</a></b> (<a href="cope.cgi?key=B7%20homolog%2d3">B7 homolog-3</a>, <a href="cope.cgi?key=B7RP%2d2">B7RP-2</a>, <a href="cope.cgi?key=B7%2drelated%20protein%202">B7-related protein 2</a>, <a href="cope.cgi?key=B7%2dH3b">B7-H3b</a>, <a href="cope.cgi?key=2IgB7%2dH3">2IgB7-H3</a>, <a href="cope.cgi?key=4IgB7%2dH3">4IgB7-H3</a>, <a href="cope.cgi?key=CD276">CD276</a>) (Petroff et al, 2005; Chen C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=bactericidal%2fpermeability%2dincreasing%20protein">Bactericidal/permeability-increasing protein</a></b> (<a href="cope.cgi?key=BPI">BPI</a>, <a href="cope.cgi?key=CAP57">CAP57</a>, <a href="cope.cgi?key=cationic%20antimicrobial%20protein%2057">cationic antimicrobial protein 57</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Wittmann et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BAFF%2dR">BAFF-R</a></b> (<a href="cope.cgi?key=BAFF%20receptor">BAFF receptor</a>, <a href="cope.cgi?key=BR3">BR3</a>, <a href="cope.cgi?key=BLyS%20receptor%203">BLyS receptor 3</a>, <a href="cope.cgi?key=BAFF%20receptor%203">BAFF receptor 3</a>, <a href="cope.cgi?key=BLySR3">BLySR3</a>, <a href="cope.cgi?key=TNFRSF13C">TNFRSF13C</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2013C">TNF receptor superfamily member 13C</a>, <a href="cope.cgi?key=CD268">CD268</a>, <a href="cope.cgi?key=Bcmd">Bcmd</a>, <a href="cope.cgi?key=B%2dcell%20maturation%20defect">B-cell maturation defect</a>, <a href="cope.cgi?key=Bcmd%2d1">Bcmd-1</a>, <a href="cope.cgi?key=B%2dcell%20maturation%20defect%2d1">B-cell maturation defect-1</a>, <a href="cope.cgi?key=Bcmd%2fBR3">Bcmd/BR3</a>) (Jeon ST et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BAI%2d1">BAI-1</a></b> (<a href="cope.cgi?key=brain%2dspecific%20angiogenesis%20inhibitor%2d1">brain-specific angiogenesis inhibitor-1</a>, <a href="cope.cgi?key=GD%2dAIF">GD-AIF</a>, <a href="cope.cgi?key=glioma%2dderived%20angiogenesis%20inhibitory%20factor">glioma-derived angiogenesis inhibitory factor</a>) (Das et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BAMBI">BAMBI</a></b> (<a href="cope.cgi?key=BMP%20and%20activin%20membrane%2dbound%20inhibitor">BMP and activin membrane-bound inhibitor</a>, <a href="cope.cgi?key=NMA">NMA</a>, <a href="cope.cgi?key=Non%2dmetastatic%20gene%20A%20protein">Non-metastatic gene A protein</a>) (Drmann et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Basigin">basigin</a></b> (<a href="cope.cgi?key=BSG">BSG</a>, <a href="cope.cgi?key=CD147">CD147</a>, <a href="cope.cgi?key=EMMPRIN">EMMPRIN</a>, <a href="cope.cgi?key=extracellular%20matrix%20metalloproteinase%20inducer">extracellular matrix metalloproteinase inducer</a>, <a href="cope.cgi?key=5A11">5A11</a>, <a href="cope.cgi?key=CE%2d9">CE-9</a>, <a href="cope.cgi?key=collagenase%20stimulatory%20factor">Collagenase stimulatory factor</a>, <a href="cope.cgi?key=gp42">gp42</a>, <a href="cope.cgi?key=HT7">HT7</a>, <a href="cope.cgi?key=M6">M6</a>, <a href="cope.cgi?key=Neurothelin">neurothelin</a>, <a href="cope.cgi?key=Oka%20blood%20group%20antigen">Oka blood group antigen</a>, <a href="cope.cgi?key=OX47">OX47</a>) (Abe et al, 2006; Seizer et al, 2010; Huang Z et al, 2012)<b style="mso-bidi-font-weight:normal"><br/> </b><b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BAT3">BAT3</a></b> (<a href="cope.cgi?key=HLA%2dB%2dassociated%20transcript%203">HLA-B-associated transcript 3</a>, <a href="cope.cgi?key=B%2dassociated%20transcript%203">B-associated transcript 3</a>, <a href="cope.cgi?key=Scythe">scythe</a>, <a href="cope.cgi?key=BAG%2d6">BAG-6</a>, <a href="cope.cgi?key=BCL2%2dassociated%20athanogene%2d6">BCL2-associated athanogene-6</a>, <a href="cope.cgi?key=RLC34">RLC34</a>) (Kmper et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BCL3">BCL3</a></b> (<a href="cope.cgi?key=B%2dcell%20lymphoma%2fleukemia%2d3">B-cell lymphoma/leukemia-3</a>) (Kuwata et al, 2003; Folco et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BDNF">BDNF</a></b> (<a href="cope.cgi?key=Brain%2dderived%20neurotrophic%20factor">Brain-derived neurotrophic factor</a>, <a href="cope.cgi?key=Abrineurin">Abrineurin</a>) (Shibata et al, 2003; Batchelor et al, 1999, 2002; Barouch et al, 2001; Bomstein et al, 2003; Asami et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BDNF">BDNF</a></b> (<a href="cope.cgi?key=Brain%2dderived%20neurotrophic%20factor">Brain-derived neurotrophic factor</a>, <a href="cope.cgi?key=Abrineurin">Abrineurin</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Asami et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Beclin">Beclin</a> </b>(<a href="cope.cgi?key=Beclin%2d1">Beclin-1</a>, <a href="cope.cgi?key=BECN1">BECN1</a>, <a href="cope.cgi?key=ATG6">ATG6</a>, <a href="cope.cgi?key=autophagy%2drelated%2d6">autophagy-related-6</a>, <a href="cope.cgi?key=coiled%20coil%20myosin%2dlike%20BCL2%2dinteracting%20protein">coiled coil myosin-like BCL2-interacting protein</a>, <a href="cope.cgi?key=vps30">vps30</a>, <a href="cope.cgi?key=vacuolar%20protein%20sorting%20protein%2030">vacuolar protein sorting protein 30</a>, <a href="cope.cgi?key=APG6">APG6</a>, <a href="cope.cgi?key=autophagy%20gene%206">autophagy gene 6</a>, <a href="cope.cgi?key=vpt30">vpt30</a>, <a href="cope.cgi?key=vacuolar%20protein%20targeting%20protein%2030">vacuolar protein targeting protein 30</a>) (Lee <a href="cope.cgi?key=MS">MS</a> et al, 2011; Mahmood et al, 2011; Schlottmann et al, 2008; Shi and Kehrl, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Beta%2d2%2dMicroglobulin">Beta-2-Microglobulin</a></b> (<a href="cope.cgi?key=Beta%2d2%2dM">Beta-2-M</a>, <a href="cope.cgi?key=B2M">B2M</a>, <a href="cope.cgi?key=Ly%2dm11">Ly-m11</a>, <a href="cope.cgi?key=BDGF%2d2">BDGF-2</a>, <a href="cope.cgi?key=Bone%2dderived%20growth%20factor%2d2">bone-derived growth factor-2</a>, <a href="cope.cgi?key=CRG%2d8">CRG-8</a>, <a href="cope.cgi?key=Cytokine%20responsive%20gene%2d8">cytokine responsive gene-8</a>, <a href="cope.cgi?key=Thymotaxin">Thymotaxin</a>, <a href="cope.cgi?key=GIP%2d2">GIP-2</a>, <a href="cope.cgi?key=Granulocyte%20inhibitory%20protein">granulocyte inhibitory protein</a>, <a href="cope.cgi?key=AURA54">AURA54</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2054">augmented in rheumatoid arthritis 54</a>) (Loke et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=beta%2dcasochemotide%2d1">beta-casochemotide-1</a></b> (<a href="cope.cgi?key=casein%2dbeta%28114%2d118%29">casein-beta(114-118)</a>, <a href="cope.cgi?key=Q1%20peptide">Q1 peptide</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Kitazawa et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Betacellulin">Betacellulin</a></b> (<a href="cope.cgi?key=BTC">BTC</a>, <a href="cope.cgi?key=Bcn">Bcn</a>) (Tamura R et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Beta%2dEndorphin">beta-Endorphin</a></b> (<a href="cope.cgi?key=POMC">POMC</a>, <a href="cope.cgi?key=Proopiomelanocortin">proopiomelanocortin</a>) (Throsby et al, 1994; Przewlocki et al, 1992; Lolait et al, 1986)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Betaglycan">betaglycan</a></b> (<a href="cope.cgi?key=TGFBR3">TGFBR3</a>, <a href="cope.cgi?key=TGFR3">TGFR3</a>, <a href="cope.cgi?key=TbetaRIII">TbetaRIII</a>, <a href="cope.cgi?key=TbetaRIII">TbetaR3</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%20receptor%203">transforming growth factor-beta receptor 3</a>; <a href="cope.cgi?key=TGF%2dbeta%20receptor%203">TGF-beta receptor 3</a>; <a href="cope.cgi?key=TGF%2dbeta%20receptor%20type%203">TGF-beta receptor type 3</a>; <a href="cope.cgi?key=type%203%20TGF%2dbeta%20receptors">type 3 TGF-beta receptors</a>) (Chong H et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Beta%2dIG%2dH3">Beta-IG-H3</a></b> (<a href="cope.cgi?key=TGF%2dbeta%2dinducible%20gene%20H3">TGF-beta-inducible gene H3</a>, <a href="cope.cgi?key=BIGH3">BIGH3</a>, <a href="cope.cgi?key=TGFBI">TGFBI</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%2dinduced%2068%20kDa%20protein">transforming growth factor-beta-induced 68 kDa protein</a>, <a href="cope.cgi?key=TGF%2dbeta%2dinduced%2068%20kDa%20protein">TGF-beta-induced 68 kDa protein</a>, <a href="cope.cgi?key=Kerato%2depithelin">Kerato-epithelin</a>, <a href="cope.cgi?key=ODM%2d42%2dI">ODM-42-I</a>, <a href="cope.cgi?key=RGD%2dCAP">RGD-CAP</a>, <a href="cope.cgi?key=RGD%2dcontaining%20collagen%2dassociated%20protein">RGD-containing collagen-associated protein</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=bFGF">bFGF</a> </b>(<a href="cope.cgi?key=Basic%20fibroblast%20growth%20factor">basic fibroblast growth factor</a>, <a href="cope.cgi?key=FGF%20basic">FGF basic</a>, <a href="cope.cgi?key=FGF%2d2">FGF-2</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2d2">Fibroblast growth factor-2</a>, <a href="cope.cgi?key=FGF%2dbeta">FGF-beta</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2dbeta">Fibroblast growth factor-beta</a>, <a href="cope.cgi?key=HBGF%2d2">HBGF-2</a>, <a href="cope.cgi?key=Heparin%20binding%20growth%20factor%2d2">heparin binding growth factor-2</a>) (Akimoto et al, 1999; Henke et al, 1993; Greisler et al, 1993; Joseph-Silverstein et al, 1988; Kouwenhoven et al, 1999; Falcone et al, 1993; Kuwabara et al, 1995; Yoon et al, 2000; Esposito I et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=bFGF">bFGF</a> </b>(<a href="cope.cgi?key=Basic%20fibroblast%20growth%20factor">basic fibroblast growth factor</a>, <a href="cope.cgi?key=FGF%20basic">FGF basic</a>, <a href="cope.cgi?key=FGF%2d2">FGF-2</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2d2">Fibroblast growth factor-2</a>, <a href="cope.cgi?key=FGF%2dbeta">FGF-beta</a>, <a href="cope.cgi?key=Fibroblast%20growth%20factor%2dbeta">Fibroblast growth factor-beta</a>, <a href="cope.cgi?key=HBGF%2d2">HBGF-2</a>, <a href="cope.cgi?key=Heparin%20binding%20growth%20factor%2d2">heparin binding growth factor-2</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Akimoto et al, 1999; Ichinose et al, 1998; Hackshaw and Shi, 1994; Liuzzo et al, 1999; Yoon et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BFL%2d1">BFL-1</a></b> (<a href="cope.cgi?key=A1">A1</a>, <a href="cope.cgi?key=BCL2%2dlike%2d5">BCL2-like-5</a>, <a href="cope.cgi?key=BCL2L5">BCL2L5</a>, <a href="cope.cgi?key=BCL2A1">BCL2A1</a>, <a href="cope.cgi?key=BCL2%2drelated%20protein%20A1">BCL2-related protein A1</a>, <a href="cope.cgi?key=GRS">GRS</a>) (Orlofsky et al, 1999; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Biglycan">Biglycan</a> </b>(<a href="cope.cgi?key=BGN">BGN</a>, <a href="cope.cgi?key=PG%2dS1">PG-S1</a>, <a href="cope.cgi?key=Bone%2fcartilage%20proteoglycan%201">Bone/cartilage proteoglycan 1</a>; <a href="cope.cgi?key=bone%20small%20proteoglycan%201">bone small proteoglycan 1</a>, <a href="cope.cgi?key=small%20proteoglycan%201">small proteoglycan 1</a>, <a href="cope.cgi?key=Proteoglycan%2d1">Proteoglycan-1</a>, <a href="cope.cgi?key=DSPG1">DSPG1</a>, <a href="cope.cgi?key=dermatan%20sulfate%20proteoglycan%2d1">dermatan sulfate proteoglycan-1</a>, <a href="cope.cgi?key=SLRR1A">SLRR1A</a>) (Alimohamad et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BIRC3">BIRC3</a></b> (<a href="cope.cgi?key=baculoviral%20IAP%20repeat%2dcontaining%20protein%2d3">baculoviral IAP repeat-containing protein-3</a>, <a href="cope.cgi?key=API2">API2</a>, <a href="cope.cgi?key=Apoptosis%20inhibitor%202">Apoptosis inhibitor 2</a>, <a href="cope.cgi?key=CA2_1">CA2_1</a>, <a href="cope.cgi?key=MIHC">MIHC</a>, <a href="cope.cgi?key=mammalian%20IAP%20homolog%20C">mammalian IAP homolog C</a>, <a href="cope.cgi?key=HIAP1">HIAP1</a>, <a href="cope.cgi?key=human%20inhibitor%20of%20apoptosis%20protein%2d1">Human inhibitor of apoptosis protein-1</a>, <a href="cope.cgi?key=cIAP2">cIAP2</a>, <a href="cope.cgi?key=cIAP2">cellular IAP2</a>, <a href="cope.cgi?key=TNFR2%2dTRAF%20signaling%20complex%20protein%201">TNFR2-TRAF signaling complex protein 1</a>, <a href="cope.cgi?key=RNF49">RNF49</a>, <a href="cope.cgi?key=RING%20finger%20protein%2049">RING finger protein 49</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=BLAME">BLAME</a></b> (<a href="cope.cgi?key=B%2dlymphocyte%20activator%20macrophage%20expressed">B-lymphocyte activator macrophage expressed</a>, <a href="cope.cgi?key=BCM%2dlike%20membrane%20protein">BCM-like membrane protein</a>, <a href="cope.cgi?key=SLAMF8">SLAMF8</a>, <a href="cope.cgi?key=SLAM%20family%20member%208">SLAM family member 8</a>, <a href="cope.cgi?key=signaling%20lymphocyte%20activation%20molecule%20family%20member%208">signaling lymphocyte activation molecule family member 8</a>, <a href="cope.cgi?key=CD353">CD353</a>) (Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BLNK">BLNK</a></b> (<a href="cope.cgi?key=B%2dcell%20linker%20protein">B-cell linker protein</a>, <a href="cope.cgi?key=SLP65">SLP65</a>, <a href="cope.cgi?key=SH2%20domain%20containing%20leukocyte%20protein%2065%20kDa">SH2 domain containing leukocyte protein 65 kDa</a>, <a href="cope.cgi?key=BASH">BASH</a>, <a href="cope.cgi?key=B%2dcell%20adaptor%20containing%20src%20homology%202%20domain">B-cell adaptor containing src homology 2 domain</a>, <a href="cope.cgi?key=Ly57">Ly57</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%2057">lymphocyte antigen 57</a>) (Bonilla et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BLyS">BLyS</a></b> (<a href="cope.cgi?key=B%2dlymphocyte%20stimulator">B-lymphocyte stimulator</a>, <a href="cope.cgi?key=BAFF">BAFF</a>, <a href="cope.cgi?key=B%2dcell%20activating%20factor%20belonging%20to%20the%20TNF%20family">B-cell activating factor belonging to the TNF family</a>, <a href="cope.cgi?key=TALL%2d1">TALL-1</a>, <a href="cope.cgi?key=TNF%20and%20ApoL%20related%20leukocyte%20expressed%20ligand%2d1">TNF and ApoL related leukocyte expressed ligand-1</a>, <a href="cope.cgi?key=THANK">THANK</a>, <a href="cope.cgi?key=TNF%20homolog%20activating%20apoptosis%20nuclear%20factor%2dkappaB%20c%2dJun%20NH2%2dterminal%20kinase">TNF homolog activating apoptosis nuclear factor-kappaB c-Jun NH2-terminal kinase</a>, <a href="cope.cgi?key=TNFSF13B">TNFSF13B</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2013B">TNF ligand superfamily member 13B</a>, <a href="cope.cgi?key=TNFSF20">TNFSF20</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2020">TNF ligand superfamily member 20</a>, <a href="cope.cgi?key=CD257">CD257</a>) (Craxton et al, 2003; Kim et al, 2008; Jeon ST et al, 2010; Kim HA et al, 2011; Seyler <a href="cope.cgi?key=TM">TM</a> et al, 2005; Thangarajh M et al, 2006; Zhang M et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BMP2">BMP2</a></b> (<a href="cope.cgi?key=Bone%20morphogenetic%20protein%2d2">bone morphogenetic protein-2</a>, <a href="cope.cgi?key=Bone%20morphogenetic%20protein%2d2A">bone morphogenetic protein-2A</a>, <a href="cope.cgi?key=BMP2A">BMP2A</a>, <a href="cope.cgi?key=BMP2%2dalpha">BMP2-alpha</a>) (Lories et al, 2003; Takebe et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BMP6">BMP6</a></b> (<a href="cope.cgi?key=DVR%2d6">DVR-6</a>, <a href="cope.cgi?key=decapentaplegic%2dVg%2drelated%2d6">decapentaplegic-Vg-related-6</a>, <a href="cope.cgi?key=Vgr%2d1">Vgr-1</a>, <a href="cope.cgi?key=vegetal%2dspecific%2drelated%2d1">vegetal-specific-related-1</a>) (Lories et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BMP6">BMP6</a></b> (<a href="cope.cgi?key=DVR%2d6">DVR-6</a>, <a href="cope.cgi?key=decapentaplegic%2dVg%2drelated%2d6">decapentaplegic-Vg-related-6</a>, <a href="cope.cgi?key=Vgr%2d1">Vgr-1</a>, <a href="cope.cgi?key=vegetal%2dspecific%2drelated%2d1">vegetal-specific-related-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Hong et al, 2009; Kwon et al, 2009; Lee GT et al, 2010, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BNIP3">BNIP3</a></b> (<a href="cope.cgi?key=BCL2%2fadenovirus%20E1B%2019%20kDa%20protein%20interacting%20protein%2d3">BCL2/adenovirus E1B 19 kDa protein interacting protein-3</a>, <a href="cope.cgi?key=NIP%2d3">NIP-3</a>) (Yook et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Bombesin">Bombesin</a></b> (<a href="cope.cgi?key=BN">BN</a>, <a href="cope.cgi?key=BBS">BBS</a>, <a href="cope.cgi?key=GRP">GRP</a>, <a href="cope.cgi?key=Gastrin%20releasing%20peptide">gastrin releasing peptide</a>, <a href="cope.cgi?key=Gastrin%20releasing%20hormone">gastrin releasing hormone</a>, <a href="cope.cgi?key=Mammalian%20bombesin">Mammalian Bombesin</a>, <a href="cope.cgi?key=BLP">BLP</a>, <a href="cope.cgi?key=Bombesin%2dlike%20peptide">Bombesin-like peptide</a>) (Meloni et al, 1996; Lemaire et al, 1991; Jin et al, 1990; Wiedermann et al, 1988)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Bombesin">Bombesin</a></b> (<a href="cope.cgi?key=BN">BN</a>, <a href="cope.cgi?key=BBS">BBS</a>, <a href="cope.cgi?key=GRP">GRP</a>, <a href="cope.cgi?key=Gastrin%20releasing%20peptide">gastrin releasing peptide</a>, <a href="cope.cgi?key=Gastrin%20releasing%20hormone">gastrin releasing hormone</a>, <a href="cope.cgi?key=Mammalian%20bombesin">Mammalian Bombesin</a>, <a href="cope.cgi?key=BLP">BLP</a>, <a href="cope.cgi?key=Bombesin%2dlike%20peptide">Bombesin-like peptide</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Meloni et al, 1996; Del Rio and De la Fuente et al, 1994; Lemaire, 1991; Wiedermann et al, 1986; Bedke J et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Bradykinin">bradykinin</a> </b>(<a href="cope.cgi?key=BK">BK</a>, <a href="cope.cgi?key=BDK">BDK</a>, <a href="cope.cgi?key=BKN">BKN</a>, <a href="cope.cgi?key=Bradykinin%281%2d9%29">Bradykinin(1-9)</a>, <a href="cope.cgi?key=BK%5b1%2d9%5d">BK[1-9]</a>, <a href="cope.cgi?key=Alpha%2d2%2dthiol%20proteinase%20inhibitor">Alpha-2-thiol proteinase inhibitor</a>, <a href="cope.cgi?key=Fitzgerald%20factor">Fitzgerald factor</a>, <a href="cope.cgi?key=Flaujeac%20factor">Flaujeac factor</a>, <a href="cope.cgi?key=HMWK">HMWK</a>, <a href="cope.cgi?key=HMWKa">HMWKa</a>, <a href="cope.cgi?key=High%20molecular%20weight%20kininogen">High molecular weight kininogen</a>, <a href="cope.cgi?key=HMWK%2dkallikrein%20factor">HMWK-kallikrein factor</a>, <a href="cope.cgi?key=KNG">KNG</a>, <a href="cope.cgi?key=KNG1">KNG1</a>, <a href="cope.cgi?key=Kininogen">Kininogen</a>, <a href="cope.cgi?key=Kininogen%2d1">Kininogen-1</a>, <a href="cope.cgi?key=LMWK">LMWK</a>, <a href="cope.cgi?key=Low%20molecular%20weight%20kininogen">Low molecular weight kininogen</a>, <a href="cope.cgi?key=Williams%20factor">Williams factor</a>, <a href="cope.cgi?key=Williams%2dFitzgerald%2dFlaujeac%20factor">Williams-Fitzgerald-Flaujeac factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Bckmann et al, 1998; Sato et al, 1996; Stadnicki et al, 2005; Stoika et al, 2001; Tsukagoshi et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BTG1">BTG1</a></b> (<a href="cope.cgi?key=B%2dcell%20translocation%20gene%2d1">B-cell translocation gene-1</a>, <a href="cope.cgi?key=BTG%20family%20member%201">BTG family member 1</a>) (Suk et al, 1997; Corjay et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=BTLA">BTLA</a></b> (<a href="cope.cgi?key=B%20and%20T%2dlymphocyte%20attenuator">B and T-lymphocyte attenuator</a>, <a href="cope.cgi?key=BTLA1">BTLA1</a>, <a href="cope.cgi?key=B%20and%20T%2dlymphocyte%20attenuator%201">B and T-lymphocyte attenuator 1</a>, <a href="cope.cgi?key=B%20and%20T%2dlymphocyte%2dassociated%20protein">B and T-lymphocyte-associated protein</a>, <a href="cope.cgi?key=CD272">CD272</a>) (Yang C et al, 2012)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=C1%20inhibitor">C1 inhibitor</a></b> (<a href="cope.cgi?key=C1INH">C1INH</a>, <a href="cope.cgi?key=Serpin%20G1">Serpin G1</a>; <a href="cope.cgi?key=HAE1">HAE1</a>, <a href="cope.cgi?key=hereditary%20angioedema%20type%201">hereditary angioedema type 1</a>, <a href="cope.cgi?key=HAE2">HAE2</a>, <a href="cope.cgi?key=hereditary%20angioedema%20type%202">hereditary angioedema type 2</a>) (Luo C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=C1q">C1q</a> </b>(<a href="cope.cgi?key=Complement%20C1q">complement C1q</a>; <a href="cope.cgi?key=Complement%20C1q">complement component 1 q</a>; <a href="cope.cgi?key=Complement%20C1q">complement factor C1q</a>, <a href="cope.cgi?key=C1QA">C1QA</a>, <a href="cope.cgi?key=complement%20component%201%20q%20subcomponent%20A%20chain">complement component 1 q subcomponent A chain</a>, <a href="cope.cgi?key=C1QB">C1QB</a>, <a href="cope.cgi?key=complement%20component%201%20q%20subcomponent%20B%20chain">complement component 1 q subcomponent B chain</a>, and <a href="cope.cgi?key=C1QC">C1QC</a>, <a href="cope.cgi?key=complement%20component%201%20q%20subcomponent%20C%20chain">complement component 1 q subcomponent C chain</a>) (Lattin et al, 2009; Kaul and Loos, 1995; Chen G et al, 2011; Mller et al, 1978; Petry et al, 1991; Terheyden et al, 2005; Trinder et al, 1995; Cao W et al, 2003; Schwaeble et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥</b> C3a (Ferluga et al, 1978)<br/> <b style="mso-bidi-font-weight:normal">¥</b> C3a receptors (Murakami et al, 1993; Gasque et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> C5a (Huber-Lang et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=C17">C17</a></b> (<a href="cope.cgi?key=CYTL1">CYTL1</a>, <a href="cope.cgi?key=cytokine%2dlike%201">cytokine-like 1</a>, <a href="cope.cgi?key=cytokine%2dlike%20protein%201">Cytokine-like protein 1</a>, <a href="cope.cgi?key=C4orf4">C4orf4</a>, <a href="cope.cgi?key=chromosome%204%20open%20reading%20frame%204">chromosome 4 open reading frame 4</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Calcitonin%20gene%2drelated%20peptide">Calcitonin gene-related peptide</a></b> (<a href="cope.cgi?key=CALC1">CALC1</a>, <a href="cope.cgi?key=CALCA">CALCA</a>, <a href="cope.cgi?key=Calcitonin%20gene%2drelated%20polypeptide%2dalpha">Calcitonin gene-related polypeptide-alpha</a>, <a href="cope.cgi?key=alpha%2dCGRP">alpha-CGRP</a>, <a href="cope.cgi?key=CGRP%2dalpha">CGRP-alpha</a>, <a href="cope.cgi?key=beta%2dCGRP">beta-CGRP</a>, <a href="cope.cgi?key=CGRP%2dbeta">CGRP-beta</a>, <a href="cope.cgi?key=CGRP1">CGRP1</a>, <a href="cope.cgi?key=Calcitonin%20gene%2drelated%20peptide%2d1">Calcitonin gene-related peptide-1</a>, <a href="cope.cgi?key=CGRP2">CGRP2</a>, <a href="cope.cgi?key=Calcitonin%20gene%2drelated%20peptide%2d2">Calcitonin gene-related peptide-2</a>, <a href="cope.cgi?key=CALCB">CALCB</a>, <a href="cope.cgi?key=Calcitonin%20gene%2drelated%20polypeptide%2dbeta">Calcitonin gene-related polypeptide-beta</a>, <a href="cope.cgi?key=CALC2">CALC2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Owan and Ibaraki, 1994; Feng et al, 1997; Fernandez et al, 2001; Liu et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=CAMP">CAMP</a></b> (<a href="cope.cgi?key=cathelicidin%20antimicrobial%20peptide">cathelicidin antimicrobial peptide</a>, <a href="cope.cgi?key=CRAMP">CRAMP</a>, <a href="cope.cgi?key=Cathelin%2drelated%20antimicrobial%20peptide">cathelin-related antimicrobial peptide</a>, <a href="cope.cgi?key=CAP%2d18">CAP-18</a>, <a href="cope.cgi?key=cationic%20antimicrobial%20protein%20of%2018%20kDa">cationic antimicrobial protein of 18 kDa</a>, <a href="cope.cgi?key=LL%2d37">LL-37</a>, <a href="cope.cgi?key=leucine%2dleucine%2d37">leucine-leucine-37</a>, <a href="cope.cgi?key=FA%2dLL%2d37">FA-LL-37</a>, <a href="cope.cgi?key=FALL39">FALL39</a>, <a href="cope.cgi?key=PR%2d39">PR-39</a>, <a href="cope.cgi?key=ALL%2d38">ALL-38</a>) (Wah et al, 2006; Rivas-Santiago et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> carboxypeptidase M (MAX1) (Scheuerer et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CARD5">CARD5</a></b> (<a href="cope.cgi?key=caspase%20recruitment%20domain%2dcontaining%20protein%2d5">caspase recruitment domain-containing protein-5</a>, <a href="cope.cgi?key=ASC">ASC</a>, <a href="cope.cgi?key=apoptosis%2dassociated%20speck%2dlike%20protein%20containing%20a%20CARD">apoptosis-associated speck-like protein containing a CARD</a>, <a href="cope.cgi?key=TMS1">TMS1</a>, <a href="cope.cgi?key=target%20of%20methylation%2dinduced%20silencing%2d1">target of methylation-induced silencing-1</a>, <a href="cope.cgi?key=PYCARD">PYCARD</a>) (Rosengren et al, 2005; Imamura R et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CARD8">CARD8</a></b> (<a href="cope.cgi?key=caspase%20recruitment%20domain%2dcontaining%20protein%2d8">caspase recruitment domain-containing protein-8</a>, <a href="cope.cgi?key=TUCAN">TUCAN</a>, <a href="cope.cgi?key=tumor%20upregulated%20CARD%20containing%20antagonist%20of%20caspase%20nine">tumor upregulated CARD containing antagonist of caspase nine</a>, <a href="cope.cgi?key=NDPP%2d1">NDPP-1</a>, <a href="cope.cgi?key=CARDINAL">CARDINAL</a>, <a href="cope.cgi?key=CARD%2dinhibitor%20of%20NF%2dkappa%2dB%2dactivating%20ligands">CARD-inhibitor of NF-kappa-B-activating ligands</a>, <a href="cope.cgi?key=Dacar">Dacar</a>, <a href="cope.cgi?key=KIAA0955">KIAA0955</a>) (Agostini et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=cathepsin%20L">cathepsin L</a></b> (<a href="cope.cgi?key=CTSL">CTSL</a>, <a href="cope.cgi?key=CAL">CAL</a>, <a href="cope.cgi?key=CATL">CATL</a>, <a href="cope.cgi?key=CTSL1">CTSL1</a>, <a href="cope.cgi?key=cathepsin%20L1">cathepsin L1</a>, <a href="cope.cgi?key=MEP">MEP</a>, <a href="cope.cgi?key=major%20excreted%20protein">major excreted protein</a>, <a href="cope.cgi?key=IL8%20converting%20enzyme">IL8 converting enzyme</a>, <a href="cope.cgi?key=CP%2d2">CP-2</a>, <a href="cope.cgi?key=cycling%20protein%2d2">cycling protein-2</a>) (Altiok et al, 2006; Beers et al, 2003; Schmid et al, 2002; Liu et al, 2006; Punturieri et al, 2000; Lavric et al, 2008; Bhling et al, 2001; Ishii et al, 1991; Kominami et al, 1988; Lah et al, 1995; Li et al, 2009; Ma et al, 2007; Menzel et al, 2006; Nepal et al, 2006; Reddy er al, 1995; Takahashi et al, 1993; Harrison et al, 2003; Liuzzo et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Caveolin%2d1">caveolin-1</a></b> (<a href="cope.cgi?key=CAV1">CAV1</a>, <a href="cope.cgi?key=caveolae%20protein%201">caveolae protein 1</a>, <a href="cope.cgi?key=Caveolin">Caveolin</a>, <a href="cope.cgi?key=CAV">CAV</a>, <a href="cope.cgi?key=caveolae%20protein%2022%20kDa">caveolae protein 22 kDa</a>, <a href="cope.cgi?key=Alpha%2dCaveolin">Alpha-Caveolin</a>, <a href="cope.cgi?key=Beta%2dCaveolin">beta-Caveolin</a>, <a href="cope.cgi?key=VIP21">VIP21</a>, <a href="cope.cgi?key=Vesicular%20Integral%2dmembrane%20Protein%20of%2021%20kDa">Vesicular Integral-membrane Protein of 21 kDa</a>, <a href="cope.cgi?key=VIP21%2fcaveolin">VIP21/caveolin</a>) (Gargalovic and Dory 201, 2003; Lei and Morrison, 2000; Wu et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> Caveolin-2 (Gargalovic and Dory, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL1">CCL1</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%201">CC chemokine ligand 1</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%201">chemokine (C-C motif) ligand 1</a>, <a href="cope.cgi?key=SCYA1">SCYA1</a>, <a href="cope.cgi?key=I%2d309">I-309</a>, <a href="cope.cgi?key=TCA%2d3">TCA-3</a>, <a href="cope.cgi?key=T%2dcell%20activation%2d3">T-cell activation-3</a>, <a href="cope.cgi?key=P500">P500</a>, <a href="cope.cgi?key=SIS%2depsilon">SIS-epsilon</a>) (Devi et al, 1995; Moreno-Altamirano et al, 2004; Ragno et al, 2001; Fischer et al, 2007; Sironi et al, 2006; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL2">CCL2</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%202">CC chemokine ligand 2</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%202">chemokine (C-C motif) ligand 2</a>, <a href="cope.cgi?key=GDCF">GDCF</a>, <a href="cope.cgi?key=Glioma%2dderived%20monocyte%20chemotactic%20factor%2d2">Glioma-derived monocyte chemotactic factor-2</a>, <a href="cope.cgi?key=GDCF%2d2">GDCF-2</a>, <a href="cope.cgi?key=HC11">HC11</a>, <a href="cope.cgi?key=JE">JE</a>, <a href="cope.cgi?key=LDCF">LDCF</a>, <a href="cope.cgi?key=MCAF">MCAF</a>, <a href="cope.cgi?key=MCP">MCP</a>, <a href="cope.cgi?key=Monocyte%20chemoattractant%20protein">monocyte chemoattractant protein</a>, <a href="cope.cgi?key=MCP%2d1">MCP-1</a>, <a href="cope.cgi?key=Monocyte%20chemoattractant%20protein%2d1">monocyte chemoattractant protein-1</a>, <a href="cope.cgi?key=SMC%2dCF">SMC-CF</a>, <a href="cope.cgi?key=Smooth%20muscle%20cell%20chemotactic%20factor">smooth muscle cell chemotactic factor</a>, <a href="cope.cgi?key=TDCF">TDCF</a>, <a href="cope.cgi?key=Tumor%2dderived%20chemotactic%20factors">tumor-derived chemotactic factors</a>, <a href="cope.cgi?key=TSG%2d8">TSG-8</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%2dstimulated%20gene%20sequence%2d8">tumor necrosis factor-stimulated gene sequence-8</a>, <a href="cope.cgi?key=SCYA2">SCYA2</a>) (Bosco et al, 2004; Albright and Gonzalez-Scarano, 2004; Fantuzzi et al, 2003; Matsuyama et al, 2004; Cappello et al, 2004; Veckman et al, 2003; Moreno-Altamirano MM et al, 2004; Xu et al, 2001; Toney et al, 2000; Matikainen et al, 2000; Jarmin et al, 1999; McKee et al, 1996; Kornbluth et al, 1998; Takeshita et al, 2001; Becker et al, 1994; Naidu et al, 2002; Ragno et al, 2001; Guo et al, 2002; Orlofsky et al, 1994; Ciesielski et al, 2002; Delgado and Ganea, 2001; Carulli et al, 2005; Luo et al, 1994; Sodhi and Tripathi, 2008; Sun et al, 2008; Kent et al, 2008; Jang et al, 2008; Fischer et al, 2007; Park et al, 2005; Lutgens et al, 2005; Denker et al, 2007; Song et al, 2009; Curat <a href="cope.cgi?key=CA">CA</a> et al, 2006; Gleissner et al, 2010; Leeper NJ et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL2">CCL2</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%202">CC chemokine ligand 2</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%202">chemokine (C-C motif) ligand 2</a>, <a href="cope.cgi?key=GDCF">GDCF</a>, <a href="cope.cgi?key=Glioma%2dderived%20monocyte%20chemotactic%20factor%2d2">Glioma-derived monocyte chemotactic factor-2</a>, <a href="cope.cgi?key=GDCF%2d2">GDCF-2</a>, <a href="cope.cgi?key=HC11">HC11</a>, <a href="cope.cgi?key=JE">JE</a>, <a href="cope.cgi?key=LDCF">LDCF</a>, <a href="cope.cgi?key=MCAF">MCAF</a>, <a href="cope.cgi?key=MCP">MCP</a>, <a href="cope.cgi?key=Monocyte%20chemoattractant%20protein">monocyte chemoattractant protein</a>, <a href="cope.cgi?key=MCP%2d1">MCP-1</a>, <a href="cope.cgi?key=Monocyte%20chemoattractant%20protein%2d1">monocyte chemoattractant protein-1</a>, <a href="cope.cgi?key=SMC%2dCF">SMC-CF</a>, <a href="cope.cgi?key=Smooth%20muscle%20cell%20chemotactic%20factor">smooth muscle cell chemotactic factor</a>, <a href="cope.cgi?key=TDCF">TDCF</a>, <a href="cope.cgi?key=Tumor%2dderived%20chemotactic%20factors">tumor-derived chemotactic factors</a>, <a href="cope.cgi?key=TSG%2d8">TSG-8</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%2dstimulated%20gene%20sequence%2d8">tumor necrosis factor-stimulated gene sequence-8</a>, <a href="cope.cgi?key=SCYA2">SCYA2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Patterson et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL3">CCL3</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%203">CC chemokine ligand 3</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%203">chemokine (C-C motif) ligand 3</a>, <a href="cope.cgi?key=MIP%2d1%2dalpha">MIP-1-alpha</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d1%2dalpha">macrophage inflammatory protein-1-alpha</a>, <a href="cope.cgi?key=464%2e1">464.1</a>, <a href="cope.cgi?key=GOS%2d19%2d1">GOS-19-1</a>, <a href="cope.cgi?key=L2G25B">L2G25B</a>, <a href="cope.cgi?key=LD78">LD78</a>, <a href="cope.cgi?key=LD78%2dalpha">LD78-alpha</a>, <a href="cope.cgi?key=SCI">SCI</a>, <a href="cope.cgi?key=Stem%20cell%20inhibition%20factor">stem cell inhibition factor</a>, <a href="cope.cgi?key=Stem%20cell%20inhibitor">stem cell inhibitor</a>, <a href="cope.cgi?key=TY5">TY5</a>, <a href="cope.cgi?key=SCYA3">SCYA3</a>, <a href="cope.cgi?key=SCYA3L1">SCYA3L1</a>) (Matsuyama et al, 2004; Rogez et al, 2003; Veckman et al, 2003; Orlofsky et al, 1994; Rodenburg et al, 1998; Flesch et al, 1998; Chen and Wang, 2002; Takeshita et al, 2001; Matikainen et al, 2000; Bosco et al, 2000; McKee et al, 1996; Bosco et al, 2000; di Marzio et al, 2000; Hohlbaum et al, 2001; Naidu et al, 2002; McKee et al, 1996; Ragno et al, 2001; Van Otteren et al, 1994; Lucas et al, 2003; Ciesielski et al, 2002; Smits et al, 2002; John et al, 1998; Delgado and Ganea, 2001; Meheus et al, 1993; Patterson et al, 2002; Sodhi and Tripathi, 2008; Kent et al, 2008; Fischer et al, 2007; Lutgens et al, 2005; Kiguchi et al, 2009; Song et al, 2009; Curat <a href="cope.cgi?key=CA">CA</a> et al, 2006; Gleissner et al, 2010; Bai T et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL4">CCL4</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%204">CC chemokine ligand 4</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%204">chemokine (C-C motif) ligand 4</a>, <a href="cope.cgi?key=SCYA4">SCYA4</a>, <a href="cope.cgi?key=ACT%2d2">ACT-2</a>, <a href="cope.cgi?key=Immune%20activation%20gene%2d2">Immune activation gene-2</a>, <a href="cope.cgi?key=744%2e1">744.1</a>, <a href="cope.cgi?key=G26">G26</a>, <a href="cope.cgi?key=H400">H400</a>, <a href="cope.cgi?key=HC21">HC21</a>, <a href="cope.cgi?key=Cytokine%2021">Cytokine 21</a>, <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a>, <a href="cope.cgi?key=LAG%2d1">LAG-1</a>, <a href="cope.cgi?key=Lymphocyte%20activation%20gene%2d1">lymphocyte activation gene-1</a>, <a href="cope.cgi?key=MIP%2d1%2dbeta">MIP-1-beta</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d1%2dbeta">macrophage inflammatory protein-1-beta</a>, <a href="cope.cgi?key=SIS%2dgamma">SIS-gamma</a>) (Rogez et al, 2003; Kornbluth et al, 1998; Flesch et al, 1998; Takeshita et al, 2001; Matikainen et al, 2000; Medvedev et al, 2000; Bosco et al, 2000; Jarmin et al, 1999; Yamamoto et al, 1996, 1997; McKee et al, 1996; di Marzio et al, 2000; Hohlbaum et al, 2001; McKee et al, 1996; Ragno et al, 2001; Smits et al, 2002; Delgado and Ganea, 2001; Meheus et al, 1993; Khuu et al, 2007; Kent et al, 2008; Fischer et al, 2007; Kiguchi et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL5">CCL5</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%205">CC chemokine ligand 5</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%205">chemokine (C-C motif) ligand 5</a>, <a href="cope.cgi?key=RANTES">RANTES</a>, <a href="cope.cgi?key=EoCP%2d1">EoCP-1</a>, <a href="cope.cgi?key=Eosinophil%20chemotactic%20polypeptide%2d1">Eosinophil chemotactic polypeptide-1</a>, <a href="cope.cgi?key=SIS%2ddelta">SIS-delta</a>, <a href="cope.cgi?key=TCP228">TCP228</a>, <a href="cope.cgi?key=T%2dcell%2dspecific%20protein%20p228">T-cell-specific protein p228</a>, <a href="cope.cgi?key=SCYA5">SCYA5</a>) (Rogez et al, 2003; Cappello et al, 2004; Veckman et al, 2003; Devergne et al, 1994; Orlofsky et al, 1994; McKee et al, 1996; Kornbluth et al, 1998; Flesch et al, 1998; Chen and Wang, 2002; Takeshita et al, 2001; Matikainen et al, 2000; di Marzio et al, 2000; Melchjorsen et al, 2002; Ragno et al, 2001; Ciesielski et al, 2002; Delgado and Ganea, 2001; Sodhi and Tripathi, 2008; Kent et al, 2008; Kiguchi et al, 2009; Gleissner et al, 2010; Kim SY et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL5">CCL5</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%205">CC chemokine ligand 5</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%205">chemokine (C-C motif) ligand 5</a>, <a href="cope.cgi?key=RANTES">RANTES</a>, <a href="cope.cgi?key=EoCP%2d1">EoCP-1</a>, <a href="cope.cgi?key=Eosinophil%20chemotactic%20polypeptide%2d1">Eosinophil chemotactic polypeptide-1</a>, <a href="cope.cgi?key=SIS%2ddelta">SIS-delta</a>, <a href="cope.cgi?key=TCP228">TCP228</a>, <a href="cope.cgi?key=T%2dcell%2dspecific%20protein%20p228">T-cell-specific protein p228</a>, <a href="cope.cgi?key=SCYA5">SCYA5</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Patterson et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL6">CCL6</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%206">CC chemokine ligand 6</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%206">chemokine (C-C motif) ligand 6</a>, <a href="cope.cgi?key=SCYA6">SCYA6</a>, <a href="cope.cgi?key=C10">C10</a>, <a href="cope.cgi?key=MRP%2d1">MRP-1</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2drelated%20protein%2d1">Macrophage inflammatory protein-related protein-1</a>, <a href="cope.cgi?key=MIP%2drelated%20protein%2d1">MIP-related protein-1</a>) (Guo et al, 2002; Toney et al, 2000; Guo et al, 2002; Orlofsky et al, 1994; Asensio et al, 1999; Yang et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL7">CCL7</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%207">CC chemokine ligand 7</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%207">chemokine (C-C motif) ligand 7</a>, <a href="cope.cgi?key=SCYA7">SCYA7</a>, <a href="cope.cgi?key=MCP%2d3">MCP-3</a>, <a href="cope.cgi?key=Monocyte%20chemoattractant%20protein%2d3">monocyte chemoattractant protein-3</a>, <a href="cope.cgi?key=FIC">FIC</a>, <a href="cope.cgi?key=Fibroblast%2dinducible%20cytokine">Fibroblast-inducible cytokine</a>, <a href="cope.cgi?key=NC28">NC28</a>, <a href="cope.cgi?key=MARC">MARC</a>, <a href="cope.cgi?key=mast%20cell%20activation%2drelated%20chemokine">mast cell activation-related chemokine</a>) (Albright and Gonzalez-Scarano, 2004; Veckman et al, 2003; Toney et al, 2000; Matikainen et al, 2000; Jarmin et al, 1999; Fischer et al, 2007; Gleissner et al, 2010; Bai T et al, 2010; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL8">CCL8</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%208">CC chemokine ligand 8</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%208">chemokine (C-C motif) ligand 8</a>, <a href="cope.cgi?key=SCYA8">SCYA8</a>, <a href="cope.cgi?key=MCP%2d2">MCP-2</a>, <a href="cope.cgi?key=monocytes">monocyte</a> <a href="cope.cgi?key=Monocyte%20chemoattractant%20protein%2d2">monocyte chemoattractant protein-2</a>, <a href="cope.cgi?key=HC14">HC14</a>, <a href="cope.cgi?key=Cytokine%2014">Cytokine 14</a>, <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a>) (Ragno et al, 2001; Kent et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL9">CCL9</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%209">CC chemokine ligand 9</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%209">chemokine (C-C motif) ligand 9</a>, <a href="cope.cgi?key=SCYA9">SCYA9</a>, <a href="cope.cgi?key=MRP%2d2">MRP-2</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2drelated%20protein%2d2">Macrophage inflammatory protein-related protein-2</a>, <a href="cope.cgi?key=MIP%2drelated%20protein%2d2">MIP-related protein-2</a>, <a href="cope.cgi?key=CCF18">CCF18</a>, <a href="cope.cgi?key=MIP%2d1%2dgamma">MIP-1-gamma</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d1%2dgamma">macrophage inflammatory protein-1-gamma</a>) (Ravindran et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL11">CCL11</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2011">CC chemokine ligand 11</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2011">chemokine (C-C motif) ligand 11</a>, <a href="cope.cgi?key=SCYA11">SCYA11</a>, <a href="cope.cgi?key=Eotaxin">Eotaxin</a>, <a href="cope.cgi?key=Eotaxin%2d1">Eotaxin-1</a>) (Ragno et al, 2001; Ying et al, 1999; Khajoee et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL11">CCL11</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2011">CC chemokine ligand 11</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2011">chemokine (C-C motif) ligand 11</a>, <a href="cope.cgi?key=SCYA11">SCYA11</a>, <a href="cope.cgi?key=Eotaxin">Eotaxin</a>, <a href="cope.cgi?key=Eotaxin%2d1">Eotaxin-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Stevenson et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL12">CCL12</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2012">CC chemokine ligand 12</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2012">chemokine (C-C motif) ligand 12</a>, <a href="cope.cgi?key=MCP%2d5">MCP-5</a>, <a href="cope.cgi?key=Monocyte%20chemotactic%20protein%2d5">Monocyte chemotactic protein-5</a>, <a href="cope.cgi?key=Monocyte%20chemoattractant%20protein%2d5">Monocyte chemoattractant protein-5</a>, <a href="cope.cgi?key=SCYA12">SCYA12</a>) (Lutgens et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL13">CCL13</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2013">CC chemokine ligand 13</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2013">chemokine (C-C motif) ligand 13</a>, <a href="cope.cgi?key=MCP%2d4">MCP-4</a>, <a href="cope.cgi?key=Monocyte%20chemotactic%20protein%2d4">Monocyte chemotactic protein-4</a>, <a href="cope.cgi?key=NCC1">NCC1</a>, <a href="cope.cgi?key=New%20CC%20chemokine%2d1">new CC chemokine-1</a>, <a href="cope.cgi?key=Ck%2dbeta%2d10">Ck-beta-10</a>, <a href="cope.cgi?key=Chemokine%2dbeta%2d10">Chemokine-beta-10</a>, <a href="cope.cgi?key=SCYL1">SCYL1</a>, <a href="cope.cgi?key=SCYA13">SCYA13</a>) (Chakravorty et al, 2001; Gratchev A et al, 2005; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL15">CCL15</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2015">CC chemokine ligand 15</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2015">chemokine (C-C motif) ligand 15</a>, <a href="cope.cgi?key=HCC2">HCC2</a>, <a href="cope.cgi?key=Hemofiltrate%20CC%2dChemokine%2d2">hemofiltrate CC-Chemokine-2</a>, <a href="cope.cgi?key=NCC3">NCC3</a>, <a href="cope.cgi?key=New%20CC%20chemokine%2d3">new CC chemokine-3</a>, <a href="cope.cgi?key=MIP%2d5">MIP-5</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d5">macrophage inflammatory protein-5</a>, <a href="cope.cgi?key=Lkn%2d1">Lkn-1</a>, <a href="cope.cgi?key=Leukotactin%2d1">leukotactin-1</a>, <a href="cope.cgi?key=MIP%2d1%2ddelta">MIP-1-delta</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d1%2ddelta">macrophage inflammatory protein-1-delta</a>, <a href="cope.cgi?key=HMRP%2d2B">HMRP-2B</a>, <a href="cope.cgi?key=human%20MIP%2drelated%20protein%202B">human MIP-related protein 2B</a>, <a href="cope.cgi?key=SCYL3">SCYL3</a>, <a href="cope.cgi?key=SCYA15">SCYA15</a>) (Kent et al, 2008; Fischer et al, 2007; Martinez et al, 2006; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL16">CCL16</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2016">CC chemokine ligand 16</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2016">chemokine (C-C motif) ligand 16</a>, <a href="cope.cgi?key=SCYA16">SCYA16</a>, <a href="cope.cgi?key=NCC4">NCC4</a>, <a href="cope.cgi?key=New%20CC%20chemokine%2d4">new CC chemokine-4</a>, <a href="cope.cgi?key=LEC">LEC</a>, <a href="cope.cgi?key=Liver%2dexpressed%20chemokine">liver-expressed chemokine</a>, <a href="cope.cgi?key=LCC%2d1">LCC-1</a>, <a href="cope.cgi?key=liver%20CC%20chemokine%2d1">liver CC chemokine-1</a>, <a href="cope.cgi?key=HCC4">HCC4</a>, <a href="cope.cgi?key=Hemofiltrate%20CC%2dChemokine%2d4">hemofiltrate CC-Chemokine-4</a>, <a href="cope.cgi?key=LMC">LMC</a>, <a href="cope.cgi?key=Lymphocyte%20and%20Monocyte%20Chemoattractant">Lymphocyte and Monocyte Chemoattractant</a>, <a href="cope.cgi?key=Ck%2dbeta%2d12">Ck-beta-12</a>, <a href="cope.cgi?key=Chemokine%2dbeta%2d12">Chemokine-beta-12</a>, <a href="cope.cgi?key=Monotactin%2d1">Monotactin-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Cappello et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL17">CCL17</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2017">CC chemokine ligand 17</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2017">chemokine (C-C motif) ligand 17</a>, <a href="cope.cgi?key=SCYA17">SCYA17</a>, <a href="cope.cgi?key=TARC">TARC</a>, <a href="cope.cgi?key=Thymus%20and%20Activation%20Regulated%20Chemokine">Thymus and Activation Regulated Chemokine</a>, <a href="cope.cgi?key=ABCD%2d2">ABCD-2</a>) (Katakura et al, 2004; Greaves et al, 2001; Wirnsberger et al, 2006; Kurowska-Stolarska M et al, 2009; Ying S et al, 2008; Gratchev A et al, 2005; Nelson <a href="cope.cgi?key=MP">MP</a> et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL18">CCL18</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2018">CC chemokine ligand 18</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2018">chemokine (C-C motif) ligand 18</a>, <a href="cope.cgi?key=AMAC%2d1">AMAC-1</a>, <a href="cope.cgi?key=Alternative%20activated%20macrophage%20associated%20CC%2dChemokine">alternative activated macrophage associated CC-Chemokine</a>, <a href="cope.cgi?key=PARC">PARC</a>, <a href="cope.cgi?key=Pulmonary%20and%20activation%2dregulated%20chemokine">pulmonary and activation-regulated chemokine</a>, <a href="cope.cgi?key=MIP%2d4">MIP-4</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d4">macrophage inflammatory protein-4</a>, <a href="cope.cgi?key=DC%2dCK1">DC-CK1</a>, <a href="cope.cgi?key=Dendritic%20cell%2dderived%20chemokine%2d1">dendritic cell-derived chemokine-1</a>, <a href="cope.cgi?key=Ck%2dbeta%2d7">Ck-beta-7</a>, <a href="cope.cgi?key=Met%2dchemokine%2dbeta%2d7">Met-chemokine-beta-7</a>, <a href="cope.cgi?key=Met%2dCk%2dbeta%2d7">Met-Ck-beta-7</a>, <a href="cope.cgi?key=SCYA18">SCYA18</a>) (Kodelja et al, 1998, 1999; Hieshima et al, 1997; Schraufstatter et al, 2004; Ragno et al, 2001; Prasse et al, 2006; Gustafsson et al, 2008; Ferrara et al, 2008; Gleissner et al, 2010; Gratchev A et al, 2005; Martinez FO et al, 2006; Almqvist S et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL19">CCL19</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2019">CC chemokine ligand 19</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2019">chemokine (C-C motif) ligand 19</a>, <a href="cope.cgi?key=ELC">ELC</a>, <a href="cope.cgi?key=EBI%2d1%2dLigand%20Chemokine">EBI-1-Ligand Chemokine</a>, <a href="cope.cgi?key=Exodus%2d3">Exodus-3</a>, <a href="cope.cgi?key=MIP%2d3%2dbeta">MIP-3-beta</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d3%2dbeta">macrophage inflammatory protein-3-beta</a>, <a href="cope.cgi?key=Ck%2dbeta%2d11">Ck-beta-11</a>, <a href="cope.cgi?key=Chemokine%2dbeta%2d11">Chemokine-beta-11</a>, <a href="cope.cgi?key=SCYA19">SCYA19</a>) (Veckman et al, 2003; Gibejova et al, 2003; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL20">CCL20</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2020">CC chemokine ligand 20</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2020">chemokine (C-C motif) ligand 20</a>, <a href="cope.cgi?key=SCYA20">SCYA20</a>, <a href="cope.cgi?key=LARC">LARC</a>, <a href="cope.cgi?key=Liver%20and%20Activation%20Regulated%20Chemokine">Liver and Activation Regulated Chemokine</a>, <a href="cope.cgi?key=Exodus">Exodus</a>, <a href="cope.cgi?key=Exodus%2d1">Exodus-1</a>, <a href="cope.cgi?key=MIP%2d3%2dalpha">MIP-3-alpha</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d3%2dalpha">macrophage inflammatory protein-3-alpha</a>, <a href="cope.cgi?key=Ck%2dbeta%2d4">Ck-beta-4</a>, <a href="cope.cgi?key=Chemokine%2dbeta%2d4">Chemokine-beta-4</a>, <a href="cope.cgi?key=ST38">ST38</a>) (Ragno et al, 2001; Veckman et al, 2003; Matikainen et al, 2000; Utans-Schneitz et al, 1998; Kent et al, 2008; Fischer et al, 2007; Martinez FO et al, 2006; Wan W et al, 2011; Suzuki M and Mihara M, 2012; Hausmann M et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL22">CCL22</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2022">CC chemokine ligand 22</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2022">chemokine (C-C motif) ligand 22</a>, <a href="cope.cgi?key=ABCD%2d1">ABCD-1</a>, <a href="cope.cgi?key=DC%2fB%2dCk">DC/B-Ck</a>, <a href="cope.cgi?key=dendritic%20cell%2fB%2dcell%20derived%20chemokine">dendritic cell/B-cell derived chemokine</a>, <a href="cope.cgi?key=MDC">MDC</a>, <a href="cope.cgi?key=human%20macrophage%2dderived%20chemokine">Human macrophage-derived chemokine</a> <a href="cope.cgi?key=STCP%2d1">STCP-1</a>, <a href="cope.cgi?key=stimulated%20T%2dcell%20chemotactic%20protein">stimulated T-cell chemotactic protein</a>, <a href="cope.cgi?key=SCYA22">SCYA22</a>) (Godiska et al, 1997; Yamashita and Kuroda, 2002; Rodenburg et al, 1998; Greaves et al, 2001; Andrew et al, 1998; Bourdonnay et al, 2009; Mantovani et al, 2002; Gleissner et al, 2010; Nelson <a href="cope.cgi?key=MP">MP</a> et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL23">CCL23</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2023">CC chemokine ligand 23</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2023">chemokine (C-C motif) ligand 23</a>, <a href="cope.cgi?key=MIP%2d3">MIP-3</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d3">macrophage inflammatory protein-3</a>, <a href="cope.cgi?key=MPIF%2d1">MPIF-1</a>, <a href="cope.cgi?key=Myeloid%20progenitor%20inhibitory%20factor%2d1">Myeloid progenitor inhibitory factor-1</a>, <a href="cope.cgi?key=Ck%2dbeta%2d8">Ck-beta-8</a>, <a href="cope.cgi?key=Chemokine%2dbeta%2d8">Chemokine-beta-8</a>, <a href="cope.cgi?key=SCYA23">SCYA23</a>) (Ragno et al, 2001; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCL24">CCL24</a></b> (<a href="cope.cgi?key=CC%20chemokine%20ligand%2024">CC chemokine ligand 24</a>, <a href="cope.cgi?key=chemokine%20%28C%2dC%20motif%29%20ligand%2024">chemokine (C-C motif) ligand 24</a>, <a href="cope.cgi?key=MPIF%2d2">MPIF-2</a>, <a href="cope.cgi?key=Myeloid%20progenitor%20inhibitory%20factor%2d2">Myeloid progenitor inhibitory factor-2</a>, <a href="cope.cgi?key=Ck%2dbeta%2d6">Ck-beta-6</a>, <a href="cope.cgi?key=Chemokine%2dbeta%2d6">Chemokine-beta-6</a>, <a href="cope.cgi?key=Eotaxin%2d2">eotaxin-2</a>, <a href="cope.cgi?key=SCYA24">SCYA24</a>) (Watanabe et al, 2002; Torra et al, 2004; Kurowska-Stolarska M et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR1">CCR1</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%201">CC-Chemokine receptor 1</a>, <a href="cope.cgi?key=RANTES%20receptor">RANTES receptor</a>, <a href="cope.cgi?key=MIP%2d1%2dalpha%20receptor">MIP-1-alpha receptor</a>, <a href="cope.cgi?key=LD78%20receptor">LD78 receptor</a>, <a href="cope.cgi?key=CC%2dCKR1">CC-CKR1</a>, <a href="cope.cgi?key=HM145">HM145</a>, <a href="cope.cgi?key=YT4">YT4</a>, <a href="cope.cgi?key=CD191">CD191</a>, <a href="cope.cgi?key=CMKBR1">CMKBR1</a>, <a href="cope.cgi?key=chemokine%2dbeta%20receptor%201">chemokine-beta receptor 1</a>) (Panaro et al, 2004; Sunnemark et al, 2003; Jeannin et al, 2003; Katschke et al, 2001; Jarmin et al, 1999; Gleissner et al, 2010; Ravindran C et al, 2010; McKimmie CS et al, 2008; Nibbs RJ et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR2">CCR2</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%202">CC-Chemokine receptor 2</a>, <a href="cope.cgi?key=CC%2dCKR2A">CC-CKR2A</a>, <a href="cope.cgi?key=CCR2A">CCR2A</a>, <a href="cope.cgi?key=CC%2dCKR2B">CC-CKR2B</a>, <a href="cope.cgi?key=CCR2B">CCR2B</a>, <a href="cope.cgi?key=MCP%2d1%20receptor%20A">MCP-1 receptor A</a>, <a href="cope.cgi?key=MCP%2d1%20receptor%20B">MCP-1 receptor B</a>, <a href="cope.cgi?key=CMKBR2">CMKBR2</a>, <a href="cope.cgi?key=chemokine%2dbeta%20receptor%202">chemokine-beta receptor 2</a>, <a href="cope.cgi?key=CD192">CD192</a>) (Katschke et al, 2001; McKimmie CS et al, 2008; Dambach et al, 2002; Worgall et al, 1999; Carulli et al, 2005; Isoda et al, 2008; Nieto et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR3">CCR3</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%203">CC-Chemokine receptor 3</a>, <a href="cope.cgi?key=CC%2dCKR3">CC-CKR3</a>, <a href="cope.cgi?key=Eotaxin%20receptor">Eotaxin receptor</a>, <a href="cope.cgi?key=CMKBR3">CMKBR3</a>, <a href="cope.cgi?key=chemokine%2dbeta%20receptor%203">chemokine-beta receptor 3</a>, <a href="cope.cgi?key=MIP%2d1%2dalpha%20RL2">MIP-1-alpha RL2</a>, <a href="cope.cgi?key=MIP%2d1%2dalpha%20receptor%2dlike%2d2">MIP-1-alpha receptor-like-2</a>, <a href="cope.cgi?key=CD193">CD193</a>) (Katschke et al, 2001; Menzies-Gow et al, 2002; Ragno et al, 2001; Worgall et al, 1999; McKimmie CS et al, 2008; Nibbs RJ et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR4">CCR4</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%204">CC-Chemokine receptor 4</a>, <a href="cope.cgi?key=CC%2dCKR4">CC-CKR4</a>, <a href="cope.cgi?key=CKR4">CKR4</a>, <a href="cope.cgi?key=CMKBR4">CMKBR4</a>, <a href="cope.cgi?key=chemokine%2dbeta%20receptor%204">chemokine-beta receptor 4</a>, <a href="cope.cgi?key=K5%2d5">K5-5</a>, <a href="cope.cgi?key=CD194">CD194</a>) (Katschke et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR5">CCR5</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%205">CC-Chemokine receptor 5</a>, <a href="cope.cgi?key=CC%2dCKR5">CC-CKR5</a>, <a href="cope.cgi?key=CMKBR5">CMKBR5</a>, <a href="cope.cgi?key=ChemR13">ChemR13</a>, <a href="cope.cgi?key=CD195">CD195</a>) (Cordelier et al, 2003; Lai et al, 2003; Jeannin et al, 2003; Yi et al, 1998; Katschke et al, 2001; Melchjorsen et al, 2002; Atemezem et al, 2002; Torres et al, 2001; Marzio et al, 2003; Shimada et al, 1998; Worgall et al, 1999; Hermann et al, 1999; Trebst et al, 2008; Shen R et al, 2009; McKimmie CS et al, 2008; Nibbs RJ et al, 1997; Nieto et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR6">CCR6</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%206">CC-Chemokine receptor 6</a>, <a href="cope.cgi?key=GPRCY4">GPRCY4</a>, <a href="cope.cgi?key=STRL22">STRL22</a>, <a href="cope.cgi?key=DRY6">DRY6</a>, <a href="cope.cgi?key=CKR%2dL3">CKR-L3</a>, <a href="cope.cgi?key=CMKBR6">CMKBR6</a>, <a href="cope.cgi?key=chemokine%2dbeta%20receptor%206">chemokine-beta receptor 6</a>, <a href="cope.cgi?key=GPR29">GPR29</a>, <a href="cope.cgi?key=CD196">CD196</a>) (Wan W et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR7">CCR7</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%207">CC-Chemokine receptor 7</a>, <a href="cope.cgi?key=EBI%2d1">EBI-1</a>, <a href="cope.cgi?key=EBV%20induced%20gene%2d1">EBV induced gene-1</a>, <a href="cope.cgi?key=blr%2d2">blr-2</a>, <a href="cope.cgi?key=CMKBR7">CMKBR7</a>, <a href="cope.cgi?key=Burkitt%20lymphoma%20receptor%2d2">Burkitt lymphoma receptor-2</a>, <a href="cope.cgi?key=CD197">CD197</a>) (Jeannin et al, 2003; Gleissner et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCR8">CCR8</a></b> (<a href="cope.cgi?key=CC%2dChemokine%20receptor%208">CC-Chemokine receptor 8</a>, <a href="cope.cgi?key=TER1">TER1</a>, <a href="cope.cgi?key=CY6">CY6</a>, <a href="cope.cgi?key=ChemR1">ChemR1</a>, <a href="cope.cgi?key=CMKBR8">CMKBR8</a>, <a href="cope.cgi?key=chemokine%2dbeta%20receptor%208">chemokine-beta receptor 8</a>, <a href="cope.cgi?key=CKR%2dL1">CKR-L1</a> <a href="cope.cgi?key=CDw198">CDw198</a>) (Trebst et al, 2003; Youn et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CCRL2">CCRL2</a></b> (<a href="cope.cgi?key=Chemokine%20CC%20Receptor%2dlike%2d2">Chemokine CC Receptor-like-2</a>, <a href="cope.cgi?key=HCR">HCR</a>, <a href="cope.cgi?key=human%20chemokine%20receptor">Human chemokine receptor</a>, <a href="cope.cgi?key=CCRL2A">CCRL2A</a>, <a href="cope.cgi?key=Chemokine%20CC%20Receptor%2dlike%2d2A">Chemokine CC Receptor-like-2A</a>, <a href="cope.cgi?key=CCRL2B">CCRL2B</a>, <a href="cope.cgi?key=Chemokine%20CC%20Receptor%2dlike%2d2B">Chemokine CC Receptor-like-2B</a>, <a href="cope.cgi?key=CRAM%2dA">CRAM-A</a>, <a href="cope.cgi?key=chemokine%20receptor%20expressed%20in%20activated%20monocytes%20A">chemokine receptor expressed in activated monocytes A</a>, <a href="cope.cgi?key=CRAM%2dB">CRAM-B</a>, <a href="cope.cgi?key=chemokine%20receptor%20expressed%20in%20activated%20monocytes%20B">chemokine receptor expressed in activated monocytes B</a>, <a href="cope.cgi?key=CRAM">CRAM</a>, <a href="cope.cgi?key=chemokine%20receptor%20expressed%20in%20activated%20monocytes">chemokine receptor expressed in activated monocytes</a>) (Migeotte et al, 2002; Galligan CL et al, 2004; Otero K et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD1">CD1</a></b> (<a href="cope.cgi?key=CD1a">CD1a</a>, <a href="cope.cgi?key=T6">T6</a>, <a href="cope.cgi?key=Leu6">Leu6</a>, <a href="cope.cgi?key=R4">R4</a>, <a href="cope.cgi?key=HTA1">HTA1</a>, <a href="cope.cgi?key=human%20thymocyte%20antigen%2d1">human thymocyte antigen-1</a>, <a href="cope.cgi?key=NA1%2f34">NA1/34</a>) (Busshoff et al, 2001; Santin et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD1c">CD1c</a></b> (<a href="cope.cgi?key=BDCA1">BDCA1</a>, <a href="cope.cgi?key=Blood%20dendritic%20cell%20antigen%201">blood dendritic cell antigen 1</a>) (Karlsson KR et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD1d1">CD1d1</a></b> (<a href="cope.cgi?key=CD1%2e1">CD1.1</a>, <a href="cope.cgi?key=R3">R3</a>, <a href="cope.cgi?key=R3G1">R3G1</a>, <a href="cope.cgi?key=Ly38">Ly38</a>) (Roark et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD4">CD4</a></b> (<a href="cope.cgi?key=T4">T4</a>, <a href="cope.cgi?key=Leu3">Leu3</a>, <a href="cope.cgi?key=OKT4">OKT4</a>, <a href="cope.cgi?key=L3T4">L3T4</a>, <a href="cope.cgi?key=Ly4">Ly4</a>, <a href="cope.cgi?key=W3%2f25">W3/25</a>, <a href="cope.cgi?key=OX38">OX38</a>, <a href="cope.cgi?key=OX35">OX35</a>) (Lee et al, 1988; Carcamo et al, 1996; Lewin et al, 1996; Hermann et al, 1999; Baba et al, 2006; Shen R et al, 2009; Karlsson KR et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD5L">CD5L</a></b> (<a href="cope.cgi?key=CD5%2dlike">CD5-like</a>, <a href="cope.cgi?key=SP%2dalpha">SP-alpha</a>, <a href="cope.cgi?key=AIM">AIM</a>, <a href="cope.cgi?key=apoptosis%20inhibitor%20expressed%20by%20macrophages">apoptosis inhibitor expressed by macrophages</a>, <a href="cope.cgi?key=API6">API6</a>, <a href="cope.cgi?key=Apoptosis%20inhibitor%206">Apoptosis inhibitor 6</a>) (Haruta et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD8">CD8</a></b> (<a href="cope.cgi?key=T8">T8</a>, <a href="cope.cgi?key=Leu2">Leu2</a>, <a href="cope.cgi?key=Lyt2">Lyt2</a>, <a href="cope.cgi?key=OKT8">OKT8</a>, <a href="cope.cgi?key=CD8%2dalpha">CD8-alpha</a>, <a href="cope.cgi?key=CD8a">CD8a</a>, <a href="cope.cgi?key=Ly2">Ly2</a>, <a href="cope.cgi?key=OX8">OX8</a>, <a href="cope.cgi?key=CD8%2dbeta">CD8-beta</a>, <a href="cope.cgi?key=CD8b">CD8b</a>, <a href="cope.cgi?key=Lyt3">Lyt3</a>, <a href="cope.cgi?key=Ly3">Ly3</a>) (Hirji et al, 1999; Baba et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD8%2dalpha">CD8-alpha</a></b> (<a href="cope.cgi?key=CD8a">CD8a</a>, <a href="cope.cgi?key=Lyt2">Lyt2</a>, <a href="cope.cgi?key=Ly2">Ly2</a>, <a href="cope.cgi?key=OX8">OX8</a>) (Lin et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD9">CD9</a></b> (<a href="cope.cgi?key=602%2d29%20antigen">602-29 antigen</a>, <a href="cope.cgi?key=ALB6%20antigen">ALB6 antigen</a>, <a href="cope.cgi?key=BA2">BA2</a>, <a href="cope.cgi?key=BTCC%2d1">BTCC-1</a>, <a href="cope.cgi?key=DRAP%2d27">DRAP-27</a>, <a href="cope.cgi?key=Diphtheria%20toxin%20receptor%20associated%20protein%2027%20kDa">Diphtheria toxin receptor associated protein 27 kDa</a>, <a href="cope.cgi?key=GIG2">GIG2</a>, <a href="cope.cgi?key=MIC3">MIC3</a>, <a href="cope.cgi?key=MRP%2d1">MRP-1</a>, <a href="cope.cgi?key=Motility%2drelated%20protein%2d1">Motility-related protein-1</a>, <a href="cope.cgi?key=NCA">NCA</a>, <a href="cope.cgi?key=neural%20cell%20surface%20antigen">neural cell surface antigen</a>, <a href="cope.cgi?key=p24">p24</a>, <a href="cope.cgi?key=SH%2d9">SH-9</a>, <a href="cope.cgi?key=TSPAN29">TSPAN29</a>, <a href="cope.cgi?key=Tetraspanin%2029">tetraspanin 29</a>) (Kaji et al, 2001; Wang et al, 2002; Ouchi et al, 1998; Taylor et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD11a">CD11a</a></b> (<a href="cope.cgi?key=ITGAL">ITGAL</a>, <a href="cope.cgi?key=integrin%2dalpha%2dL">integrin-alpha-L</a>, <a href="cope.cgi?key=LFA%2d1">LFA-1</a>, <a href="cope.cgi?key=Ly15">Ly15</a>, <a href="cope.cgi?key=Ly21">Ly21</a>, <a href="cope.cgi?key=LFA%2d1">LFA-1</a>, <a href="cope.cgi?key=lymphocyte%20function%2dassociated%20antigen%2d1">lymphocyte function-associated antigen-1</a>, <a href="cope.cgi?key=LFA%2d1%2dalpha">LFA-1-alpha</a>, <a href="cope.cgi?key=lymphocyte%20function%2dassociated%20antigen%2d1%2dalpha">lymphocyte function-associated antigen-1-alpha</a>, <a href="cope.cgi?key=neutrophil%20adherence%20receptor%20alpha%2dM%20subunit">neutrophil adherence receptor alpha-M subunit</a>, <a href="cope.cgi?key=OND%28a%29">OND(a)</a>, <a href="cope.cgi?key=OND">OND</a>) Carcamo et al, 1996; Prieto et al, 1994; Stent et al, 1995; Ammon et al, 2000; Schaberg et al, 1992; Athanasou and Quinn, 1990; Lee et al, 1988)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD11b">CD11b</a></b> (<a href="cope.cgi?key=CR3">CR3</a>, <a href="cope.cgi?key=CR3a">CR3a</a>, <a href="cope.cgi?key=complement%20receptor%2d3">complement receptor-3</a>, <a href="cope.cgi?key=C3bi%20receptor">C3bi receptor</a>, <a href="cope.cgi?key=ITGAM">ITGAM</a>, <a href="cope.cgi?key=integrin%2dalpha%2dM">integrin-alpha-M</a>, <a href="cope.cgi?key=HNA4a">HNA4a</a>, <a href="cope.cgi?key=human%20neutrophil%20antigen%204a">human neutrophil antigen 4a</a>, <a href="cope.cgi?key=MART">MART</a>, <a href="cope.cgi?key=MART%28a%29">MART(a)</a>, <a href="cope.cgi?key=Mo1">Mo1</a>, <a href="cope.cgi?key=Ly40">Ly40</a>, <a href="cope.cgi?key=Mac%2d1">Mac-1</a>, <a href="cope.cgi?key=OKM1">OKM1</a>, <a href="cope.cgi?key=OX42">OX42</a>, <a href="cope.cgi?key=VIM12">VIM12</a>) (Carcamo et al, 1996; Husemann et al, 2001; Prieto et al, 1994; Stent et al, 1995; Ammon et al, 2000; Schaberg et al, 1992; Athanasou and Quinn, 1990; Maruyama et al, 2005; Yamada et al, 2005; Gil et al, 2009; Sakata et al, 1992; Lee et al, 1988; Lifshitz et al, 2010; van der Laan et al, 1996; Liu L et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD11c">CD11c</a></b> (<a href="cope.cgi?key=CR4">CR4</a>, <a href="cope.cgi?key=complement%20receptor%2d4">complement receptor-4</a>, <a href="cope.cgi?key=iC3b%20receptor">iC3b receptor</a>, <a href="cope.cgi?key=ITGAX">ITGAX</a>, <a href="cope.cgi?key=integrin%2dalpha%2dX">integrin-alpha-X</a>, <a href="cope.cgi?key=Leu%20M5">Leu M5</a>, <a href="cope.cgi?key=myeloid%20membrane%20antigen">myeloid membrane antigen</a>, <a href="cope.cgi?key=OX42">OX42</a>, <a href="cope.cgi?key=p150%2c95">p150,95</a>) (Carcamo et al, 1996; Prieto et al, 1994; Stent et al, 1995; Ammon et al, 2000; Schaberg et al, 1992; Athanasou and Quinn, 1990; Taylor et al, 2000; Gil et al, 2009; Lee et al, 1988)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD11d">CD11d</a></b> (<a href="cope.cgi?key=ITGAD">ITGAD</a>, <a href="cope.cgi?key=integrin%2dalpha%2dD">integrin-alpha-D</a>, <a href="cope.cgi?key=leukointegrin%2dalpha%2dD">leukointegrin-alpha-D</a>) (Noti, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD13">CD13</a></b> (<a href="cope.cgi?key=Alanyl%20aminopeptidase">alanyl aminopeptidase</a>, <a href="cope.cgi?key=AAP">AAP</a>, <a href="cope.cgi?key=ANPEP">ANPEP</a>, <a href="cope.cgi?key=alpha%2daminoacyl%2dpeptide%20hydrolase">alpha-aminoacyl-peptide hydrolase</a> (microsomal), <a href="cope.cgi?key=aminopeptidase%20N">aminopeptidase N</a>, <a href="cope.cgi?key=PEPN">PEPN</a>, <a href="cope.cgi?key=APN">APN</a>, <a href="cope.cgi?key=APM">APM</a>, <a href="cope.cgi?key=Aminopeptidase%20M">aminopeptidase M</a>, <a href="cope.cgi?key=EC3%2e4%2e11%2e2">EC3.4.11.2</a>, <a href="cope.cgi?key=LAP1">LAP1</a>, <a href="cope.cgi?key=Microsomal%20aminopeptidase">microsomal aminopeptidase</a>, <a href="cope.cgi?key=MY7">MY7</a>, <a href="cope.cgi?key=MCS%2d2">MCS-2</a>, <a href="cope.cgi?key=gp150">gp150</a>) (Hoogsteden et al, 1989; Lee et al, 1988; Chen et al, 1996; Van Hal et al, 1992; Taylor et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD14">CD14</a></b> (<a href="cope.cgi?key=endotoxin%20receptor">endotoxin receptor</a>, <a href="cope.cgi?key=Leu%20M3">Leu M3</a>, <a href="cope.cgi?key=LPS%2dR">LPS-R</a>, <a href="cope.cgi?key=Mo2">Mo2</a>, <a href="cope.cgi?key=MY4">MY4</a>, <a href="cope.cgi?key=myeloid%20cell%2dspecific%20leucine%2drich%20glycoprotein">myeloid cell-specific leucine-rich glycoprotein</a>, <a href="cope.cgi?key=hdl">hdl</a>, <a href="cope.cgi?key=heedless">heedless</a>) (Hoogsteden et al, 1989; Lee et al, 1988; Carcamo et al, 1996; Cauli et al, 1997; Schoppmann et al, 2002; Santin et al, 1999; Ocklind et al, 1992; Sarkar et al, 2003; Tobias and Ulevitch, 1993; Liu et al, 2000; Iwahashi et al, 2000; Athanasou and Quinn, 1990; Austin et al, 2005; Yoshioka et al, 2009; Shen R et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD15">CD15</a></b> (<a href="cope.cgi?key=3%2dFAL">3-FAL</a>, <a href="cope.cgi?key=3%2dFucosyl%2dN%2dAcetyllactosamine">3-Fucosyl-N-Acetyllactosamine</a>, <a href="cope.cgi?key=3%2dFL">3-FL</a>, <a href="cope.cgi?key=3%2dFucosyl%2dlactosamine">3-Fucosyl-lactosamine</a>, <a href="cope.cgi?key=80H%2e5">80H.5</a>, <a href="cope.cgi?key=AGF%204%2e48">AGF 4.48</a>, <a href="cope.cgi?key=C3D%2d1">C3D-1</a>, <a href="cope.cgi?key=DAKO%2dM1">DAKO-M1</a>, <a href="cope.cgi?key=ELFT">ELFT</a>, <a href="cope.cgi?key=ELAM%2d1%20ligand%20fucosyltransferase">ELAM-1 ligand fucosyltransferase</a>, <a href="cope.cgi?key=FAL">FAL</a>, <a href="cope.cgi?key=Fucosyl%2dN%2dAcetyllactosamine">Fucosyl-N-Acetyllactosamine</a>, <a href="cope.cgi?key=3%2dalpha%2dfucosyl%2dN%2dacetyl%2dlactosamine">3-alpha-fucosyl-N-acetyl-lactosamine</a>, <a href="cope.cgi?key=FCT3A">FCT3A</a>, <a href="cope.cgi?key=alpha%2d3%2dfucosyltransferase">alpha-3-fucosyltransferase</a>, <a href="cope.cgi?key=FUC%2dT%2dIV">FUC-T-IV</a>, <a href="cope.cgi?key=fucosyltransferase%204">fucosyltransferase 4</a>, <a href="cope.cgi?key=FUT%2d4">FUT-4</a>, <a href="cope.cgi?key=fucosyltransferase%204">fucosyltransferase 4</a>, <a href="cope.cgi?key=LeuM1">LeuM1</a>, <a href="cope.cgi?key=LeX">LeX</a>, <a href="cope.cgi?key=Lewis%20X">Lewis X</a>, <a href="cope.cgi?key=X%2dhapten">X-hapten</a>, <a href="cope.cgi?key=hapten%20X">hapten X</a>, <a href="cope.cgi?key=X%2ddeterminant">X-determinant</a>, <a href="cope.cgi?key=LNF%2d3">LNF-3</a>, <a href="cope.cgi?key=lacto%2dN%2dfucopentaose%203">lacto-N-fucopentaose 3</a>, <a href="cope.cgi?key=LNFP%2d3">LNFP-3</a>, <a href="cope.cgi?key=Lacto%2dN%2dFucopentose%203%20ceramide">Lacto-N-Fucopentose 3 ceramide</a>, <a href="cope.cgi?key=MMA">MMA</a>, <a href="cope.cgi?key=My%2d1">My-1</a>, <a href="cope.cgi?key=myeloid%2dassociated%20surface%20antigen">myeloid-associated surface antigen</a>, <a href="cope.cgi?key=PMN7">PMN7</a>, <a href="cope.cgi?key=polymorphonuclear%20leukocyte%20antigen%207">polymorphonuclear leukocyte antigen 7</a>, <a href="cope.cgi?key=SSEA%2d1">SSEA-1</a>, <a href="cope.cgi?key=stage%2dspecific%20embryonic%20antigen%2d1">stage-specific embryonic antigen-1</a>) (Prieto et al, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD15s">CD15s</a></b> (<a href="cope.cgi?key=CD15">CD15</a>, <a href="cope.cgi?key=3%2dFAL">3-FAL</a>, <a href="cope.cgi?key=3%2dFucosyl%2dN%2dAcetyllactosamine">3-Fucosyl-N-Acetyllactosamine</a>, <a href="cope.cgi?key=3%2dFL">3-FL</a>, <a href="cope.cgi?key=3%2dFucosyl%2dlactosamine">3-Fucosyl-lactosamine</a>, <a href="cope.cgi?key=80H%2e5">80H.5</a>, <a href="cope.cgi?key=AGF%204%2e48">AGF 4.48</a>, <a href="cope.cgi?key=C3D%2d1">C3D-1</a>, <a href="cope.cgi?key=DAKO%2dM1">DAKO-M1</a>, <a href="cope.cgi?key=ELFT">ELFT</a>, <a href="cope.cgi?key=ELAM%2d1%20ligand%20fucosyltransferase">ELAM-1 ligand fucosyltransferase</a>, <a href="cope.cgi?key=FAL">FAL</a>, <a href="cope.cgi?key=Fucosyl%2dN%2dAcetyllactosamine">Fucosyl-N-Acetyllactosamine</a>, <a href="cope.cgi?key=3%2dalpha%2dfucosyl%2dN%2dacetyl%2dlactosamine">3-alpha-fucosyl-N-acetyl-lactosamine</a>, <a href="cope.cgi?key=FCT3A">FCT3A</a>, <a href="cope.cgi?key=alpha%2d3%2dfucosyltransferase">alpha-3-fucosyltransferase</a>, <a href="cope.cgi?key=FUC%2dT%2dIV">FUC-T-IV</a>, <a href="cope.cgi?key=fucosyltransferase%204">fucosyltransferase 4</a>, <a href="cope.cgi?key=FUT%2d4">FUT-4</a>, <a href="cope.cgi?key=fucosyltransferase%204">fucosyltransferase 4</a>, <a href="cope.cgi?key=LeuM1">LeuM1</a>, <a href="cope.cgi?key=LeX">LeX</a>, <a href="cope.cgi?key=Lewis%20X">Lewis X</a>, <a href="cope.cgi?key=X%2dhapten">X-hapten</a>, <a href="cope.cgi?key=hapten%20X">hapten X</a>, <a href="cope.cgi?key=X%2ddeterminant">X-determinant</a>, <a href="cope.cgi?key=LNF%2d3">LNF-3</a>, <a href="cope.cgi?key=lacto%2dN%2dfucopentaose%203">lacto-N-fucopentaose 3</a>, <a href="cope.cgi?key=LNFP%2d3">LNFP-3</a>, <a href="cope.cgi?key=Lacto%2dN%2dFucopentose%203%20ceramide">Lacto-N-Fucopentose 3 ceramide</a>, <a href="cope.cgi?key=MMA">MMA</a>, <a href="cope.cgi?key=My%2d1">My-1</a>, <a href="cope.cgi?key=myeloid%2dassociated%20surface%20antigen">myeloid-associated surface antigen</a>, <a href="cope.cgi?key=PMN7">PMN7</a>, <a href="cope.cgi?key=polymorphonuclear%20leukocyte%20antigen%207">polymorphonuclear leukocyte antigen 7</a>, <a href="cope.cgi?key=SSEA%2d1">SSEA-1</a>, <a href="cope.cgi?key=stage%2dspecific%20embryonic%20antigen%2d1">stage-specific embryonic antigen-1</a>) (Prieto et al, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD16">CD16</a></b> (<a href="cope.cgi?key=hFcRIII">hFcRIII</a>, <a href="cope.cgi?key=Fc%2dgamma%20R3">Fc-gamma R3</a>, <a href="cope.cgi?key=FCGR3A">FCGR3A</a>, <a href="cope.cgi?key=FCGR3">FCGR3</a>, <a href="cope.cgi?key=Neutrophil%20antigen%20NA">Neutrophil antigen NA</a>, <a href="cope.cgi?key=HNA1">HNA1</a>, <a href="cope.cgi?key=human%20neutrophil%20antigen%201">human neutrophil antigen 1</a>, <a href="cope.cgi?key=Leu11">Leu11</a>, <a href="cope.cgi?key=VEP13">VEP13</a>, <a href="cope.cgi?key=B73%2e1">B73.1</a>, <a href="cope.cgi?key=31D8">31D8</a>, <a href="cope.cgi?key=N901">N901</a>) (Hashimoto et al, 1997; Carcamo et al, 1996; Bonilla et al, 2000; Kedzierska et al, 2001; Shushakova et al, 2002; Masuda et al, 2003; Kramer et al, 2004; Loke et al, 2004; Chang, 1995; Sivo et al, 1993; Athanasou and Quinn, 1990; Masuda et al, 2006; Lee et al, 1988; Arikawa et al, 2009; Shen R et al, 2009; Ambarus et al, 2012; Wu Z et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD18">CD18</a></b> (<a href="cope.cgi?key=ITGB2">ITGB2</a>, <a href="cope.cgi?key=integrin%2dbeta%2d2">integrin-beta-2</a>, <a href="cope.cgi?key=2E6">2E6</a>, <a href="cope.cgi?key=AURA46">AURA46</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2046">augmented in rheumatoid arthritis 46</a>) (Carcamo et al, 1996; Husemann et al, 2001; Stent et al, 1995; Sethi and Sodhi, 2004; Ammon et al, 2000; Schaberg et al, 1992; Athanasou and Quinn, 1990; Vaisar et al, 2009; Lee et al, 1988; Karlsson KR et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD20L5">CD20L5</a></b> (<a href="cope.cgi?key=CD20%2dlike%2d5">CD20-like-5</a>, <a href="cope.cgi?key=MS4A8A">MS4A8A</a>, <a href="cope.cgi?key=Membrane%2dspanning%204%2ddomains%20subfamily%20A%20member%208A">Membrane-spanning 4-domains subfamily A member 8A</a>) (Schmieder et al, 2011, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD23">CD23</a></b> (<a href="cope.cgi?key=CD23a">CD23a</a>, <a href="cope.cgi?key=CD23b">CD23b</a>, <a href="cope.cgi?key=FCER2">FCER2</a>, <a href="cope.cgi?key=Fc%2depsilon%20R2">Fc-epsilon R2</a>, <a href="cope.cgi?key=Leu20">Leu20</a>, <a href="cope.cgi?key=B6">B6</a>, <a href="cope.cgi?key=Blast%2d2">Blast-2</a>, <a href="cope.cgi?key=18%2e6%20antigen">18.6 antigen</a>, <a href="cope.cgi?key=Ly42">Ly42</a>, <a href="cope.cgi?key=CLEC4J">CLEC4J</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%204%20member%20J">C-type lectin domain family 4 member J</a>, <a href="cope.cgi?key=EBVCS">EBVCS</a>, <a href="cope.cgi?key=EBV%20cell%20surface%20antigen">EBV cell surface antigen</a>, <a href="cope.cgi?key=EBVCS1">EBVCS1</a>, <a href="cope.cgi?key=EBVCS2">EBVCS2</a>, <a href="cope.cgi?key=EBVCS3">EBVCS3</a>, <a href="cope.cgi?key=EBVCS4">EBVCS4</a>, <a href="cope.cgi?key=EBVCS5">EBVCS5</a>, <a href="cope.cgi?key=MHM6">MHM6</a>) (Dugas et al, 1996; Schoppmann et al, 2002; Matz et al, 1994; Van Hal et al, 1992)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD24">CD24</a></b> (<a href="cope.cgi?key=CD24a">CD24a</a>, <a href="cope.cgi?key=30F1">30F1</a>, <a href="cope.cgi?key=B2A2">B2A2</a>, <a href="cope.cgi?key=BA%2d1">BA-1</a>, <a href="cope.cgi?key=HB8">HB8</a>, <a href="cope.cgi?key=VIB%20E3">VIB E3</a>, <a href="cope.cgi?key=HIS50">HIS50</a>, <a href="cope.cgi?key=HSA">HSA</a>, <a href="cope.cgi?key=heat%20stable%20antigen">heat stable antigen</a>, <a href="cope.cgi?key=J11d">J11d</a>, <a href="cope.cgi?key=JIId">JIId</a>, <a href="cope.cgi?key=Ly52">Ly52</a>, <a href="cope.cgi?key=M1%2f69">M1/69</a>, <a href="cope.cgi?key=Nectadrin">Nectadrin</a>, <a href="cope.cgi?key=LR%2d1">LR-1</a>, <a href="cope.cgi?key=SCLC%20surface%20antigen%20Cluster%2d4">SCLC surface antigen Cluster-4</a>, <a href="cope.cgi?key=CL%2d4">CL-4</a>; <a href="cope.cgi?key=R13%2dAg">R13-Ag</a>, <a href="cope.cgi?key=R13%20antigen">R13 antigen</a>, <a href="cope.cgi?key=X62%20heat%20stable%20antigen">X62 heat stable antigen</a>)<b style="mso-bidi-font-weight:normal"> </b>(Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD26">CD26</a></b> (<a href="cope.cgi?key=1F7">1F7</a>, <a href="cope.cgi?key=2B9">2B9</a>, <a href="cope.cgi?key=5F8">5F8</a>, <a href="cope.cgi?key=ACT%2d3">ACT-3</a>, <a href="cope.cgi?key=ADABP">ADABP</a>, <a href="cope.cgi?key=ADA%20binding%20protein">ADA binding protein</a>, <a href="cope.cgi?key=ADCP2">ADCP2</a>, <a href="cope.cgi?key=adenosine%20deaminase%20complexing%20protein%202">adenosine deaminase complexing protein 2</a>, <a href="cope.cgi?key=BT5%2f9">BT5/9</a>, <a href="cope.cgi?key=DPCR1">DPCR1</a>, <a href="cope.cgi?key=DPP4">DPP4</a>, <a href="cope.cgi?key=dipeptidyl%20peptidase%204">dipeptidyl peptidase 4</a>, <a href="cope.cgi?key=HAM%2e4">HAM.4</a>, <a href="cope.cgi?key=intestinal%20dipeptidyl%20peptidase">intestinal dipeptidyl peptidase</a>, <a href="cope.cgi?key=EC3%2e4%2e14%2e5">EC3.4.14.5</a>, <a href="cope.cgi?key=OX61">OX61</a>, <a href="cope.cgi?key=TA1">TA1</a>, <a href="cope.cgi?key=TA5%2f9">TA5/9</a>, <a href="cope.cgi?key=THAM">THAM</a>, <a href="cope.cgi?key=thymocyte%2dactivating%20molecule">thymocyte-activating molecule</a>, <a href="cope.cgi?key=TP103">TP103</a>, <a href="cope.cgi?key=WC10%20antigen">WC10 antigen</a>, <a href="cope.cgi?key=FAP%2dbeta">FAP-beta</a>, <a href="cope.cgi?key=Fibroblast%20activation%20protein%2dbeta">Fibroblast activation protein-beta</a>) (Watkins et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD27%20ligand">CD27 ligand</a></b> (<a href="cope.cgi?key=CD27L">CD27L</a>, <a href="cope.cgi?key=CD27LG">CD27LG</a>, <a href="cope.cgi?key=CD70">CD70</a>, <a href="cope.cgi?key=Ki%2d24">Ki-24</a>, <a href="cope.cgi?key=TNFSF7">TNFSF7</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%207">TNF ligand superfamily member 7</a>) (Moreno-Altamirano et al, 2004; de Boer OJ et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD28">CD28</a></b> (<a href="cope.cgi?key=T90%2f44">T90/44</a>, <a href="cope.cgi?key=Tp44">Tp44</a>, <a href="cope.cgi?key=Kolt%2d2">Kolt-2</a>) (de Boer OJ et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD29">CD29</a></b> (<a href="cope.cgi?key=FNRB">FNRB</a>, <a href="cope.cgi?key=fibronectin%20receptor%20beta%20chain">fibronectin receptor beta chain</a>, <a href="cope.cgi?key=ITGB1">ITGB1</a>, <a href="cope.cgi?key=integrin%2dbeta%2d1">integrin-beta-1</a>, <a href="cope.cgi?key=platelet%20protein%20GPIIa">platelet protein GPIIa</a>, <a href="cope.cgi?key=VLA%2dbeta">VLA-beta</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%2dbeta">very late activation antigen-beta</a>, <a href="cope.cgi?key=VLA%2dbeta%2d1">VLA-beta-1</a>, <a href="cope.cgi?key=VLA%2d4%20beta%20subunit">VLA-4 beta subunit</a>) (Ammon et al, 2000; Taylor et al, 2000; Suzuki et al, 2007; Liakka KA, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD30">CD30</a></b> (<a href="cope.cgi?key=Ki%2d1">Ki-1</a>, <a href="cope.cgi?key=Ki%2d2">Ki-2</a>, <a href="cope.cgi?key=R4%2d4">R4-4</a>, <a href="cope.cgi?key=Ber%20H2">Ber H2</a> antigen, <a href="cope.cgi?key=TNFRSF8">TNFRSF8</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%208">TNF receptor superfamily member 8</a>) (Horie et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=CD30%20ligand">CD30 ligand</a></b> (<a href="cope.cgi?key=CD30L">CD30L</a>, <a href="cope.cgi?key=CD153">CD153</a>, <a href="cope.cgi?key=TNFSF8">TNFSF8</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%208">TNF ligand superfamily member 8</a>) (Nicod and Isler, 1997; Moreno-Altamirano et al, 2004; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD31">CD31</a></b> (<a href="cope.cgi?key=EndoCAM">EndoCAM</a>, <a href="cope.cgi?key=endothelial%20cellular%20adhesion%20molecule">endothelial cellular adhesion molecule</a>, <a href="cope.cgi?key=ER%2dMP12">ER-MP12</a>, <a href="cope.cgi?key=PECAM%2d1">PECAM-1</a>, <a href="cope.cgi?key=platelet%2dendothelial%20cell%20adhesion%20molecule%201">platelet-endothelial cell adhesion molecule 1</a>) (He et al, 2009; Lee et al, 1988; Athanasou and Quinn, 1990; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD32">CD32</a></b> (<a href="cope.cgi?key=hFcRII">hFcRII</a>, <a href="cope.cgi?key=Fc%2dgamma%20R2">Fc-gamma R2</a>, <a href="cope.cgi?key=FCG2">FCG2</a>, <a href="cope.cgi?key=FCGR2">FCGR2</a>, <a href="cope.cgi?key=CD32a">CD32a</a>, <a href="cope.cgi?key=CD32b">CD32b</a>, <a href="cope.cgi?key=FCGR2A">FCGR2A</a>, <a href="cope.cgi?key=Fc%2dgamma%20R2a">Fc-gamma R2a</a>, <a href="cope.cgi?key=FCGR2B">FCGR2B</a>, <a href="cope.cgi?key=Fc%2dgamma%20R2b">Fc-gamma R2b</a>, <a href="cope.cgi?key=IGFR2">IGFR2</a>, <a href="cope.cgi?key=immunoglobulin%20G%20Fc%20receptor%202">immunoglobulin G Fc receptor 2</a>) (Lee et al, 1988; Hashimoto et al, 1997; Bonilla et al, 2000; Kedzierska et al, 2001; Kovalenko et al, 2004; Bonfield et al, 2003; Susaki et al, 1998; Chang, 1995; Sivo et al, 1993; Athanasou and Quinn, 1990; Arikawa et al, 2009; Shen R et al, 2009; Gleissner et al, 2010; Karlsson KR et al, 2008; Ambarus et al, 2012; Ban JY et al, 2011; Wu Z et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD33">CD33</a></b> (<a href="cope.cgi?key=CD33M">CD33M</a>, <a href="cope.cgi?key=CD33m">CD33m</a>, <a href="cope.cgi?key=MY9">MY9</a>, <a href="cope.cgi?key=SIGLEC%2d3">SIGLEC-3</a>, <a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%203">sialic acid binding immunoglobulin-like lectin 3</a>) (Munday et al, 1999; Rogler et al, 1998; Karlsson KR et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD35">CD35</a></b> (<a href="cope.cgi?key=C3%20binding%20protein">C3 binding protein</a>, <a href="cope.cgi?key=C3b%20receptor">C3b receptor</a>, <a href="cope.cgi?key=C3bR">C3bR</a>, <a href="cope.cgi?key=C3b%2fC4b%20receptor">C3b/C4b receptor</a>, <a href="cope.cgi?key=C4b%20receptor">C4b receptor</a>, <a href="cope.cgi?key=complement%203b%2f4b%20receptor">complement 3b/4b receptor</a>, <a href="cope.cgi?key=CR1">CR1</a>, <a href="cope.cgi?key=complement%20receptor%2d1">complement receptor-1</a>, <a href="cope.cgi?key=Knops%20blood%20group%20antigen">Knops blood group antigen</a>, <a href="cope.cgi?key=Kn%28a%29">Kn(a)</a>, <a href="cope.cgi?key=Kn%28b%29">Kn(b)</a>, <a href="cope.cgi?key=McCoy%20blood%20group%20antigen">McCoy blood group antigen</a>, <a href="cope.cgi?key=McC">McC</a>, <a href="cope.cgi?key=Swain%2dLangley%20blood%20group%20antigen">Swain-Langley blood group antigen</a>, <a href="cope.cgi?key=Sl">Sl</a>, <a href="cope.cgi?key=Yk%28a%29">Yk(a)</a>, <a href="cope.cgi?key=York%20blood%20group%20antigen">York blood group antigen</a>) (Athanasou and Quinn, 1990; Karlsson KR et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD36">CD36</a></b> (<a href="cope.cgi?key=collagen%20type%201%20receptor">collagen type 1 receptor</a>, <a href="cope.cgi?key=FAT">FAT</a>, <a href="cope.cgi?key=fatty%20acid%20translocase">fatty acid translocase</a>, <a href="cope.cgi?key=glycoprotein%203b">glycoprotein 3b</a>, <a href="cope.cgi?key=GP4">GP4</a>, <a href="cope.cgi?key=platelet%20glycoprotein%204">platelet glycoprotein 4</a>, <a href="cope.cgi?key=GPIIIb">GPIIIb</a>, <a href="cope.cgi?key=Naka%20blood%20group%20antigen">Naka blood group antigen</a>, <a href="cope.cgi?key=OKM5">OKM5</a>, <a href="cope.cgi?key=PAS%2d4%20protein">PAS-4 protein</a>, <a href="cope.cgi?key=periodic%20acid%2fSchiff%2dpositive%20protein%204">periodic acid/Schiff-positive protein 4</a>, <a href="cope.cgi?key=PASIV">PASIV</a>, <a href="cope.cgi?key=periodic%20acid%2fSchiff%2dpositive%20band%204">periodic acid/Schiff-positive band 4</a>, <a href="cope.cgi?key=platelet%20collagen%20receptor">platelet collagen receptor</a>, <a href="cope.cgi?key=thrombospondin%20receptor">thrombospondin receptor</a>, <a href="cope.cgi?key=UA009">UA009</a>, <a href="cope.cgi?key=obl">obl</a>, <a href="cope.cgi?key=oblivious">oblivious</a>) (Janabi et al, 2001; Lonati et al, 1996; Nakata et al, 1999; Wintergerst et al, 1998; Nakagawa et al, 1998; Zhang et al, 2003; Liang et al, 2004; Hodgkinson and Ye, 2003; Tsukamoto et al, 2002; Vallve et al, 2002; Draude and Lorenz, 2000; Yoshida et al, 1998; Athanasou and Quinn, 1990; Taylor et al, 2000; Maruyama et al, 2008; Yun et al, 2009; Martens et al, 2006; Gleissner et al, 2010; Ren J et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD37">CD37</a></b> (<a href="cope.cgi?key=gp40%2d52">gp40-52</a>, <a href="cope.cgi?key=GP52%2d40">GP52-40</a>, <a href="cope.cgi?key=HD28">HD28</a>, <a href="cope.cgi?key=BL14">BL14</a>, <a href="cope.cgi?key=IPO%2d24">IPO-24</a>, <a href="cope.cgi?key=MB%2d1">MB-1</a>, <a href="cope.cgi?key=TSPAN26">TSPAN26</a>, <a href="cope.cgi?key=Tetraspanin%2026">Tetraspanin 26</a>) (Athanasou and Quinn, 1990)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD38">CD38</a></b> (<a href="cope.cgi?key=ADP%2dribosyl%20cyclase">ADP-ribosyl cyclase</a>, <a href="cope.cgi?key=ADP%2dribosyl%20cyclase%2d1">ADP-ribosyl cyclase-1</a>, <a href="cope.cgi?key=cyclic%20ADP%2dribose%20hydrolase">cyclic ADP-ribose hydrolase</a>, <a href="cope.cgi?key=ecto%2dNAD%2b%20glycohydrolase">ecto-NAD+ glycohydrolase</a>, <a href="cope.cgi?key=Ecto%2dnicotinamide%20adenine%20dinucleotide%20glycohydrolase">Ecto-nicotinamide adenine dinucleotide glycohydrolase</a>, <a href="cope.cgi?key=EC3%2e2%2e2%2e5">EC3.2.2.5</a>, <a href="cope.cgi?key=Leu17">Leu17</a>, <a href="cope.cgi?key=OKT10">OKT10</a>, <a href="cope.cgi?key=T10">T10</a>) (Pfister et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD39">CD39</a></b> (<a href="cope.cgi?key=apyrase">apyrase</a>, <a href="cope.cgi?key=ATPDase">ATPDase</a>, <a href="cope.cgi?key=ATP%20diphosphohydrolase">ATP diphosphohydrolase</a>, <a href="cope.cgi?key=EC3%2e6%2e1%2e5">EC3.6.1.5</a>, <a href="cope.cgi?key=Ecto%2dApyrase">Ecto-Apyrase</a>, <a href="cope.cgi?key=Ecto%2dATPase">Ecto-ATPase</a>, <a href="cope.cgi?key=ENTPD1">ENTPD1</a>, <a href="cope.cgi?key=ectonucleoside%20triphosphate%20diphosphohydrolase%201">ectonucleoside triphosphate diphosphohydrolase 1</a>, <a href="cope.cgi?key=NTPDase%2d1">NTPDase-1</a>, <a href="cope.cgi?key=vascular%20ATP%20diphosphohydrolase">vascular ATP diphosphohydrolase</a>, <a href="cope.cgi?key=G28%2d8">G28-8</a>, <a href="cope.cgi?key=Bgp95">Bgp95</a>) (Kansas et al, 1991; Athanasou and Quinn, 1990)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD40">CD40</a></b> (<a href="cope.cgi?key=Bp50">Bp50</a>, <a href="cope.cgi?key=TNFRSF5">TNFRSF5</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%205">TNF receptor superfamily member 5</a>) (Barker et al, 2002; Lai et al, 2003; Kornbluth et al, 1998; di Marzio et al, 2000; Nguyen and Benveniste, 2002; Wesemann et al, 2002; Nicod and Isler, 1997; Wang and Lewis, 2001; Mulhaupt et al, 2003; Quesniaux et al, 2004; Marzio et al, 2003; Santin et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD40%20ligand">CD40 ligand</a></b> (<a href="cope.cgi?key=CD40L">CD40L</a>, <a href="cope.cgi?key=CD40LG">CD40LG</a>, <a href="cope.cgi?key=TRAP">TRAP</a>, <a href="cope.cgi?key=TNF%2drelated%20activation%20protein">TNF-related activation protein</a>, <a href="cope.cgi?key=CD154">CD154</a>, <a href="cope.cgi?key=5c8">5c8</a>, <a href="cope.cgi?key=gp39">gp39</a>, <a href="cope.cgi?key=Ly62">Ly62</a>, <a href="cope.cgi?key=T%2dBAM">T-BAM</a>, <a href="cope.cgi?key=IMD3">IMD3</a>, <a href="cope.cgi?key=TNFSF5">TNFSF5</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%205">TNF ligand superfamily member 5</a>) (Mach et al, 1997; Yang et al, 2000; Glik et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD43">CD43</a></b> (<a href="cope.cgi?key=3E8%20antigen">3E8 antigen</a>, <a href="cope.cgi?key=GALGP">GALGP</a>, <a href="cope.cgi?key=Galactoglycoprotein">galactoglycoprotein</a>, <a href="cope.cgi?key=gpL115">gpL115</a>, <a href="cope.cgi?key=L60">L60</a>, <a href="cope.cgi?key=Leu22">Leu22</a>, <a href="cope.cgi?key=Lp%2d3">Lp-3</a>, <a href="cope.cgi?key=LSN">LSN</a>, <a href="cope.cgi?key=leukosialin">leukosialin</a>, <a href="cope.cgi?key=Ly48">Ly48</a>, <a href="cope.cgi?key=MT1">MT1</a>, <a href="cope.cgi?key=OX75">OX75</a>, <a href="cope.cgi?key=S7%20antigen">S7 antigen</a>, <a href="cope.cgi?key=SPN">SPN</a>, <a href="cope.cgi?key=sialophorin">sialophorin</a>, <a href="cope.cgi?key=W3%2f13">W3/13</a>) (Athanasou and Quinn, 1990)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD44">CD44</a></b> (<a href="cope.cgi?key=CDw44">CDw44</a>, <a href="cope.cgi?key=CD44H">CD44H</a>, <a href="cope.cgi?key=CD44A">CD44A</a>, <a href="cope.cgi?key=CD44s">CD44s</a>, <a href="cope.cgi?key=CD44st">CD44st</a>, <a href="cope.cgi?key=CD44std">CD44std</a>, <a href="cope.cgi?key=AnWj%20blood%20group%20antigen">AnWj blood group antigen</a>, <a href="cope.cgi?key=ECMR%2d3">ECMR-3</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d3">extracellular matrix receptor-3</a>, <a href="cope.cgi?key=class%203%20ECMR">class 3 ECMR</a>, <a href="cope.cgi?key=gp85">gp85</a>, <a href="cope.cgi?key=HCAM">HCAM</a>, <a href="cope.cgi?key=homing%2dassociated%20cell%20adhesion%20molecule">homing-associated cell adhesion molecule</a>, <a href="cope.cgi?key=Hermes%2d1">Hermes-1</a>, <a href="cope.cgi?key=Hermes%20antigen">Hermes antigen</a>, <a href="cope.cgi?key=HUTCH%2d1">HUTCH-1</a>, <a href="cope.cgi?key=Indian%20blood%20group%20antigen">Indian blood group antigen</a>, <a href="cope.cgi?key=In%20blood%20group%20antigen">In blood group antigen</a>, <a href="cope.cgi?key=Ly24">Ly24</a>, <a href="cope.cgi?key=MC56">MC56</a>, <a href="cope.cgi?key=MDU2">MDU2</a>, <a href="cope.cgi?key=MDU3">MDU3</a>, <a href="cope.cgi?key=MIC4">MIC4</a>, <a href="cope.cgi?key=MUC%202%2d63">MUC 2-63</a>, <a href="cope.cgi?key=OX49">OX49</a>, <a href="cope.cgi?key=PGP1">PGP1</a>, <a href="cope.cgi?key=PGP1%2e1">PGP1.1</a>, <a href="cope.cgi?key=phagocytic%20glycoprotein%2d1">phagocytic glycoprotein-1</a>, <a href="cope.cgi?key=GM35%20antigen">GM35 antigen</a>) (Jones et al, 2000; Khaldoyanidi et al, 1999; Krettek et al, 2004; Rogler et al, 1998; Taylor et al, 2000; Cui et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD44v">CD44v</a></b> (<a href="cope.cgi?key=CD44">CD44</a>, <a href="cope.cgi?key=CD44H">CD44H</a>, <a href="cope.cgi?key=CD44A">CD44A</a>, <a href="cope.cgi?key=AnWj%20blood%20group%20antigen">AnWj blood group antigen</a>, <a href="cope.cgi?key=ECMR%2d3">ECMR-3</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d3">extracellular matrix receptor-3</a>, <a href="cope.cgi?key=HCAM">HCAM</a>, <a href="cope.cgi?key=homing%2dassociated%20cell%20adhesion%20molecule">homing-associated cell adhesion molecule</a>, <a href="cope.cgi?key=Hermes%2d1">Hermes-1</a>, <a href="cope.cgi?key=Hermes%20antigen">Hermes antigen</a>, <a href="cope.cgi?key=HUTCH%2d1">HUTCH-1</a>, <a href="cope.cgi?key=Indian%20blood%20group%20antigen">Indian blood group antigen</a>, <a href="cope.cgi?key=In%20blood%20group%20antigen">In blood group antigen</a>, <a href="cope.cgi?key=Ly24">Ly24</a>, <a href="cope.cgi?key=MC56">MC56</a>, <a href="cope.cgi?key=MDU2">MDU2</a>, <a href="cope.cgi?key=MDU3">MDU3</a>, <a href="cope.cgi?key=MIC4">MIC4</a>, <a href="cope.cgi?key=MUC%202%2d63">MUC 2-63</a>, <a href="cope.cgi?key=OX49">OX49</a>, <a href="cope.cgi?key=PGP1">PGP1</a>, <a href="cope.cgi?key=PGP1%2e1">PGP1.1</a>, <a href="cope.cgi?key=phagocytic%20glycoprotein%2d1">phagocytic glycoprotein-1</a>, <a href="cope.cgi?key=GM35%20antigen">GM35 antigen</a>) (Arch et al, 1992)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD44v6">CD44v6</a></b> (<a href="cope.cgi?key=CD44">CD44</a>, <a href="cope.cgi?key=CD44v">CD44v</a>, <a href="cope.cgi?key=CD44H">CD44H</a>, <a href="cope.cgi?key=CD44A">CD44A</a>, <a href="cope.cgi?key=AnWj%20blood%20group%20antigen">AnWj blood group antigen</a>, <a href="cope.cgi?key=ECMR%2d3">ECMR-3</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d3">extracellular matrix receptor-3</a>, <a href="cope.cgi?key=HCAM">HCAM</a>, <a href="cope.cgi?key=homing%2dassociated%20cell%20adhesion%20molecule">homing-associated cell adhesion molecule</a>, <a href="cope.cgi?key=Hermes%2d1">Hermes-1</a>, <a href="cope.cgi?key=Hermes%20antigen">Hermes antigen</a>, <a href="cope.cgi?key=HUTCH%2d1">HUTCH-1</a>, <a href="cope.cgi?key=Indian%20blood%20group%20antigen">Indian blood group antigen</a>, <a href="cope.cgi?key=In%20blood%20group%20antigen">In blood group antigen</a>, <a href="cope.cgi?key=Ly24">Ly24</a>, <a href="cope.cgi?key=MC56">MC56</a>, <a href="cope.cgi?key=MDU2">MDU2</a>, <a href="cope.cgi?key=MDU3">MDU3</a>, <a href="cope.cgi?key=MIC4">MIC4</a>, <a href="cope.cgi?key=MUC%202%2d63">MUC 2-63</a>, <a href="cope.cgi?key=OX49">OX49</a>, <a href="cope.cgi?key=PGP1">PGP1</a>, <a href="cope.cgi?key=PGP1%2e1">PGP1.1</a>, <a href="cope.cgi?key=phagocytic%20glycoprotein%2d1">phagocytic glycoprotein-1</a>, <a href="cope.cgi?key=GM35%20antigen">GM35 antigen</a>) (Krettek et al, 2004; Braumller H et al, 2000; Buckner et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD44v4%2f5">CD44v4/5</a></b> (<a href="cope.cgi?key=CD44">CD44</a>, <a href="cope.cgi?key=CD44v">CD44v</a>, <a href="cope.cgi?key=CD44H">CD44H</a>, <a href="cope.cgi?key=CD44A">CD44A</a>, <a href="cope.cgi?key=AnWj%20blood%20group%20antigen">AnWj blood group antigen</a>, <a href="cope.cgi?key=ECMR%2d3">ECMR-3</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d3">extracellular matrix receptor-3</a>, <a href="cope.cgi?key=HCAM">HCAM</a>, <a href="cope.cgi?key=homing%2dassociated%20cell%20adhesion%20molecule">homing-associated cell adhesion molecule</a>, <a href="cope.cgi?key=Hermes%2d1">Hermes-1</a>, <a href="cope.cgi?key=Hermes%20antigen">Hermes antigen</a>, <a href="cope.cgi?key=HUTCH%2d1">HUTCH-1</a>, <a href="cope.cgi?key=Indian%20blood%20group%20antigen">Indian blood group antigen</a>, <a href="cope.cgi?key=In%20blood%20group%20antigen">In blood group antigen</a>, <a href="cope.cgi?key=Ly24">Ly24</a>, <a href="cope.cgi?key=MC56">MC56</a>, <a href="cope.cgi?key=MDU2">MDU2</a>, <a href="cope.cgi?key=MDU3">MDU3</a>, <a href="cope.cgi?key=MIC4">MIC4</a>, <a href="cope.cgi?key=MUC%202%2d63">MUC 2-63</a>, <a href="cope.cgi?key=OX49">OX49</a>, <a href="cope.cgi?key=PGP1">PGP1</a>, <a href="cope.cgi?key=PGP1%2e1">PGP1.1</a>, <a href="cope.cgi?key=phagocytic%20glycoprotein%2d1">phagocytic glycoprotein-1</a>, <a href="cope.cgi?key=GM35%20antigen">GM35 antigen</a>) (Krettek et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD44v7%2f8">CD44v7/8</a></b> (<a href="cope.cgi?key=CD44">CD44</a>, <a href="cope.cgi?key=CD44v">CD44v</a>, <a href="cope.cgi?key=CD44H">CD44H</a>, <a href="cope.cgi?key=CD44A">CD44A</a>, <a href="cope.cgi?key=AnWj%20blood%20group%20antigen">AnWj blood group antigen</a>, <a href="cope.cgi?key=ECMR%2d3">ECMR-3</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d3">extracellular matrix receptor-3</a>, <a href="cope.cgi?key=HCAM">HCAM</a>, <a href="cope.cgi?key=homing%2dassociated%20cell%20adhesion%20molecule">homing-associated cell adhesion molecule</a>, <a href="cope.cgi?key=Hermes%2d1">Hermes-1</a>, <a href="cope.cgi?key=Hermes%20antigen">Hermes antigen</a>, <a href="cope.cgi?key=HUTCH%2d1">HUTCH-1</a>, <a href="cope.cgi?key=Indian%20blood%20group%20antigen">Indian blood group antigen</a>, <a href="cope.cgi?key=In%20blood%20group%20antigen">In blood group antigen</a>, <a href="cope.cgi?key=Ly24">Ly24</a>, <a href="cope.cgi?key=MC56">MC56</a>, <a href="cope.cgi?key=MDU2">MDU2</a>, <a href="cope.cgi?key=MDU3">MDU3</a>, <a href="cope.cgi?key=MIC4">MIC4</a>, <a href="cope.cgi?key=MUC%202%2d63">MUC 2-63</a>, <a href="cope.cgi?key=OX49">OX49</a>, <a href="cope.cgi?key=PGP1">PGP1</a>, <a href="cope.cgi?key=PGP1%2e1">PGP1.1</a>, <a href="cope.cgi?key=phagocytic%20glycoprotein%2d1">phagocytic glycoprotein-1</a>, <a href="cope.cgi?key=GM35%20antigen">GM35 antigen</a>) (Krettek et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD45">CD45</a></b> (<a href="cope.cgi?key=B220">B220</a>, <a href="cope.cgi?key=HuLy%2dm4">HuLy-m4</a>, <a href="cope.cgi?key=LCA">LCA</a>, <a href="cope.cgi?key=leukocyte%20common%20antigen">leukocyte common antigen</a>, <a href="cope.cgi?key=Ly5">Ly5</a>, <a href="cope.cgi?key=OX1">OX1</a>, <a href="cope.cgi?key=OX22">OX22</a>, <a href="cope.cgi?key=OX30">OX30</a>, <a href="cope.cgi?key=PTPRC">PTPRC</a>, <a href="cope.cgi?key=protein%20tyrosine%20phosphatase%20receptor%20type%20C">protein tyrosine phosphatase receptor type C</a>, <a href="cope.cgi?key=EC3%2e1%2e3%2e4">EC3.1.3.4</a>, <a href="cope.cgi?key=T200">T200</a>) (Schaberg et al, 1992; Taylor et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD46">CD46</a></b> (<a href="cope.cgi?key=gp45%2d70">gp45-70</a>, <a href="cope.cgi?key=HuLy%2dm5">HuLy-m5</a>, <a href="cope.cgi?key=MCP">MCP</a>, <a href="cope.cgi?key=membrane%20cofactor%20protein">membrane cofactor protein</a>, <a href="cope.cgi?key=measles%20virus%20receptor">measles virus receptor</a>, <a href="cope.cgi?key=MIC10">MIC10</a>, <a href="cope.cgi?key=TLX">TLX</a>, <a href="cope.cgi?key=TRA%2d2%2d10">TRA-2-10</a>, <a href="cope.cgi?key=trophoblast%2dleukocyte%20common%20antigen">trophoblast-leukocyte common antigen</a>, <a href="cope.cgi?key=trophoblast%2dlymphocyte%20cross%2dreactive%20antigen">trophoblast-lymphocyte cross-reactive antigen</a>) (Hirano et al, 2002; Kadayama et al, 2000; Korte-Sarfaty et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD49a">CD49a</a></b> (<a href="cope.cgi?key=ITGA1">ITGA1</a>, <a href="cope.cgi?key=integrin%2dalpha%2d1">integrin-alpha-1</a>, <a href="cope.cgi?key=VLA%2d1">VLA-1</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%201">very late activation antigen 1</a>, <a href="cope.cgi?key=VLA%2dalpha%201">VLA-alpha 1</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%20alpha%2d1">very late activation antigen alpha-1</a>) (Ammon et al, 2000; Suzuki et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD49b">CD49b</a></b> (<a href="cope.cgi?key=Br%20alloantigen">Br alloantigen</a>, <a href="cope.cgi?key=DX5">DX5</a>, <a href="cope.cgi?key=ECMR%2d2">ECMR-2</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d2">extracellular matrix receptor-2</a>, <a href="cope.cgi?key=GPIa">GPIa</a>, <a href="cope.cgi?key=HPA%2d5">HPA-5</a>, <a href="cope.cgi?key=human%20platelet%20antigen%2d5">human platelet antigen-5</a>, <a href="cope.cgi?key=ITGA2">ITGA2</a>, <a href="cope.cgi?key=integrin%2dalpha%2d2">integrin-alpha-2</a>, <a href="cope.cgi?key=platelet%20glycoprotein%20Ia%2fIIa">platelet glycoprotein Ia/IIa</a>, <a href="cope.cgi?key=VLA%2d2">VLA-2</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%202">very late activation antigen 2</a>, <a href="cope.cgi?key=VLAA2">VLAA2</a>, <a href="cope.cgi?key=VLA2%20receptor%20alpha%202%20subunit">VLA2 receptor alpha 2 subunit</a>, <a href="cope.cgi?key=Zav%20alloantigen">Zav alloantigen</a>) (Prieto et al, 1994; Kang et al, 1995; Ammon et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD49c">CD49c</a></b> (<a href="cope.cgi?key=CSAT%20antigen%20band%202%20protein">CSAT antigen band 2 protein</a>, <a href="cope.cgi?key=FRP%2d2">FRP-2</a>, <a href="cope.cgi?key=fusion%20regulatory%20protein%2d2">fusion regulatory protein-2</a>, <a href="cope.cgi?key=GAP%2dB3">GAP-B3</a>, <a href="cope.cgi?key=galactoprotein%20B3">galactoprotein B3</a>, <a href="cope.cgi?key=ITGA3">ITGA3</a>, <a href="cope.cgi?key=integrin%2dalpha%2d3">integrin-alpha-3</a>, <a href="cope.cgi?key=MSK18">MSK18</a>, <a href="cope.cgi?key=VLA%2d3">VLA-3</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%203">very late activation antigen 3</a>, <a href="cope.cgi?key=ECMR%2d1">ECMR-1</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d1">Extracellular matrix receptor-1</a>, <a href="cope.cgi?key=class%201%20ECMR">class 1 ECMR</a>, <a href="cope.cgi?key=VLA%2dalpha%203">VLA-alpha 3</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%20alpha%2d3">very late activation antigen alpha-3</a>, <a href="cope.cgi?key=VLAA3">VLAA3</a>, <a href="cope.cgi?key=VLA%2d3%20receptor%20alpha%203%20subunit%29">VLA-3 receptor alpha 3 subunit)</a> (Prieto et al, 1994; Kang et al, 1995; Ragno et al, 2001; Ammon et al, 2000; Liakka KA, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD49d">CD49d</a></b> (<a href="cope.cgi?key=ITGA4">ITGA4</a>, <a href="cope.cgi?key=integrin%2dalpha%2d4">integrin-alpha-4</a>, <a href="cope.cgi?key=VLA%2d4">VLA-4</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%204">very late activation antigen 4</a>, <a href="cope.cgi?key=VLAA4">VLAA4</a>, <a href="cope.cgi?key=VLA4%20receptor%20alpha%204%20subunit">VLA4 receptor alpha 4 subunit</a>, <a href="cope.cgi?key=VLA%2dalpha%204">VLA-alpha 4</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%20alpha%2d4">very late activation antigen alpha-4</a>) (Prieto et al, 1994; Ammon et al, 2000; Liakka KA, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD49e">CD49e</a></b> (<a href="cope.cgi?key=fibronectin%20receptor%20alpha%20chain">fibronectin receptor alpha chain</a>, <a href="cope.cgi?key=FNRA">FNRA</a>, <a href="cope.cgi?key=ITGA5">ITGA5</a>, <a href="cope.cgi?key=integrin%2dalpha%2d5">integrin-alpha-5</a>, <a href="cope.cgi?key=ECMR%2d6">ECMR-6</a>, <a href="cope.cgi?key=extracellular%20matrix%20receptor%2d6">Extracellular matrix receptor-6</a>, <a href="cope.cgi?key=class%206%20ECMR">class 6 ECMR</a>, <a href="cope.cgi?key=GPIc">GPIc</a>, <a href="cope.cgi?key=platelet%20glycoprotein%20Ic">platelet glycoprotein Ic</a>, <a href="cope.cgi?key=VLA%2dalpha%205">VLA-alpha 5</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%20alpha%2d5">very late activation antigen alpha-5</a>, <a href="cope.cgi?key=VLA%2d5">VLA-5</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%205">very late activation antigen 5</a>, <a href="cope.cgi?key=VLA%2d5%2dalpha">VLA-5-alpha</a>) (Kang et al, 1995; Shinji et al, 2003; Ammon et al, 2000; Taylor et al, 2000; Liakka KA, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD49f">CD49f</a></b> (<a href="cope.cgi?key=ITGA6">ITGA6</a>, <a href="cope.cgi?key=integrin%2dalpha%2d6">integrin-alpha-6</a>, <a href="cope.cgi?key=platelet%20gpI">platelet gpI</a>, <a href="cope.cgi?key=VLA%2d6">VLA-6</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%206">very late activation antigen 6</a>, <a href="cope.cgi?key=VLA%2d6%20alpha%20chain">VLA-6 alpha chain</a>, <a href="cope.cgi?key=VLA%2dalpha%206">VLA-alpha 6</a>, <a href="cope.cgi?key=very%20late%20activation%20antigen%20alpha%2d6">very late activation antigen alpha-6</a>, <a href="cope.cgi?key=GPIc%2a">GPIc*</a>, <a href="cope.cgi?key=platelet%20glycoprotein%20Ic%2a">platelet glycoprotein Ic*</a>) (Prieto et al, 1994; Ammon et al, 2000; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD51">CD51</a></b> (<a href="cope.cgi?key=ITGAV">ITGAV</a>, <a href="cope.cgi?key=integrin%2dalpha%2dV">integrin-alpha-V</a>, <a href="cope.cgi?key=L230">L230</a>, <a href="cope.cgi?key=MSK8">MSK8</a> <a href="cope.cgi?key=vitronectin%20receptor">vitronectin receptor</a> <a href="cope.cgi?key=VNRA">VNRA</a>, <a href="cope.cgi?key=vitronectin%20receptor">vitronectin receptor</a> alpha subunit) (Liakka KA, 1994; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD52">CD52</a></b> (<a href="cope.cgi?key=CAMPATH%2d1">CAMPATH-1</a>, <a href="cope.cgi?key=Cambridge%20pathology%201%20antigen">Cambridge pathology 1 antigen</a>, <a href="cope.cgi?key=Epididymal%20secretory%20protein%20E5">Epididymal secretory protein E5</a>, <a href="cope.cgi?key=H6%2d3C4%20antigen">H6-3C4 antigen</a>, <a href="cope.cgi?key=HE5">HE5</a>, <a href="cope.cgi?key=human%20epididymis%20secretory%20protein%2d5">human epididymis secretory protein-5</a>, <a href="cope.cgi?key=SAGA%2d1">SAGA-1</a>, <a href="cope.cgi?key=Sperm%20Agglutination%20Antigen%2d1">Sperm Agglutination Antigen-1</a>, <a href="cope.cgi?key=SMemG">SMemG</a>, <a href="cope.cgi?key=sperm%20membrane%20glycopeptide">sperm membrane glycopeptide</a>) (Taylor et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD53">CD53</a></b> (<a href="cope.cgi?key=MRC%20OX44">MRC OX44</a>, <a href="cope.cgi?key=MOX44">MOX44</a>, <a href="cope.cgi?key=TSPAN25">TSPAN25</a>, <a href="cope.cgi?key=Tetraspanin%2025">tetraspanin 25</a>) (Taylor et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD54">CD54</a></b> (<a href="cope.cgi?key=7F7">7F7</a>, <a href="cope.cgi?key=BB2">BB2</a>, <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">human</a> <a href="cope.cgi?key=rhinovirus%20receptor">rhinovirus receptor</a>, <a href="cope.cgi?key=ICAM%2d1">ICAM-1</a>, <a href="cope.cgi?key=intercellular%20adhesion%20molecule%201">intercellular adhesion molecule 1</a>, <a href="cope.cgi?key=IFN%2dgamma%20regulated%20human%20melanoma%2dassociated%20antigen">IFN-gamma regulated human melanoma-associated antigen</a>, <a href="cope.cgi?key=Ly47">Ly47</a>, <a href="cope.cgi?key=MALA%2d2">MALA-2</a>, <a href="cope.cgi?key=Me14%2dD12">Me14-D12</a>, <a href="cope.cgi?key=P3%2e58">P3.58</a>) (Santin et al, 1999; Ocklind et al, 1992; Bernatchez et al, 1997; Carcamo et al, 1996; Stent et al, 1995; Wang and Lewis, 2001; Bomstein et al, 2003; Taylor et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD55">CD55</a></b> (<a href="cope.cgi?key=CD55a">CD55a</a>, <a href="cope.cgi?key=CD55b">CD55b</a>, <a href="cope.cgi?key=complement%20decay%2daccelerating%20factor">complement decay-accelerating factor</a>, <a href="cope.cgi?key=decay%2daccelerating%20factor">decay-accelerating factor</a>, <a href="cope.cgi?key=DAF">DAF</a>, <a href="cope.cgi?key=DAF%2dGPI">DAF-GPI</a>, <a href="cope.cgi?key=DAF%2dTM">DAF-TM</a>, <a href="cope.cgi?key=GPI%2dDAF">GPI-DAF</a>, <a href="cope.cgi?key=TM%2dDAF">TM-DAF</a>, <a href="cope.cgi?key=DAF1">DAF1</a>, <a href="cope.cgi?key=decay%2daccelerating%20factor%201">decay-accelerating factor 1</a>, <a href="cope.cgi?key=DAF2">DAF2</a>, <a href="cope.cgi?key=decay%2daccelerating%20factor%202">decay-accelerating factor 2</a>, <a href="cope.cgi?key=Cromer%20blood%20group%20antigen">Cromer blood group antigen</a>) (Luo C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD58">CD58</a></b> (<a href="cope.cgi?key=LFA%2d3">LFA-3</a>, <a href="cope.cgi?key=lymphocyte%20function%2dassociated%20antigen%2d3">lymphocyte function-associated antigen-3</a>, <a href="cope.cgi?key=T11TS">T11TS</a>, <a href="cope.cgi?key=T11%20target%20structure">T11 target structure</a>) (Santin et al, 1999; Kirby et al, 1995; Ocklind et al, 1992)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD59">CD59</a></b> (<a href="cope.cgi?key=CD59a">CD59a</a>, <a href="cope.cgi?key=Protectin">protectin</a>, <a href="cope.cgi?key=MIC11">MIC11</a>, <a href="cope.cgi?key=MIN2">MIN2</a>, <a href="cope.cgi?key=MIN3">MIN3</a>, <a href="cope.cgi?key=MSK21">MSK21</a>, <a href="cope.cgi?key=HRF20">HRF20</a>, <a href="cope.cgi?key=homologous%20restriction%20factor%2d20%20kDa">homologous restriction factor-20 kDa</a>, <a href="cope.cgi?key=MACIF">MACIF</a>, <a href="cope.cgi?key=membrane%20attack%20complex%20inhibitory%20factor">membrane attack complex inhibitory factor</a>, <a href="cope.cgi?key=MAC%2dIP">MAC-IP</a>, <a href="cope.cgi?key=MAC%2dinhibitory%20protein">MAC-inhibitory protein</a>, <a href="cope.cgi?key=H19">H19</a>, <a href="cope.cgi?key=MIRL">MIRL</a>, <a href="cope.cgi?key=membrane%20inhibitor%20of%20reactive%20lysis">membrane inhibitor of reactive lysis</a>, <a href="cope.cgi?key=p18">P18</a>, <a href="cope.cgi?key=1F5">1F5</a>, <a href="cope.cgi?key=16%2e3A5">16.3A5</a>, <a href="cope.cgi?key=BRIC%20229">BRIC 229</a>, <a href="cope.cgi?key=YTH%2053%2e1">YTH 53.1</a>) (Luo C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD62E">CD62E</a></b> (<a href="cope.cgi?key=ELAM">ELAM</a>, <a href="cope.cgi?key=ELAM%2d1">ELAM-1</a>, <a href="cope.cgi?key=endothelium%20leukocyte%20adhesion%20molecule%201">endothelium leukocyte adhesion molecule 1</a>, <a href="cope.cgi?key=ESEL">ESEL</a>, <a href="cope.cgi?key=E%2dselectin">E-selectin</a>, <a href="cope.cgi?key=selectin%2dE">selectin-E</a>, <a href="cope.cgi?key=SELE">SELE</a>, <a href="cope.cgi?key=GMP%2d140">GMP-140</a>, <a href="cope.cgi?key=GRMP">GRMP</a>, <a href="cope.cgi?key=granulocyte%20membrane%20protein">granulocyte membrane protein</a>, <a href="cope.cgi?key=LECAM%2d2">LECAM-2</a>, <a href="cope.cgi?key=leukocyte%20adhesion%20molecule%202">leukocyte adhesion molecule 2</a>, <a href="cope.cgi?key=platelet%20alpha%2dgranule%20membrane%20protein">platelet alpha-granule membrane protein</a>) (Vabulas et al, 2003<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD62L">CD62L</a></b> (<a href="cope.cgi?key=gp90%2dMEL">gp90-MEL</a>, <a href="cope.cgi?key=LAM%2d1">LAM-1</a>, <a href="cope.cgi?key=leukocyte%20adhesion%20molecule%201">leukocyte adhesion molecule 1</a>, <a href="cope.cgi?key=LECAM%2d1">LECAM-1</a>, <a href="cope.cgi?key=leukocyte%20adhesion%20molecule%201">leukocyte adhesion molecule 1</a>, <a href="cope.cgi?key=Leu8">Leu8</a>, <a href="cope.cgi?key=LSEL">LSEL</a>, <a href="cope.cgi?key=L%2dselectin">L-selectin</a>, <a href="cope.cgi?key=selectin%2dL">selectin-L</a>, <a href="cope.cgi?key=SELL">SELL</a>, <a href="cope.cgi?key=LYAM1">LYAM1</a>, <a href="cope.cgi?key=MEL%2d14">MEL-14</a>, <a href="cope.cgi?key=OX85">OX85</a>, <a href="cope.cgi?key=PLNHR">PLNHR</a>, <a href="cope.cgi?key=TQ%2d1">TQ-1</a>) (Prieto et al, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD63">CD63</a></b> (<a href="cope.cgi?key=81H">81H</a>, <a href="cope.cgi?key=AD1">AD1</a>, <a href="cope.cgi?key=GP55">GP55</a>, <a href="cope.cgi?key=granulophysin">granulophysin</a>, <a href="cope.cgi?key=HOP%2d26">HOP-26</a>, <a href="cope.cgi?key=LIMP">LIMP</a>, <a href="cope.cgi?key=lysosomal%20integral%20membrane%20protein">lysosomal integral membrane protein</a>, <a href="cope.cgi?key=LIMP%2d1">LIMP-1</a>, <a href="cope.cgi?key=lysosomal%20integral%20membrane%20protein%2d1">lysosomal integral membrane protein-1</a>, <a href="cope.cgi?key=ME491">ME491</a>, <a href="cope.cgi?key=melanoma%20associated%20antigen%20ME491">melanoma associated antigen ME491</a>, <a href="cope.cgi?key=MLA1">MLA1</a>, <a href="cope.cgi?key=melanoma%2dassociated%20antigen%201">melanoma-associated antigen 1</a>, <a href="cope.cgi?key=NGA">NGA</a>, <a href="cope.cgi?key=neuroglandular%20antigen">neuroglandular antigen</a>, <a href="cope.cgi?key=NKI%2dC3">NKI-C3</a>, <a href="cope.cgi?key=OMA81H">OMA81H</a>, <a href="cope.cgi?key=ocular%20melanoma%2dassociated%20antigen%2081H">ocular melanoma-associated antigen 81H</a>, <a href="cope.cgi?key=PLTGP40">PLTGP40</a>, <a href="cope.cgi?key=platelet%20glycoprotein%20gp40">platelet glycoprotein gp40</a>, <a href="cope.cgi?key=TSPAN30">TSPAN30</a>, <a href="cope.cgi?key=Tetraspanin%2030">tetraspanin 30</a>) (Miyamoto et al, 1994; von Lindern et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD64">CD64</a></b> (<a href="cope.cgi?key=hFcRI">hFcRI</a>, <a href="cope.cgi?key=FCGR1">FCGR1</a>, <a href="cope.cgi?key=Fc%2dgamma%20R1">Fc-gamma R1</a>, <a href="cope.cgi?key=FCGR1A">FCGR1A</a>, <a href="cope.cgi?key=Fc%2dgamma%20R1A">Fc-gamma R1A</a>, <a href="cope.cgi?key=FCGR1B">FCGR1B</a>, <a href="cope.cgi?key=Fc%2dgamma%20R1B">Fc-gamma R1B</a>, <a href="cope.cgi?key=FCGR1C">FCGR1C</a>, <a href="cope.cgi?key=Fc%2dgamma%20R1C">Fc-gamma R1C</a>) (Hashimoto et al, 1997; Carcamo et al, 1996; Bonilla et al, 2000; Cassatella et al, 1990; Kedzierska et al, 2001; Susaki et al, 1998; Chang, 1995; Sivo et al, 1993; Shen R et al, 2009; Ambarus et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD66f">CD66f</a></b> (<a href="cope.cgi?key=B1G1">B1G1</a>, <a href="cope.cgi?key=FL%2dNCA%2d1%2f2">FL-NCA-1/2</a>, <a href="cope.cgi?key=fetal%20liver%20nonspecific%20crossreactive%20antigen%201%2f2">fetal liver nonspecific crossreactive antigen 1/2</a>, <a href="cope.cgi?key=PBG1">PBG1</a>, <a href="cope.cgi?key=pregnancy%2dspecific%20b1%20glycoprotein">pregnancy-specific b1 glycoprotein</a>, <a href="cope.cgi?key=pregnancy%2dspecific%20beta%2d1%20glycoprotein%20C%2fD">pregnancy-specific beta-1 glycoprotein C/D</a>, <a href="cope.cgi?key=PSBG1">PSBG1</a>, <a href="cope.cgi?key=PSG1">PSG1</a>, <a href="cope.cgi?key=pregnancy%2dspecific%20beta%2d1%20glycoprotein%201">pregnancy-specific beta-1 glycoprotein 1</a>, <a href="cope.cgi?key=PSG">PSG</a>, <a href="cope.cgi?key=pregnancy%2dspecific%20glycoprotein">pregnancy-specific glycoprotein</a>, <a href="cope.cgi?key=PSG95">PSG95</a>, <a href="cope.cgi?key=pregnancy%2dspecific%20glycoprotein%2095">pregnancy-specific glycoprotein 95</a>, <a href="cope.cgi?key=PSGGA">PSGGA</a>, <a href="cope.cgi?key=Pregnancy%2dspecific%20glycoprotein%20gene%20A">pregnancy-specific glycoprotein gene A</a>, <a href="cope.cgi?key=SP%2d1">SP-1</a>, <a href="cope.cgi?key=Schwangerschaftsprotein%201">Schwangerschaftsprotein 1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Snyder et al, 2001; Ha et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD68">CD68</a></b> (<a href="cope.cgi?key=EBM11">EBM11</a>, <a href="cope.cgi?key=gp110">gp110</a>, <a href="cope.cgi?key=Ki%2dM6">Ki-M6</a>, <a href="cope.cgi?key=Ki%2dM7">Ki-M7</a>, <a href="cope.cgi?key=KP%2d1">KP-1</a>, <a href="cope.cgi?key=macrosialin">macrosialin</a>, <a href="cope.cgi?key=microsialin">microsialin</a>, <a href="cope.cgi?key=PG%2dM1">PG-M1</a>, <a href="cope.cgi?key=PM%2d1k">PM-1k</a>, <a href="cope.cgi?key=SCARD1">SCARD1</a>, <a href="cope.cgi?key=scavenger%20receptor%20class%20D%20member%201">scavenger receptor class D member 1</a>, <a href="cope.cgi?key=Y1%2f82A">Y1/82A</a>, <a href="cope.cgi?key=Y2%2f131">Y2/131</a>) (Baldus et al, 1998; Gough et al, 2001; Kurushima et al, 2000; Pulford et al, 1990; Schoppmann et al, 2002; van Lent et al, 2003; Tsukamoto et al, 2002; Rogler et al, 1998; Yoshida et al, 1998; Schaberg et al, 1992; Smith et al, 1999; Kawamura et al, 2009; Karlsson KR et al, 2008; Gleissner et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD69">CD69</a></b> (<a href="cope.cgi?key=AIM">AIM</a>, <a href="cope.cgi?key=activation%20inducer%20molecule">activation inducer molecule</a>, <a href="cope.cgi?key=BL%2dAC%2fP26">BL-AC/P26</a>, <a href="cope.cgi?key=CLEC2C">CLEC2C</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%202%20member%20C">C-type lectin domain family 2 member C</a>, <a href="cope.cgi?key=EA1">EA1</a>, <a href="cope.cgi?key=early%20antigen%201">early antigen 1</a>, <a href="cope.cgi?key=early%20T%2dcell%20activation%20antigen%20p60">early T-cell activation antigen p60</a>, <a href="cope.cgi?key=gp34%2f28">gp34/28</a>, <a href="cope.cgi?key=Leu23">Leu23</a>, <a href="cope.cgi?key=MLR3">MLR3</a>, <a href="cope.cgi?key=VEA">VEA</a>) (Carcamo et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD72">CD72</a></b> (<a href="cope.cgi?key=CD72a">CD72a</a>, <a href="cope.cgi?key=CD72b">CD72b</a>, <a href="cope.cgi?key=CD72c">CD72c</a>, <a href="cope.cgi?key=Lyb2">Lyb2</a>, <a href="cope.cgi?key=Ly19">Ly19</a>, <a href="cope.cgi?key=Ly19%2e2">Ly19.2</a>, <a href="cope.cgi?key=Ly32">Ly32</a>, <a href="cope.cgi?key=Ly32%2e2">Ly32.2</a>) (Schwarting et al, 1992)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD74">CD74</a></b> (<a href="cope.cgi?key=HLA%2dDR%2dgamma">HLA-DR-gamma</a>, <a href="cope.cgi?key=HLADG">HLADG</a>, <a href="cope.cgi?key=HLA%2dDR%2dgamma">HLA class 2 histocompatibility antigen gamma chain</a>, <a href="cope.cgi?key=HLA%2dDR%2dgamma">HLA-DR associated invariant chain</a>, <a href="cope.cgi?key=Ia%2dgamma">Ia-gamma</a>, <a href="cope.cgi?key=LN2">LN2</a>, <a href="cope.cgi?key=HLA%2dDR%2dgamma">MHC class 2 invariant chain</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD80">CD80</a></b> (<a href="cope.cgi?key=B7">B7</a>, <a href="cope.cgi?key=B7%2d1">B7-1</a>, <a href="cope.cgi?key=BB1">BB1</a>, <a href="cope.cgi?key=B%2dlymphoblast%20antigen%2d1">B-lymphoblast antigen-1</a>, <a href="cope.cgi?key=Ly53">Ly53</a>) (Agrewala et al, 1998; Lai et al, 2003; Delgado et al, 1999; Rogler et al, 1999; Ohtani et al, 1997; Bomstein et al, 2003; Venuprasad et al, 2002; Hermann et al, 1999; Santin et al, 1999; de Boer OJ et al, 1997; Lifshitz et al, 2010; Ambarus et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD84">CD84</a></b> (<a href="cope.cgi?key=CDw84">CDw84</a>, <a href="cope.cgi?key=Ly9b">Ly9b</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%209b">lymphocyte antigen 9b</a>, <a href="cope.cgi?key=lymphocytes">lymphocyte</a> antigen 9-beta, <a href="cope.cgi?key=Ly9%2dbeta">Ly9-beta</a>, <a href="cope.cgi?key=MAX%2e3%20antigen">MAX.3 antigen</a>, <a href="cope.cgi?key=SLAMF5">SLAMF5</a>, <a href="cope.cgi?key=signaling%20lymphocyte%20activation%20molecule%20family%20member%205">signaling lymphocyte activation molecule family member 5</a>, <a href="cope.cgi?key=SLAM%20family%20member%205">SLAM family member 5</a>) (Emmrich and Andreesen, 1985; Zaiss et al, 2003; Krause et al, 2000; Sintes et al, 2010; Morra et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD85d">CD85d</a></b> (<a href="cope.cgi?key=LILRB2">LILRB2</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%20subfamily%20B%20member%202">leukocyte immunoglobulin-like receptor subfamily B member 2</a>, <a href="cope.cgi?key=ILT4">ILT4</a>, <a href="cope.cgi?key=immunoglobulin%2dlike%20transcript%204">immunoglobulin-like transcript 4</a>, <a href="cope.cgi?key=LIR2">LIR2</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%202">leukocyte immunoglobulin-like receptor 2</a>, <a href="cope.cgi?key=MIR10">MIR10</a>, <a href="cope.cgi?key=monocyte%2fmacrophage%20immunoglobulin%2dlike%20receptor%2010">monocyte/macrophage immunoglobulin-like receptor 10</a>) (Petroff et al, 2002; Hunt et al, 2000; Petroff et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD85h">CD85h</a></b> (<a href="cope.cgi?key=LILRA2">LILRA2</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%20subfamily%20A%20member%202">leukocyte immunoglobulin-like receptor subfamily A member 2</a>, <a href="cope.cgi?key=ILT1">ILT1</a>, <a href="cope.cgi?key=immunoglobulin%2dlike%20transcript%201">immunoglobulin-like transcript 1</a>, <a href="cope.cgi?key=LIR7">LIR7</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%207">leukocyte immunoglobulin-like receptor 7</a>) (Huynh et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD85j">CD85j</a> </b>(<a href="cope.cgi?key=ILT2">ILT2</a>, <a href="cope.cgi?key=immunoglobulin%2dlike%20transcript%202">immunoglobulin-like transcript 2</a>, <a href="cope.cgi?key=LIR1">LIR1</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%201">leukocyte immunoglobulin-like receptor 1</a>, <a href="cope.cgi?key=MIR7">MIR7</a>, <a href="cope.cgi?key=monocyte%2fmacrophage%20immunoglobulin%2dlike%20receptor%207">monocyte/macrophage immunoglobulin-like receptor 7</a>, <a href="cope.cgi?key=LILRB1">LILRB1</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%20subfamily%20B%20member%201">leukocyte immunoglobulin-like receptor subfamily B member 1</a>) (Petroff et al, 2002; Hunt et al, 2000; Li et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD85k">CD85k</a></b> (<a href="cope.cgi?key=LILRB4">LILRB4</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%20subfamily%20B%20member%204">leukocyte immunoglobulin-like receptor subfamily B member 4</a>, <a href="cope.cgi?key=ILT3">ILT3</a>, <a href="cope.cgi?key=immunoglobulin%2dlike%20transcript%203">immunoglobulin-like transcript 3</a>, <a href="cope.cgi?key=LIR5">LIR5</a>, <a href="cope.cgi?key=leukocyte%20immunoglobulin%2dlike%20receptor%205">leukocyte immunoglobulin-like receptor 5</a>, <a href="cope.cgi?key=HM18">HM18</a>, <a href="cope.cgi?key=Monocyte%20inhibitory%20receptor%20HM18">Monocyte inhibitory receptor HM18</a>, <a href="cope.cgi?key=gp49B">gp49B</a>, <a href="cope.cgi?key=gp49B1">gp49B1</a>, <a href="cope.cgi?key=gp49B2">gp49B2</a>) (Cella et al, 1997; Cortesini, 2007; Matsumoto et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD86">CD86</a></b> (<a href="cope.cgi?key=B70">B70</a>, <a href="cope.cgi?key=B72">B72</a>, <a href="cope.cgi?key=B7%2d2">B7-2</a>, <a href="cope.cgi?key=BU%2d63">BU-63</a>, <a href="cope.cgi?key=CD28%20ligand%2d2">CD28 ligand-2</a>, <a href="cope.cgi?key=CD28LG2">CD28LG2</a>, <a href="cope.cgi?key=CLS1">CLS1</a>, <a href="cope.cgi?key=FUN%2d1">FUN-1</a>, <a href="cope.cgi?key=GR65">GR65</a>, <a href="cope.cgi?key=LAB7%2d2">LAB7-2</a>, <a href="cope.cgi?key=Ly58">Ly58</a>, <a href="cope.cgi?key=MB7">MB7</a>) (Lai et al, 2003; Scheuerer et al, 2000; Delgado et al, 1999; Rogler et al, 1999; Santin et al, 1999; Nicod and Isler, 1997; Ohtani et al, 1997; Wang and Lewis, 2001; Quesniaux et al, 2004; Bomstein et al, 2003; Hermann et al, 1999; Hagg et al, 2008; Park et al, 2005; de Boer OJ et al, 1997; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD87">CD87</a></b> (<a href="cope.cgi?key=MO3">MO3</a>, <a href="cope.cgi?key=PLAUR">PLAUR</a>, <a href="cope.cgi?key=plasminogen%20activator%20urokinase%20receptor">plasminogen activator urokinase receptor</a>, <a href="cope.cgi?key=UPA%2dR">UPA-R</a>, <a href="cope.cgi?key=urokinase%20plasminogen%20activator%20receptor">urokinase plasminogen activator receptor</a>, <a href="cope.cgi?key=URKR">URKR</a>, <a href="cope.cgi?key=Urokinase%20receptor">urokinase receptor</a>) (Oka et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD88">CD88</a></b> (<a href="cope.cgi?key=C5aR">C5aR</a>, <a href="cope.cgi?key=C5a%20receptor">C5a receptor</a>, <a href="cope.cgi?key=C5R1">C5R1</a>, <a href="cope.cgi?key=complement%20component%205%20receptor%201">complement component 5 receptor 1</a>) (Cavaillon et al, 1990; Chenoweth et al, 1982; Fayyazi et al, 1999; Goodman et al, 1982; Hunt et al, 2005; Kastl et al, 2008; Oksjoki et al, 2007; Shushakova et al, 2002; Soruri et al, 2003; Vogen et al, 2001; Wang YP et al, 2003; Zwirner et al, 1999; Speidl WS et al, 2011; Manthey et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD89">CD89</a></b> (<a href="cope.cgi?key=FCAR">FCAR</a>, <a href="cope.cgi?key=Fc%20fragment%20of%20IgA%20receptor">Fc fragment of IgA receptor</a>, <a href="cope.cgi?key=IgA%20receptor">IgA receptor</a>, <a href="cope.cgi?key=Immunoglobulin%20A%20Fc%20receptor">immunoglobulin A Fc receptor</a>, <a href="cope.cgi?key=Fc%2dalpha%20R">Fc-alpha R</a>, <a href="cope.cgi?key=Fc%2dalpha%20RI">Fc-alpha RI</a>) (Patry et al, 1996; Shen R et al, 2009; Stockmeyer et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD92">CD92</a></b> (<a href="cope.cgi?key=CTL1">CTL1</a>, <a href="cope.cgi?key=CHTL1">CHTL1</a>, <a href="cope.cgi?key=choline%20transporter%2dlike%20protein%201">choline transporter-like protein 1</a>, <a href="cope.cgi?key=GR9">GR9</a>, <a href="cope.cgi?key=SLC44A1">SLC44A1</a> [<a href="cope.cgi?key=solute%20carrier%20family%2044%20member%201">solute carrier family 44 member 1</a>) (Fullerton et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD93">CD93</a></b> (<a href="cope.cgi?key=AA4">AA4</a>, <a href="cope.cgi?key=C1q%20receptor">C1q receptor</a>, <a href="cope.cgi?key=C1qR1">C1qR1</a>, <a href="cope.cgi?key=C1qRp">C1qRp</a>, <a href="cope.cgi?key=collectin%20receptor">collectin receptor</a>, <a href="cope.cgi?key=GR11">GR11</a>, <a href="cope.cgi?key=Ly68">Ly68</a>, <a href="cope.cgi?key=MXRA4">MXRA4</a>) (Dean et al, 2000, 2001; Lovik et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD95">CD95</a> </b>(<a href="cope.cgi?key=FAS">FAS</a>, <a href="cope.cgi?key=APO%2d1">APO-1</a>, <a href="cope.cgi?key=apoptosis%20antigen%2d1">apoptosis antigen-1</a>, <a href="cope.cgi?key=APT1">APT1</a>, <a href="cope.cgi?key=TNFRSF6">TNFRSF6</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%206">TNF receptor superfamily member 6</a>, <a href="cope.cgi?key=FASTM">FASTM</a>, <a href="cope.cgi?key=FASL%20receptor">FASL receptor</a>) (Philipps et al, 2001; Gleissner et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD97">CD97</a></b> (<a href="cope.cgi?key=BL%2dKDD%2fF12">BL-KDD/F12</a>, <a href="cope.cgi?key=GR1">GR1</a>, <a href="cope.cgi?key=TM7LN1">TM7LN1</a>, <a href="cope.cgi?key=AURA51">AURA51</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2051">augmented in rheumatoid arthritis 51</a>) (Hamann et al, 1999; Kwakkenbos et al, 2005; van Eijk et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD98">CD98</a></b> (<a href="cope.cgi?key=CD98LC">CD98LC</a>, <a href="cope.cgi?key=4F2lc">4F2lc</a>, <a href="cope.cgi?key=4F2">4F2</a>, <a href="cope.cgi?key=4F2hc">4F2hc</a>, <a href="cope.cgi?key=FRP%2d1">FRP-1</a>, <a href="cope.cgi?key=fusion%20regulatory%20protein%2d1">fusion regulatory protein-1</a>, <a href="cope.cgi?key=LAT1">LAT1</a>, <a href="cope.cgi?key=system%2dL%20amino%20acid%20transporter%201">system-L amino acid transporter 1</a>, <a href="cope.cgi?key=L%2dtype%20amino%20acid%20transporter%201">L-type amino acid transporter 1</a>, <a href="cope.cgi?key=Ly10">Ly10</a>, <a href="cope.cgi?key=Ly%2dm10">Ly-m10</a>, <a href="cope.cgi?key=MDU1">MDU1</a>, <a href="cope.cgi?key=MPE16">MPE16</a>, <a href="cope.cgi?key=membrane%20protein%20E16">membrane protein E16</a>, <a href="cope.cgi?key=RL%2d388">RL-388</a>, <a href="cope.cgi?key=SLC3A2">SLC3A2</a>, <a href="cope.cgi?key=solute%20carrier%20family%203%20member%202">solute carrier family 3 member 2</a>, <a href="cope.cgi?key=SLC7A5">SLC7A5</a>, <a href="cope.cgi?key=solute%20carrier%20family%207%20member%205">solute carrier family 7 member 5</a>) (Taylor et al, 2000; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD105">CD105</a></b> (<a href="cope.cgi?key=endoglin">endoglin</a>, <a href="cope.cgi?key=ENG">ENG</a>, <a href="cope.cgi?key=Edg">Edg</a>, <a href="cope.cgi?key=L%2dendoglin">L-endoglin</a>, <a href="cope.cgi?key=S%2dendoglin">S-endoglin</a>, <a href="cope.cgi?key=E9%20protein">E9 protein</a>, <a href="cope.cgi?key=MJ7%2f18%20antigen">MJ7/18 antigen</a>, <a href="cope.cgi?key=HHT1">HHT1</a>, <a href="cope.cgi?key=hereditary%20hemorrhagic%20telangiectasia%20type%201">hereditary hemorrhagic telangiectasia type 1</a>, <a href="cope.cgi?key=ORW">ORW</a>, <a href="cope.cgi?key=Osler%2dRendu%2dWeber%20syndrome">Osler-Rendu-Weber syndrome</a>, <a href="cope.cgi?key=ORW1">ORW1</a>, <a href="cope.cgi?key=SH%2d2">SH-2</a>) (Jeziorska M, 2001; Lastres P et al, 1992; O'Connell PJ et al, 1992)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD106">CD106</a></b> (<a href="cope.cgi?key=alpha%2d4%2dbeta%2d1%20ligand">alpha-4-beta-1 ligand</a>, <a href="cope.cgi?key=INCAM%2d110">INCAM-110</a>, <a href="cope.cgi?key=inducible%20cellular%20adhesion%20molecule%20110%20kDa">inducible cellular adhesion molecule 110 kDa</a>, <a href="cope.cgi?key=VCAM%2d1">VCAM-1</a>, <a href="cope.cgi?key=vascular%20cellular%20adhesion%20molecule%201">vascular cellular adhesion molecule 1</a>) (Ragno et al, 2001; Stojakovic et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD109">CD109</a></b> (<a href="cope.cgi?key=7D1">7D1</a>, <a href="cope.cgi?key=8A3">8A3</a>, <a href="cope.cgi?key=E123">E123</a>, <a href="cope.cgi?key=Gov%20alloantigen">Gov alloantigen</a>, <a href="cope.cgi?key=Gov%28a%29">Gov(a)</a>, <a href="cope.cgi?key=Gov%28b%29">Gov(b)</a>, <a href="cope.cgi?key=HPA%2d15">HPA-15</a>, <a href="cope.cgi?key=human%20platelet%20antigen%2d15">human platelet antigen-15</a>, <a href="cope.cgi?key=GR56">GR56</a>, <a href="cope.cgi?key=r150">r150</a>, <a href="cope.cgi?key=W7C5">W7C5</a>, <a href="cope.cgi?key=platelet%20activation%20factor">platelet activation factor</a>, <a href="cope.cgi?key=150%20KDa%20TGF%2dbeta%2d1%2dbinding%20protein">150 KDa TGF-beta-1-binding protein</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD141">CD141</a></b> (<a href="cope.cgi?key=thrombomodulin">thrombomodulin</a>, <a href="cope.cgi?key=TM">TM</a>, <a href="cope.cgi?key=THBD">THBD</a>, <a href="cope.cgi?key=THRM">THRM</a>, <a href="cope.cgi?key=Alpha%2dThrombomodulin">Alpha-Thrombomodulin</a>, <a href="cope.cgi?key=Beta%2dThrombomodulin">Beta-Thrombomodulin</a>, <a href="cope.cgi?key=fetomodulin">fetomodulin</a>, <a href="cope.cgi?key=FM">FM</a>) (Grey and Hancock, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD143">CD143</a></b> (<a href="cope.cgi?key=ACE">ACE</a>, <a href="cope.cgi?key=angiotensin%20converting%20enzyme">angiotensin converting enzyme</a>, <a href="cope.cgi?key=angiotensin%2d1%20converting%20enzyme">angiotensin-1 converting enzyme</a>, <a href="cope.cgi?key=dipeptidyl%20carboxypeptidase">dipeptidyl carboxypeptidase</a>, <a href="cope.cgi?key=dipeptidyl%20carboxypeptidase%201">dipeptidyl carboxypeptidase 1</a>, <a href="cope.cgi?key=EC3%2e4%2e15%2e1">EC3.4.15.1</a>, <a href="cope.cgi?key=kininase%202">kininase 2</a>, <a href="cope.cgi?key=peptidase%20P">peptidase P</a>, <a href="cope.cgi?key=peptidyl%20dipeptidase%20A">peptidyl dipeptidase A</a>) (Ohishi et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD148">CD148</a></b> (<a href="cope.cgi?key=143%2d41%20antigen">143-41 antigen</a>, <a href="cope.cgi?key=DEP%2d1">DEP-1</a>, <a href="cope.cgi?key=high%20cell%20density%2denhanced%20PTP%2d1">high cell density-enhanced PTP-1</a>, <a href="cope.cgi?key=Density%20enhanced%20phosphatase%2d1">Density enhanced phosphatase-1</a>, <a href="cope.cgi?key=EC3%2e1%2e3%2e48">EC3.1.3.48</a>, <a href="cope.cgi?key=HPTP%2deta">HPTP-eta</a>, <a href="cope.cgi?key=human%20protein%20tyrosine%20phosphatase%2deta">human protein tyrosine phosphatase-eta</a>, <a href="cope.cgi?key=protein%20tyrosine%20phosphatase%2deta">protein tyrosine phosphatase-eta</a>, <a href="cope.cgi?key=p260">p260</a>, <a href="cope.cgi?key=PTPRJ">PTPRJ</a>, <a href="cope.cgi?key=Protein%20tyrosine%20phosphatase%20receptor%20type%20J">Protein tyrosine phosphatase receptor type J</a>, <a href="cope.cgi?key=SCC1">SCC1</a>, <a href="cope.cgi?key=susceptibility%20to%20colon%20cancer%201">susceptibility to colon cancer 1</a>, <a href="cope.cgi?key=protein%20tyrosine%20phosphatase%2deta">protein tyrosine phosphatase-eta</a>) (Osborne et al, 1998; Autschbach et al, 1999; Dave et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD152">CD152</a></b> (<a href="cope.cgi?key=CTLA%2d4">CTLA-4</a>, <a href="cope.cgi?key=Cytotoxic%20T%2dlymphocyte%20associated%20antigen%204">cytotoxic T-lymphocyte associated antigen 4</a>, <a href="cope.cgi?key=Ly56">Ly56</a>) (Hua et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD163">CD163</a></b> (<a href="cope.cgi?key=Ber%2dMAC3">Ber-MAC3</a>, <a href="cope.cgi?key=GHI%2f61">GHI/61</a>, <a href="cope.cgi?key=HbSR">HbSR</a>, <a href="cope.cgi?key=hemoglobin%20scavenger%20receptor">hemoglobin scavenger receptor</a>, <a href="cope.cgi?key=hemoglobin%2fhaptoglobin%20scavenger%20receptor">hemoglobin/haptoglobin scavenger receptor</a>, <a href="cope.cgi?key=Ki%2dM8">Ki-M8</a>, <a href="cope.cgi?key=M130">M130</a>, <a href="cope.cgi?key=p155">p155</a>, <a href="cope.cgi?key=Mac%202%2d48">Mac 2-48</a>, <a href="cope.cgi?key=RM3%2f1">RM3/1</a>, <a href="cope.cgi?key=SM4">SM4</a>) (Schaer et al, 2008; He et al, 2009; Baeten et al, 2002; Van den Heuvel et al, 1999; Buechler et al, 2000; Sulahian et al, 2000; Bckle et al, 2008; Martens et al, 2006; Patton et al, 2009; Kawamura et al, 2009; Martens et al, 2006; Gleissner et al, 2010; Ambarus et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD168">CD168</a></b> (<a href="cope.cgi?key=HMMR">HMMR</a>, <a href="cope.cgi?key=hyaluran%2dmediated%20motility%20receptor">hyaluran-mediated motility receptor</a>, <a href="cope.cgi?key=IHABP">IHABP</a>, <a href="cope.cgi?key=intracellular%20hyaluronic%20acid%20binding%20protein">intracellular hyaluronic acid binding protein</a>, <a href="cope.cgi?key=RHAMM">RHAMM</a>, <a href="cope.cgi?key=receptor%20for%20hyaluronic%20acid%2dmediated%20motility">receptor for hyaluronic acid-mediated motility</a>, <a href="cope.cgi?key=Receptor%20for%20HA%2dMediated%20Motility">Receptor for HA-Mediated Motility</a>) (Foley et al, 2012; Zaman et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD172B">CD172B</a></b> (<a href="cope.cgi?key=SIRPB1">SIRPB1</a>, <a href="cope.cgi?key=SIRP%2dbeta">SIRP-beta</a>, <a href="cope.cgi?key=SIRP%2dbeta%2d1">SIRP-beta-1</a>, <a href="cope.cgi?key=signal%20regulatory%20protein%2dbeta%2d1">signal regulatory protein-beta-1</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD180">CD180</a></b> (<a href="cope.cgi?key=BGP95">BGP95</a>, <a href="cope.cgi?key=Ly64">Ly64</a>, <a href="cope.cgi?key=Ly78">Ly78</a>, <a href="cope.cgi?key=RP105">RP105</a>, <a href="cope.cgi?key=radioprotective%20protein%20105%20kDa">radioprotective protein 105 kDa</a>) (Divanovic et al, 2005; Gottfried et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=CD200">CD200</a></b> (<a href="cope.cgi?key=OX2">OX2</a>, <a href="cope.cgi?key=MOX2">MOX2</a>, <a href="cope.cgi?key=MRC%20OX2">MRC OX2</a>, <a href="cope.cgi?key=OX104">OX104</a>, <a href="cope.cgi?key=My033">My033</a>) (Cortez et al, 2011; Mukhopadhyay et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD200R">CD200R</a></b> (<a href="cope.cgi?key=CD200R1">CD200R1</a> <a href="cope.cgi?key=CD200%20receptor">CD200 receptor</a>, <a href="cope.cgi?key=CD200%20receptor%201">CD200 receptor 1</a>, <a href="cope.cgi?key=OX2%20receptor">OX2 receptor</a>, <a href="cope.cgi?key=OX2R">OX2R</a>, <a href="cope.cgi?key=MOX2">MOX2</a> receptor, <a href="cope.cgi?key=MOX2R">MOX2R</a>) (Cherwinski et al, 2005; Wright et al, 2000; Snelgrove et al, 2008; Foster-Cuevas et al, 2004; Mukhopadhyay et al, 2010; Ambarus et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD204">CD204</a></b> (<a href="cope.cgi?key=Macrophage%20acetylated%20LDL%20receptor">Macrophage acetylated LDL receptor</a>, <a href="cope.cgi?key=Macrophage%20acetylated%20LDL%20receptor%20I">Macrophage acetylated LDL receptor I</a>, <a href="cope.cgi?key=Macrophage%20acetylated%20LDL%20receptor%20II">Macrophage acetylated LDL receptor II</a>, <a href="cope.cgi?key=MSR1">MSR1</a>, <a href="cope.cgi?key=macrophage%20scavenger%20receptor">macrophage scavenger receptor</a>, <a href="cope.cgi?key=Scvr">Scvr</a>, <a href="cope.cgi?key=scavenger%20receptor%20class%20A">Scavenger receptor class A</a>, <a href="cope.cgi?key=SRA">SRA</a>, <a href="cope.cgi?key=scavenger%20receptor%20A">scavenger receptor A</a>, <a href="cope.cgi?key=SCARA1">SCARA1</a>, <a href="cope.cgi?key=scavenger%20receptor%20class%20A%20member%201">scavenger receptor class A member 1</a>, <a href="cope.cgi?key=SRA%2dI">SRA-I</a>, <a href="cope.cgi?key=scavenger%20receptor%20AI">scavenger receptor AI</a>, <a href="cope.cgi?key=SRA%2dII">SRA-II</a>, <a href="cope.cgi?key=scavenger%20receptor%20AII">scavenger receptor AII</a>) (Kawamura et al, 2009; Gleissner et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD206">CD206</a></b> (<a href="cope.cgi?key=CLEC13D">CLEC13D</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%2013%20member%20D">C-type lectin domain family 13 member D</a>, <a href="cope.cgi?key=MMR">MMR</a>, <a href="cope.cgi?key=macrophage%20mannose%20receptor">macrophage mannose receptor</a>, <a href="cope.cgi?key=MRC1">MRC1</a>, <a href="cope.cgi?key=mannose%20receptor%20C%20type%2d1">mannose receptor C type-1</a>, <a href="cope.cgi?key=MR">MR</a>, <a href="cope.cgi?key=mannose%20receptor">mannose receptor</a>) (Harris et al, 1992; Gleissner et al, 2010; Martinez FO et al, 2006; Ambarus et al, 2012; Pinto et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD243">CD243</a></b> (<a href="cope.cgi?key=ABCB1">ABCB1</a>, <a href="cope.cgi?key=ATP%2dbinding%20cassette%20subfamily%20B%20member%201">ATP-binding cassette subfamily B member 1</a>, <a href="cope.cgi?key=CLCS">CLCS</a>, <a href="cope.cgi?key=Colchicine%20sensitivity">Colchicine sensitivity</a>, <a href="cope.cgi?key=gp170">gp170</a>, <a href="cope.cgi?key=MDR%2d1">MDR-1</a>, <a href="cope.cgi?key=multidrug%20resistance%20to%20cancer%201">multidrug resistance to cancer 1</a>, <a href="cope.cgi?key=Mod%2d2">Mod-2</a>, <a href="cope.cgi?key=P%2dglycoprotein%2d1">P-glycoprotein-1</a>, <a href="cope.cgi?key=PGY1">PGY1</a>) (Puddu et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=CD275">CD275</a> </b>(<a href="cope.cgi?key=B7%2dH2">B7-H2</a>, <a href="cope.cgi?key=B7RP%2d1">B7RP-1</a>, <a href="cope.cgi?key=B7%2drelated%20protein%201">B7-related protein 1</a>, <a href="cope.cgi?key=GL50">GL50</a>, <a href="cope.cgi?key=H4">H4</a>, <a href="cope.cgi?key=ICOSL">ICOSL</a>, <a href="cope.cgi?key=inducible%20T%2dcell%20co%2dstimulator%20ligand">inducible T-cell co-stimulator ligand</a>, <a href="cope.cgi?key=ICOS%20ligand">ICOS ligand</a>, <a href="cope.cgi?key=KIAA0653">KIAA0653</a>, <a href="cope.cgi?key=LICOS">LICOS</a>, <a href="cope.cgi?key=ligand%20for%20ICOS">ligand for ICOS</a>) (Yoshinaga et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD280">CD280</a></b> (<a href="cope.cgi?key=CLEC13E">CLEC13E</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%2013%20member%20E">C-type lectin domain family 13 member E</a>, <a href="cope.cgi?key=ENDO180">ENDO180</a>, <a href="cope.cgi?key=KIAA0709">KIAA0709</a>, <a href="cope.cgi?key=MRC2">MRC2</a>, <a href="cope.cgi?key=mannose%20receptor%20C%20type%202">mannose receptor C type 2</a>, <a href="cope.cgi?key=p180">p180</a>, <a href="cope.cgi?key=uPARAP">uPARAP</a>, <a href="cope.cgi?key=Urokinase%20receptor%2dassociated%20protein">Urokinase receptor-associated protein</a>) (Honardoust et al, 2006; Schnack Nielsen et al, 2002; Sheikh et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD300A">CD300A</a></b> (<a href="cope.cgi?key=CMRF35H">CMRF35H</a>, <a href="cope.cgi?key=CMRF35H9">CMRF35H9</a>, <a href="cope.cgi?key=IGSF12">IGSF12</a>, <a href="cope.cgi?key=immunoglobulin%20superfamily%20member%2012">immunoglobulin superfamily member 12</a>, <a href="cope.cgi?key=IRC1">IRC1</a>, <a href="cope.cgi?key=IRC2">IRC2</a>, <a href="cope.cgi?key=IRp60">IRp60</a>, <a href="cope.cgi?key=Inhibitory%20receptor%20protein%2060">Inhibitory receptor protein 60</a>, <a href="cope.cgi?key=MAIR%2dI">MAIR-I</a>, <a href="cope.cgi?key=myeloid%2dassociated%20immunoglobulin%2dlike%20receptor%20I">myeloid-associated immunoglobulin-like receptor I</a>, <a href="cope.cgi?key=CLM8">CLM8</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d8">CMRF35-like molecule-8</a>, <a href="cope.cgi?key=LMIR1">LMIR1</a>, <a href="cope.cgi?key=leukocyte%20mono%2dIg%2dlike%20receptor%201">leukocyte mono-Ig-like receptor 1</a>) (Yotsumoto et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD300B">CD300B</a> </b>(<a href="cope.cgi?key=CD300LB">CD300LB</a>, <a href="cope.cgi?key=CD300%20molecule%2dlike%20family%20member%20B">CD300 molecule-like family member B</a>, <a href="cope.cgi?key=CLM7">CLM7</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d7">CMRF35-like molecule-7</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d7">CMRF35-like molecule-7</a>, <a href="cope.cgi?key=IREM3">IREM3</a>, <a href="cope.cgi?key=immune%20receptor%20expressed%20by%20myeloid%20cells%203">immune receptor expressed by myeloid cells 3</a>, <a href="cope.cgi?key=TREM5">TREM5</a>, <a href="cope.cgi?key=triggering%20receptor%20expressed%20on%20myeloid%20cells%205">triggering receptor expressed on myeloid cells 5</a>, <a href="cope.cgi?key=MAIR%2dVII">MAIR-VII</a>, <a href="cope.cgi?key=myeloid%2dassociated%20immunoglobulin%2dlike%20receptor%20VII">myeloid-associated immunoglobulin-like receptor VII</a>, <a href="cope.cgi?key=LMIR5">LMIR5</a>, <a href="cope.cgi?key=leukocyte%20mono%2dIg%2dlike%20receptor%205">leukocyte mono-Ig-like receptor 5</a>) (Gleissner et al, 2010; Yamanishi et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD300C">CD300C</a></b> (<a href="cope.cgi?key=CMRF35">CMRF35</a>, <a href="cope.cgi?key=CMRF35A">CMRF35A</a>, <a href="cope.cgi?key=CMRF35A1">CMRF35A1</a>, <a href="cope.cgi?key=IGSF16">IGSF16</a>, <a href="cope.cgi?key=immunoglobulin%20superfamily%20member%2016">immunoglobulin superfamily member 16</a>, <a href="cope.cgi?key=LIR">LIR</a>, <a href="cope.cgi?key=MAIR%2dIII">MAIR-III</a>, <a href="cope.cgi?key=myeloid%2dassociated%20immunoglobulin%2dlike%20receptor%20III">myeloid-associated immunoglobulin-like receptor III</a>, <a href="cope.cgi?key=CLM6">CLM6</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d6">CMRF35-like molecule-6</a>) (Jackson et al, 1992; Daish et al, 1993)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD300D">CD300D</a></b> (<a href="cope.cgi?key=CD300LD">CD300LD</a>; <a href="cope.cgi?key=MAIR%2dII">MAIR-II</a>, <a href="cope.cgi?key=myeloid%2dassociated%20immunoglobulin%2dlike%20receptor%20II">myeloid-associated immunoglobulin-like receptor II</a>, <a href="cope.cgi?key=CLM4">CLM4</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d4">CMRF35-like molecule-4</a>, <a href="cope.cgi?key=LMIR2">LMIR2</a>, <a href="cope.cgi?key=leukocyte%20mono%2dIg%2dlike%20receptor%202">leukocyte mono-Ig-like receptor 2</a>, <a href="cope.cgi?key=DIgR1">DIgR1</a>, <a href="cope.cgi?key=DC%2dderived%20Ig%2dlike%20receptor%201">DC-derived Ig-like receptor 1</a>; <a href="cope.cgi?key=Dendritic%20cell%2dderived%20Ig%2dlike%20receptor%201">Dendritic cell-derived Ig-like receptor 1</a>, <a href="cope.cgi?key=CMRF35A4">CMRF35A4</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%20A4">CMRF35-like molecule A4</a>) (Nakahashi et al, 2007; Luo K et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD300F">CD300F</a></b> (<a href="cope.cgi?key=CD300LF">CD300LF</a>, <a href="cope.cgi?key=CD300%20molecule%2dlike%20family%20member%20F">CD300 molecule-like family member F</a>, <a href="cope.cgi?key=CLM1">CLM1</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d1">CMRF35-like molecule-1</a>, <a href="cope.cgi?key=IGSF13">IGSF13</a>, <a href="cope.cgi?key=immunoglobulin%20superfamily%20member%2013">immunoglobulin superfamily member 13</a>, <a href="cope.cgi?key=IREM1">IREM1</a>, <a href="cope.cgi?key=immune%20receptor%20expressed%20on%20myeloid%20cells%201">immune receptor expressed on myeloid cells 1</a>, <a href="cope.cgi?key=NKIR">NKIR</a>, <a href="cope.cgi?key=NK%20inhibitory%20receptor">NK inhibitory receptor</a>, <a href="cope.cgi?key=MAIR%2dV">MAIR-V</a>, <a href="cope.cgi?key=myeloid%2dassociated%20immunoglobulin%2dlike%20receptor%20V">myeloid-associated immunoglobulin-like receptor V</a>, <a href="cope.cgi?key=LMIR3">LMIR3</a>, <a href="cope.cgi?key=leukocyte%20mono%2dIg%2dlike%20receptor%203">leukocyte mono-Ig-like receptor 3</a>, <a href="cope.cgi?key=CLM1">CLM1</a>, <a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d1">CMRF35-like molecule-1</a>, <a href="cope.cgi?key=DIgR2">DIgR2</a>, <a href="cope.cgi?key=DC%2dderived%20Ig%2dlike%20receptor%202">DC-derived Ig-like receptor 2</a>; <a href="cope.cgi?key=Dendritic%20cell%2dderived%20Ig%2dlike%20receptor%202">Dendritic cell-derived Ig-like receptor 2</a>) (Can et al, 2008; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD301">CD301</a></b> (<a href="cope.cgi?key=CD301a">CD301a</a>, <a href="cope.cgi?key=MGL1">MGL1</a> [<a href="cope.cgi?key=Macrophage%20galactose%2dtype%20C%2dtype%20lectin%2d1">Macrophage galactose-type C-type lectin-1</a>, <a href="cope.cgi?key=CD301b">CD301b</a>, <a href="cope.cgi?key=MGL2">MGL2</a>, <a href="cope.cgi?key=Macrophage%20galactose%2dtype%20C%2dtype%20lectin%2d2">Macrophage galactose-type C-type lectin-2</a>, <a href="cope.cgi?key=CLEC10A">CLEC10A</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%2010%20member%20A">C-type lectin domain family 10 member A</a>, <a href="cope.cgi?key=CLECSF13">CLECSF13</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20superfamily%20member%2013">C-type lectin domain superfamily member 13</a>, <a href="cope.cgi?key=CLECSF14">CLECSF14</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20superfamily%20member%2014">C-type lectin domain superfamily member 14</a>, <a href="cope.cgi?key=HML">HML</a>, <a href="cope.cgi?key=human%20macrophage%20lectin">human macrophage lectin</a>, <a href="cope.cgi?key=HML2">HML2</a>, <a href="cope.cgi?key=human%20macrophage%20lectin%202">human macrophage lectin 2</a>, <a href="cope.cgi?key=Macrophage%20lectin%202">Macrophage lectin 2</a>) (Raes et al, 2005; Tsuiji et al, 2005; Martinez FO et al, 2006; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD302">CD302</a></b> (<a href="cope.cgi?key=BIMLEC">BIMLEC</a>, <a href="cope.cgi?key=CLEC13A">CLEC13A</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%2013%20member%20A">C-type lectin domain family 13 member A</a>, <a href="cope.cgi?key=DCL%2d1">DCL-1</a>, <a href="cope.cgi?key=DEC%2d205%2dassociated%20C%2dtype%20lectin%2d1">DEC-205-associated C-type lectin-1</a>) (Kato et al, 2007; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD312">CD312</a></b> (<a href="cope.cgi?key=EMR2">EMR2</a>, <a href="cope.cgi?key=EGF%2dlike%20module%20containing%20mucin%2dlike%20hormone%20receptor%2dlike%2d2">EGF-like module containing mucin-like hormone receptor-like-2</a>) (Chang GW et al, 2007; Karlsson KR et al, 2008; Kop et al, 2005; Kwakkenbos et al, 2002, 2005; Lin et al, 2000; van Eijk et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CD320">CD320</a></b> (<a href="cope.cgi?key=transcobalamin%20receptor">Transcobalamin receptor</a>, <a href="cope.cgi?key=TcblR">TcblR</a>, <a href="cope.cgi?key=8D6">8D6</a>, <a href="cope.cgi?key=8D6A">8D6A</a>, <a href="cope.cgi?key=FDC%2dSM%2d8D6">FDC-SM-8D6</a>, <a href="cope.cgi?key=FDC%2dsignaling%20molecule%208D6">FDC-signaling molecule 8D6</a>, <a href="cope.cgi?key=NG29">NG29</a>)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ceruloplasmin">ceruloplasmin</a></b> (<a href="cope.cgi?key=Cp">Cp</a>, <a href="cope.cgi?key=Ferroxidase">ferroxidase</a>, <a href="cope.cgi?key=Fe%28II%29%20%2d%20oxygen%20oxidoreductase">Fe(II) - oxygen oxidoreductase</a>, <a href="cope.cgi?key=iron%20%28II%29%20%2d%20oxygen%20oxidoreductase">iron (II) - oxygen oxidoreductase</a>, <a href="cope.cgi?key=EC1%2e16%2e3%2e1">EC1.16.3.1</a>, <a href="cope.cgi?key=Ran%2d2%20antigen">Ran-2 antigen</a>, <a href="cope.cgi?key=rat%20neural%20antigen%2d2">rat neural antigen-2</a>, <a href="cope.cgi?key=PACAP%281%2d38%29%20binding%20factor">PACAP(1-38) binding factor</a>, <a href="cope.cgi?key=pituitary%20adenylate%20cyclase%2dactivating%20polypeptide1%2d38%2dbinding%20factor">pituitary adenylate cyclase-activating polypeptide1-38-binding factor</a>) (Yang et al, 1986; Pan et al, 1998; Mazumder et al, 2005; Marques L et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CFLAR">CFLAR</a></b> (<a href="cope.cgi?key=Caspase%2d8%20and%20FADD%2dlike%20apoptosis%20regulator">Caspase-8 and FADD-like apoptosis regulator</a>, <a href="cope.cgi?key=CASH">CASH</a>, <a href="cope.cgi?key=caspase%20homolog">caspase homolog</a>, <a href="cope.cgi?key=Casper">Casper</a>, <a href="cope.cgi?key=Caspase%20eight%2drelated%20protein">caspase eight-related protein</a>, <a href="cope.cgi?key=Caspase%2d8%20related%20protein">Caspase-8 related protein</a>, <a href="cope.cgi?key=CLARP">CLARP</a>, <a href="cope.cgi?key=caspase%2dlike%20apoptosis%2dregulatory%20protein">caspase-like apoptosis-regulatory protein</a>, <a href="cope.cgi?key=FLAME%2d1">FLAME-1</a>, <a href="cope.cgi?key=FADD%2dlike%20anti%2dapoptotic%20molecule%2d1">FADD-like anti-apoptotic molecule-1</a>, <a href="cope.cgi?key=c%2dFLIP">c-FLIP</a>, <a href="cope.cgi?key=FLIP">FLIP</a>, <a href="cope.cgi?key=FLICE%2dinhibitory%20proteins">FLICE-inhibitory proteins</a>, <a href="cope.cgi?key=I%2dFLICE">I-FLICE</a>, <a href="cope.cgi?key=Inhibitor%20of%20FLICE">Inhibitor of FLICE</a>, <a href="cope.cgi?key=MRIT">MRIT</a>, <a href="cope.cgi?key=Mach%2dRelated%20Inducer%20of%20Toxicity">Mach-Related Inducer of Toxicity</a>, <a href="cope.cgi?key=Usurpin">Usurpin</a>) (Perlman et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Chemerin">Chemerin</a></b> (<a href="cope.cgi?key=RARRES2">RARRES2</a>, <a href="cope.cgi?key=retinoic%20acid%20receptor%20responder%202">retinoic acid receptor responder 2</a>, <a href="cope.cgi?key=tazarotene%2dinduced%20gene%2d2">tazarotene-induced gene-2</a>, <a href="cope.cgi?key=TIG2">TIG2</a>) (Spiroglou SG et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Chemerin">Chemerin</a></b> (<a href="cope.cgi?key=RARRES2">RARRES2</a>, <a href="cope.cgi?key=retinoic%20acid%20receptor%20responder%202">retinoic acid receptor responder 2</a>, <a href="cope.cgi?key=tazarotene%2dinduced%20gene%2d2">tazarotene-induced gene-2</a>, <a href="cope.cgi?key=TIG2">TIG2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=chemerinR">ChemerinR</a>, <a href="cope.cgi?key=ChemR23">ChemR23</a>, <a href="cope.cgi?key=chemokine%20receptor%2023">chemokine receptor 23</a>, <a href="cope.cgi?key=CMKLR1">CMKLR1</a>, <a href="cope.cgi?key=chemokine%2dlike%20receptor%201">chemokine-like receptor 1</a>, <a href="cope.cgi?key=Dez">Dez</a>) (Samson et al, 1998; Luangsay et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CHI3L1">CHI3L1</a></b> (<a href="cope.cgi?key=chitinase%203%2dlike%2d1">chitinase 3-like-1</a>, <a href="cope.cgi?key=cartilage%20glycoprotein%2039">cartilage glycoprotein 39</a>, <a href="cope.cgi?key=gp39">gp39</a>; <a href="cope.cgi?key=gp39k">gp39k</a> <a href="cope.cgi?key=HC%2dgp39">HC-gp39</a>, <a href="cope.cgi?key=chondrocyte%20protein%20YKL40">chondrocyte protein YKL40</a>, <a href="cope.cgi?key=YKL40">YKL40</a>, <a href="cope.cgi?key=Chondrex">Chondrex</a>) (Rehli et al, 2003; Krause et al, 1996; Kirkpatrick et al, 1997; Bonneh-Barkay et al, 2008; Nol W et al, 2002; Raes G et al, 2002; Ponomarev ED et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CHI3L1">CHI3L1</a></b> (<a href="cope.cgi?key=chitinase%203%2dlike%2d1">chitinase 3-like-1</a>, <a href="cope.cgi?key=cartilage%20glycoprotein%2039">cartilage glycoprotein 39</a>, <a href="cope.cgi?key=gp39">gp39</a>; <a href="cope.cgi?key=gp39k">gp39k</a> <a href="cope.cgi?key=HC%2dgp39">HC-gp39</a>, <a href="cope.cgi?key=chondrocyte%20protein%20YKL40">chondrocyte protein YKL40</a>, <a href="cope.cgi?key=YKL40">YKL40</a>, <a href="cope.cgi?key=Chondrex">Chondrex</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Letuve et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CHI3L2">CHI3L2</a></b> (<a href="cope.cgi?key=chitinase%203%2dlike%2d2">chitinase 3-like-2</a>, <a href="cope.cgi?key=YKL39">YKL39</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CHI3L3">CHI3L3</a></b> (<a href="cope.cgi?key=chitinase%203%2dlike%2d3">chitinase 3-like-3</a>, <a href="cope.cgi?key=ECF%2dL">ECF-L</a>, <a href="cope.cgi?key=eosinophil%20chemotactic%20cytokine%2dL">eosinophil chemotactic cytokine-L</a>, <a href="cope.cgi?key=T%2dlymphocyte%2dderived%20eosinophil%20chemotactic%20factor">T-lymphocyte-derived eosinophil chemotactic factor</a>, <a href="cope.cgi?key=Ym1">Ym1</a>) (Chang et al, 2001; Raes et al, 2002; Loke et al, 2001; Maresz et al, 2008; Waern I et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Cholecystokinin">cholecystokinin</a></b> (<a href="cope.cgi?key=CCK">CCK</a>, <a href="cope.cgi?key=pancreozymin">pancreozymin</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Li et al, 2002; Cong et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CISH">CISH</a></b> (<a href="cope.cgi?key=cytokine%20inducible%20SH2%2dcontaining%20protein">Cytokine inducible SH2-containing protein</a>, <a href="cope.cgi?key=CIS">CIS</a>, <a href="cope.cgi?key=cytokine%20inducible%20SH2%2dcontaining%20protein">Cytokine inducible SH2-containing protein</a>, <a href="cope.cgi?key=CIS1">CIS1</a>, <a href="cope.cgi?key=G18">G18</a>, <a href="cope.cgi?key=SOCS">SOCS</a>, <a href="cope.cgi?key=Suppressor%20of%20cytokine%20signaling">Suppressor of cytokine signaling</a>) (Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CLM5">CLM5</a></b> (<a href="cope.cgi?key=CMRF35%2dlike%20molecule%2d5">CMRF35-like molecule-5</a>, <a href="cope.cgi?key=MAIR%2dIV">MAIR-IV</a>, <a href="cope.cgi?key=myeloid%2dassociated%20immunoglobulin%2dlike%20receptor%20IV">myeloid-associated immunoglobulin-like receptor IV</a>; <a href="cope.cgi?key=LMIR4">LMIR4</a>; <a href="cope.cgi?key=leukocyte%20mono%2dIg%2dlike%20receptor%204">leukocyte mono-Ig-like receptor 4</a>) (Nakano et al, 2008; Fujimoto et al, 2006; Izawa et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Clusterin">Clusterin</a></b> (<a href="cope.cgi?key=CLU">CLU</a>, <a href="cope.cgi?key=dimeric%20acidic%20glycoprotein">dimeric acidic glycoprotein</a>, <a href="cope.cgi?key=DAG%20protein">DAG protein</a>, <a href="cope.cgi?key=testosterone%20repressed%20prostate%20message%2d2">testosterone repressed prostate message-2</a>, <a href="cope.cgi?key=TRPM%2d2">TRPM-2</a>, <a href="cope.cgi?key=sulfated%20glycoprotein%2d2">sulfated glycoprotein-2</a>, <a href="cope.cgi?key=SGP%2d2">SGP-2</a>, <a href="cope.cgi?key=complement%2dassociated%20protein%20SP%2d40%2c40">complement-associated protein SP-40,40</a>, <a href="cope.cgi?key=SP%2d40%2c40">SP-40,40</a>, <a href="cope.cgi?key=complement%20lysis%20inhibitor">complement lysis inhibitor</a>, <a href="cope.cgi?key=CLI">CLI</a>, <a href="cope.cgi?key=Apolipoprotein%20J">Apolipoprotein J</a>)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=CMGF">cMGF</a> (Kim et al, 1998) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CNTF">CNTF</a> </b>(<a href="cope.cgi?key=Ciliary%20neuronotrophic%20factor">Ciliary neuronotrophic factor</a>, <a href="cope.cgi?key=Ciliary%20neurotrophic%20factor">ciliary neurotrophic factor</a>, <a href="cope.cgi?key=MANS">MANS</a>, <a href="cope.cgi?key=Membrane%2dassociated%20neurotransmitter%20stimulating%20factor">membrane-associated neurotransmitter stimulating factor</a>) (Li et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=collectin%2d12">Collectin-12</a> </b>(<a href="cope.cgi?key=COLEC12">COLEC12</a>, <a href="cope.cgi?key=CL%2dP1">CL-P1</a>, <a href="cope.cgi?key=collectin%20placenta%201">collectin placenta 1</a>, <a href="cope.cgi?key=SRCL">SRCL</a>, <a href="cope.cgi?key=scavenger%20receptor%20with%20C%2dtype%20lectin">scavenger receptor with C-type lectin</a>, <a href="cope.cgi?key=SCARA4">SCARA4</a>, <a href="cope.cgi?key=Scavenger%20receptor%20class%20A%20member%204">Scavenger receptor class A member 4</a>) (Samsen et al, 2010; Selman L et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=Complement%20C1q">complement factor C1q</a> (Faust et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=complement%20factor%20C3">complement factor C3</a></b> (<a href="cope.cgi?key=ECI">ECI</a>, <a href="cope.cgi?key=Eosinophil%20cytotoxicity%20inhibitor">Eosinophil cytotoxicity inhibitor</a>, <a href="cope.cgi?key=C3%2dbeta%2dc">C3-beta-c</a>, <a href="cope.cgi?key=Complement%20factor%20C3b">complement factor C3b</a>, <a href="cope.cgi?key=ETF%2d3">ETF-3</a>, <a href="cope.cgi?key=embryotrophic%20factor%2d3">embryotrophic factor-3</a>, <a href="cope.cgi?key=HSE%2dMSF">HSE-MSF</a>, <a href="cope.cgi?key=Hepatic%20sinusoidal%20endothelial%20cell%2dderived%20migration%20stimulating%20factor">hepatic sinusoidal endothelial cell-derived migration stimulating factor</a>) (Bajtay et al, 1998; Goldman et al, 1991; Mogilenko DA et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> complement factor C6 (Qian et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Complement%20factor%20H">complement factor H</a></b> (<a href="cope.cgi?key=Factor%20H">factor H</a>, <a href="cope.cgi?key=CFH">CFH</a>, <a href="cope.cgi?key=H%20factor">H factor</a>, <a href="cope.cgi?key=HF">HF</a>, <a href="cope.cgi?key=H%20factor%2d1">H factor-1</a>, <a href="cope.cgi?key=HF1">HF1</a>, <a href="cope.cgi?key=beta%201%20H%20globulin">beta 1 H globulin</a>, <a href="cope.cgi?key=C3b%20inactivator%20accelerator">C3b inactivator accelerator</a>, <a href="cope.cgi?key=A%2dC3bINA">A-C3bINA</a>, <a href="cope.cgi?key=AMBP%2d1">AMBP-1</a>, <a href="cope.cgi?key=AM34%20antigen">AM34 antigen</a>, <a href="cope.cgi?key=Adrenomedullin%20binding%20protein%2d1">Adrenomedullin binding protein-1</a>, <a href="cope.cgi?key=AM%20binding%20protein%2d1">AM binding protein-1</a>) (Luo C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Corticotropin%20releasing%20hormone">Corticotropin releasing hormone</a></b> (<a href="cope.cgi?key=CRH">CRH</a>, <a href="cope.cgi?key=CRF">CRF</a>, <a href="cope.cgi?key=Corticotropin%20releasing%20factor">Corticotropin releasing factor</a>, <a href="cope.cgi?key=Corticoliberin">Corticoliberin</a>) (Wang W et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Cortistatin">cortistatin</a></b> (<a href="cope.cgi?key=Cort">Cort</a>, <a href="cope.cgi?key=CST">CST</a>, <a href="cope.cgi?key=CST%2d14">CST-14</a>, <a href="cope.cgi?key=Cortistatin%2d14">Cortistatin-14</a>, <a href="cope.cgi?key=CST%2d17">CST-17</a>, <a href="cope.cgi?key=Cortistatin%2d17">Cortistatin-17</a>) (Dalm et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Cortistatin">cortistatin</a></b> (<a href="cope.cgi?key=Cort">Cort</a>, <a href="cope.cgi?key=CST">CST</a>, <a href="cope.cgi?key=CST%2d14">CST-14</a>, <a href="cope.cgi?key=Cortistatin%2d14">Cortistatin-14</a>, <a href="cope.cgi?key=CST%2d17">CST-17</a>, <a href="cope.cgi?key=Cortistatin%2d17">Cortistatin-17</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Dalm et al, 2003; Gonzalez-Rey et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CRIM1">CRIM1</a></b> (<a href="cope.cgi?key=cysteine%2drich%20BMP%20regulator%2d1">cysteine-rich BMP regulator-1</a>, <a href="cope.cgi?key=cysteine%2drich%20motor%20neuron%20protein%201">cysteine-rich motor neuron protein 1</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CRP">CRP</a></b> (<a href="cope.cgi?key=C%2dreactive%20protein">C-reactive protein</a>, <a href="cope.cgi?key=PTX1">PTX1</a>, <a href="cope.cgi?key=pentraxin%2d1">pentraxin-1</a>, <a href="cope.cgi?key=PCBP">PCBP</a>, <a href="cope.cgi?key=phosphorylcholine%2dbinding%20protein">phosphorylcholine-binding protein</a>)<b style="mso-bidi-font-weight:normal"> </b>(Dong and Wright, 1996; Kaplan M et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=CRP">CRP</a></b> (<a href="cope.cgi?key=C%2dreactive%20protein">C-reactive protein</a>, <a href="cope.cgi?key=PTX1">PTX1</a>, <a href="cope.cgi?key=pentraxin%2d1">pentraxin-1</a>, <a href="cope.cgi?key=PCBP">PCBP</a>, <a href="cope.cgi?key=phosphorylcholine%2dbinding%20protein">phosphorylcholine-binding protein</a>)<b style="mso-bidi-font-weight:normal"> </b><b style="mso-bidi-font-weight:normal">receptors </b>(Abe et al, 2006; Galve-de Rochemonteix, 1993)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CTRP6">CTRP6</a> </b>(<a href="cope.cgi?key=C1q%2fTNF%2drelated%20protein%206">C1q/TNF-related protein 6</a>, <a href="cope.cgi?key=C1QTNF6">C1QTNF6</a>, <a href="cope.cgi?key=Complement%20C1q%20tumor%20necrosis%20factor%2drelated%20protein%206">Complement C1q tumor necrosis factor-related protein 6</a>, <a href="cope.cgi?key=C1q%20and%20tumor%20necrosis%20factor%20related%20protein%206">C1q and tumor necrosis factor related protein 6</a>, <a href="cope.cgi?key=ZACRP6">ZACRP6</a>) (Kim MJ et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=C%2dtype%20natriuretic%20peptide">C-type natriuretic peptide</a> </b>(<a href="cope.cgi?key=CNP">CNP</a>, <a href="cope.cgi?key=ANP%2dC">ANP-C</a>, <a href="cope.cgi?key=NPPC">NPPC</a>, <a href="cope.cgi?key=natriuretic%20peptide%20precursor%20type%20C">natriuretic peptide precursor type C</a>, <a href="cope.cgi?key=CNP%2d22">CNP-22</a>, <a href="cope.cgi?key=CNP%2d53">CNP-53</a>, <a href="cope.cgi?key=NPPC">NPPC</a>) (Kubo et al, 2001; Vollmar et al, 1995; Kubo et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥ </b><b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CX3CL1">CX3CL1</a></b> (<a href="cope.cgi?key=Fractalkine">fractalkine</a>, <a href="cope.cgi?key=FKN">FKN</a>, <a href="cope.cgi?key=FK">FK</a>, <a href="cope.cgi?key=CX3C%20membrane%2danchored%20chemokine">CX3C membrane-anchored chemokine</a>, <a href="cope.cgi?key=C3Xkine">C3Xkine</a>, <a href="cope.cgi?key=Neurotactin">neurotactin</a>, <a href="cope.cgi?key=NTT">NTT</a>, <a href="cope.cgi?key=NTN">NTN</a>, <a href="cope.cgi?key=ABCD%2d3">ABCD-3</a>, <a href="cope.cgi?key=SCYD1">SCYD1</a>) (Greaves et al, 2001; Ishida et al, 2008; McComb et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CX3CL1">CX3CL1</a></b> (<a href="cope.cgi?key=Fractalkine">fractalkine</a>, <a href="cope.cgi?key=FKN">FKN</a>, <a href="cope.cgi?key=FK">FK</a>, <a href="cope.cgi?key=CX3C%20membrane%2danchored%20chemokine">CX3C membrane-anchored chemokine</a>, <a href="cope.cgi?key=C3Xkine">C3Xkine</a>, <a href="cope.cgi?key=Neurotactin">neurotactin</a>, <a href="cope.cgi?key=NTT">NTT</a>, <a href="cope.cgi?key=NTN">NTN</a>, <a href="cope.cgi?key=ABCD%2d3">ABCD-3</a>, <a href="cope.cgi?key=SCYD1">SCYD1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=CX3CR1">CX3CR1</a>, <a href="cope.cgi?key=V28">V28</a>, <a href="cope.cgi?key=CMKBRL1">CMKBRL1</a>, <a href="cope.cgi?key=chemokine%20beta%20receptor%2dlike%2d1">chemokine beta receptor-like-1</a>, <a href="cope.cgi?key=GPR13">GPR13</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d13">G-protein-coupled receptor-13</a>) (Ishida et al, 2008, <a href="cope.cgi?key=Lu">Lu</a> et al, 2008; Ishida et al, 2008; Truman et al, 2008; Hannan et al, 2004; Holmes et al, 2008; McComb et al, 2008; Mizutani et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=CXCL1">CXCL1</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%201">CXC chemokine ligand 1</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%201">chemokine (C-X-C motif) ligand 1</a>, <a href="cope.cgi?key=SCYB1">SCYB1</a>, <a href="cope.cgi?key=CINC%2d1">CINC-1</a>, <a href="cope.cgi?key=Cytokine%20induced%20neutrophil%20chemoattractant%2d1">Cytokine induced neutrophil chemoattractant-1</a>, <a href="cope.cgi?key=fsp">fsp</a>, <a href="cope.cgi?key=fibroblast%20secretory%20protein">fibroblast secretory protein</a>, <a href="cope.cgi?key=GRO1">GRO1</a>, <a href="cope.cgi?key=GRO%2dalpha">GRO-alpha</a>, <a href="cope.cgi?key=KC">KC</a>, <a href="cope.cgi?key=MGSA">MGSA</a>, <a href="cope.cgi?key=Melanoma%20growth%20stimulatory%20activity">melanoma growth stimulatory activity</a>, <a href="cope.cgi?key=MGSA%2dalpha">MGSA-alpha</a>, <a href="cope.cgi?key=Melanoma%20growth%20stimulatory%20activity%2dalpha">melanoma growth stimulatory activity-alpha</a>, <a href="cope.cgi?key=NAP%2d3">NAP-3</a>, <a href="cope.cgi?key=Neutrophil%2dactivating%20protein%2d3">neutrophil-activating protein-3</a>, <a href="cope.cgi?key=N51">N51</a>) (Moreno-Altamirano MM et al, 2004; Yamasawa et al, 1999; Alonso et al, 1986; Shibata et al, 2000; Amano et al, 2000; Bai T et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=CXCL1">CXCL1</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%201">CXC chemokine ligand 1</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%201">chemokine (C-X-C motif) ligand 1</a>, <a href="cope.cgi?key=SCYB1">SCYB1</a>, <a href="cope.cgi?key=CINC%2d1">CINC-1</a>, <a href="cope.cgi?key=Cytokine%20induced%20neutrophil%20chemoattractant%2d1">Cytokine induced neutrophil chemoattractant-1</a>, <a href="cope.cgi?key=fsp">fsp</a>, <a href="cope.cgi?key=fibroblast%20secretory%20protein">fibroblast secretory protein</a>, <a href="cope.cgi?key=GRO1">GRO1</a>, <a href="cope.cgi?key=GRO%2dalpha">GRO-alpha</a>, <a href="cope.cgi?key=KC">KC</a>, <a href="cope.cgi?key=MGSA">MGSA</a>, <a href="cope.cgi?key=Melanoma%20growth%20stimulatory%20activity">melanoma growth stimulatory activity</a>, <a href="cope.cgi?key=MGSA%2dalpha">MGSA-alpha</a>, <a href="cope.cgi?key=Melanoma%20growth%20stimulatory%20activity%2dalpha">melanoma growth stimulatory activity-alpha</a>, <a href="cope.cgi?key=NAP%2d3">NAP-3</a>, <a href="cope.cgi?key=Neutrophil%2dactivating%20protein%2d3">neutrophil-activating protein-3</a>, <a href="cope.cgi?key=N51">N51</a>) (Moreno-Altamirano et al, 2004; Kurosaka et al, 2003; Yamamoto et al, 1996, 1997; Rodenburg et al, 1998; Flesch et al, 1998; Goodman et al, 1998; Major et al, 2002; Takeshita et al, 2001; Medvedev et al, 2000; Hohlbaum et al, 2001; Naidu et al, 2002; Hasko et al, 2002; Li et al, 2001; Lucas et al, 2003; Becker et al, 1994; Kim et al, 1999; Ciesielski et al, 2002; Call et al, 2001; Delgado and Ganea, 2001; Kent et al, 2008; Fischer et al, 2007; Alonso et al, 1996; Mitsui et al, 2002; Nakagawa et al, 1996; Shibata et al, 2000; Naidu et al, 2002; Nakagawa et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL2">CXCL2</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%202">CXC chemokine ligand 2</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%202">chemokine (C-X-C motif) ligand 2</a>, <a href="cope.cgi?key=CINC%2d2%2dalpha">CINC-2-alpha</a>, <a href="cope.cgi?key=Cytokine%20induced%20neutrophil%20chemoattractant%2d2%2dalpha">Cytokine induced neutrophil chemoattractant-2-alpha</a>, <a href="cope.cgi?key=GRO2">GRO2</a>, <a href="cope.cgi?key=growth%2drelated%20oncogene%2d2">growth-related oncogene-2</a>, <a href="cope.cgi?key=GRO%2dbeta">GRO-beta</a>, <a href="cope.cgi?key=Growth%20regulated%20oncogene%2dbeta">growth regulated oncogene-beta</a>, <a href="cope.cgi?key=MIP%2d2%2dalpha">MIP-2-alpha</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d2%2dalpha">macrophage inflammatory protein-2-alpha</a>, <a href="cope.cgi?key=MGSA%2dbeta">MGSA-beta</a>, <a href="cope.cgi?key=Melanoma%20growth%20stimulatory%20activity%2dbeta">melanoma growth stimulatory activity-beta</a>, <a href="cope.cgi?key=SCYB2">SCYB2</a>) (Goodman et al, 1998; Hasko et al, 2002; Moreno-Altamirano et al, 2004; Becker et al, 1994; Ragno et al, 2001; Sun et al, 2008; Kent et al, 2008; Fischer et al, 2007; Bourdonnay et al, 2009; Alonso et al, 1996; Mitsui et al, 2002; Shibata et al, 2000; Nakagawa et al, 1996; Yamasawa et al, 1999; Shibata et al, 2000; Bai T et al, 2010; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL3">CXCL3</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%203">CXC chemokine ligand 3</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%203">chemokine (C-X-C motif) ligand 3</a>, <a href="cope.cgi?key=CINC%2d2%2dbeta">CINC-2-beta</a>, <a href="cope.cgi?key=Cytokine%20induced%20neutrophil%20chemoattractant%2d2%2dbeta">Cytokine induced neutrophil chemoattractant-2-beta</a>, <a href="cope.cgi?key=DCIP%2d1">DCIP-1</a>, <a href="cope.cgi?key=DC%20inflammatory%20protein%2d1">DC inflammatory protein-1</a>, <a href="cope.cgi?key=GRO3">GRO3</a>, <a href="cope.cgi?key=GRO%2dgamma">GRO-gamma</a>, <a href="cope.cgi?key=Growth%20regulated%20oncogene%2dgamma">growth regulated oncogene-gamma</a>, <a href="cope.cgi?key=growth%2drelated%20oncogene%2d3">growth-related oncogene-3</a>, <a href="cope.cgi?key=MGSA%2dgamma">MGSA-gamma</a>, <a href="cope.cgi?key=Melanoma%20growth%20stimulatory%20activity%2dgamma">melanoma growth stimulatory activity-gamma</a>, <a href="cope.cgi?key=MIP%2d2%2dbeta">MIP-2-beta</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d2%2dbeta">macrophage inflammatory protein-2-beta</a>) (Goodman et al, 1998; Moreno-Altamirano et al, 2004; Becker et al, 1994; Ragno et al, 2001; Nolan et al, 2004; Fischer et al, 2007; Mitsui et al, 2002; Nakagawa et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL4">CXCL4</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%204">CXC chemokine ligand 4</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%204">chemokine (C-X-C motif) ligand 4</a>, <a href="cope.cgi?key=PF4">PF4</a>, <a href="cope.cgi?key=Platelet%20factor%2d4">platelet factor-4</a>, <a href="cope.cgi?key=Endothelial%20cell%20growth%20inhibitor">Endothelial cell growth inhibitor</a>, <a href="cope.cgi?key=Heparin%20neutralizing%20protein">Heparin neutralizing protein</a>, <a href="cope.cgi?key=Megakaryocyte%2dstimulatory%2dfactor">Megakaryocyte-stimulatory-factor</a>, <a href="cope.cgi?key=Oncostatin%20A">Oncostatin A</a>, <a href="cope.cgi?key=SCYB4">SCYB4</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Gleissner <a href="cope.cgi?key=CA">CA</a> et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL5">CXCL5</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%205">CXC chemokine ligand 5</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%205">chemokine (C-X-C motif) ligand 5</a>, <a href="cope.cgi?key=ENA%2d78">ENA-78</a>, <a href="cope.cgi?key=Epithelial%20neutrophil%2dactivating%20protein%2078">Epithelial neutrophil-activating protein 78</a>, <a href="cope.cgi?key=epithelial%20cell%2dderived%20neutrophil%20attractant%2d78">epithelial cell-derived neutrophil attractant-78</a>, <a href="cope.cgi?key=LIX">LIX</a>, <a href="cope.cgi?key=LPS%20induced%20CXC%20chemokine">LPS induced CXC chemokine</a>, <a href="cope.cgi?key=AMCF%2d2">AMCF-2</a>, <a href="cope.cgi?key=alveolar%20macrophage%20chemotactic%20factor%2d2">Alveolar macrophage chemotactic factor-2</a>, <a href="cope.cgi?key=SCYB5">SCYB5</a>) (Goodman et al, 1998; Albright and Gonzalez-Scarano, 2004; Ciesielski et al, 2002; Fischer et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL7">CXCL7</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%207">CXC chemokine ligand 7</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%207">chemokine (C-X-C motif) ligand 7</a>, <a href="cope.cgi?key=CTAP%2d3">CTAP-3</a>, <a href="cope.cgi?key=Connective%20tissue%20activating%20protein%2d3">Connective tissue activating protein-3</a>, <a href="cope.cgi?key=LA%2dPF4">LA-PF4</a>, <a href="cope.cgi?key=Low%20affinity%20platelet%20factor%2d4">low affinity platelet factor-4</a>, <a href="cope.cgi?key=LDGF">LDGF</a>, <a href="cope.cgi?key=Leukocyte%2dderived%20growth%20factor">Leukocyte-derived growth factor</a>, <a href="cope.cgi?key=MDGF">MDGF</a>, <a href="cope.cgi?key=Macrophage%2dderived%20growth%20factor">macrophage-derived growth factor</a>, <a href="cope.cgi?key=NAP%2d2">NAP-2</a>, <a href="cope.cgi?key=Neutrophil%2dactivating%20protein%2d2">Neutrophil-activating protein-2</a>, <a href="cope.cgi?key=PPBP">PPBP</a>, <a href="cope.cgi?key=Pro%2dplatelet%20basic%20protein">pro-platelet basic protein</a>, <a href="cope.cgi?key=PBP">PBP</a>, <a href="cope.cgi?key=Platelet%20basic%20protein">platelet basic protein</a>, <a href="cope.cgi?key=SCYB7">SCYB7</a>) (Khajoee et al, 2006; <a href="cope.cgi?key=fu">Fu</a> WX et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL9">CXCL9</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%209">CXC chemokine ligand 9</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%209">chemokine (C-X-C motif) ligand 9</a>, <a href="cope.cgi?key=mig">mig</a>, <a href="cope.cgi?key=Monokine%20induced%20by%20gamma%2dInterferon">monokine induced by gamma-Interferon</a>, <a href="cope.cgi?key=Humig">Humig</a>, <a href="cope.cgi?key=Mumig">Mumig</a>, <a href="cope.cgi?key=CRG%2d10">CRG-10</a>, <a href="cope.cgi?key=Cytokine%20responsive%20gene%2d10">cytokine responsive gene-10</a>, <a href="cope.cgi?key=M119">M119</a>, <a href="cope.cgi?key=SCYB9">SCYB9</a>) (Algood et al, 2004; Veckman et al, 2003; Horton et al, 1998; Okamoto et al, 2008; Martinez et al, 2008; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL10">CXCL10</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%2010">CXC chemokine ligand 10</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%2010">chemokine (C-X-C motif) ligand 10</a>, <a href="cope.cgi?key=IP%2d10">IP-10</a>, <a href="cope.cgi?key=INP%2d10">INP-10</a>, <a href="cope.cgi?key=inflammatory%20protein%2010">inflammatory protein 10</a>, <a href="cope.cgi?key=Interferon%2dinducible%20protein%2d10">Interferon-inducible protein-10</a>, <a href="cope.cgi?key=IFN%2dinducible%20protein%2010">IFN-inducible protein 10</a>, <a href="cope.cgi?key=Immune%20protein%2d10">immune protein-10</a>; <a href="cope.cgi?key=10%20kDa%20interferon%2dinducible%20protein">10 kDa interferon-inducible protein</a>, <a href="cope.cgi?key=Gamma%2dIP%2d10">gamma-IP-10</a>, <a href="cope.cgi?key=CRG%2d2">CRG-2</a>, <a href="cope.cgi?key=Cytokine%20responsive%20gene%2d2">cytokine responsive gene-2</a>, <a href="cope.cgi?key=C7">C7</a>, <a href="cope.cgi?key=Ifi10">Ifi10</a>, <a href="cope.cgi?key=Interferon%2dinducible%2d10">interferon-inducible-10</a>, <a href="cope.cgi?key=mob%2d1">mob-1</a>, <a href="cope.cgi?key=SCYB10">SCYB10</a>) (McKee et al, 1996; Schilling et al, 2002; Okamoto et al, 2008; Algood et al, 2004; Veckman et al, 2003; McKee et al, 1996; Flesch et al, 1998; Horton et al, 1998; Takeshita et al, 2001; Matikainen et al, 2000; Medvedev et al, 2000; Nakamichi et al, 2004; Narumi and Hamilton, 1991; Sodhi and Tripathi, 2008; Kent et al, 2008; Jang et al, 2008; Martinez FO et al, 2006; Martinez et al, 2008; Ying S et al, 2008; Bai T et al, 2010; Kim SY et al, 2010; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL11">CXCL11</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%2011">CXC chemokine ligand 11</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%2011">chemokine (C-X-C motif) ligand 11</a>, <a href="cope.cgi?key=H174">H174</a>, <a href="cope.cgi?key=Beta%2dR1">beta-R1</a>, <a href="cope.cgi?key=I%2dTAC">I-TAC</a>, <a href="cope.cgi?key=Interferon%2dinducible%20T%2dcell%20alpha%20chemoattractant">Interferon-inducible T-cell alpha chemoattractant</a>, <a href="cope.cgi?key=IP%2d9">IP-9</a>, <a href="cope.cgi?key=interferon%2dgamma%2dinducible%20protein%2d9">interferon-gamma-inducible protein-9</a>, <a href="cope.cgi?key=SCYB11">SCYB11</a>, <a href="cope.cgi?key=SCYB9B">SCYB9B</a>) (Okamoto et al, 2008; Martinez FO et al, 2006; Martinez et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL12">CXCL12</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%2012">CXC chemokine ligand 12</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%2012">chemokine (C-X-C motif) ligand 12</a>, <a href="cope.cgi?key=IRH">IRH</a>, <a href="cope.cgi?key=intercrine%20reduced%20in%20hepatomas">intercrine reduced in hepatomas</a>, <a href="cope.cgi?key=hIRH">hIRH</a>, <a href="cope.cgi?key=intercrine%20reduced%20in%20hepatomas">intercrine reduced in hepatomas</a>, <a href="cope.cgi?key=SDF%2d1%2dalpha">SDF-1-alpha</a>, <a href="cope.cgi?key=CXCL12%2dalpha">CXCL12-alpha</a>, <a href="cope.cgi?key=SDF%2d1%2dbeta">SDF-1-beta</a>, <a href="cope.cgi?key=CXCL12%2dbeta">CXCL12-beta</a>, <a href="cope.cgi?key=SDF">SDF</a>, <a href="cope.cgi?key=SDF%2d1">SDF-1</a>, <a href="cope.cgi?key=Stromal%20cell%2dderived%20factor">Stromal cell-derived factor</a>, <a href="cope.cgi?key=Stromal%20cell%2dderived%20factor%2d1%2dalpha">Stromal cell-derived factor-1-alpha</a>, <a href="cope.cgi?key=Stromal%20cell%2dderived%20factor%2d1%2dbeta">Stromal cell-derived factor-1-beta</a>, <a href="cope.cgi?key=PBSF">PBSF</a>, <a href="cope.cgi?key=Pre%2dB%2dcell%20growth%20stimulating%20factor">pre-B-cell growth stimulating factor</a>, <a href="cope.cgi?key=TLSF">TLSF</a>, <a href="cope.cgi?key=Thymic%20lymphoma%20cell%20stimulating%20factor">Thymic lymphoma cell stimulating factor</a>, <a href="cope.cgi?key=Thymic%20lymphoma%20cell%20stimulating%20factor%2dalpha">Thymic lymphoma cell stimulating factor-alpha</a>, <a href="cope.cgi?key=Thymic%20lymphoma%20cell%20stimulating%20factor%2dbeta">Thymic lymphoma cell stimulating factor-beta</a>, <a href="cope.cgi?key=TLSF%2dalpha">TLSF-alpha</a>, <a href="cope.cgi?key=TLSF%2dbeta">TLSF-beta</a>, <a href="cope.cgi?key=TPAR%2d1">TPAR-1</a>, <a href="cope.cgi?key=TPA%20repressed%20gene%2d1">TPA repressed gene-1</a>, <a href="cope.cgi?key=SCYB12">SCYB12</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Campana et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL13">CXCL13</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%2013">CXC chemokine ligand 13</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%2013">chemokine (C-X-C motif) ligand 13</a>, <a href="cope.cgi?key=BLC">BLC</a>, <a href="cope.cgi?key=B%2dlymphocyte%20chemoattractant">B-lymphocyte chemoattractant</a>, <a href="cope.cgi?key=BCA%2d1">BCA-1</a>, <a href="cope.cgi?key=B%2dcell%20attracting%20chemokine%201">B-cell attracting chemokine 1</a>, <a href="cope.cgi?key=blr%2d1L">blr-1L</a>, <a href="cope.cgi?key=blr%2d1%20ligand">blr-1 ligand</a>, <a href="cope.cgi?key=Angie%2d2">Angie-2</a>, <a href="cope.cgi?key=SCYB13">SCYB13</a>) (Carlsen et al, 2004; Di Carlo E et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL14">CXCL14</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%2014">CXC chemokine ligand 14</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%2014">chemokine (C-X-C motif) ligand 14</a>, <a href="cope.cgi?key=BMAC">BMAC</a>, <a href="cope.cgi?key=B%2dcell%20and%20monocyte%2dactivating%20chemokine">B-cell and monocyte-activating chemokine</a>, <a href="cope.cgi?key=Bolekine">bolekine</a>, <a href="cope.cgi?key=BRAK">BRAK</a>, <a href="cope.cgi?key=breast%20and%20kidney%20cell%20chemokine">breast and kidney cell chemokine</a>, <a href="cope.cgi?key=KEC">KEC</a>, <a href="cope.cgi?key=kidney%2dexpressed%20chemokine">kidney-expressed chemokine</a>, <a href="cope.cgi?key=KS1">KS1</a>, <a href="cope.cgi?key=MIP%2d2%2dgamma">MIP-2-gamma</a>, <a href="cope.cgi?key=Macrophage%20inflammatory%20protein%2d2%2dgamma">macrophage inflammatory protein-2-gamma</a>, <a href="cope.cgi?key=NJAC">NJAC</a>, <a href="cope.cgi?key=SCYB14">SCYB14</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Nara et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCL16">CXCL16</a></b> (<a href="cope.cgi?key=CXC%20chemokine%20ligand%2016">CXC chemokine ligand 16</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%2016">chemokine (C-X-C motif) ligand 16</a>, <a href="cope.cgi?key=SR%2dPSOX">SR-PSOX</a>, <a href="cope.cgi?key=scavenger%20receptor%20that%20binds%20phosphatidylserine%20and%20oxidized%20lipoprotein">scavenger receptor that binds phosphatidylserine and oxidized lipoprotein</a>, <a href="cope.cgi?key=SCYB16">SCYB16</a>) (Wilbanks et al, 2001; van der Voort et al, 2005; Tabata et al, 2005; Lehrke et al, 2007; Kang et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCR3">CXCR3</a></b> (<a href="cope.cgi?key=CXCR3A">CXCR3A</a>, <a href="cope.cgi?key=CXC%2dChemokine%20receptor%203">CXC-Chemokine receptor 3</a>, <a href="cope.cgi?key=IP%2d10%20receptor">IP-10 receptor</a>, <a href="cope.cgi?key=Mig%20receptor">Mig receptor</a>, <a href="cope.cgi?key=CKR%2dL2">CKR-L2</a>, <a href="cope.cgi?key=GPR9">GPR9</a>, <a href="cope.cgi?key=CD183">CD183</a>) (Nieto et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=CXCR4">CXCR4</a></b> (<a href="cope.cgi?key=CXC%2dChemokine%20receptor%204">CXC-Chemokine receptor 4</a>, <a href="cope.cgi?key=LESTR">LESTR</a>, <a href="cope.cgi?key=Leukocyte%2dderived%207%2dtransmembrane%20domain%20receptor">leukocyte-derived 7-transmembrane domain receptor</a>, <a href="cope.cgi?key=HUMSTR">HUMSTR</a>, <a href="cope.cgi?key=NPYRL">NPYRL</a>, <a href="cope.cgi?key=neuropeptide%20Y%20receptor%2dlike">neuropeptide Y receptor-like</a>, <a href="cope.cgi?key=NPY3R">NPY3R</a>, <a href="cope.cgi?key=neuropeptide%20Y%20receptor%20Y3">neuropeptide Y receptor Y3</a>, <a href="cope.cgi?key=HM89">HM89</a>, <a href="cope.cgi?key=Fusin">Fusin</a>, <a href="cope.cgi?key=LCR%2d1">LCR-1</a>, <a href="cope.cgi?key=FB22">FB22</a>, <a href="cope.cgi?key=LAP3">LAP3</a>, <a href="cope.cgi?key=Lipopolysaccharide%2dassociated%20protein%203">Lipopolysaccharide-associated protein 3</a>, <a href="cope.cgi?key=SDF%2d1%20receptor">SDF-1 receptor</a>, <a href="cope.cgi?key=CD184">CD184</a>, <a href="cope.cgi?key=AURA86">AURA86</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2086">augmented in rheumatoid arthritis 86</a>) (Hoshino et al, 2004; Hamon et al, 2004; Yi et al, 1998; Martinez FO et al, 2006; Torres et al, 2001; Worgall et al, 1999; Hermann et al, 1999; Shen R et al, 2009; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Cyclophilin%20A">cyclophilin A</a></b> (<a href="cope.cgi?key=CYPA">CYPA</a>, <a href="cope.cgi?key=CYPH">CYPH</a>, <a href="cope.cgi?key=Cyclosporin%20A%20binding%20protein">Cyclosporin A binding protein</a>, <a href="cope.cgi?key=PPIA">PPIA</a>, <a href="cope.cgi?key=peptidyl%2dprolyl%20cis%2dtrans%20isomerase%20A">peptidyl-prolyl cis-trans isomerase A</a>, <a href="cope.cgi?key=peptidylprolyl%20isomerase%20A">peptidylprolyl isomerase A</a>, <a href="cope.cgi?key=PPIase%20A">PPIase A</a>, <a href="cope.cgi?key=Rotamase%20A">Rotamase A</a>, <a href="cope.cgi?key=sp18">sp18</a>, <a href="cope.cgi?key=secreted%20protein%2018%20kDa">secreted protein 18 kDa</a>) (Krumrei et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Cyclophilin%20A">cyclophilin A</a></b> (<a href="cope.cgi?key=CYPA">CYPA</a>, <a href="cope.cgi?key=CYPH">CYPH</a>, <a href="cope.cgi?key=Cyclosporin%20A%20binding%20protein">Cyclosporin A binding protein</a>, <a href="cope.cgi?key=PPIA">PPIA</a>, <a href="cope.cgi?key=peptidyl%2dprolyl%20cis%2dtrans%20isomerase%20A">peptidyl-prolyl cis-trans isomerase A</a>, <a href="cope.cgi?key=peptidylprolyl%20isomerase%20A">peptidylprolyl isomerase A</a>, <a href="cope.cgi?key=PPIase%20A">PPIase A</a>, <a href="cope.cgi?key=Rotamase%20A">Rotamase A</a>, <a href="cope.cgi?key=sp18">sp18</a>, <a href="cope.cgi?key=secreted%20protein%2018%20kDa">secreted protein 18 kDa</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Seizer et al, 2010; Sherry et al, 2007; Kim H et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Cystatin%20A">Cystatin A</a></b> (<a href="cope.cgi?key=CSTA">CSTA</a>, <a href="cope.cgi?key=keratolinin">Keratolinin</a>, <a href="cope.cgi?key=Stefin%20A">Stefin A</a>, <a href="cope.cgi?key=STFA">STFA</a>, <a href="cope.cgi?key=STF1">STF1</a>, <a href="cope.cgi?key=ACPI">ACPI</a>, <a href="cope.cgi?key=acid%20cysteine%20proteinase%20inhibitor">acid cysteine proteinase inhibitor</a>) (Sarsfield et al, 1996; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Cystatin%20C">Cystatin C</a></b> (<a href="cope.cgi?key=CST3">CST3</a>, <a href="cope.cgi?key=Cystatin%2d3">Cystatin-3</a>, <a href="cope.cgi?key=Gamma%2dTRACE">Gamma-TRACE</a>, <a href="cope.cgi?key=post%2dgamma%20globulin">post-gamma globulin</a>) (Chapman et al, 1990; Warfel et al, 1987; Lignelid H et al, 1997)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=D6">D6</a></b> (<a href="cope.cgi?key=CCBP2">CCBP2</a>, <a href="cope.cgi?key=chemokine%20binding%20protein%2d2">chemokine binding protein-2</a>, <a href="cope.cgi?key=CMKBR9">CMKBR9</a>, <a href="cope.cgi?key=chemokine%2dbeta%20receptor%209">chemokine-beta receptor 9</a>) (McKimmie CS and Graham <a href="cope.cgi?key=gJ">GJ</a>, 2006; Nibbs RJ et al, 1997; Trujillo G et al, 2008; Bazzan E et al, 2013)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=DC%2dSIGN">DC-SIGN</a></b> (<a href="cope.cgi?key=dendritic%20cell%2dspecific%20ICAM3%2dgrabbing%20nonintegrin">dendritic cell-specific ICAM3-grabbing nonintegrin</a>, <a href="cope.cgi?key=DC%2dSIGN%2d1">DC-SIGN-1</a>, <a href="cope.cgi?key=dendritic%20cell%2dspecific%20ICAM3%2dgrabbing%20nonintegrin%2d1">dendritic cell-specific ICAM3-grabbing nonintegrin-1</a>, <a href="cope.cgi?key=CD209">CD209</a>, <a href="cope.cgi?key=CD209a">CD209a</a>, <a href="cope.cgi?key=CIRE">CIRE</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20immune%20receptor">C-type lectin immune receptor</a>, <a href="cope.cgi?key=CLEC4L">CLEC4L</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%204%20member%20L">C-type lectin domain family 4 member L</a>, <a href="cope.cgi?key=gp120%20binding%20protein">gp120 binding protein</a>, <a href="cope.cgi?key=HIV%20gp120%20binding%20protein">HIV gp120 binding protein</a>, <a href="cope.cgi?key=SIGNR1">SIGNR1</a>, <a href="cope.cgi?key=SIGN%20related%20gene%201">SIGN related gene 1</a>) (van Lent et al, 203; Simmons et al, 2003; Soilleux et al, 2002; van Lent et al, 2003; Geijtenbeek et al, 2002; Bckle et al, 2008; De Jesus et al, 2008; Koppel et al, 2008; Martinez FO et al, 2006; Gustafsson et al, 2008; Martens et al, 2006; Yagi Y et al, 2010; Takahara et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=DC%2dSIGN">DC-SIGN</a></b> (<a href="cope.cgi?key=dendritic%20cell%2dspecific%20ICAM3%2dgrabbing%20nonintegrin">dendritic cell-specific ICAM3-grabbing nonintegrin</a>, <a href="cope.cgi?key=DC%2dSIGN%2d1">DC-SIGN-1</a>, <a href="cope.cgi?key=dendritic%20cell%2dspecific%20ICAM3%2dgrabbing%20nonintegrin%2d1">dendritic cell-specific ICAM3-grabbing nonintegrin-1</a>, <a href="cope.cgi?key=CD209">CD209</a>, <a href="cope.cgi?key=CD209a">CD209a</a>, <a href="cope.cgi?key=CIRE">CIRE</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20immune%20receptor">C-type lectin immune receptor</a>, <a href="cope.cgi?key=CLEC4L">CLEC4L</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%204%20member%20L">C-type lectin domain family 4 member L</a>, <a href="cope.cgi?key=gp120%20binding%20protein">gp120 binding protein</a>, <a href="cope.cgi?key=HIV%20gp120%20binding%20protein">HIV gp120 binding protein</a>, <a href="cope.cgi?key=SIGNR1">SIGNR1</a>, <a href="cope.cgi?key=SIGN%20related%20gene%201">SIGN related gene 1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Simmons et al, 2003; Martens et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=DC%2dSTAMP">DC-STAMP</a></b> (<a href="cope.cgi?key=dendritic%20cell%2dspecific%20transmembrane%20protein">dendritic cell-specific transmembrane protein</a>, <a href="cope.cgi?key=FIND">FIND</a>, <a href="cope.cgi?key=TM7SF4">TM7SF4</a>, <a href="cope.cgi?key=transmembrane%207%20superfamily%20member%204">transmembrane 7 superfamily member 4</a>) (Staege et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=D%2ddopachrome%20tautomerase">D-dopachrome tautomerase</a></b> (<a href="cope.cgi?key=DDT">DDT</a>, <a href="cope.cgi?key=DDCT">DDCT</a>, <a href="cope.cgi?key=phenylpyruvate%20tautomerase">Phenylpyruvate tautomerase</a>, <a href="cope.cgi?key=D%2ddopachrome%20carboxy%2dlyase">D-dopachrome carboxy-lyase</a>, <a href="cope.cgi?key=D%2ddopachrome%20decarboxylase">D-dopachrome decarboxylase</a>, <a href="cope.cgi?key=Phenylpyruvate%20tautomerase%20II">Phenylpyruvate tautomerase II</a>, <a href="cope.cgi?key=EC4%2e1%2e1%2e84">EC4.1.1.84</a>, <a href="cope.cgi?key=MIF%2d2">MIF-2</a>, <a href="cope.cgi?key=Macrophage%20migration%20inhibitory%20factor%2d2">macrophage migration inhibitory factor-2</a>) (Ban JY et al, 2011; Merk et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Dectin%2d1">Dectin-1</a> </b>(<a href="cope.cgi?key=DC%2dassociated%20C%2dtype%20lectin%201">DC-associated C-type lectin 1</a>, <a href="cope.cgi?key=Dendritic%20cell%2dassociated%20C%2dtype%20lectin%201">Dendritic cell-associated C-type lectin 1</a>, <a href="cope.cgi?key=Dectin%2d1A">dectin-1A</a>, <a href="cope.cgi?key=Dectin%2d1B">dectin-1B</a>, <a href="cope.cgi?key=CLEC7A">CLEC7A</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%207%20member%20A">C-type lectin domain family 7 member A</a>, <a href="cope.cgi?key=CLECSF12">CLECSF12</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20superfamily%20member%2012">C-type lectin domain superfamily member 12</a>, <a href="cope.cgi?key=BGR">BGR</a>, <a href="cope.cgi?key=Beta%2dglucan%20receptor">beta-glucan receptor</a>, <a href="cope.cgi?key=BGRA">BGRA</a>, <a href="cope.cgi?key=Beta%2dglucan%20receptor%20A">Beta-glucan receptor A</a>, <a href="cope.cgi?key=BGRB">BGRB</a>, <a href="cope.cgi?key=Beta%2dglucan%20receptor%20B">Beta-glucan receptor B</a>) (Martinez FO et al, 2006<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=DDR1">DDR1</a></b> (<a href="cope.cgi?key=discoidin%20domain%20receptor%201">discoidin domain receptor 1</a>, <a href="cope.cgi?key=DDR">DDR</a>, <a href="cope.cgi?key=discoidin%20domain%20receptor">discoidin domain receptor</a>, <a href="cope.cgi?key=CD167">CD167</a>, <a href="cope.cgi?key=CD167a">CD167a</a>, <a href="cope.cgi?key=cak">Cak</a>, <a href="cope.cgi?key=cell%20adhesion%20kinase">cell adhesion kinase</a>, <a href="cope.cgi?key=EDDR1">EDDR1</a>, <a href="cope.cgi?key=epithelial%20discoidin%20domain%20receptor%201">epithelial discoidin domain receptor 1</a>, <a href="cope.cgi?key=EDDR2">EDDR2</a>, <a href="cope.cgi?key=epithelial%20discoidin%20domain%20receptor%202">epithelial discoidin domain receptor 2</a>, <a href="cope.cgi?key=HGK2">HGK2</a>, <a href="cope.cgi?key=MCK10">MCK10</a>, <a href="cope.cgi?key=mammary%20carcinoma%20kinase%2010">mammary carcinoma kinase 10</a> , <a href="cope.cgi?key=NEP">NEP</a>, <a href="cope.cgi?key=neuroepithelial%20tyrosine%20kinase">neuroepithelial tyrosine kinase</a>, <a href="cope.cgi?key=NTRK4">NTRK4</a>, <a href="cope.cgi?key=neurotrophic%20tyrosine%20kinase%20receptor%204">neurotrophic tyrosine kinase receptor 4</a>, <a href="cope.cgi?key=PTK3">PTK3</a>, <a href="cope.cgi?key=protein%20tyrosine%20kinase%203">protein tyrosine kinase 3</a>, <a href="cope.cgi?key=RTK6">RTK6</a>, <a href="cope.cgi?key=receptor%20tyrosine%20kinase%206">receptor tyrosine kinase 6</a>, <a href="cope.cgi?key=trk6">trk6</a>, <a href="cope.cgi?key=trkE">trkE</a>, <a href="cope.cgi?key=tyrosine%20kinase%20receptor%20E">tyrosine kinase receptor E</a>) (Kamohara et al, 2001; Matsuyama et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Dectin%2d1">Dectin-1</a> </b>(<a href="cope.cgi?key=DC%2dassociated%20C%2dtype%20lectin%201">DC-associated C-type lectin 1</a>, <a href="cope.cgi?key=Dendritic%20cell%2dassociated%20C%2dtype%20lectin%201">Dendritic cell-associated C-type lectin 1</a>, <a href="cope.cgi?key=Dectin%2d1A">dectin-1A</a>, <a href="cope.cgi?key=Dectin%2d1B">dectin-1B</a>, <a href="cope.cgi?key=CLEC7A">CLEC7A</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%207%20member%20A">C-type lectin domain family 7 member A</a>, <a href="cope.cgi?key=CLECSF12">CLECSF12</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20superfamily%20member%2012">C-type lectin domain superfamily member 12</a>, <a href="cope.cgi?key=BGR">BGR</a>, <a href="cope.cgi?key=Beta%2dglucan%20receptor">beta-glucan receptor</a>, <a href="cope.cgi?key=BGRA">BGRA</a>, <a href="cope.cgi?key=Beta%2dglucan%20receptor%20A">Beta-glucan receptor A</a>, <a href="cope.cgi?key=BGRB">BGRB</a>, <a href="cope.cgi?key=Beta%2dglucan%20receptor%20B">Beta-glucan receptor B</a>) (Allavena et al, 2010; Ariizumi et al, 2000; Bonfim et al, 2009; Brown GD et al, 2002; de Vries et al; 2009; Esteban et al, 2011; Ferwerda et al, 2008; Hermanz-Falcn et al, 2001; Kankkunen et al, 2010; Lee HM et al, 2011; Masuda Y et al, 2012; Minari et al, 2011; Parti et al, 2010; Reid et al, 2004; Tam JM et al, 2012; Taylor et al, 2002; Underhill et al, 2005; Willment et al, 2001, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=dectin%2d2">dectin-2</a> </b>(<a href="cope.cgi?key=dectin%2d2%2dalpha">Dectin-2-alpha</a>, <a href="cope.cgi?key=DC%2dassociated%20C%2dtype%20lectin%202">DC-associated C-type lectin 2</a>, <a href="cope.cgi?key=Dendritic%20cell%2dassociated%20C%2dtype%20lectin%202">Dendritic cell-associated C-type lectin 2</a>, <a href="cope.cgi?key=CLEC6A">CLEC6A</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%206%20member%20A">C-type lectin domain family 6 member A</a>, <a href="cope.cgi?key=CLECSF10">CLECSF10</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20superfamily%20member%2010">C-type lectin domain superfamily member 10</a>, <a href="cope.cgi?key=CLEC4N">CLEC4N</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%204%20member%20N">C-type lectin domain family 4 member N</a>) (Ban JY et al, 2011; Kushida et al, 2011; Taylor et al, 2005; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Decysin">decysin</a></b> (<a href="cope.cgi?key=Decysin%201">Decysin 1</a>, <a href="cope.cgi?key=ADAMDEC1">ADAMDEC1</a>) (Bates et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dalpha%2d1">defensin-alpha-1</a></b> (<a href="cope.cgi?key=Defensin%2d1">Defensin-1</a>, <a href="cope.cgi?key=Alpha%2dDefensin%2d1">Alpha-Defensin-1</a>, <a href="cope.cgi?key=HNP%2d1">HNP-1</a>, <a href="cope.cgi?key=human%20neutrophil%20peptide%2d1">human neutrophil peptide-1</a>, <a href="cope.cgi?key=HP%2d1">HP-1</a>, <a href="cope.cgi?key=DEFA1">DEFA1</a>, <a href="cope.cgi?key=MRS">MRS</a>, <a href="cope.cgi?key=myeloid%2drelated%20sequence">myeloid-related sequence</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Grigat J et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dalpha%2d3">defensin-alpha-3</a></b> (<a href="cope.cgi?key=Alpha%2dDefensin%2d3">Alpha-Defensin-3</a>, <a href="cope.cgi?key=Defensin%2dalpha%2d3">defensin-alpha-3</a>, <a href="cope.cgi?key=DEFA3">DEFA3</a>, <a href="cope.cgi?key=DEF3">DEF3</a>, <a href="cope.cgi?key=HNP%2d3">HNP-3</a>, <a href="cope.cgi?key=human%20neutrophil%20peptide%2d3">human neutrophil peptide-3</a>, <a href="cope.cgi?key=HP%2d3">HP-3</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Grigat J et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dalpha%2d5">defensin-alpha-5</a></b> (<a href="cope.cgi?key=HD%2d5">HD-5</a>, <a href="cope.cgi?key=Defensin%2d5">defensin-5</a>, <a href="cope.cgi?key=Alpha%2dDefensin%2d5">alpha-Defensin-5</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Grigat J et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dbeta%2d1">defensin-beta-1</a></b> (<a href="cope.cgi?key=Beta%2dDefensin%2d1">beta-Defensin-1</a>, <a href="cope.cgi?key=HBD%2d1">HBD-1</a>, <a href="cope.cgi?key=DEFB1">DEFB1</a>, <a href="cope.cgi?key=DEFB101">DEFB101</a>) (Wah et al, 2006; Duits et al, 2000, 2002; Alp et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dbeta%2d1">defensin-beta-1</a></b> (<a href="cope.cgi?key=Beta%2dDefensin%2d1">beta-Defensin-1</a>, <a href="cope.cgi?key=HBD%2d1">HBD-1</a>, <a href="cope.cgi?key=DEFB1">DEFB1</a>, <a href="cope.cgi?key=DEFB101">DEFB101</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Soruri et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dbeta%2d2">defensin-beta-2</a></b> (<a href="cope.cgi?key=Beta%2dDefensin%2d2">beta-Defensin-2</a>, <a href="cope.cgi?key=DEFB4">DEFB4</a>, <a href="cope.cgi?key=HBD%2d2">HBD-2</a>, <a href="cope.cgi?key=SAP%2d1">SAP-1</a>, <a href="cope.cgi?key=skin%20antimicrobial%20peptide%201">skin antimicrobial peptide 1</a>) (Duits et al, 2002; Wu M et al, 2009; Alp et al, 2005; Wah et al, 2006; Nickel D et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dbeta%2d2">defensin-beta-2</a></b> (<a href="cope.cgi?key=Beta%2dDefensin%2d2">beta-Defensin-2</a>, <a href="cope.cgi?key=DEFB4">DEFB4</a>, <a href="cope.cgi?key=HBD%2d2">HBD-2</a>, <a href="cope.cgi?key=SAP%2d1">SAP-1</a>, <a href="cope.cgi?key=skin%20antimicrobial%20peptide%201">skin antimicrobial peptide 1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Soruri et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dbeta%2d3">defensin-beta-3</a></b> (<a href="cope.cgi?key=Beta%2dDefensin%2d3">beta-Defensin-3</a>, <a href="cope.cgi?key=HBD%2d3">HBD-3</a>, <a href="cope.cgi?key=DEFB103">DEFB103</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Jin G et al, 2010; Soruri et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensin%2dbeta%2d4">defensin-beta-4</a></b> (<a href="cope.cgi?key=Beta%2dDefensin%2d4">beta-Defensin-4</a>, <a href="cope.cgi?key=DEFB104">DEFB104</a>, <a href="cope.cgi?key=HBD%2d4">HBD-4</a>) <b style="mso-bidi-font-weight:normal">receptors </b>(Soruri et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensins">Defensins</a></b> (Agerberth et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensins">Defensins</a></b> (<a href="cope.cgi?key=macrophage%20cationic%20peptide%2d1">macrophage cationic peptide-1</a>, <a href="cope.cgi?key=macrophage%20cationic%20peptide%2d2">macrophage cationic peptide-2</a>) (Ganz et al, 1989)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Defensins">Defensins</a></b> (<a href="cope.cgi?key=Beta%2dDefensins">Beta-Defensins</a>) (Ryan et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=DEK">DEK</a></b> (Mor-Vaknin et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=delta%2d1">delta-1</a></b> (<a href="cope.cgi?key=dll1">dll1</a>, <a href="cope.cgi?key=delta%2dlike%2d1">delta-like-1</a>, <a href="cope.cgi?key=delta%2dlike%20ligand%2d1">delta-like ligand-1</a>, <a href="cope.cgi?key=Drosophila%20delta%20homolog%201">Drosophila delta homolog 1</a>, <a href="cope.cgi?key=CRLM%2d2">CRLM-2</a>, <a href="cope.cgi?key=cytokine%20receptor%2dlike%20molecule%2d2">cytokine receptor-like molecule-2</a>) (Moriyama et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=dermokine">dermokine</a></b> (<a href="cope.cgi?key=Dmkn">Dmkn</a>, <a href="cope.cgi?key=sk30">sk30</a>, <a href="cope.cgi?key=sk30%2fsk89">sk30/sk89</a>, <a href="cope.cgi?key=sk89">sk89</a>, <a href="cope.cgi?key=sk89%2fsk30">sk89/sk30</a>, <a href="cope.cgi?key=Epidermis%2dspecific%20secreted%20protein%20sk89">Epidermis-specific secreted protein sk89</a>) (Naso et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=DLC1">DLC1</a></b> (<a href="cope.cgi?key=deleted%20in%20liver%20cancer%201">deleted in liver cancer 1</a>, <a href="cope.cgi?key=STARD12">STARD12</a>, <a href="cope.cgi?key=StAR%2drelated%20lipid%20transfer%20protein%2012">StAR-related lipid transfer protein 12</a>, <a href="cope.cgi?key=ARHGAP7">ARHGAP7</a>, <a href="cope.cgi?key=Rho%20GTPase%2dactivating%20protein%207">Rho GTPase-activating protein 7</a>, <a href="cope.cgi?key=p122%2dRhoGAP">p122-RhoGAP</a>, <a href="cope.cgi?key=p122%20Rho%20GTPase%2dactivating%20protein">p122 Rho GTPase-activating protein</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=DMBT1">DMBT1</a></b> (<a href="cope.cgi?key=deleted%20in%20malignant%20brain%20tumors%201">deleted in malignant brain tumors 1</a>, <a href="cope.cgi?key=gp300">gp300</a>, <a href="cope.cgi?key=Glycoprotein%20300">Glycoprotein 300</a>; <a href="cope.cgi?key=GP340">GP340</a>, <a href="cope.cgi?key=Glycoprotein%20340">Glycoprotein 340</a>; <a href="cope.cgi?key=lung%20glycoprotein%20340">lung glycoprotein 340</a>; <a href="cope.cgi?key=Surfactant%20pulmonary%2dassociated%20D%2dbinding%20protein">Surfactant pulmonary-associated D-binding protein</a>; <a href="cope.cgi?key=SAG">SAG</a>, <a href="cope.cgi?key=Salivary%20agglutinin">Salivary agglutinin</a>; <a href="cope.cgi?key=CRP%2dductin">CRP-ductin</a>, <a href="cope.cgi?key=CRP%2dalpha">CRP-alpha</a>, <a href="cope.cgi?key=CRP%2dbeta">CRP-beta</a>, <a href="cope.cgi?key=CRP%2dductin%20alpha">CRP-ductin alpha</a>, <a href="cope.cgi?key=CRP%2dductin%20beta">CRP-ductin beta</a>; <a href="cope.cgi?key=Crpd">Crpd</a>; <a href="cope.cgi?key=ebnerin">ebnerin</a>; <a href="cope.cgi?key=Hensin">Hensin</a>, <a href="cope.cgi?key=muclin">muclin</a>, <a href="cope.cgi?key=Mucin%2dlike%20glycoprotein">Mucin-like glycoprotein</a>, <a href="cope.cgi?key=Apactin">Apactin</a>, <a href="cope.cgi?key=vomeroglandin">vomeroglandin</a>) (Mollenhauer et al, 2000; Holmskov et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=DR6">DR6</a></b> (<a href="cope.cgi?key=death%20receptor%2d6">death receptor-6</a>, <a href="cope.cgi?key=TNFRSF21">TNFRSF21</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2021">TNF receptor superfamily member 21</a>, <a href="cope.cgi?key=CD358">CD358</a>) (Philipps et al, 2001; Gleissner et al, 2010)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EBI%2d3">EBI-3</a></b> (<a href="cope.cgi?key=EBV%20induced%20gene%2d3">EBV induced gene-3</a>, <a href="cope.cgi?key=IL27B">IL27B</a>; <a href="cope.cgi?key=IL27%2dbeta">IL27-beta</a>, <a href="cope.cgi?key=interleukin%2d27%2dbeta">interleukin-27-beta</a>) (Christ AD et al, 1998; Hause L et al, 2007; Larousserie F et al, 2004; Nelson DA et al, 2010; Pirhonen J et al, 2007; Schuetze N et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ECE%2d1">ECE-1</a></b> (<a href="cope.cgi?key=Endothelin%2dconverting%20enzyme%201">Endothelin-converting enzyme 1</a>, <a href="cope.cgi?key=ECE">ECE</a>, <a href="cope.cgi?key=Endothelin%2dconverting%20enzyme">Endothelin-converting enzyme</a>) (Ihling et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EDIL3">EDIL3</a> </b>(<a href="cope.cgi?key=EGF%2dlike%20repeats%20and%20discoidin%20I%2dlike%20domains%203">EGF-like repeats and discoidin I-like domains 3</a>, <a href="cope.cgi?key=Del%2d1">Del-1</a>, <a href="cope.cgi?key=Developmental%20endothelial%20locus%2d1">Developmental endothelial locus-1</a>, <a href="cope.cgi?key=Developmentally%2dregulated%20endothelial%20cell%20locus%201%20protein">Developmentally-regulated endothelial cell locus 1 protein</a>) (Hanayama et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EGF">EGF</a></b> (<a href="cope.cgi?key=Epidermal%20growth%20factor">epidermal growth factor</a>, <a href="cope.cgi?key=EGF%2dURO">EGF-URO</a>, <a href="cope.cgi?key=HMGF">HMGF</a>, <a href="cope.cgi?key=human%20milk%20growth%20factor">human milk growth factor</a>, <a href="cope.cgi?key=PGF">PGF</a>, <a href="cope.cgi?key=Prostatic%20growth%20factor">prostatic growth factor</a>, <a href="cope.cgi?key=Beta%2dUrogastrone">beta-Urogastrone</a>, <a href="cope.cgi?key=URO">URO</a>, <a href="cope.cgi?key=URG">URG</a>, <a href="cope.cgi?key=Urogastrone">Urogastrone</a>, <a href="cope.cgi?key=tooth%2dlid%20factor">tooth-lid factor</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=erbB1">erbB1</a>, <a href="cope.cgi?key=HER1">HER1</a>) (Lamb et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Egr%2d1">Egr-1</a></b> (<a href="cope.cgi?key=Early%20growth%20response%20gene%2d1">Early growth response gene-1</a>, <a href="cope.cgi?key=ETR103">ETR103</a>, <a href="cope.cgi?key=d2">d2</a>, <a href="cope.cgi?key=zif268">zif268</a>, <a href="cope.cgi?key=NGFI%2dA">NGFI-A</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dinducible%20A">nerve growth factor-inducible A</a>, <a href="cope.cgi?key=Krox%2d24">Krox-24</a>, <a href="cope.cgi?key=GOS%2d30">GOS-30</a>, <a href="cope.cgi?key=G0%2fG1%20switch%20gene%2030">G0/G1 switch gene 30</a>, <a href="cope.cgi?key=TIS8">TIS8</a>, <a href="cope.cgi?key=TPA%2dinducible%20sequence%2d8">TPA-inducible sequence-8</a>, <a href="cope.cgi?key=tetradecanoyl%20phorbol%20acetate%2dinducible%20sequence%2d8">tetradecanoyl phorbol acetate-inducible sequence-8</a>, <a href="cope.cgi?key=ZENK">ZENK</a>, <a href="cope.cgi?key=zfp6">zfp6</a>, <a href="cope.cgi?key=Zinc%20finger%20protein%206">Zinc finger protein 6</a>) (Xu Y et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Egr%2d2">Egr-2</a></b> (<a href="cope.cgi?key=Early%20growth%20response%20gene%2d2">Early growth response gene-2</a>, <a href="cope.cgi?key=Krox%2d20">krox-20</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EG%2dVEGF">EG-VEGF</a></b> (<a href="cope.cgi?key=Endocrine%20gland%2dderived%20vascular%20endothelial%20growth%20factor">Endocrine gland-derived vascular endothelial growth factor</a>, <a href="cope.cgi?key=prokineticin%2d1">prokineticin-1</a>, <a href="cope.cgi?key=PROK1">PROK1</a>, <a href="cope.cgi?key=PK1">PK1</a>, <a href="cope.cgi?key=PRK1">PRK1</a>, <a href="cope.cgi?key=mambakine">mambakine</a>, <a href="cope.cgi?key=black%20mamba%20toxin%2drelated%20protein">black mamba toxin-related protein</a>, <a href="cope.cgi?key=MIT1">MIT1</a>, <a href="cope.cgi?key=mamba%20intestinal%20protein%201">mamba intestinal protein 1</a>, <a href="cope.cgi?key=Bv8">Bv8</a>, <a href="cope.cgi?key=Bombina%20variagata%20peptide%208">Bombina variagata peptide 8</a>) (Denison FC et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EG%2dVEGF">EG-VEGF</a></b> (<a href="cope.cgi?key=Endocrine%20gland%2dderived%20vascular%20endothelial%20growth%20factor">Endocrine gland-derived vascular endothelial growth factor</a>, <a href="cope.cgi?key=prokineticin%2d1">prokineticin-1</a>, <a href="cope.cgi?key=PROK1">PROK1</a>, <a href="cope.cgi?key=PK1">PK1</a>, <a href="cope.cgi?key=PRK1">PRK1</a>, <a href="cope.cgi?key=mambakine">mambakine</a>, <a href="cope.cgi?key=black%20mamba%20toxin%2drelated%20protein">black mamba toxin-related protein</a>, <a href="cope.cgi?key=MIT1">MIT1</a>, <a href="cope.cgi?key=mamba%20intestinal%20protein%201">mamba intestinal protein 1</a>, <a href="cope.cgi?key=Bv8">Bv8</a>, <a href="cope.cgi?key=Bombina%20variagata%20peptide%208">Bombina variagata peptide 8</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=PROKR1">PROKR1</a>, <a href="cope.cgi?key=ZAQ">ZAQ</a>, <a href="cope.cgi?key=PK%2dR1">PK-R1</a>, <a href="cope.cgi?key=GPR73">GPR73</a>, <a href="cope.cgi?key=GPR73a">GPR73a</a>, <a href="cope.cgi?key=GPR73b">GPR73b</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73">G-protein-coupled receptor-73</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73a">G-protein-coupled receptor-73a</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73b">G-protein-coupled receptor-73b</a>, <a href="cope.cgi?key=PROKR2">PROKR2</a>, <a href="cope.cgi?key=I5E">I5E</a>, <a href="cope.cgi?key=PK%2dR2">PK-R2</a>, <a href="cope.cgi?key=GPR73L1">GPR73L1</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73%2dlike%201">G-protein-coupled receptor-73-like 1</a> ) (Denison FC et al, 2008; Dorsch M et al <a href="cope.cgi?key=PK1">PK1</a>, 2005; Martucci C et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Elafin">Elafin</a></b> (<a href="cope.cgi?key=EIA">EIA</a>, <a href="cope.cgi?key=Elastase%20inhibiting%20activity">Elastase inhibiting activity</a>, <a href="cope.cgi?key=ESI">ESI</a>, <a href="cope.cgi?key=Elastase%2dspecific%20inhibitor">Elastase-specific inhibitor</a>, <a href="cope.cgi?key=PI3">PI3</a>, <a href="cope.cgi?key=Peptidase%20inhibitor%203">Peptidase inhibitor 3</a>, <a href="cope.cgi?key=SKALP">SKALP</a>, <a href="cope.cgi?key=Skin%2dderived%20antileukoproteinase">Skin-derived antileukoproteinase</a>, <a href="cope.cgi?key=Trappin%2d2">Trappin-2</a>, <a href="cope.cgi?key=TOM">TOM</a>, <a href="cope.cgi?key=Trappin%20ovine%20molecule">Trappin ovine molecule</a>, <a href="cope.cgi?key=WAP3">WAP3</a>, <a href="cope.cgi?key=Whey%20acidic%20protein%203">whey acidic protein 3</a>, <a href="cope.cgi?key=WFDC14">WFDC14</a>, <a href="cope.cgi?key=WAP%204%2ddisulfide%20core%20domain%20protein%2014">WAP 4-disulfide core domain protein 14</a>) (Mihaila and Tremblay, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=elastokines">elastokine</a> receptors</b> (<a href="cope.cgi?key=67%2dkDa%20elastin%2dbinding%20protein">67-kDa elastin-binding protein</a>, <a href="cope.cgi?key=EBP">EBP</a>, <a href="cope.cgi?key=67%20kDa%20EBP">67 kDa EBP</a>, <a href="cope.cgi?key=EBP67">EBP67</a>), <a href="cope.cgi?key=GLB1">GLB1</a>, <a href="cope.cgi?key=Bgl%2de">Bgl-e</a>, <a href="cope.cgi?key=beta%2dgalactosidase%2d1">beta-galactosidase-1</a>, <a href="cope.cgi?key=GM1%20gangliosidase">GM1 gangliosidase</a>, <a href="cope.cgi?key=GM1%20ganglioside%20beta%2dgalactosidase">GM1 ganglioside beta-galactosidase</a>, <a href="cope.cgi?key=EC3%2e2%2e1%2e23">EC3.2.1.23</a>, <a href="cope.cgi?key=Acid%20beta%2dgalactosidase">Acid beta-galactosidase</a>) (Samokhin AO et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EMAP%2d2">EMAP-2</a></b> (<a href="cope.cgi?key=Endothelial%2dmonocyte%20activating%20polypeptide%2d2">Endothelial-monocyte activating polypeptide-2</a>, <a href="cope.cgi?key=p43">p43</a>, <a href="cope.cgi?key=AIMP1">AIMP1</a>, <a href="cope.cgi?key=ARS%2dinteracting%20multi%2dfunctional%20protein%201">ARS-interacting multi-functional protein 1</a>, <a href="cope.cgi?key=SCYE1">SCYE1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Kim E et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EMP%2d1">EMP-1</a></b> (<a href="cope.cgi?key=epithelial%20membrane%20protein%2d1">epithelial membrane protein-1</a>, <a href="cope.cgi?key=B4B">B4B</a>, <a href="cope.cgi?key=TMP">TMP</a>, <a href="cope.cgi?key=tumor%2dassociated%20membrane%20protein">tumor-associated membrane protein</a>, <a href="cope.cgi?key=CL%2d20">CL-20</a>) (Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Endothelin%2d1">endothelin-1</a> </b>(<a href="cope.cgi?key=ET%2d1%281%2d21%29">ET-1(1-21)</a>, <a href="cope.cgi?key=ET%2d1">ET-1</a>, <a href="cope.cgi?key=EDN1">EDN1</a>) (Haug et al, 2001; Kobayashi et al, 1997; Li et al, 1999; Odoux et al, 1997; Finsnes et al, 1998; Odoux et al, 1997; Martin-Nizard et al, 1991; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Endothelin%2d1">endothelin-1</a> </b>(<a href="cope.cgi?key=ET%2d1%281%2d21%29">ET-1(1-21)</a>, <a href="cope.cgi?key=ET%2d1">ET-1</a>, <a href="cope.cgi?key=EDN1">EDN1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Haug et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Endothelin%2d2">endothelin-2</a></b> (<a href="cope.cgi?key=ET%2d2">ET-2</a>, <a href="cope.cgi?key=EDN2">EDN2</a>) (Kobayashi et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Endothelin%2d3">endothelin-3</a></b> (<a href="cope.cgi?key=ET%2d3">ET-3</a>, <a href="cope.cgi?key=EDN3">EDN3</a>) (Kobayashi et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=Endothelins">Endothelin</a> receptors (Speciale et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EphB1">EphB1</a></b> (<a href="cope.cgi?key=Eph%20receptor%20B1">Eph receptor B1</a>, <a href="cope.cgi?key=HEK6">HEK6</a>, <a href="cope.cgi?key=human%20embryo%20kinase%2d6">human embryo kinase-6</a>, <a href="cope.cgi?key=ELK">ELK</a>, <a href="cope.cgi?key=Eph%2dlike%20kinase">Eph-like kinase</a>, <a href="cope.cgi?key=NET">NET</a>, <a href="cope.cgi?key=neuronally%20expressed%20EPH%2drelated%20tyrosine%20kinase">neuronally expressed EPH-related tyrosine kinase</a>, <a href="cope.cgi?key=Cek6">Cek6</a>, <a href="cope.cgi?key=chicken%20embryonic%20kinase%206">chicken embryonic kinase 6</a>, <a href="cope.cgi?key=Xek">Xek</a>, <a href="cope.cgi?key=Xenopus%20Elk%2dlike%20kinase">Xenopus Elk-like kinase</a>) (Yu et al, 2004; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=EphB3">EphB3</a></b> (<a href="cope.cgi?key=Eph%20receptor%20B3">Eph receptor B3</a>, <a href="cope.cgi?key=HEK2">HEK2</a>, <a href="cope.cgi?key=human%20embryo%20kinase%2d2">human embryo kinase-2</a>, <a href="cope.cgi?key=tyro6">Tyro6</a>, <a href="cope.cgi?key=MDK5">MDK5</a>, <a href="cope.cgi?key=mouse%20Developmental%20Kinase%2d5">Mouse Developmental Kinase-5</a>, <a href="cope.cgi?key=Sek4">Sek4</a>, <a href="cope.cgi?key=Cek10">Cek10</a>, <a href="cope.cgi?key=chicken%20embryonic%20kinase%2010">chicken embryonic kinase 10</a>) (Yu et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Ephrin%20B1">ephrin B1</a></b> (<a href="cope.cgi?key=EFNB1">EFNB1</a>, <a href="cope.cgi?key=ELK%2dL">ELK-L</a>, <a href="cope.cgi?key=ELK%20ligand">ELK ligand</a>, <a href="cope.cgi?key=25H11%20antigen">25H11 antigen</a>, <a href="cope.cgi?key=EPLG2">EPLG2</a>, <a href="cope.cgi?key=EPH%2drelated%20receptor%20tyrosine%20kinase%20ligand%2d2">EPH-related receptor tyrosine kinase ligand-2</a>, <a href="cope.cgi?key=LERK2">LERK2</a>, <a href="cope.cgi?key=Ligand%20of%20eph%2drelated%20kinase%2d2">Ligand of eph-related kinase-2</a>) (Yu et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Ephrin%20B3">Ephrin B3</a></b> (<a href="cope.cgi?key=EFNB3">EFNB3</a>, <a href="cope.cgi?key=Elk%2dL3">Elk-L3</a>, <a href="cope.cgi?key=NLERK2">NLERK2</a>, <a href="cope.cgi?key=LERK8">LERK8</a>, <a href="cope.cgi?key=Ligand%20of%20eph%2drelated%20kinase%2d8">Ligand of eph-related kinase-8</a>, <a href="cope.cgi?key=EPLG8">EPLG8</a>, <a href="cope.cgi?key=EPH%2drelated%20receptor%20tyrosine%20kinase%20ligand%2d8">EPH-related receptor tyrosine kinase ligand-8</a>) (Yu et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Epiregulin">Epiregulin</a></b> (<a href="cope.cgi?key=EREG">EREG</a>, <a href="cope.cgi?key=EPR">EPR</a>) (Oshima et al, 2011; Nalbandian A et al, 2009; Thuong et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Erythropoietin">erythropoietin</a> </b>(<a href="cope.cgi?key=Epo">Epo</a>, <a href="cope.cgi?key=Ep">Ep</a>, <a href="cope.cgi?key=ECSA">ECSA</a>, <a href="cope.cgi?key=Erythroid%20colony%20stimulating%20activity">erythroid colony stimulating activity</a>, <a href="cope.cgi?key=ESF">ESF</a>, <a href="cope.cgi?key=Erythropoiesis%20stimulating%20factor">erythropoiesis stimulating factor</a>) (Ohls et al, 1994; Rich et al, 1988)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Erythropoietin">erythropoietin</a> </b>(<a href="cope.cgi?key=Epo">Epo</a>, <a href="cope.cgi?key=Ep">Ep</a>, <a href="cope.cgi?key=ECSA">ECSA</a>, <a href="cope.cgi?key=Erythroid%20colony%20stimulating%20activity">erythroid colony stimulating activity</a>, <a href="cope.cgi?key=ESF">ESF</a>, <a href="cope.cgi?key=Erythropoiesis%20stimulating%20factor">erythropoiesis stimulating factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=EPOR">EPOR</a>) (Lifshitz et al, 2010)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=F4%2f80">F4/80</a></b> (<a href="cope.cgi?key=BM8">BM8</a>, <a href="cope.cgi?key=Ly71">Ly71</a>, <a href="cope.cgi?key=EMR1">EMR1</a>, <a href="cope.cgi?key=EGF%20module%2dcontaining%20mucin%2dlike%20hormone%20receptor">EGF module-containing mucin-like hormone receptor</a>, <a href="cope.cgi?key=EGF%2dlike%20module%20containing%20mucin%2dlike%20hormone%20receptor%2dlike%2d1">EGF-like module containing mucin-like hormone receptor-like-1</a>) (Wu and Davidson, 2004; Yamada et al, 2005; <a href="cope.cgi?key=Lu">Lu</a> et al, 2008; Bassaganya-Riera et al, 2009; Nakamura et al, 2009; Karlsson KR et al, 2008; Lifshitz et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FABP4">FABP4</a></b> (<a href="cope.cgi?key=Fatty%20acid%20binding%20protein%204">fatty acid binding protein 4</a>, <a href="cope.cgi?key=aP2">aP2</a>, <a href="cope.cgi?key=adipocyte%20P2">adipocyte P2</a>, <a href="cope.cgi?key=adipocyte%20protein%202">adipocyte protein 2</a>, <a href="cope.cgi?key=ALBP">ALBP</a>, <a href="cope.cgi?key=Adipocyte%20lipid%2dbinding%20protein">adipocyte lipid-binding protein</a>, <a href="cope.cgi?key=H%2dALBP">H-ALBP</a>, <a href="cope.cgi?key=Human%20adipocyte%20lipid%2dbinding%20protein">Human adipocyte lipid-binding protein</a>, <a href="cope.cgi?key=A%2dFABP">A-FABP</a>, <a href="cope.cgi?key=Adipocyte%2dtype%20fatty%20acid%2dbinding%20protein">Adipocyte-type fatty acid-binding protein</a>, <a href="cope.cgi?key=adipocyte%20fatty%20acid%20binding%20protein">adipocyte fatty acid binding protein</a>, <a href="cope.cgi?key=adipose%20FABP">adipose FABP</a>, <a href="cope.cgi?key=adipocyte%20FABP">adipocyte FABP</a>, <a href="cope.cgi?key=422%20protein">422 protein</a>) (Agardh et al, 2011; Coleman et al, 2011; Hui X et al, 2010; Kazemi et al, 2005; Liu QY et al, 2007; Liaverias et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Factor%20X">factor X</a> </b>(<a href="cope.cgi?key=FX">FX</a>, <a href="cope.cgi?key=F10">F10</a>, <a href="cope.cgi?key=coagulation%20factor%20X">coagulation factor X</a>) (Pejler et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FAIM3">FAIM3</a></b> (<a href="cope.cgi?key=FAS%20apoptotic%20inhibitory%20molecule%203">FAS apoptotic inhibitory molecule 3</a>, <a href="cope.cgi?key=Regulator%20of%20FAS%20induced%20Apoptosis">Regulator of FAS induced Apoptosis</a>, <a href="cope.cgi?key=Toso">Toso</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FAS%20ligand">FAS ligand</a></b> (<a href="cope.cgi?key=FASL">FASL</a>, <a href="cope.cgi?key=FASLG">FASLG</a>, <a href="cope.cgi?key=APT1LG1">APT1LG1</a>, <a href="cope.cgi?key=apoptosis%20antigen%20ligand%201">apoptosis antigen ligand 1</a>, <a href="cope.cgi?key=CD95%20ligand">CD95 ligand</a>, <a href="cope.cgi?key=CD95L">CD95L</a>, <a href="cope.cgi?key=APO%2d1%20ligand">APO-1 ligand</a>, <a href="cope.cgi?key=APTL">APTL</a>, <a href="cope.cgi?key=Apoptosis%20antigen%20ligand">Apoptosis antigen ligand</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%206">TNF ligand superfamily member 6</a>, <a href="cope.cgi?key=TNFSF6">TNFSF6</a>, <a href="cope.cgi?key=CD178">CD178</a>) (Imanishi et al, 2002; Philipps et al, 2001; Baba et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FCAMR">FCAMR</a> </b>(<a href="cope.cgi?key=Fc%20fragment%20of%20IgA%20and%20IgM%20receptor">Fc fragment of IgA and IgM receptor</a>; <a href="cope.cgi?key=High%20affinity%20immunoglobulin%20alpha%20and%20immunoglobulin%20mu%20Fc%20receptor">High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor</a>, <a href="cope.cgi?key=Fc%20alpha%2fmu%20receptor">Fc alpha/mu receptor</a>, <a href="cope.cgi?key=Fcalpha%2fmuR">Fcalpha/muR</a>, <a href="cope.cgi?key=Fc%20alpha%2fmicroR">Fc alpha/microR</a>, <a href="cope.cgi?key=FKSG87">FKSG87</a>, <a href="cope.cgi?key=CD351">CD351</a>) (Feng X et al, 2010; Shibuya A et al, 2000; Wang R et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> Fc-epsilon <a href="cope.cgi?key=R1">R1</a> (Dombrowicz et al, 2000; Ochiai et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FEM%2d1">FEM-1</a></b> (<a href="cope.cgi?key=femininization%2d1">femininization-1</a>, <a href="cope.cgi?key=FEM%2d1a">FEM-1a</a>, <a href="cope.cgi?key=fem%2d1%20homolog%20a">fem-1 homolog a</a>, <a href="cope.cgi?key=FEM%2d1b">FEM-1b</a>, <a href="cope.cgi?key=fem%2d1%20homolog%20b">fem-1 homolog b</a>, <a href="cope.cgi?key=KIAA0396">KIAA0396</a>) (Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Ferritin">ferritin</a></b> (<a href="cope.cgi?key=H%2dFerritin">H-Ferritin</a>, <a href="cope.cgi?key=FTH1">FTH1</a>, <a href="cope.cgi?key=FTH">FTH</a>, <a href="cope.cgi?key=L%2dFerritin">L-Ferritin</a>, <a href="cope.cgi?key=FTL">FTL</a>, <a href="cope.cgi?key=CD%2dGF">CD-GF</a>, <a href="cope.cgi?key=carcinoma%2dderived%20growth%20factor">carcinoma-derived growth factor</a>) (Kuriyama-Matsumura et al, 1998; Recalcati et al, 1998; Cohen <a href="cope.cgi?key=LA">LA</a> et al, 2010; Koorts <a href="cope.cgi?key=AM">AM</a> et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Ferroportin">ferroportin</a></b> (<a href="cope.cgi?key=FPN">FPN</a>, <a href="cope.cgi?key=FPN1">FPN1</a>, <a href="cope.cgi?key=Ferroportin%2d1">ferroportin-1</a>, <a href="cope.cgi?key=SLC40A1">SLC40A1</a>, <a href="cope.cgi?key=solute%20carrier%20family%2040%20%28iron%2dregulated%20transporter%29%20member%201">solute carrier family 40 (iron-regulated transporter) member 1</a>, <a href="cope.cgi?key=SLC11A3">SLC11A3</a>, <a href="cope.cgi?key=Solute%20carrier%20family%2011%20member%203">Solute carrier family 11 member 3</a>, <a href="cope.cgi?key=IREG1">IREG1</a>, <a href="cope.cgi?key=iron%2dregulated%20transporter%2d1">iron-regulated transporter-1</a>, <a href="cope.cgi?key=MTP1">MTP1</a>, <a href="cope.cgi?key=metal%20transporting%20protein%201">metal transporting protein 1</a>, <a href="cope.cgi?key=weissherbst">weissherbst</a>, <a href="cope.cgi?key=flatiron">flatiron</a>, <a href="cope.cgi?key=ffe">ffe</a>) (Adams et al, 2003; Chung et al, 2009; Aydemir et al, 2009; D'Anna et al, 2009; Kartikasari et al, 2008; Ward et al, 2009; Wang et al, 2008; Van Zandt et al, 2008; Paradkar et al, 2008; Delaby et al, 2008; Nguyen et al, 2006; Liu et al, 2005; Canonne-Hergaux et al, 2006; Yang et al, 2002; Gleissner et al, 2010; Marques L et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=fibroleukin">fibroleukin</a></b> (<a href="cope.cgi?key=T49">T49</a>, <a href="cope.cgi?key=pT49">pT49</a>, <a href="cope.cgi?key=FGL2">FGL2</a>, <a href="cope.cgi?key=fibrinogen%2dlike%2d2">fibrinogen-like-2</a>, <a href="cope.cgi?key=HEP64">HEP64</a>) (Parr et al, 1995; Fingerote et al, 1996; McGilvray et al, 1998; Levy et al, 2000; Ning et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=fibromodulin">Fibromodulin</a></b> (<a href="cope.cgi?key=FMOD">FMOD</a>, <a href="cope.cgi?key=collagen%20binding%2059%20kDa%20protein">collagen binding 59 kDa protein</a>, <a href="cope.cgi?key=SLRR2E">SLRR2E</a>) (Alimohamad et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Fibronectin">fibronectin</a></b> (<a href="cope.cgi?key=FN">FN</a>, <a href="cope.cgi?key=Fibronectin%2d1">fibronectin-1</a>, <a href="cope.cgi?key=FN1">FN1</a>, <a href="cope.cgi?key=LETS">LETS</a>, <a href="cope.cgi?key=large%20external%20transformation%2dsensitive%20protein">large external transformation-sensitive protein</a>, <a href="cope.cgi?key=fibroblast%20surface%20antigen">Fibroblast surface antigen</a>, <a href="cope.cgi?key=SF%20antigen">SF antigen</a>, <a href="cope.cgi?key=SFA">SFA</a>, <a href="cope.cgi?key=CIg">CIg</a>, <a href="cope.cgi?key=CI%20globulin">CI globulin</a>, <a href="cope.cgi?key=cold%2dinsoluble%20globulin">cold-insoluble globulin</a>, <a href="cope.cgi?key=CSP">CSP</a>, <a href="cope.cgi?key=galactoprotein%20A">galactoprotein A</a>, <a href="cope.cgi?key=MSF">MSF</a>, <a href="cope.cgi?key=Migration%20stimulating%20factor">migration stimulating factor</a>, <a href="cope.cgi?key=Z%20protein">Z protein</a>) (Loke et al, 2002; Hershkoviz et al, 1992; Gustafsson et al, 2008; Gleissner et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Ficolin%2d1">Ficolin-1</a></b> (<a href="cope.cgi?key=FCN1">FCN1</a>, <a href="cope.cgi?key=FCNM">FCNM</a>, <a href="cope.cgi?key=Ficolin%2dA">Ficolin-A</a>, <a href="cope.cgi?key=Ficolin%2dalpha">Ficolin-alpha</a>, <a href="cope.cgi?key=M%2dficolin">M-ficolin</a>, <a href="cope.cgi?key=collagen%2ffibrinogen%20domain%2dcontaining%20protein%201">collagen/fibrinogen domain-containing protein 1</a>, <a href="cope.cgi?key=AURA32">AURA32</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2032">augmented in rheumatoid arthritis 32</a>) (Honore et al, 2008; Liu et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Ficolin%2d2">Ficolin-2</a></b> (<a href="cope.cgi?key=FCN2">FCN2</a>, <a href="cope.cgi?key=Ficolin%2dbeta">Ficolin-beta</a>, <a href="cope.cgi?key=FCNL">FCNL</a>, <a href="cope.cgi?key=Ficolin%2dB">Ficolin-B</a>, <a href="cope.cgi?key=L%2dficolin">L-ficolin</a>, <a href="cope.cgi?key=serum%20lectin%20p35">serum lectin p35</a>, <a href="cope.cgi?key=Hucolin">Hucolin</a>, <a href="cope.cgi?key=collagen%2ffibrinogen%20domain%2dcontaining%20protein%202">collagen/fibrinogen domain-containing protein 2</a>, <a href="cope.cgi?key=p35">P35</a>, <a href="cope.cgi?key=EBP%2d37">EBP-37</a>, <a href="cope.cgi?key=Elastin%20binding%20protein%2d37">elastin binding protein-37</a>) (Runza et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=FIM">FIM</a> [<a href="cope.cgi?key=factor%20increasing%20monocytopoiesis">factor increasing monocytopoiesis</a>]<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FIZZ%2d1">FIZZ-1</a></b> (<a href="cope.cgi?key=found%20in%20inflammatory%20zone%2d1">found in inflammatory zone-1</a>, <a href="cope.cgi?key=HIMF">HIMF</a>, <a href="cope.cgi?key=Hypoxia%2dinduced%20mitogenic%20factor">Hypoxia-induced mitogenic factor</a>, <a href="cope.cgi?key=resistin%2dlike%20molecule%2dalpha">Resistin-like molecule-alpha</a>, <a href="cope.cgi?key=RELM%2dalpha">RELM-alpha</a>, <a href="cope.cgi?key=Retnla">Retnla</a>, <a href="cope.cgi?key=Resistin%2dlike%20alpha">resistin-like alpha</a>, <a href="cope.cgi?key=XCP2">XCP2</a>, <a href="cope.cgi?key=ten%2dcysteine%20protein%202">ten-cysteine protein 2</a>) (Loke et al, 2002; Nair MG et al, 2005, 2009; Atochina et al, 2008; Hoffman SM and Fleming SD, 2010; Reyes JL et al, 2009; Mylonas KJ et al, 2009; Nelson <a href="cope.cgi?key=MP">MP</a> et al, 2011; Nol W et al, 2002; Raes G et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=FIZZ%2d1">FIZZ-1</a></b> (<a href="cope.cgi?key=found%20in%20inflammatory%20zone%2d1">found in inflammatory zone-1</a>, <a href="cope.cgi?key=HIMF">HIMF</a>, <a href="cope.cgi?key=Hypoxia%2dinduced%20mitogenic%20factor">Hypoxia-induced mitogenic factor</a>, <a href="cope.cgi?key=resistin%2dlike%20molecule%2dalpha">Resistin-like molecule-alpha</a>, <a href="cope.cgi?key=RELM%2dalpha">RELM-alpha</a>, <a href="cope.cgi?key=Retnla">Retnla</a>, <a href="cope.cgi?key=Resistin%2dlike%20alpha">resistin-like alpha</a>, <a href="cope.cgi?key=XCP2">XCP2</a>, <a href="cope.cgi?key=ten%2dcysteine%20protein%202">ten-cysteine protein 2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Yamaji-Kegan K et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FIZZ%2d2">FIZZ-2</a></b> (<a href="cope.cgi?key=found%20in%20inflammatory%20zone%2d2">found in inflammatory zone-2</a>, <a href="cope.cgi?key=RELM%2dbeta">RELM-beta</a>, <a href="cope.cgi?key=resistin%2dlike%20molecule%2dbeta">resistin-like molecule-beta</a>, <a href="cope.cgi?key=RETNLB">RETNLB</a>, <a href="cope.cgi?key=Resistin">resistin</a> like beta, <a href="cope.cgi?key=XCP3">XCP3</a>, <a href="cope.cgi?key=ten%2dcysteine%20protein%203">ten-cysteine protein 3</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (McVay LD et al, 2006; Barnes <a href="cope.cgi?key=SL">SL</a> et al, 2006; Nair et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FPR1">FPR1</a></b> (<a href="cope.cgi?key=formyl%20peptide%20receptor%2d1">formyl peptide receptor-1</a>, <a href="cope.cgi?key=fMLP%20receptor">fMLP receptor</a>, <a href="cope.cgi?key=FRP">FRP</a>, <a href="cope.cgi?key=N%2dformyl%20peptide%20receptor">N-formyl peptide receptor</a>, <a href="cope.cgi?key=formyl%20peptide%20receptor">formyl peptide receptor</a>) (Mandal P et al, 2005; Mandal P and Hamilton T, 2007; Dai Y et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FPRL1">FPRL1</a></b> (<a href="cope.cgi?key=formyl%20peptide%20receptor%2dlike%2d1">formyl peptide receptor-like-1</a>, <a href="cope.cgi?key=FPRH1">FPRH1</a>, <a href="cope.cgi?key=formyl%20peptide%20receptor%20homolog%2d1">formyl peptide receptor homolog-1</a>, <a href="cope.cgi?key=FPR2">FPR2</a>, <a href="cope.cgi?key=formyl%20peptide%20receptor%2d2">formyl peptide receptor-2</a>, <a href="cope.cgi?key=Lipoxin%20A4%20receptor">lipoxin A4 receptor</a>, <a href="cope.cgi?key=ALXR">ALXR</a>, <a href="cope.cgi?key=LXA4R">LXA4R</a>, <a href="cope.cgi?key=HM63">HM63</a>) (Yang D et al, 2001; Schepetkin IA et al, 2008; Yazawa H et al, 2001; Shen W et al, 2001; O'Hara R et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=FPRL2">FPRL2</a></b> (<a href="cope.cgi?key=formyl%20peptide%20receptor%2dlike%2d2">formyl peptide receptor-like-2</a>, <a href="cope.cgi?key=FPR%2dlike%2d2">FPR-like-2</a>, <a href="cope.cgi?key=FPRH2">FPRH2</a>, <a href="cope.cgi?key=formyl%20peptide%20receptor%20homolog%2d2">formyl peptide receptor homolog-2</a>, <a href="cope.cgi?key=FPR3">FPR3</a>, <a href="cope.cgi?key=formyl%20peptide%20receptor%2d3">formyl peptide receptor-3</a>) (Devosse T et al, 2009; Gleissner et al, 2010)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=G2A">G2A</a></b> (<a href="cope.cgi?key=G2%20accumulation%20protein">G2 accumulation protein</a>; <a href="cope.cgi?key=GPR132">GPR132</a>; <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d132">G-protein-coupled receptor-132</a>) (Rikitake et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=gadd45%2dgamma">gadd45-gamma</a></b> (<a href="cope.cgi?key=gadd45G">gadd45G</a>, <a href="cope.cgi?key=growth%20arrest%20and%20DNA%20damage%20induced%20gene%2d45%2dgamma">growth arrest and DNA damage induced gene-45-gamma</a>) (Edwards JP et al, 2006; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=gadd153">gadd153</a></b> (<a href="cope.cgi?key=growth%20arrest%20and%20DNA%20damage%20induced%20gene%2d153">growth arrest and DNA damage induced gene-153</a>, <a href="cope.cgi?key=DDIT3">DDIT3</a>, <a href="cope.cgi?key=DNA%20damage%2dinducible%20transcript%2d3">DNA damage-inducible transcript-3</a>, <a href="cope.cgi?key=CHOP">CHOP</a>, <a href="cope.cgi?key=C%2fEBP%2dhomologous%20protein">C/EBP-homologous protein</a>, <a href="cope.cgi?key=CHOP%2d10">CHOP-10</a>, <a href="cope.cgi?key=C%2fEBP%2dhomologous%20protein%2d10">C/EBP-homologous protein-10</a>, <a href="cope.cgi?key=C%2fEBP%2dzeta">C/EBP-zeta</a>, <a href="cope.cgi?key=CCAAT%2fenhancer%20binding%20protein%20zeta">CCAAT/enhancer binding protein zeta</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Galectin%2d1">Galectin-1</a></b> (<a href="cope.cgi?key=Gal%2d1">Gal-1</a>, <a href="cope.cgi?key=LGALS1">LGALS1</a>, <a href="cope.cgi?key=galactose%2dspecific%20soluble%20lectin%201">galactose-specific soluble lectin 1</a>, <a href="cope.cgi?key=L%2d14%2dI">L-14-I</a>, <a href="cope.cgi?key=Lactose%2dbinding%20lectin%201">Lactose-binding lectin 1</a>, <a href="cope.cgi?key=S%2dlac%20lectin%2d1">S-lac lectin-1</a>, <a href="cope.cgi?key=Galaptin">Galaptin</a>, <a href="cope.cgi?key=14%20kDa%20beta%2dgalactoside%2dbinding%20lectin">14 kDa beta-galactoside-binding lectin</a>, <a href="cope.cgi?key=14%20kDa%20lectin">14 kDa lectin</a>, <a href="cope.cgi?key=HLBP14">HLBP14</a>, <a href="cope.cgi?key=14%20kDa%20laminin%20binding%20protein">14 kDa laminin binding protein</a>) (Gil et al, 2006; Novak et al, 2012; Than et al, 2008; Nio-Kobayashi and Iwanaga, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Galectin%2d1">Galectin-1</a></b> (<a href="cope.cgi?key=Gal%2d1">Gal-1</a>, <a href="cope.cgi?key=LGALS1">LGALS1</a>, <a href="cope.cgi?key=galactose%2dspecific%20soluble%20lectin%201">galactose-specific soluble lectin 1</a>, <a href="cope.cgi?key=L%2d14%2dI">L-14-I</a>, <a href="cope.cgi?key=Lactose%2dbinding%20lectin%201">Lactose-binding lectin 1</a>, <a href="cope.cgi?key=S%2dlac%20lectin%2d1">S-lac lectin-1</a>, <a href="cope.cgi?key=Galaptin">Galaptin</a>, <a href="cope.cgi?key=14%20kDa%20beta%2dgalactoside%2dbinding%20lectin">14 kDa beta-galactoside-binding lectin</a>, <a href="cope.cgi?key=14%20kDa%20lectin">14 kDa lectin</a>, <a href="cope.cgi?key=HLBP14">HLBP14</a>, <a href="cope.cgi?key=14%20kDa%20laminin%20binding%20protein">14 kDa laminin binding protein</a>) receptors (Echigo et al, 2010; Novak R et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Galectin%2d3">Galectin-3</a></b> (<a href="cope.cgi?key=Gal%2d3">Gal-3</a>, <a href="cope.cgi?key=LGALS3">LGALS3</a>, <a href="cope.cgi?key=galactose%2dspecific%20soluble%20lectin%203">galactose-specific soluble lectin 3</a>, <a href="cope.cgi?key=Mac%2d2">Mac-2</a>, <a href="cope.cgi?key=macrophage%20galactose%2dspecific%20lectin%2d2">macrophage galactose-specific lectin-2</a>, <a href="cope.cgi?key=L%2d29">L-29</a>, <a href="cope.cgi?key=CBP%2d35">CBP-35</a>, <a href="cope.cgi?key=carbohydrate%20binding%20protein%2d35">carbohydrate binding protein-35</a>, <a href="cope.cgi?key=IgE%20binding%20factor%20epsilon">IgE binding factor epsilon</a>, <a href="cope.cgi?key=Epsilon%20BP">Epsilon BP</a>) (Liu et al, 1995; Baldus et al, 1998; Saada et al, 1996; Sato and Hughes, 1994; Yang et al, 1995; Henderson et al, 2008; Gil et al, 2006; Smetana et al, 1998; Hsu et al, 2009; Sakata et al, 1992; Edwards JP et al, 2006; Esteban et al, 2011; Novak et al, 2012; Nio-Kobayashi and Iwanaga, 2010; Juniantito et al, 2013, 2011; Novak R et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=galectin%2d3%2dbinding%20protein">galectin-3-binding protein</a></b> (<a href="cope.cgi?key=LGALS3BP">LGALS3BP</a>, <a href="cope.cgi?key=Mac2BP">Mac2BP</a>, <a href="cope.cgi?key=M2BP">M2BP</a>, <a href="cope.cgi?key=Mac%2d2%2dbinding%20protein">Mac-2-binding protein</a>, <a href="cope.cgi?key=TAA90K">TAA90K</a>, <a href="cope.cgi?key=Tumor%2dassociated%20antigen%2090K">Tumor-associated antigen 90K</a>, <a href="cope.cgi?key=serum%20protein%2090K">serum protein 90K</a>, <a href="cope.cgi?key=L3%20antigen">L3 antigen</a>, <a href="cope.cgi?key=CyCAP">CyCAP</a>, <a href="cope.cgi?key=cyclophilin%20C%2dassociated%20protein">cyclophilin C-associated protein</a>, <a href="cope.cgi?key=alpha%2d2%2dSGP">alpha-2-SGP</a>, <a href="cope.cgi?key=alpha%2d2%2dseminoglycoprotein">alpha-2-seminoglycoprotein</a>) (Kong et al, 2007; Chicheportiche and Vassalli, 1994; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Galectin%2d9">Galectin-9</a></b> (<a href="cope.cgi?key=LGALS9">LGALS9</a>, <a href="cope.cgi?key=galactose%2dspecific%20soluble%20lectin%209">galactose-specific soluble lectin 9</a>, <a href="cope.cgi?key=Ecalectin">Ecalectin</a>, <a href="cope.cgi?key=UAT">UAT</a>, <a href="cope.cgi?key=urate%20transporter">urate transporter</a>, <a href="cope.cgi?key=Tim%2d3L">Tim-3L</a>, <a href="cope.cgi?key=Tim%2d3%20ligand">Tim-3 ligand</a>) (Shim et al, 2012; Jayaraman et al, 2010; Mengshol et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Galectin%2d9">Galectin-9</a></b> (<a href="cope.cgi?key=LGALS9">LGALS9</a>, <a href="cope.cgi?key=galactose%2dspecific%20soluble%20lectin%209">galactose-specific soluble lectin 9</a>, <a href="cope.cgi?key=Ecalectin">Ecalectin</a>, <a href="cope.cgi?key=UAT">UAT</a>, <a href="cope.cgi?key=urate%20transporter">urate transporter</a>, <a href="cope.cgi?key=Tim%2d3L">Tim-3L</a>, <a href="cope.cgi?key=Tim%2d3%20ligand">Tim-3 ligand</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Arikawa et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=gas%2d6">gas-6</a></b> (<a href="cope.cgi?key=Growth%20arrest%2dspecific%20gene%2d6">Growth arrest-specific gene-6</a>, <a href="cope.cgi?key=Growth%2dpotentiating%20factor">Growth-potentiating factor</a>, <a href="cope.cgi?key=GPF">GPF</a>, <a href="cope.cgi?key=AXLLG">AXLLG</a>, <a href="cope.cgi?key=axl%20receptor%20tyrosine%20kinase%20ligand">axl receptor tyrosine kinase ligand</a>, <a href="cope.cgi?key=AXSF">AXSF</a>, <a href="cope.cgi?key=axl%20stimulatory%20factor">axl stimulatory factor</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Alciato et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=gas%2d7">gas-7</a></b> (<a href="cope.cgi?key=Growth%20arrest%2dspecific%20gene%2d7">Growth arrest-specific gene-7</a>, <a href="cope.cgi?key=KIAA0394">KIAA0394</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Gastrin">gastrin</a> </b>(<a href="cope.cgi?key=Gastrin%2d17">gastrin-17</a>, <a href="cope.cgi?key=Gastrin%20component%203">Gastrin component 3</a>, <a href="cope.cgi?key=Little%20Gastrin">little Gastrin</a>, <a href="cope.cgi?key=Cholecystokinin%20B">Cholecystokinin B</a>)<b style="mso-bidi-font-weight: normal"> receptors</b> (de la Fuente et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=G%2dCSF">G-CSF</a></b> (<a href="cope.cgi?key=Granulocyte%20colony%20stimulating%20factor">Granulocyte colony stimulating factor</a>, <a href="cope.cgi?key=CSF%2d3">CSF-3</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d3">colony stimulating factor-3</a>, <a href="cope.cgi?key=CSF%2dbeta">CSF-beta</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2dbeta">colony stimulating factor-beta</a>, <a href="cope.cgi?key=G%2dCSA">G-CSA</a>, <a href="cope.cgi?key=Granulocytic%20neutrophil%20colony%20stimulating%20activity">granulocytic neutrophil colony stimulating activity</a>, <a href="cope.cgi?key=Pluripoietin%2dbeta">Pluripoietin-beta</a>) (Ogawa et al, 1994; Temeles et al, 1993; Wieser et al, 1989; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GDNF">GDNF</a> </b>(<a href="cope.cgi?key=Glial%20cell%20line%2dderived%20neurotrophic%20factor">Glial cell line-derived neurotrophic factor</a>, <a href="cope.cgi?key=B49%2dderived%20neurotrophic%20factor">B49-derived neurotrophic factor</a>, <a href="cope.cgi?key=Astrocyte%2dderived%20trophic%20factor">Astrocyte-derived trophic factor</a>, <a href="cope.cgi?key=ATF">ATF</a>, <a href="cope.cgi?key=ATF%2d1">ATF-1</a>, <a href="cope.cgi?key=Astrocyte%2dderived%20trophic%20factor%2d1">Astrocyte-derived trophic factor-1</a>, <a href="cope.cgi?key=ATF%2d2">ATF-2</a>, <a href="cope.cgi?key=Astrocyte%2dderived%20trophic%20factor%2d2">Astrocyte-derived trophic factor-2</a>) (Batchelor et al, 1999, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Ghrelin">ghrelin</a> </b>(<a href="cope.cgi?key=GHRL">GHRL</a>, <a href="cope.cgi?key=GRLN">GRLN</a>, <a href="cope.cgi?key=MTLRP">MTLRP</a>, <a href="cope.cgi?key=motilin%2drelated%20peptide">motilin-related peptide</a>, <a href="cope.cgi?key=GHSR%20ligand">GHSR ligand</a>, <a href="cope.cgi?key=growth%20hormone%20secretagogue%20receptor%20ligand">growth hormone secretagogue receptor ligand</a>, <a href="cope.cgi?key=GGDT">GGDT</a>, <a href="cope.cgi?key=ghrelin%20gene%2dderived%20transcript">ghrelin gene-derived transcript</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=GHSR">GHSR</a>, <a href="cope.cgi?key=growth%20hormone%20secretagogue%20receptor">growth hormone secretagogue receptor</a>, <a href="cope.cgi?key=Growth%20hormone%20secretagogue%20receptor%20type%201">Growth hormone secretagogue receptor type 1</a>, <a href="cope.cgi?key=GHSR%2d1a">GHSR-1a</a>, <a href="cope.cgi?key=growth%20hormone%20secretagogue%20receptor%201a">growth hormone secretagogue receptor 1a</a>, <a href="cope.cgi?key=GHSR%2d1b">GHSR-1b</a>, <a href="cope.cgi?key=growth%20hormone%20secretagogue%20receptor%201b">growth hormone secretagogue receptor 1b</a>, <a href="cope.cgi?key=GRLNR">GRLNR</a>, <a href="cope.cgi?key=GH%2dreleasing%20peptide%20receptor">GH-releasing peptide receptor</a>) (Avallone R et al, 2006; Cheng B et al, 2010; Demers et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GITR">GITR</a></b> (<a href="cope.cgi?key=Glucocorticoid%20induced%20tumor%20necrosis%20factor%20receptor%20family%20related%20gene">glucocorticoid induced tumor necrosis factor receptor family related gene</a>, <a href="cope.cgi?key=AITR">AITR</a>, <a href="cope.cgi?key=activation%2dinducible%20TNFR">activation-inducible TNFR</a>, <a href="cope.cgi?key=TNFRSF18">TNFRSF18</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2018">TNF receptor superfamily member 18</a>, <a href="cope.cgi?key=CD357">CD357</a>) (Shin et al, 2002; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GITR%20ligand">GITR ligand</a></b> (<a href="cope.cgi?key=GITRL">GITRL</a>, <a href="cope.cgi?key=Glucocorticoid%20induced%20tumor%20necrosis%20factor%20receptor%20family%20related%20gene">glucocorticoid induced tumor necrosis factor receptor family related gene</a> ligand, <a href="cope.cgi?key=TNFSF18">TNFSF18</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2018">TNF ligand superfamily member 18</a>, <a href="cope.cgi?key=AITRL">AITRL</a>, <a href="cope.cgi?key=activation%2dinducible%20TNFR%20ligand">activation-inducible TNFR ligand</a>, <a href="cope.cgi?key=TL6">TL6</a>, <a href="cope.cgi?key=TNF%2dlike%2d6">TNF-like-6</a>, <a href="cope.cgi?key=Endokine">Endokine</a>) (Shin et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Glucagon">Glucagon</a> </b>(<a href="cope.cgi?key=GCG">GCG</a>, <a href="cope.cgi?key=glucagon%2d29">glucagon-29</a>, <a href="cope.cgi?key=pancreatic%2dtype%20glucagon">pancreatic-type glucagon</a>) (<a href="cope.cgi?key=proglucagon">proglucagon</a>) (Throsby et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Glycodelin">glycodelin</a></b> (<a href="cope.cgi?key=PP14">PP14</a>, <a href="cope.cgi?key=placental%20protein%2014">placental protein 14</a>, <a href="cope.cgi?key=GdA">GdA</a>, <a href="cope.cgi?key=Glycodelin%2dA">Glycodelin-A</a>, <a href="cope.cgi?key=GdS">GdS</a>, <a href="cope.cgi?key=Glycodelin%2dS">Glycodelin-S</a>, <a href="cope.cgi?key=PAEP">PAEP</a>, <a href="cope.cgi?key=progestagen%2dassociated%20endometrial%20protein">progestagen-associated endometrial protein</a>, <a href="cope.cgi?key=pregnancy%2dassociated%20endometrial%20alpha%2d2%2dglobulin">pregnancy-associated endometrial alpha-2-globulin</a>, <a href="cope.cgi?key=progestagen%2ddependent%20endometrial%20protein">progestagen-dependent endometrial protein</a>) (Lang and Venkatraman, 2007; Kunert-Keil C et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=glypican%2d4">glypican-4</a></b> (<a href="cope.cgi?key=GPC4">GPC4</a>, <a href="cope.cgi?key=K%2dglypican">K-glypican</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GM%2dCSF">GM-CSF</a></b> (<a href="cope.cgi?key=Granulocyte%2dmacrophage%20colony%20stimulating%20factor">Granulocyte-macrophage colony stimulating factor</a>, <a href="cope.cgi?key=BPA">BPA</a>, <a href="cope.cgi?key=Burst%20promoting%20activity">burst promoting activity</a>, <a href="cope.cgi?key=CSF%2d2">CSF-2</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d2">colony stimulating factor-2</a>, <a href="cope.cgi?key=GM%2dCSA">GM-CSA</a>, <a href="cope.cgi?key=Granulocyte%2dmacrophage%20colony%20stimulating%20activity">Granulocyte-macrophage colony stimulating activity</a>, <a href="cope.cgi?key=MGI%2d1GM">MGI-1GM</a>, <a href="cope.cgi?key=Macrophage%2dgranulocyte%20inducer">macrophage-granulocyte inducer</a>, <a href="cope.cgi?key=Pluripoietin%2dalpha">Pluripoietin-alpha</a>) (Fadok et al, 1998; Van den Heuvel et al, 1999; Yamamoto et al, 1996, 1997; Medvedev et al, 2000; Ogawa et al, 1994; Cho et al, 2003; Sarady et al, 2002; Zhang et al, 2002; John et al, 1998; Kamdar et al, 1997; Song et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GM%2dCSF">GM-CSF</a></b> (<a href="cope.cgi?key=Granulocyte%2dmacrophage%20colony%20stimulating%20factor">Granulocyte-macrophage colony stimulating factor</a>, <a href="cope.cgi?key=BPA">BPA</a>, <a href="cope.cgi?key=Burst%20promoting%20activity">burst promoting activity</a>, <a href="cope.cgi?key=CSF%2d2">CSF-2</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d2">colony stimulating factor-2</a>, <a href="cope.cgi?key=GM%2dCSA">GM-CSA</a>, <a href="cope.cgi?key=Granulocyte%2dmacrophage%20colony%20stimulating%20activity">Granulocyte-macrophage colony stimulating activity</a>, <a href="cope.cgi?key=MGI%2d1GM">MGI-1GM</a>, <a href="cope.cgi?key=Macrophage%2dgranulocyte%20inducer">macrophage-granulocyte inducer</a>, <a href="cope.cgi?key=Pluripoietin%2dalpha">Pluripoietin-alpha</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=CSF2RA">CSF2RA</a>, <a href="cope.cgi?key=CSF%2d2%20receptor%2dA">CSF-2 receptor-A</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d2%20receptor%20A">Colony stimulating factor-2 receptor A</a>, <a href="cope.cgi?key=colony%20stimulating%20factor%2d2%20receptor%2dalpha">Colony stimulating factor-2 receptor-alpha</a>, <a href="cope.cgi?key=CSF2R">CSF2R</a>, <a href="cope.cgi?key=CSF%2d2%20receptor">CSF-2 receptor</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d2%20receptor">Colony stimulating factor-2 receptor</a>, <a href="cope.cgi?key=CSF2RY">CSF2RY</a>, <a href="cope.cgi?key=GMCSFR">GMCSFR</a>, <a href="cope.cgi?key=GM%2dCSF%20receptor">GM-CSF receptor</a>, <a href="cope.cgi?key=CDw116">CDw116</a>, <a href="cope.cgi?key=CD116">CD116</a>; <a href="cope.cgi?key=common%20beta">common beta</a>, <a href="cope.cgi?key=beta%20c">beta c</a>, <a href="cope.cgi?key=beta%20c">betac</a>, <a href="cope.cgi?key=common%20cytokine%20receptor%2dbeta">common cytokine receptor-beta</a>, <a href="cope.cgi?key=cytokine%20receptor%20common%20subunit%20beta">cytokine receptor common subunit beta</a>, <a href="cope.cgi?key=IL3RB">IL3RB</a>, <a href="cope.cgi?key=IL3%20receptor%20subunit%20beta">IL3 receptor subunit beta</a>, <a href="cope.cgi?key=IL3R%2dbeta">IL3R-beta</a>, <a href="cope.cgi?key=IL5RB">IL5RB</a>, <a href="cope.cgi?key=IL5%20receptor%20subunit%20beta">IL5 receptor subunit beta</a>, <a href="cope.cgi?key=IL5R%2dbeta">IL5R-beta</a>, <a href="cope.cgi?key=GM%2dCSF%20receptor%20subunit%20beta">GM-CSF receptor subunit beta</a>, <a href="cope.cgi?key=CSF2RB">CSF2RB</a>, <a href="cope.cgi?key=colony%20stimulating%20factor%2d2%20receptor%2dbeta">colony stimulating factor-2 receptor-beta</a>, <a href="cope.cgi?key=CD131">CD131</a>) (Orlofsky et al, 1994; Jarmin et al, 1999; Neale and Athanasou, 1999; Zhu et al, 1991; Schafer et al, 1998; Gratchev A et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GMF%2dgamma">GMF-gamma</a> </b>(<a href="cope.cgi?key=Glial%20maturation%20factor%2dgamma">Glial maturation factor-gamma</a>, <a href="cope.cgi?key=GMFG">GMFG</a>) (Ideka et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=gp130">gp130</a></b> (<a href="cope.cgi?key=IL6ST">IL6ST</a>, <a href="cope.cgi?key=IL6%20signal%20transducer">IL6 signal transducer</a>, <a href="cope.cgi?key=IL6R%2dbeta">IL6R-beta</a>, <a href="cope.cgi?key=IL6RB">IL6RB</a>, <a href="cope.cgi?key=CDw130">CDw130</a>, <a href="cope.cgi?key=CD130">CD130</a>) (Neale and Athanasou, 1999; Meisel et al, 1999; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=GPR30">GPR30</a></b> (<a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d30">G-protein-coupled receptor-30</a>; <a href="cope.cgi?key=CMKRL2">CMKRL2</a>; <a href="cope.cgi?key=chemokine%20receptor%2dlike%202">chemokine receptor-like 2</a>; <a href="cope.cgi?key=CEPR">CEPR</a>; <a href="cope.cgi?key=constitutively%2fcommonly%20expressed%20peptide%2dlike%20receptor">constitutively/commonly expressed peptide-like receptor</a>; <a href="cope.cgi?key=LyGPR">LyGPR</a>; <a href="cope.cgi?key=lymphocyte%2dderived%20G%2dprotein%2dcoupled%20receptor">lymphocyte-derived G-protein-coupled receptor</a>; <a href="cope.cgi?key=FEG1">FEG1</a>; <a href="cope.cgi?key=flow%20induced%20endothelial%20G%2dprotein%2dcoupled%20receptor%20gene%2d1">flow induced endothelial G-protein-coupled receptor gene-1</a>, <a href="cope.cgi?key=GPER">GPER</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20estrogen%20receptor">G-protein-coupled estrogen receptor</a>, <a href="cope.cgi?key=GPER1">GPER1</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20estrogen%20receptor1">G-protein-coupled estrogen receptor1</a>, <a href="cope.cgi?key=DRY12">DRY12</a>, <a href="cope.cgi?key=GPCR%2dBr">GPCR-Br</a>) (Kanda and Watanabe, 2003; Blasko et al, 2009; Rettew et al, 2010; Owman et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GPR77">GPR77</a></b> (<a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d77">G-protein-coupled receptor-77</a>, <a href="cope.cgi?key=C5L2">C5L2</a>, <a href="cope.cgi?key=C5a%20receptor%2dlike%202">C5a receptor-like 2</a>, <a href="cope.cgi?key=complement%205a%2dlike%20receptor%202">complement 5a-like receptor 2</a>) (Chen NJ et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=GRAIL">GRAIL</a></b> (<a href="cope.cgi?key=gene%20related%20to%20anergy%20in%20lymphocytes">gene related to anergy in lymphocytes</a>, <a href="cope.cgi?key=RNF128">RNF128</a>, <a href="cope.cgi?key=RING%20finger%20protein%20128">RING finger protein 128</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Granzyme%20B">Granzyme B</a></b> (<a href="cope.cgi?key=GZMB">GZMB</a>, <a href="cope.cgi?key=Granzyme%202">Granzyme 2</a>, <a href="cope.cgi?key=serine%20protease%20B">serine protease B</a>, <a href="cope.cgi?key=SE%2d2">SE-2</a>, <a href="cope.cgi?key=serine%20esterase%2d2">serine esterase-2</a>, <a href="cope.cgi?key=CSP%2dB">CSP-B</a>, <a href="cope.cgi?key=cytotoxic%20serine%20protease%20B">cytotoxic serine protease B</a>, <a href="cope.cgi?key=CCP1">CCP1</a>, <a href="cope.cgi?key=cytotoxic%20cell%20protease%2d1">cytotoxic cell protease-1</a>, <a href="cope.cgi?key=Asp%2dase">Asp-ase</a>, <a href="cope.cgi?key=CGL1">CGL1</a>, <a href="cope.cgi?key=cathepsin%20G%2dlike%2d1">cathepsin G-like-1</a>, <a href="cope.cgi?key=CTLA%2d1">CTLA-1</a>, <a href="cope.cgi?key=cytotoxic%20T%2dlymphocyte%2dassociated%20serine%20esterase%2d1">cytotoxic T-lymphocyte-associated serine esterase-1</a>, <a href="cope.cgi?key=fragmentin%2d2">fragmentin-2</a>, <a href="cope.cgi?key=RNKP1">RNKP1</a>, <a href="cope.cgi?key=Cytokine%20Inter%2dspecies%20Reactivities">rat</a> <a href="cope.cgi?key=natural%20killer%20protease%2d1">natural killer protease-1</a>) (Kim et al, 2007; Baba et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Gremlin">Gremlin</a></b> (<a href="cope.cgi?key=Gremlin%2d1">gremlin-1</a>, <a href="cope.cgi?key=GREM1">GREM1</a>, <a href="cope.cgi?key=BMP%20antagonist%201">BMP antagonist 1</a>, <a href="cope.cgi?key=CKTSF1B1">CKTSF1B1</a>, <a href="cope.cgi?key=DAND2">DAND2</a>, <a href="cope.cgi?key=DAN%20domain%20family%20member%202">DAN domain family member 2</a>, <a href="cope.cgi?key=IHG%2d2">IHG-2</a>, <a href="cope.cgi?key=increased%20in%20high%20clucose%2d2">increased in high clucose-2</a>, <a href="cope.cgi?key=DRM">DRM</a>, <a href="cope.cgi?key=Downregulated%20by%20mos">Downregulated by mos</a>, <a href="cope.cgi?key=PIG2">PIG2</a>, <a href="cope.cgi?key=proliferation%20inducing%20gene%2d2">proliferation inducing gene-2</a>, <a href="cope.cgi?key=Cell%20proliferation%2dinducing%20gene%202%20protein">Cell proliferation-inducing gene 2 protein</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Growth%20hormone">growth hormone</a></b> (<a href="cope.cgi?key=GH">GH</a>, <a href="cope.cgi?key=somatotropic%20hormone">Somatotropic hormone</a>, <a href="cope.cgi?key=Somatotropin">Somatotropin</a>, <a href="cope.cgi?key=GH1">GH1</a>, <a href="cope.cgi?key=Growth%20hormone%201">growth hormone 1</a>, <a href="cope.cgi?key=GHN">GHN</a>, <a href="cope.cgi?key=Growth%20hormone%20normal">growth hormone normal</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Sodhi and Tripathi, 2008)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=HAF">HAF</a> [<a href="cope.cgi?key=human%20angiogenic%20factor">human angiogenic factor</a>] (Fruhbeis et al, 1988; Osthoff et al, 1987)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HB%2dEGF">HB-EGF</a></b> (<a href="cope.cgi?key=Heparin%20binding%20EGF%2dlike%20factor">Heparin binding EGF-like factor</a>, <a href="cope.cgi?key=Heparin%20binding%20EGF%2dlike%20growth%20factor">Heparin binding EGF-like growth factor</a>, <a href="cope.cgi?key=Hegfl">Hegfl</a>, <a href="cope.cgi?key=par%2d2">par-2</a>, <a href="cope.cgi?key=prostate%20apoptosis%20response%20protein%202">prostate apoptosis response protein 2</a>, <a href="cope.cgi?key=DTR">DTR</a>, <a href="cope.cgi?key=Diphtheria%20toxin%20receptor">Diphtheria toxin receptor</a>) (Ouchi et al, 1998; Edwards JP et al, 2006; Edwards et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Hemoglobin">hemoglobin</a></b> (<a href="cope.cgi?key=HbA">HbA</a>, <a href="cope.cgi?key=alpha%2dhemoglobin">Alpha-hemoglobin</a>, <a href="cope.cgi?key=hemoglobin%2dalpha">hemoglobin-alpha</a>, <a href="cope.cgi?key=Alpha%2dglobin">Alpha-globin</a>, <a href="cope.cgi?key=HbB">HbB</a>, <a href="cope.cgi?key=beta%2dhemoglobin">Beta-hemoglobin</a>, <a href="cope.cgi?key=hemoglobin%2dbeta">hemoglobin-beta</a>, <a href="cope.cgi?key=Beta%2dglobin">Beta-globin</a>) (Liu L et al, 1999; Tommila et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Hemokinin%2d1">Hemokinin-1</a></b> (<a href="cope.cgi?key=HK%2d1">HK-1</a>, <a href="cope.cgi?key=TAC4">TAC4</a>, <a href="cope.cgi?key=Tachykinin%2d4">tachykinin-4</a>, <a href="cope.cgi?key=PPTC">PPTC</a>, <a href="cope.cgi?key=preprotachykinin%2dC">preprotachykinin-C</a>) (Nelson et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Hemopexin">Hemopexin</a></b> (<a href="cope.cgi?key=HPX">HPX</a>, <a href="cope.cgi?key=Hpxn">Hpxn</a>, <a href="cope.cgi?key=Hx">hx</a>, <a href="cope.cgi?key=Beta%2d1B%2dglycoprotein">Beta-1B-glycoprotein</a>, <a href="cope.cgi?key=LB">LB</a>, <a href="cope.cgi?key=alpha%201%2dglobulin%20M">alpha 1-globulin M</a>, <a href="cope.cgi?key=100KF">100KF</a>, <a href="cope.cgi?key=GIG%2d3">GIG-3</a>, <a href="cope.cgi?key=growth%20hormone%20inducible%20gene%2d3">growth hormone inducible gene-3</a>, <a href="cope.cgi?key=GIG%2d7">GIG-7</a>, <a href="cope.cgi?key=growth%20hormone%20inducible%20gene%2d7">growth hormone inducible gene-7</a>, <a href="cope.cgi?key=GIG%2d10">GIG-10</a>, <a href="cope.cgi?key=growth%20hormone%20inducible%20gene%2d10">growth hormone inducible gene-10</a>) (Camborieux et al, 1998, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Hemopexin">Hemopexin</a></b> (<a href="cope.cgi?key=HPX">HPX</a>, <a href="cope.cgi?key=Hpxn">Hpxn</a>, <a href="cope.cgi?key=Hx">hx</a>, <a href="cope.cgi?key=Beta%2d1B%2dglycoprotein">Beta-1B-glycoprotein</a>, <a href="cope.cgi?key=LB">LB</a>, <a href="cope.cgi?key=alpha%201%2dglobulin%20M">alpha 1-globulin M</a>, <a href="cope.cgi?key=100KF">100KF</a>, <a href="cope.cgi?key=GIG%2d3">GIG-3</a>, <a href="cope.cgi?key=growth%20hormone%20inducible%20gene%2d3">growth hormone inducible gene-3</a>, <a href="cope.cgi?key=GIG%2d7">GIG-7</a>, <a href="cope.cgi?key=growth%20hormone%20inducible%20gene%2d7">growth hormone inducible gene-7</a>, <a href="cope.cgi?key=GIG%2d10">GIG-10</a>, <a href="cope.cgi?key=growth%20hormone%20inducible%20gene%2d10">growth hormone inducible gene-10</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Hvidberg et al, 2005; Liang et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Hepassocin">Hepassocin</a></b> (<a href="cope.cgi?key=HFREP1">HFREP1</a>, <a href="cope.cgi?key=hepatocyte%2dderived%20fibrinogen%2drelated%20protein%201">hepatocyte-derived fibrinogen-related protein 1</a>, <a href="cope.cgi?key=FGL1">FGL1</a>, <a href="cope.cgi?key=fibrinogen%2dlike%2d1">fibrinogen-like-1</a>, <a href="cope.cgi?key=LFIRE%2d1">LFIRE-1</a>, <a href="cope.cgi?key=liver%20fibrinogen%2drelated%20protein%2d1">liver fibrinogen-related protein-1</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Hepcidin">Hepcidin</a></b> (<a href="cope.cgi?key=HEPC">HEPC</a>, <a href="cope.cgi?key=Hepc25">Hepc25</a>, <a href="cope.cgi?key=hepcidin%2d25">hepcidin-25</a>, <a href="cope.cgi?key=Hep%2d25">Hep-25</a>, <a href="cope.cgi?key=Hepc20">Hepc20</a>, <a href="cope.cgi?key=hepcidin%2d20">hepcidin-20</a>, <a href="cope.cgi?key=Hep%2d20">Hep-20</a>, <a href="cope.cgi?key=LEAP%2d1">LEAP-1</a>, <a href="cope.cgi?key=liver%2dexpressed%20antimicrobial%20peptide">liver-expressed antimicrobial peptide</a>, <a href="cope.cgi?key=liver%2dexpressed%20antimicrobial%20peptide%2d1">liver-expressed antimicrobial peptide-1</a>, <a href="cope.cgi?key=HAMP">HAMP</a>, <a href="cope.cgi?key=Hepcidin%20antimicrobial%20peptide">Hepcidin antimicrobial peptide</a>, <a href="cope.cgi?key=Hamp1">Hamp1</a>, <a href="cope.cgi?key=Hepcidin%20antimicrobial%20peptide%2d1">Hepcidin antimicrobial peptide-1</a>, <a href="cope.cgi?key=Hamp2">Hamp2</a>, <a href="cope.cgi?key=Hepcidin%20antimicrobial%20peptide%2d2">Hepcidin antimicrobial peptide-2</a>, <a href="cope.cgi?key=Hepc1">Hepc1</a>, <a href="cope.cgi?key=Hepcidin%2d1">hepcidin-1</a>, <a href="cope.cgi?key=Hepc2">Hepc2</a>, <a href="cope.cgi?key=Hepcidin%2d2">hepcidin-2</a> ) (Liu et al, 2005, Sow et al, 2007; Edwards JP et al, 2006; Layoun A and Santos MM, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Hepcidin">Hepcidin</a></b> (<a href="cope.cgi?key=HEPC">HEPC</a>, <a href="cope.cgi?key=Hepc25">Hepc25</a>, <a href="cope.cgi?key=hepcidin%2d25">hepcidin-25</a>, <a href="cope.cgi?key=Hep%2d25">Hep-25</a>, <a href="cope.cgi?key=Hepc20">Hepc20</a>, <a href="cope.cgi?key=hepcidin%2d20">hepcidin-20</a>, <a href="cope.cgi?key=Hep%2d20">Hep-20</a>, <a href="cope.cgi?key=LEAP%2d1">LEAP-1</a>, <a href="cope.cgi?key=liver%2dexpressed%20antimicrobial%20peptide">liver-expressed antimicrobial peptide</a>, <a href="cope.cgi?key=liver%2dexpressed%20antimicrobial%20peptide%2d1">liver-expressed antimicrobial peptide-1</a>, <a href="cope.cgi?key=HAMP">HAMP</a>, <a href="cope.cgi?key=Hepcidin%20antimicrobial%20peptide">Hepcidin antimicrobial peptide</a>, <a href="cope.cgi?key=Hamp1">Hamp1</a>, <a href="cope.cgi?key=Hepcidin%20antimicrobial%20peptide%2d1">Hepcidin antimicrobial peptide-1</a>, <a href="cope.cgi?key=Hamp2">Hamp2</a>, <a href="cope.cgi?key=Hepcidin%20antimicrobial%20peptide%2d2">Hepcidin antimicrobial peptide-2</a>, <a href="cope.cgi?key=Hepc1">Hepc1</a>, <a href="cope.cgi?key=Hepcidin%2d1">hepcidin-1</a>, <a href="cope.cgi?key=Hepc2">Hepc2</a>, <a href="cope.cgi?key=Hepcidin%2d2">hepcidin-2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Chung et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HGF">HGF</a></b> (<a href="cope.cgi?key=Hepatocyte%20growth%20factor">hepatocyte growth factor</a>, <a href="cope.cgi?key=HGF%2fSF">HGF/SF</a>, <a href="cope.cgi?key=Hepatocyte%20growth%20factor%2dscatter%20factor">Hepatocyte growth factor-scatter factor</a>, <a href="cope.cgi?key=F%2dTCF">F-TCF</a>, <a href="cope.cgi?key=Fibroblast%20tumor%20cytotoxic%20factor">fibroblast tumor cytotoxic factor</a>, <a href="cope.cgi?key=HPTA">HPTA</a>, <a href="cope.cgi?key=Hepatopoietin%20A">Hepatopoietin A</a>, <a href="cope.cgi?key=SF">SF</a>, <a href="cope.cgi?key=Scatter%20factor">scatter factor</a>, <a href="cope.cgi?key=TCF">TCF</a>, <a href="cope.cgi?key=Tumor%20cytotoxic%20factor">tumor cytotoxic factor</a>, <a href="cope.cgi?key=Lung%20fibroblast%2dderived%20mitogen">Lung fibroblast-derived mitogen</a>) (Kodelja et al, 1997; Park HJ et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HGF%20activator%20inhibitor%20type%202">HGF activator inhibitor type 2</a> </b>(<a href="cope.cgi?key=HAI%2d2">HAI-2</a>, <a href="cope.cgi?key=Hepatocyte%20growth%20factor%20activator%20inhibitor%2d2">Hepatocyte growth factor activator inhibitor-2</a>, <a href="cope.cgi?key=SPINT2">SPINT2</a>, <a href="cope.cgi?key=serine%20peptidase%20inhibitor%20Kunitz%20type%202">serine peptidase inhibitor Kunitz type 2</a>, <a href="cope.cgi?key=placental%20bikunin">placental bikunin</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HGF%2dlike%20protein">HGF-like protein</a></b> (<a href="cope.cgi?key=Hepatocyte%20growth%20factor%2dlike%20protein">Hepatocyte growth factor-like protein</a>, <a href="cope.cgi?key=HLP">HLP</a>, <a href="cope.cgi?key=HGFL">HGFL</a>, <a href="cope.cgi?key=HGFLP">HGFLP</a>, <a href="cope.cgi?key=Macrophage%20stimulating%201">Macrophage stimulating 1</a>, <a href="cope.cgi?key=MST1">MST1</a>, <a href="cope.cgi?key=MST1">MST1</a>, <a href="cope.cgi?key=MSP">MSP</a>, <a href="cope.cgi?key=Macrophage%20stimulating%20protein">macrophage stimulating protein</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=RON">RON</a>, <a href="cope.cgi?key=recepteur%20d%27origine%20nantais">recepteur d'origine nantais</a>, <a href="cope.cgi?key=STK">STK</a>, <a href="cope.cgi?key=Fv2">Fv2</a>, <a href="cope.cgi?key=Friend%20virus%20susceptibility%202">Friend virus susceptibility 2</a>, <a href="cope.cgi?key=MST1R">MST1R</a>, <a href="cope.cgi?key=Macrophage%20stimulating%201%20receptor">macrophage stimulating 1 receptor</a>) (Brunelleschi et al, 2001; Wang et al, 2000; Wang et al, 1994; Lee et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Histogranin">Histogranin</a></b> (Poirier et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Histogranin">Histogranin</a> receptors</b> (Lemaire et al, 1993, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HLA%2dG">HLA-G</a></b> (<a href="cope.cgi?key=human%20leukocyte%20antigen%20G">Human leukocyte antigen G</a>, <a href="cope.cgi?key=HLA%2d6%2e0">HLA-6.0</a>, <a href="cope.cgi?key=HLA60">HLA60</a>, <a href="cope.cgi?key=Qa">Qa</a>) (Chu et al, 1998; Pangault et al, 2002; Yang et al, 1996; Wiendl et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HLA%2dG">HLA-G</a></b> (<a href="cope.cgi?key=human%20leukocyte%20antigen%20G">Human leukocyte antigen G</a>, <a href="cope.cgi?key=HLA%2d6%2e0">HLA-6.0</a>, <a href="cope.cgi?key=HLA60">HLA60</a>, <a href="cope.cgi?key=Qa">Qa</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=LILRB1">LILRB1</a>) (Li et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HMG%2d1">HMG-1</a></b> (<a href="cope.cgi?key=high%20mobility%20group%20protein%2d1">high mobility group protein-1</a>, <a href="cope.cgi?key=HMGB1">HMGB1</a>, <a href="cope.cgi?key=high%20mobility%20group%20box%2d1">high mobility group box-1</a>, <a href="cope.cgi?key=Amphoterin">amphoterin</a>, <a href="cope.cgi?key=DEF">DEF</a>, <a href="cope.cgi?key=Differentiation%20enhancing%20factor">Differentiation enhancing factor</a>, <a href="cope.cgi?key=Neurite%20growth%2dpromoting%20protein">Neurite growth-promoting protein</a>, <a href="cope.cgi?key=SBP%2d1">SBP-1</a>, <a href="cope.cgi?key=Sulfoglucuronyl%20carbohydrate%20binding%20protein%2d1">Sulfoglucuronyl carbohydrate binding protein-1</a>) (Jiang and Pisetsky, 2007; Ding et al, 2009; Campana et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HMG%2d1">HMG-1</a></b> (<a href="cope.cgi?key=high%20mobility%20group%20protein%2d1">high mobility group protein-1</a>, <a href="cope.cgi?key=HMGB1">HMGB1</a>, <a href="cope.cgi?key=high%20mobility%20group%20box%2d1">high mobility group box-1</a>, <a href="cope.cgi?key=Amphoterin">amphoterin</a>, <a href="cope.cgi?key=DEF">DEF</a>, <a href="cope.cgi?key=Differentiation%20enhancing%20factor">Differentiation enhancing factor</a>, <a href="cope.cgi?key=Neurite%20growth%2dpromoting%20protein">Neurite growth-promoting protein</a>, <a href="cope.cgi?key=SBP%2d1">SBP-1</a>, <a href="cope.cgi?key=Sulfoglucuronyl%20carbohydrate%20binding%20protein%2d1">Sulfoglucuronyl carbohydrate binding protein-1</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Park et al, 2004; Wang et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=hsp27">hsp27</a></b> (<a href="cope.cgi?key=hsp27a">hsp27a</a>, <a href="cope.cgi?key=hsp27b">hsp27b</a>, <a href="cope.cgi?key=hsp27c">hsp27c</a>, <a href="cope.cgi?key=heat%20shock%20protein%2027">heat shock protein 27</a>, <a href="cope.cgi?key=HSPB1">HSPB1</a>, <a href="cope.cgi?key=Heat%20shock%20protein%20beta%2d1">Heat shock protein beta-1</a>, <a href="cope.cgi?key=heat%20shock%2027%20kDa%20protein%201">heat shock 27 kDa protein 1</a>, <a href="cope.cgi?key=estrogen%2dregulated%20protein%2024K">estrogen-regulated protein 24K</a>, <a href="cope.cgi?key=p29%20estrogen%20receptor%2dassociated%20protein">p29 estrogen receptor-associated protein</a>, <a href="cope.cgi?key=estrogen%20receptor%2drelated%20protein">estrogen receptor-related protein</a>, <a href="cope.cgi?key=GC1">GC1</a>, <a href="cope.cgi?key=germ%20cell%2ddependent%20phosphoprotein%2d1">germ cell-dependent phosphoprotein-1</a>) (Ragno et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=hsp60">hsp60</a></b> (<a href="cope.cgi?key=heat%20shock%20protein%2060">heat shock protein 60</a>, <a href="cope.cgi?key=HSPD1">HSPD1</a>, <a href="cope.cgi?key=heat%20shock%2060%20kDa%20protein%201">heat shock 60 kDa protein 1</a>, <a href="cope.cgi?key=GroEL">GroEL</a>, <a href="cope.cgi?key=chaperonin%2060">chaperonin 60</a>, <a href="cope.cgi?key=cpn60">cpn60</a>) (Dupont et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=hsp70">hsp70</a></b> (<a href="cope.cgi?key=heat%20shock%20protein%2070">heat shock protein 70</a>) (Zhang et al, 1994; Dupont et al, 2008; Wang G et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=HVEM">HVEM</a></b> (<a href="cope.cgi?key=Herpesvirus%20entry%20mediator">Herpesvirus entry mediator</a>, <a href="cope.cgi?key=HveA">HveA</a>, <a href="cope.cgi?key=Herpes%20simplex%20virus%20entry%20protein%20A">Herpes simplex virus entry protein A</a>, <a href="cope.cgi?key=HveAt">HveAt</a>, <a href="cope.cgi?key=TR2">TR2</a>, <a href="cope.cgi?key=TNF%20receptor%2dlike%2d2">TNF receptor-like-2</a>, <a href="cope.cgi?key=ATAR">ATAR</a>, <a href="cope.cgi?key=another%20TRAF%2dassociated%20receptor">another TRAF-associated receptor</a>, <a href="cope.cgi?key=TNFRSF14">TNFRSF14</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2014">TNF receptor superfamily member 14</a>, <a href="cope.cgi?key=LIGHTR">LIGHTR</a>, <a href="cope.cgi?key=LIGHT%20receptor">LIGHT receptor</a>) (Wei CY et al, 2006; Kim WJ et al, 2005; Kim HM et al, 2011)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ID2">ID2</a></b> (<a href="cope.cgi?key=Inhibitor%20of%20differentiation%2d2">Inhibitor of differentiation-2</a>, <a href="cope.cgi?key=Inhibitor%20of%20DNA%20binding%2d2">Inhibitor of DNA binding-2</a>, <a href="cope.cgi?key=IDB2">IDB2</a>) (Burke et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ID3">ID3</a></b> (<a href="cope.cgi?key=Inhibitor%20of%20differentiation%2d3">Inhibitor of differentiation-3</a>, <a href="cope.cgi?key=Inhibitor%20of%20DNA%20binding%2d3">Inhibitor of DNA binding-3</a>, <a href="cope.cgi?key=IDB3">IDB3</a>) (Gratchev A et al, 2008; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IEX1">IEX1</a></b> (<a href="cope.cgi?key=Early%20response%20gene">immediate-early response gene</a>, <a href="cope.cgi?key=PRG1">PRG1</a>, <a href="cope.cgi?key=PACAP%2dresponsive%20gene%2d1">PACAP-responsive gene-1</a>, <a href="cope.cgi?key=GLY96">GLY96</a>, <a href="cope.cgi?key=IER3">IER3</a>, <a href="cope.cgi?key=immediate%2dearly%20response%2d3">immediate-early response-3</a>, <a href="cope.cgi?key=DIF%2d2">DIF-2</a>, <a href="cope.cgi?key=differentiation%2ddependent%20gene%2d2">differentiation-dependent gene-2</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IFI16">IFI16</a></b> (<a href="cope.cgi?key=interferon%2dinduced%20protein%2016">interferon-induced protein 16</a>, <a href="cope.cgi?key=interferon%2dgamma%2dinducible%20protein%2d16">interferon-gamma-inducible protein-16</a>, <a href="cope.cgi?key=IFNGIP1">IFNGIP1</a>, <a href="cope.cgi?key=interferon%2dgamma%2dinducible%20protein%2d1">interferon-gamma-inducible protein-1</a>, <a href="cope.cgi?key=PYHIN2">PYHIN2</a>) (Dawson and Trapani, 1995; Unterholzner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IFN%2dalpha">IFN-alpha</a> </b>(<a href="cope.cgi?key=Interferon%2dalpha">interferon-alpha</a>, <a href="cope.cgi?key=Alpha%2dInterferon">Alpha-Interferon</a>, <a href="cope.cgi?key=aIFN">aIFN</a>, <a href="cope.cgi?key=B%2dcell%20interferon">B-cell interferon</a>, <a href="cope.cgi?key=Leukocyte%20interferon">Leukocyte interferon</a>, <a href="cope.cgi?key=LeIFN">LeIFN</a>, <a href="cope.cgi?key=Lymphoblast%20interferon">Lymphoblast interferon</a>, <a href="cope.cgi?key=LyIFN%2dalpha">LyIFN-alpha</a>) (Chen and Wang, 2002; Wang et al, 1995; Zhou et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IFN%2dalpha">IFN-alpha</a> </b>(<a href="cope.cgi?key=Interferon%2dalpha">interferon-alpha</a>, <a href="cope.cgi?key=Alpha%2dInterferon">Alpha-Interferon</a>, <a href="cope.cgi?key=aIFN">aIFN</a>, <a href="cope.cgi?key=B%2dcell%20interferon">B-cell interferon</a>, <a href="cope.cgi?key=Leukocyte%20interferon">Leukocyte interferon</a>, <a href="cope.cgi?key=LeIFN">LeIFN</a>, <a href="cope.cgi?key=Lymphoblast%20interferon">Lymphoblast interferon</a>, <a href="cope.cgi?key=LyIFN%2dalpha">LyIFN-alpha</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IFNAR1">IFNAR1</a>, <a href="cope.cgi?key=IFN%2dalpha%2fbeta%20receptor%201">IFN-alpha/beta receptor 1</a>, <a href="cope.cgi?key=interferon%20%28alpha%2c%20beta%20and%20omega%29%20receptor%201">interferon (alpha, beta and omega) receptor 1</a>, <a href="cope.cgi?key=IFN%2dalphaR1">IFN-alphaR1</a>, <a href="cope.cgi?key=IFRC">IFRC</a>, <a href="cope.cgi?key=IFNAR">IFNAR</a>, <a href="cope.cgi?key=IFNAR2">IFNAR2</a>, <a href="cope.cgi?key=IFN%2dalpha%2fbeta%20receptor%202">IFN-alpha/beta receptor 2</a>, <a href="cope.cgi?key=interferon%20%28alpha%2c%20beta%20and%20omega%29%20receptor%202">interferon (alpha, beta and omega) receptor 2</a>, <a href="cope.cgi?key=IFN%2dalphaR2">IFN-alphaR2</a>, <a href="cope.cgi?key=IFNABR">IFNABR</a>) (Dhanani et al, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IFN%2dbeta">IFN-beta</a> </b>(<a href="cope.cgi?key=Beta%2dInterferon">Beta-Interferon</a>, <a href="cope.cgi?key=Interferon%2dbeta">Interferon-beta</a>, <a href="cope.cgi?key=bIFN">bIFN</a>, <a href="cope.cgi?key=Fibroblast%20interferon">Fibroblast interferon</a>, <a href="cope.cgi?key=Fi%2dIFN">Fi-IFN</a>, <a href="cope.cgi?key=F%2dIFN">F-IFN</a>) (Wang et al, 1995; Zhou et al, 1995; Gessani et al, 1989; Nickolaus and Zawatzky, 1994; Rintahaka et al, 2008; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IFN%2dbeta">IFN-beta</a> </b>(<a href="cope.cgi?key=Beta%2dInterferon">Beta-Interferon</a>, <a href="cope.cgi?key=Interferon%2dbeta">Interferon-beta</a>, <a href="cope.cgi?key=bIFN">bIFN</a>, <a href="cope.cgi?key=Fibroblast%20interferon">Fibroblast interferon</a>, <a href="cope.cgi?key=Fi%2dIFN">Fi-IFN</a>, <a href="cope.cgi?key=F%2dIFN">F-IFN</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IFNAR1">IFNAR1</a>, <a href="cope.cgi?key=IFN%2dalpha%2fbeta%20receptor%201">IFN-alpha/beta receptor 1</a>, <a href="cope.cgi?key=interferon%20%28alpha%2c%20beta%20and%20omega%29%20receptor%201">interferon (alpha, beta and omega) receptor 1</a>, <a href="cope.cgi?key=IFN%2dalphaR1">IFN-alphaR1</a>, <a href="cope.cgi?key=IFRC">IFRC</a>, <a href="cope.cgi?key=IFNAR">IFNAR</a>, <a href="cope.cgi?key=IFNAR2">IFNAR2</a>, <a href="cope.cgi?key=IFN%2dalpha%2fbeta%20receptor%202">IFN-alpha/beta receptor 2</a>, <a href="cope.cgi?key=interferon%20%28alpha%2c%20beta%20and%20omega%29%20receptor%202">interferon (alpha, beta and omega) receptor 2</a>, <a href="cope.cgi?key=IFN%2dalphaR2">IFN-alphaR2</a>, <a href="cope.cgi?key=IFNABR">IFNABR</a>) (Jiang and Dhib-Jalbut, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IFN%2dgamma">IFN-gamma</a></b> (<a href="cope.cgi?key=IFNG">IFNG</a>, <a href="cope.cgi?key=Interferon%2dgamma">interferon-gamma</a>, <a href="cope.cgi?key=Gamma%2dInterferon">Gamma-Interferon</a>, <a href="cope.cgi?key=gIFN">gIFN</a>) (Amber et al, 1991; Fenton et al, 1997; Fernandez-Lago et al, 1999; Puddu et al, 1997; Di Marzio et al, 1994; Munder et al, 1998; Lidstrom et al, 2003; Kito et al, 2003; John et al, 1998;<b style="mso-bidi-font-weight:normal"> </b>Sodhi and Tripathi, 2008; Darwich et al, 2009; Ishida et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IFN%2dgamma">IFN-gamma</a></b> (<a href="cope.cgi?key=IFNG">IFNG</a>, <a href="cope.cgi?key=Interferon%2dgamma">interferon-gamma</a>, <a href="cope.cgi?key=Gamma%2dInterferon">Gamma-Interferon</a>, <a href="cope.cgi?key=gIFN">gIFN</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=IFNGR1">IFNGR1</a>, <a href="cope.cgi?key=IFN%2dgamma%20receptor%2d1">IFN-gamma receptor-1</a>, <a href="cope.cgi?key=IFN%2dgamma%2dR1">IFN-gamma-R1</a>, <a href="cope.cgi?key=interferon%2dgamma%20receptor%201">interferon-gamma receptor 1</a>, <a href="cope.cgi?key=immune%20interferon%20receptor%201">immune interferon receptor 1</a>, <a href="cope.cgi?key=AVP%20type%202">AVP type 2</a>, <a href="cope.cgi?key=antiviral%20protein%20type%202">antiviral protein type 2</a>, <a href="cope.cgi?key=CD119">CD119</a>, <a href="cope.cgi?key=IFNGR2">IFNGR2</a>, <a href="cope.cgi?key=interferon%2dgamma%20receptor%202">interferon-gamma receptor 2</a>, <a href="cope.cgi?key=IFN%2dgamma%20receptor%202">IFN-gamma receptor 2</a>, <a href="cope.cgi?key=IFN%2dgamma%2dR2">IFN-gamma-R2</a>, <a href="cope.cgi?key=IFGR2">IFGR2</a>, <a href="cope.cgi?key=IFNGT1">IFNGT1</a>, <a href="cope.cgi?key=interferon%2dgamma%20transducer%201">interferon-gamma transducer 1</a>) (Corradin et al, 1993; Di Marzio et al, 1994; Horton et al, 1998; Major et al, 2002; Jiang and Dhib-Jalbut, 1998; Gessani et al, 1989; Krettek et al, 2001; Malaguarnera et al, 2005; Sodhi and Tripathi, 2008; Kim et al, 2008; Li F et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=IgE%2dHRF">IgE-HRF</a> (Teshima et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IGF%2d1">IGF-1</a></b> (<a href="cope.cgi?key=Insulin%2dlike%20growth%20factor%2d1">Insulin-like growth factor-1</a>, <a href="cope.cgi?key=Erythropoietic%20factor">Erythropoietic factor</a>, <a href="cope.cgi?key=mechano%20growth%20factor">mechano growth factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=ILGF1">ILGF1</a>, <a href="cope.cgi?key=Somatomedin%20C">somatomedin C</a>, <a href="cope.cgi?key=NSILA">NSILA</a>, <a href="cope.cgi?key=Non%2dsuppressible%20insulin%2dlike%20activity">non-suppressible insulin-like activity</a>, <a href="cope.cgi?key=Somatomedin%20A">Somatomedin A</a>, <a href="cope.cgi?key=Somatomedin%20C">Somatomedin C</a>, <a href="cope.cgi?key=Sulfation%20factor">sulfation factor</a>, <a href="cope.cgi?key=Mecasermin">Mecasermin</a>)<b style="mso-bidi-font-weight: normal"> </b>(Arkins et al, 1993; Fournier et al, 1995; Noble et al, 1993; Kodelja et al, 1997; Wynes and Riches, 2003; Nagaoka et al, 1991; Rappolee et al, 1988; Gustafsson et al, 2008; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IGF%2d1">IGF-1</a></b> (<a href="cope.cgi?key=Insulin%2dlike%20growth%20factor%2d1">Insulin-like growth factor-1</a>, <a href="cope.cgi?key=Erythropoietic%20factor">Erythropoietic factor</a>, <a href="cope.cgi?key=mechano%20growth%20factor">mechano growth factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=ILGF1">ILGF1</a>, <a href="cope.cgi?key=Somatomedin%20C">somatomedin C</a>, <a href="cope.cgi?key=NSILA">NSILA</a>, <a href="cope.cgi?key=Non%2dsuppressible%20insulin%2dlike%20activity">non-suppressible insulin-like activity</a>, <a href="cope.cgi?key=Somatomedin%20A">Somatomedin A</a>, <a href="cope.cgi?key=Somatomedin%20C">Somatomedin C</a>, <a href="cope.cgi?key=Sulfation%20factor">sulfation factor</a>, <a href="cope.cgi?key=Mecasermin">Mecasermin</a>)<b style="mso-bidi-font-weight:normal"> receptors</b> (<a href="cope.cgi?key=IGF1R">IGF1R</a>, <a href="cope.cgi?key=CD221">CD221</a>, <a href="cope.cgi?key=JTK13">JTK13</a>) (Renier et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IGFBP4">IGFBP4</a></b> (<a href="cope.cgi?key=Insulin%2dlike%20growth%20factor%20binding%20protein%2d4">Insulin-like growth factor binding protein-4</a>, <a href="cope.cgi?key=IGF%20binding%20protein%2d4">IGF binding protein-4</a>, <a href="cope.cgi?key=Colon%20cancer%20cell%20growth%20inhibitor">Colon cancer cell growth inhibitor</a>, <a href="cope.cgi?key=HT29%2dIGFBP">HT29-IGFBP</a>, <a href="cope.cgi?key=HT29%20insulin%2dlike%20growth%20factor%20binding%20protein">HT29 insulin-like growth factor binding protein</a>) (Li et al, 1996; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IGFBP10">IGFBP10</a></b> (<a href="cope.cgi?key=Insulin%2dlike%20growth%20factor%20binding%20protein%2d10">Insulin-like growth factor binding protein-10</a>, <a href="cope.cgi?key=IGF%20binding%20protein%2d10">IGF binding protein-10</a>, <a href="cope.cgi?key=Cyr%2d61">cyr-61</a>, <a href="cope.cgi?key=Cysteine%2drich%20angiogenic%20inducer%2061">Cysteine-rich angiogenic inducer 61</a>, <a href="cope.cgi?key=Cysteine%2drich%2061">cysteine-rich 61</a>, <a href="cope.cgi?key=CCN1">CCN1</a>) (Bai et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1">IL1</a></b> (<a href="cope.cgi?key=Interleukin%2d1">interleukin-1</a>) (Cauli et al, 1997; Sethi and Sodhi, 2004; Eden and Turino, 1986)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1%2dalpha">IL1-alpha</a></b> (<a href="cope.cgi?key=IL1A">IL1A</a>, <a href="cope.cgi?key=Interleukin%2d1%2dalpha">interleukin-1-alpha</a>, <a href="cope.cgi?key=IL1F1">IL1F1</a>, <a href="cope.cgi?key=Interleukin%2d1%20family%20member%201">Interleukin-1 family member 1</a>, <a href="cope.cgi?key=BAF">BAF</a>, <a href="cope.cgi?key=B%2dcell%20activating%20factor">B-cell activating factor</a>, <a href="cope.cgi?key=BCAF">BCAF</a>, <a href="cope.cgi?key=B%2dcell%20activating%20factor">B-cell activating factor</a>, <a href="cope.cgi?key=EP">EP</a>, <a href="cope.cgi?key=endogenous%20pyrogens">endogenous pyrogens</a>, <a href="cope.cgi?key=LAF">LAF</a>, <a href="cope.cgi?key=Lymphocyte%20activating%20factor">lymphocyte activating factor</a>, <a href="cope.cgi?key=LEM">LEM</a>, <a href="cope.cgi?key=Leukocyte%20endogenous%20mediator">leukocyte endogenous mediator</a>, <a href="cope.cgi?key=MCF">MCF</a>, <a href="cope.cgi?key=mononuclear%20cell%20factor">mononuclear cell factor</a>, <a href="cope.cgi?key=MNCF">MNCF</a>, <a href="cope.cgi?key=mononuclear%20cell%20factor">mononuclear cell factor</a>, <a href="cope.cgi?key=MP">MP</a>, <a href="cope.cgi?key=mitogenic%20protein">mitogenic protein</a>, <a href="cope.cgi?key=TRF%2d3">TRF-3</a>, <a href="cope.cgi?key=T%2dcell%20replacing%20factor%2d3">T-cell replacing factor-3</a>, <a href="cope.cgi?key=Tumor%20inhibitory%20factor%2d2">Tumor inhibitory factor-2</a>) (Janson et al, 1995; Major et al, 2002; Brough et al, 2003; Bai T et al, 2010; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1%2dbeta">IL1-beta</a></b> (<a href="cope.cgi?key=IL1B">IL1B</a>, <a href="cope.cgi?key=Interleukin%2d1%2dbeta">interleukin-1-beta</a>, <a href="cope.cgi?key=IL1F2">IL1F2</a>, <a href="cope.cgi?key=Interleukin%2d1%20family%20member%202">Interleukin-1 family member 2</a>, <a href="cope.cgi?key=Catabolin">Catabolin</a>, <a href="cope.cgi?key=H1">H1</a>, <a href="cope.cgi?key=Hematopoietin%2d1">Hematopoietin-1</a>, <a href="cope.cgi?key=IFN%2dbeta%20inducing%20factor">IFN-beta inducing factor</a>, <a href="cope.cgi?key=Interleukin%2dbeta">Interleukin-beta</a>, <a href="cope.cgi?key=OAF">OAF</a>, <a href="cope.cgi?key=Osteoclast%20activating%20factor">osteoclast activating factor</a>) (Rubartelli et al, 1990; Moreno-Altamirano et al, 2004; Cappello et al, 2004; Yamamoto et al, 1996, 1997; Rodenburg et al, 1998; Chen and Wang, 2002; Fadok et al, 1998; Hohlbaum et al, 2001; Khaldoyanidi et al, 1999; Janson et al, 1995; Pruimboom et al, 1994; Ragno et al, 2001; Schilling et al, 2001; Brough et al, 2003; Mathy et al, 2000; Sodhi and Tripathi, 2008; Kent et al, 2008; Lavric et al, 2008; Ishida et al, 2008; Song et al, 2009; Rintahaka et al, 2008; Kim DK et al, 2009; Bai T et al, 2010; Gleissner et al, 2010; Babelova et al, 2009; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1%2dbeta%20Convertase">IL1-beta Convertase</a></b> (<a href="cope.cgi?key=ICE">ICE</a>, <a href="cope.cgi?key=IL1BC">IL1BC</a>, <a href="cope.cgi?key=IL1%2dbeta%20converting%20enzyme">IL1-beta converting enzyme</a>, <a href="cope.cgi?key=Caspase%2d1">Caspase-1</a>, <a href="cope.cgi?key=CASP1">CASP1</a>) (McAlindon et al, 1998; Laliberte et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1F5">IL1F5</a></b> (<a href="cope.cgi?key=Interleukin%2d1%20family%20member%205">Interleukin-1 family member 5</a>, <a href="cope.cgi?key=FIL1%2ddelta">FIL1-delta</a>, <a href="cope.cgi?key=FIL1D">FIL1D</a>, <a href="cope.cgi?key=IL1%2dHY1">IL1-HY1</a>, <a href="cope.cgi?key=IL1%2ddelta">IL1-delta</a>, <a href="cope.cgi?key=IL1RP3">IL1RP3</a>, <a href="cope.cgi?key=IL1%2drelated%20protein%2d3">IL1-related protein-3</a>, <a href="cope.cgi?key=IL36Ra">IL36Ra</a>, <a href="cope.cgi?key=IL36RN">IL36RN</a>, <a href="cope.cgi?key=interleukin%2d36%20receptor%20antagonist">interleukin-36 receptor antagonist</a>) (Mulero et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1F6">IL1F6</a> </b>(<a href="cope.cgi?key=Interleukin%2d1%20family%20member%206">Interleukin-1 family member 6</a>, <a href="cope.cgi?key=FIL1%2depsilon">FIL1-epsilon</a>, <a href="cope.cgi?key=FIL1E">FIL1E</a>, <a href="cope.cgi?key=Family%20of%20IL1%2depsilon">Family of IL1-epsilon</a>, <a href="cope.cgi?key=IL1H1">IL1H1</a>, <a href="cope.cgi?key=IL1%2depsilon">IL1-epsilon</a>; <a href="cope.cgi?key=IL36%2dalpha">IL36-alpha</a>, <a href="cope.cgi?key=interleukin%2d36%2dalpha">interleukin-36-alpha</a>) (van Asseldonk EJ et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1F9">IL1F9</a></b> (<a href="cope.cgi?key=Interleukin%2d1%20family%20member%209">Interleukin-1 family member 9</a>, <a href="cope.cgi?key=IL1H1">IL1H1</a>, <a href="cope.cgi?key=IL1%20homolog%2d1">IL1 homolog-1</a>, <a href="cope.cgi?key=IL1RP2">IL1RP2</a>, <a href="cope.cgi?key=IL1%2drelated%20protein%2d2">IL1-related protein-2</a>; <a href="cope.cgi?key=IL36%2dgamma">IL36-gamma</a>, <a href="cope.cgi?key=interleukin%2d36%2dgamma">interleukin-36-gamma</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Ramadas RA et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1ra">IL1ra</a></b> (<a href="cope.cgi?key=IL1%20receptor%20antagonist">IL1 receptor antagonist</a>, <a href="cope.cgi?key=IL1RN">IL1RN</a>, <a href="cope.cgi?key=IL1%20inhibitor">IL1 inhibitor</a>, <a href="cope.cgi?key=IRAP">IRAP</a>, <a href="cope.cgi?key=IL1%20receptor%20antagonist%20protein">IL1 receptor antagonist protein</a>, <a href="cope.cgi?key=IL1%20inhibitory%20activity">IL1 inhibitory activity</a>, <a href="cope.cgi?key=ILS">ILS</a>, <a href="cope.cgi?key=IL1F3">IL1F3</a>, <a href="cope.cgi?key=IL1%20family%20member%203">IL1 family member 3</a>, <a href="cope.cgi?key=DIRA">DIRA</a>, <a href="cope.cgi?key=deficiency%20of%20the%20IL1%20receptor%20antagonist">deficiency of the IL1 receptor antagonist</a>) (Cauli et al, 1997; Wilson et al, 2004; Chang, 1995; Koch et al, 1992; Darragh et al, 2010; Kim DK et al, 2009; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL1">IL1</a></b> (<a href="cope.cgi?key=Interleukin%2d1">interleukin-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL1RA">IL1RA</a>, <a href="cope.cgi?key=IL1R%2dalpha">IL1R-alpha</a>, <a href="cope.cgi?key=IL1%20receptor%2dalpha">IL1 receptor-alpha</a>; <a href="cope.cgi?key=Interleukin%2d1%20receptor%2dalpha">interleukin-1 receptor-alpha</a>, <a href="cope.cgi?key=IL1R1">IL1R1</a>, <a href="cope.cgi?key=IL1%20receptor%20type%201">IL1 receptor type 1</a>, <a href="cope.cgi?key=Interleukin%2d1%20receptor%201">Interleukin-1 receptor 1</a>, <a href="cope.cgi?key=IL1%20receptor%20R1">IL1 receptor R1</a>, <a href="cope.cgi?key=CD121a">CD121a</a>; <a href="cope.cgi?key=IL1RB">IL1RB</a>, <a href="cope.cgi?key=IL1R%2dbeta">IL1R-beta</a>, <a href="cope.cgi?key=IL1%20receptor%2dbeta">IL1 receptor-beta</a>; <a href="cope.cgi?key=Interleukin%2d1%20receptor%2dbeta">interleukin-1 receptor-beta</a>, <a href="cope.cgi?key=IL1R2">IL1R2</a>, <a href="cope.cgi?key=IL1%20receptor%20type%202">IL1 receptor type 2</a>, <a href="cope.cgi?key=Interleukin%2d1%20receptor%202">Interleukin-1 receptor 2</a>, <a href="cope.cgi?key=IL1%20receptor%20R2">IL1 receptor R2</a>, <a href="cope.cgi?key=CD121b">CD121b</a>, <a href="cope.cgi?key=AURA31">AURA31</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2031">augmented in rheumatoid arthritis 31</a>) (Neale and Athanasou, 1999; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL2">IL2</a> </b>(<a href="cope.cgi?key=Interleukin%2d2">Interleukin-2</a>, <a href="cope.cgi?key=BF">BF</a>, <a href="cope.cgi?key=Blastogenic%20factor">blastogenic factor</a>, <a href="cope.cgi?key=EDF">EDF</a>, <a href="cope.cgi?key=Eosinophil%20differentiation%20factor">eosinophil differentiation factor</a>, <a href="cope.cgi?key=KHF">KHF</a>, <a href="cope.cgi?key=Killer%20cell%20helper%20factor">killer cell helper factor</a>, <a href="cope.cgi?key=LMF">LMF</a>, <a href="cope.cgi?key=Lymphocyte%20mitogenic%20factor">lymphocyte mitogenic factor</a>, <a href="cope.cgi?key=LPF">LPF</a>, <a href="cope.cgi?key=Lymphocyte%20proliferation%20factor">lymphocyte proliferation factor</a>, <a href="cope.cgi?key=MAF%2dC%20I">MAF-C I</a>, <a href="cope.cgi?key=Macrophage%2dactivating%20factor%20for%20cytotoxicity%20I">macrophage-activating factor for cytotoxicity I</a>, <a href="cope.cgi?key=PFC%2dEA">PFC-EA</a>, <a href="cope.cgi?key=Plaque%20forming%20cell%20enhancing%20factor">plaque forming cell enhancing factor</a>, <a href="cope.cgi?key=SCIF">SCIF</a>, <a href="cope.cgi?key=secondary%20cytotoxic%20T%2dcell%20inducing%20factor">secondary cytotoxic T-cell inducing factor</a>, <a href="cope.cgi?key=TCGF">TCGF</a>, <a href="cope.cgi?key=T%2dcell%20growth%20factor">T-cell growth factor</a>, <a href="cope.cgi?key=TCPA">TCPA</a>, <a href="cope.cgi?key=T%20colony%2dpromoting%20activity">T colony-promoting activity</a>, <a href="cope.cgi?key=TDF">TDF</a>, <a href="cope.cgi?key=Thymocyte%20differentiation%20factor">thymocyte differentiation factor</a>, <a href="cope.cgi?key=T%2dLPF">T-LPF</a>, <a href="cope.cgi?key=T%2dlymphocyte%20promotor%20factor">T-lymphocyte promotor factor</a>, <a href="cope.cgi?key=TMF">TMF</a>, <a href="cope.cgi?key=Thymocyte%20mitogenic%20factor">thymocyte mitogenic factor</a>, <a href="cope.cgi?key=T%2dcell%20maturation%20factor">T-cell maturation factor</a>, <a href="cope.cgi?key=T%2dcell%20mitogenic%20factor">T-cell mitogenic factor</a>, <a href="cope.cgi?key=TRF%2d3">TRF-3</a>, <a href="cope.cgi?key=T%2dcell%20replacing%20factor%2d3">T-cell replacing factor-3</a>, <a href="cope.cgi?key=TSF">TSF</a>, <a href="cope.cgi?key=Thymocyte%20stimulating%20factor">thymocyte stimulating factor</a>) (Ragno et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL2">IL2</a> </b>(<a href="cope.cgi?key=Interleukin%2d2">Interleukin-2</a>, <a href="cope.cgi?key=BF">BF</a>, <a href="cope.cgi?key=Blastogenic%20factor">blastogenic factor</a>, <a href="cope.cgi?key=EDF">EDF</a>, <a href="cope.cgi?key=Eosinophil%20differentiation%20factor">eosinophil differentiation factor</a>, <a href="cope.cgi?key=KHF">KHF</a>, <a href="cope.cgi?key=Killer%20cell%20helper%20factor">killer cell helper factor</a>, <a href="cope.cgi?key=LMF">LMF</a>, <a href="cope.cgi?key=Lymphocyte%20mitogenic%20factor">lymphocyte mitogenic factor</a>, <a href="cope.cgi?key=LPF">LPF</a>, <a href="cope.cgi?key=Lymphocyte%20proliferation%20factor">lymphocyte proliferation factor</a>, <a href="cope.cgi?key=MAF%2dC%20I">MAF-C I</a>, <a href="cope.cgi?key=Macrophage%2dactivating%20factor%20for%20cytotoxicity%20I">macrophage-activating factor for cytotoxicity I</a>, <a href="cope.cgi?key=PFC%2dEA">PFC-EA</a>, <a href="cope.cgi?key=Plaque%20forming%20cell%20enhancing%20factor">plaque forming cell enhancing factor</a>, <a href="cope.cgi?key=SCIF">SCIF</a>, <a href="cope.cgi?key=secondary%20cytotoxic%20T%2dcell%20inducing%20factor">secondary cytotoxic T-cell inducing factor</a>, <a href="cope.cgi?key=TCGF">TCGF</a>, <a href="cope.cgi?key=T%2dcell%20growth%20factor">T-cell growth factor</a>, <a href="cope.cgi?key=TCPA">TCPA</a>, <a href="cope.cgi?key=T%20colony%2dpromoting%20activity">T colony-promoting activity</a>, <a href="cope.cgi?key=TDF">TDF</a>, <a href="cope.cgi?key=Thymocyte%20differentiation%20factor">thymocyte differentiation factor</a>, <a href="cope.cgi?key=T%2dLPF">T-LPF</a>, <a href="cope.cgi?key=T%2dlymphocyte%20promotor%20factor">T-lymphocyte promotor factor</a>, <a href="cope.cgi?key=TMF">TMF</a>, <a href="cope.cgi?key=Thymocyte%20mitogenic%20factor">thymocyte mitogenic factor</a>, <a href="cope.cgi?key=T%2dcell%20maturation%20factor">T-cell maturation factor</a>, <a href="cope.cgi?key=T%2dcell%20mitogenic%20factor">T-cell mitogenic factor</a>, <a href="cope.cgi?key=TRF%2d3">TRF-3</a>, <a href="cope.cgi?key=T%2dcell%20replacing%20factor%2d3">T-cell replacing factor-3</a>, <a href="cope.cgi?key=TSF">TSF</a>, <a href="cope.cgi?key=Thymocyte%20stimulating%20factor">thymocyte stimulating factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL2RA">IL2RA</a>, <a href="cope.cgi?key=interleukin%2d2%20receptor%2dalpha">interleukin-2 receptor-alpha</a>; <a href="cope.cgi?key=IL2R%2dalpha">IL2R-alpha</a>; <a href="cope.cgi?key=IL2%20receptor%2dalpha">IL2 receptor-alpha</a>, <a href="cope.cgi?key=IL2R">IL2R</a>, <a href="cope.cgi?key=interleukin%2d2%20receptor">interleukin-2 receptor</a>, <a href="cope.cgi?key=TAC%20antigen">TAC antigen</a>, <a href="cope.cgi?key=TCGFR">TCGFR</a>, <a href="cope.cgi?key=T%2dcell%20growth%20factor%20receptor">T-cell growth factor receptor</a>, <a href="cope.cgi?key=IDDM10">IDDM10</a>, <a href="cope.cgi?key=insulin%2ddependent%20diabetes%20mellitus%2010">insulin-dependent diabetes mellitus 10</a>, <a href="cope.cgi?key=CD25">CD25</a>; <a href="cope.cgi?key=Ly43">Ly43</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%2043">lymphocyte antigen 43</a>, <a href="cope.cgi?key=OX39">OX39</a>, <a href="cope.cgi?key=IL2RB">IL2RB</a>, <a href="cope.cgi?key=interleukin%2d2%20receptor%2dbeta">interleukin-2 receptor-beta</a>; <a href="cope.cgi?key=IL2R%2dbeta">IL2R-beta</a>; <a href="cope.cgi?key=IL2%20receptor%2dbeta">IL2 receptor-beta</a>, <a href="cope.cgi?key=CD122">CD122</a>; <a href="cope.cgi?key=IL2RG">IL2RG</a>, <a href="cope.cgi?key=IL2%20receptor%2dgamma">IL2 receptor-gamma</a>, <a href="cope.cgi?key=interleukin%2d2%20receptor%2dgamma">interleukin-2 receptor-gamma</a>, <a href="cope.cgi?key=IL2R%2dgamma">IL2R-gamma</a>, <a href="cope.cgi?key=common%20gamma">common gamma</a>, <a href="cope.cgi?key=gammac">gammac</a>, <a href="cope.cgi?key=Gamma%20common">gamma common</a>, <a href="cope.cgi?key=common%20cytokine%20receptor%2dgamma">common cytokine receptor-gamma</a>; <a href="cope.cgi?key=cytokine%20receptor%20common%20subunit%20gamma">cytokine receptor common subunit gamma</a>, <a href="cope.cgi?key=CD132">CD132</a>, <a href="cope.cgi?key=SCIDX1">SCIDX1</a>, <a href="cope.cgi?key=X%2dlinked%20severe%20combined%20immunodeficiency%2d1">X-linked severe combined immunodeficiency-1</a>) (Kovacs et al, 1994; Major et al, 2002; Matsui, 1999; Nelson et al, 1994; Dubinett et al, 1993; Cox et al, 1990; Hermann et al, 1998; Neale and Athanasou, 1999; Athanasou and Quinn, 1990; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL3">IL3</a> </b>(<a href="cope.cgi?key=Interleukin%2d3">Interleukin-3</a>, <a href="cope.cgi?key=20%2dalpha%2dhydroxysteroid%20dehydrogenase%20inducing%20factor">20-alpha-hydroxysteroid dehydrogenase inducing factor</a>, <a href="cope.cgi?key=BPA">BPA</a>, <a href="cope.cgi?key=Burst%20promoting%20activity">burst promoting activity</a>, <a href="cope.cgi?key=CFU%2dS">CFU-S</a>, <a href="cope.cgi?key=Colony%2dforming%20unit%20spleen">colony-forming unit spleen</a>, <a href="cope.cgi?key=CSF%2d2%2dalpha">CSF-2-alpha</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d2%2dalpha">colony stimulating factor-2-alpha</a>, <a href="cope.cgi?key=CSF%2d2%2dbeta">CSF-2-beta</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d2%2dbeta">colony stimulating factor-2-beta</a>, <a href="cope.cgi?key=ECSF">ECSF</a>, <a href="cope.cgi?key=Erythroid%20colony%20stimulating%20factor">erythroid colony stimulating factor</a>, <a href="cope.cgi?key=Eo%2dCSF">Eo-CSF</a>, <a href="cope.cgi?key=Eosinophil%20colony%20stimulating%20factor">eosinophil colony stimulating factor</a>, <a href="cope.cgi?key=HCGF">HCGF</a>, <a href="cope.cgi?key=Hematopoietic%20cell%20growth%20factor">Hematopoietic cell growth factor</a>, <a href="cope.cgi?key=HP2">HP2</a>, <a href="cope.cgi?key=Hematopoietin%2d2">Hematopoietin-2</a>, <a href="cope.cgi?key=HPGF">HPGF</a>, <a href="cope.cgi?key=Hematopoietic%20cell%20growth%20factor">hematopoietic cell growth factor</a>, <a href="cope.cgi?key=MCGF">MCGF</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20factor">mast cell growth factor</a>, <a href="cope.cgi?key=MCSA">MCSA</a>, <a href="cope.cgi?key=Multi%2dcolony%20stimulating%20activity">multi-colony stimulating activity</a>, <a href="cope.cgi?key=Meg%2dCSF">Meg-CSF</a>, <a href="cope.cgi?key=Megakaryocyte%20colony%20stimulating%20factor">megakaryocyte colony stimulating factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20factor">mast cell growth factor</a>, <a href="cope.cgi?key=Mixed%20colony%20stimulating%20factor">Mixed colony stimulating factor</a>, <a href="cope.cgi?key=Multi%2dCSF">Multi-CSF</a>, <a href="cope.cgi?key=Multi%2dcolony%20stimulating%20factor">Multi-colony stimulating factor</a>, <a href="cope.cgi?key=multi%2dHGF">multi-HGF</a>, <a href="cope.cgi?key=Multilineage%20hemopoietic%20growth%20factor">multilineage hemopoietic growth factor</a>, <a href="cope.cgi?key=Multipoietin">Multipoietin</a>, <a href="cope.cgi?key=NC%20cell%20growth%20factor">NC cell growth factor</a>, <a href="cope.cgi?key=Natural%20cytotoxic%20cell%20growth%20factor">natural cytotoxic cell growth factor</a>, <a href="cope.cgi?key=Neutrophil%2dgranulocyte%20colony%20stimulating%20factor">Neutrophil-granulocyte colony stimulating factor</a>, <a href="cope.cgi?key=PSF">PSF</a>, <a href="cope.cgi?key=Progenitor%20stimulating%20factor">progenitor stimulating factor</a>, <a href="cope.cgi?key=PSH">PSH</a>, <a href="cope.cgi?key=panspecific%20hemopoietin">panspecific hemopoietin</a>, <a href="cope.cgi?key=SAF">SAF</a>, <a href="cope.cgi?key=Stem%20cell%20activating%20factor">stem cell activating factor</a>, <a href="cope.cgi?key=Thy1%20inducing%20factor">Thy1 inducing factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL3RA">IL3RA</a>, <a href="cope.cgi?key=interleukin%2d3%20receptor%2dalpha">interleukin-3 receptor-alpha</a>, <a href="cope.cgi?key=IL3R%2dalpha">IL3R-alpha</a>, <a href="cope.cgi?key=common%20beta">common beta</a>, <a href="cope.cgi?key=beta%20c">beta c</a>, <a href="cope.cgi?key=beta%20c">betac</a>, <a href="cope.cgi?key=common%20cytokine%20receptor%2dbeta">common cytokine receptor-beta</a>, <a href="cope.cgi?key=cytokine%20receptor%20common%20subunit%20beta">cytokine receptor common subunit beta</a>, <a href="cope.cgi?key=IL3RB">IL3RB</a>, <a href="cope.cgi?key=IL3%20receptor%20subunit%20beta">IL3 receptor subunit beta</a>, <a href="cope.cgi?key=IL3R%2dbeta">IL3R-beta</a>, <a href="cope.cgi?key=IL3%20receptor%20subunit%20beta">IL3 receptor subunit beta</a>; <a href="cope.cgi?key=interleukin%2d3%20receptor%2dbeta">interleukin-3 receptor-beta</a>, <a href="cope.cgi?key=IL5RB">IL5RB</a>, <a href="cope.cgi?key=IL5%20receptor%20subunit%20beta">IL5 receptor subunit beta</a>, <a href="cope.cgi?key=IL5R%2dbeta">IL5R-beta</a>, <a href="cope.cgi?key=GM%2dCSF%20receptor%20subunit%20beta">GM-CSF receptor subunit beta</a>, <a href="cope.cgi?key=CSF2RB">CSF2RB</a>, <a href="cope.cgi?key=colony%20stimulating%20factor%2d2%20receptor%2dbeta">colony stimulating factor-2 receptor-beta</a>, <a href="cope.cgi?key=CD131">CD131</a>) (Cohen et al, 1991; Orlofsky et al, 1994; Jarmin et al, 1999; Olmos et al, 2004; Frendl et al, 1990)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL4">IL4</a> </b>(<a href="cope.cgi?key=Interleukin%2d4">Interleukin-4</a>, <a href="cope.cgi?key=BCDF%2depsilon">BCDF-epsilon</a>, <a href="cope.cgi?key=B%2dcell%20differentiation%20factor%2depsilon">B-cell differentiation factor-epsilon</a>, <a href="cope.cgi?key=BCDF%2dgamma">BCDF-gamma</a>, <a href="cope.cgi?key=B%2dcell%20differentiation%20factor%2dgamma">B-cell differentiation factor-gamma</a>, <a href="cope.cgi?key=BCGF%2dgamma">BCGF-gamma</a>, <a href="cope.cgi?key=B%2dcell%20growth%20factor%2dgamma">B-cell growth factor-gamma</a>, <a href="cope.cgi?key=BCGF%2d1">BCGF-1</a>, <a href="cope.cgi?key=B%2dcell%20growth%20factor%2d1">B-cell growth factor-1</a>, <a href="cope.cgi?key=Binetrakin">Binetrakin</a>, <a href="cope.cgi?key=BSF%2d1">BSF-1</a>, <a href="cope.cgi?key=B%2dcell%20stimulating%20factor%2d1">B-cell stimulating factor-1</a>, <a href="cope.cgi?key=BSF%2dp1">BSF-p1</a>, <a href="cope.cgi?key=B%2dcell%20stimulating%20factor%20p1">B-cell stimulating factor p1</a>, <a href="cope.cgi?key=EL4%2dBCGF">EL4-BCGF</a>, <a href="cope.cgi?key=EL4%20B%2dcell%20growth%20factor">EL4 B-cell growth factor</a>, <a href="cope.cgi?key=HCGF">HCGF</a>, <a href="cope.cgi?key=Hodgkin%27s%20cell%20growth%20factor">Hodgkin's cell growth factor</a>, <a href="cope.cgi?key=IgE%2dEF">IgE-EF</a>, <a href="cope.cgi?key=IgE%20enhancing%20factor">IgE enhancing factor</a>, <a href="cope.cgi?key=IgG1%2denhancing%20factor">IgG1-enhancing factor</a>, <a href="cope.cgi?key=IgG1%2dinduction%20factor">IgG1-induction factor</a>, <a href="cope.cgi?key=LMW%2dBCGF">LMW-BCGF</a>, <a href="cope.cgi?key=Low%20molecular%20weight%20B%2dcell%20growth%20factor">low molecular weight B-cell growth factor</a>, <a href="cope.cgi?key=MaGEF">MaGEF</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20enhancing%20factor">Mast cell growth enhancing factor</a>, <a href="cope.cgi?key=MCGF%2d2">MCGF-2</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20factor%2d2">mast cell growth factor-2</a>, <a href="cope.cgi?key=MFF">MFF</a>, <a href="cope.cgi?key=Macrophage%20fusion%20factor">macrophage fusion factor</a>, <a href="cope.cgi?key=Pitrakinra">Pitrakinra</a>, <a href="cope.cgi?key=TCGF%2d2">TCGF-2</a>, <a href="cope.cgi?key=T%2dcell%20growth%20factor%2d2">T-cell growth factor-2</a>) (Lidstrom et al, 2003; Buttner et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL4">IL4</a> </b>(<a href="cope.cgi?key=Interleukin%2d4">Interleukin-4</a>, <a href="cope.cgi?key=BCDF%2depsilon">BCDF-epsilon</a>, <a href="cope.cgi?key=B%2dcell%20differentiation%20factor%2depsilon">B-cell differentiation factor-epsilon</a>, <a href="cope.cgi?key=BCDF%2dgamma">BCDF-gamma</a>, <a href="cope.cgi?key=B%2dcell%20differentiation%20factor%2dgamma">B-cell differentiation factor-gamma</a>, <a href="cope.cgi?key=BCGF%2dgamma">BCGF-gamma</a>, <a href="cope.cgi?key=B%2dcell%20growth%20factor%2dgamma">B-cell growth factor-gamma</a>, <a href="cope.cgi?key=BCGF%2d1">BCGF-1</a>, <a href="cope.cgi?key=B%2dcell%20growth%20factor%2d1">B-cell growth factor-1</a>, <a href="cope.cgi?key=Binetrakin">Binetrakin</a>, <a href="cope.cgi?key=BSF%2d1">BSF-1</a>, <a href="cope.cgi?key=B%2dcell%20stimulating%20factor%2d1">B-cell stimulating factor-1</a>, <a href="cope.cgi?key=BSF%2dp1">BSF-p1</a>, <a href="cope.cgi?key=B%2dcell%20stimulating%20factor%20p1">B-cell stimulating factor p1</a>, <a href="cope.cgi?key=EL4%2dBCGF">EL4-BCGF</a>, <a href="cope.cgi?key=EL4%20B%2dcell%20growth%20factor">EL4 B-cell growth factor</a>, <a href="cope.cgi?key=HCGF">HCGF</a>, <a href="cope.cgi?key=Hodgkin%27s%20cell%20growth%20factor">Hodgkin's cell growth factor</a>, <a href="cope.cgi?key=IgE%2dEF">IgE-EF</a>, <a href="cope.cgi?key=IgE%20enhancing%20factor">IgE enhancing factor</a>, <a href="cope.cgi?key=IgG1%2denhancing%20factor">IgG1-enhancing factor</a>, <a href="cope.cgi?key=IgG1%2dinduction%20factor">IgG1-induction factor</a>, <a href="cope.cgi?key=LMW%2dBCGF">LMW-BCGF</a>, <a href="cope.cgi?key=Low%20molecular%20weight%20B%2dcell%20growth%20factor">low molecular weight B-cell growth factor</a>, <a href="cope.cgi?key=MaGEF">MaGEF</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20enhancing%20factor">Mast cell growth enhancing factor</a>, <a href="cope.cgi?key=MCGF%2d2">MCGF-2</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20factor%2d2">mast cell growth factor-2</a>, <a href="cope.cgi?key=MFF">MFF</a>, <a href="cope.cgi?key=Macrophage%20fusion%20factor">macrophage fusion factor</a>, <a href="cope.cgi?key=Pitrakinra">Pitrakinra</a>, <a href="cope.cgi?key=TCGF%2d2">TCGF-2</a>, <a href="cope.cgi?key=T%2dcell%20growth%20factor%2d2">T-cell growth factor-2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL4RA">IL4RA</a>, <a href="cope.cgi?key=IL4R%2dalpha">IL4R-alpha</a>, <a href="cope.cgi?key=interleukin%2d4%20receptor%2dalpha">interleukin-4 receptor-alpha</a>, <a href="cope.cgi?key=IL4R">IL4R</a>, <a href="cope.cgi?key=interleukin%2d4%20receptor">interleukin-4 receptor</a>, <a href="cope.cgi?key=CD124">CD124</a>) (Greaves et al, 2001; Mottonen et al, 2002; Zlotnik et al, 1987; Orlofsky et al, 1994; Yamamoto et al, 1997; Major et al, 2002; Wynes and Riches, 2003; Neale and Athanasou, 1999; Yang et al, 2009; Kurowska-Stolarska M et al, 2009; Gratchev A et al, 2005; Ogawa H et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL6">IL6</a></b> (<a href="cope.cgi?key=Interleukin%2d6">interleukin-6</a>, <a href="cope.cgi?key=26%20kDa%20protein">26 kDa protein</a>, <a href="cope.cgi?key=BSF%2d2">BSF-2</a>, <a href="cope.cgi?key=B%2dcell%20stimulating%20factor%2d2">B-cell stimulating factor-2</a>, <a href="cope.cgi?key=CDF">CDF</a>, <a href="cope.cgi?key=CAT%20development%20factor">CAT development factor</a>, <a href="cope.cgi?key=Choline%20acetyltransferase%20development%20factor">choline acetyltransferase development factor</a>, <a href="cope.cgi?key=cytolytic%20differentiation%20factor%20for%20T%2dlymphocytes">Cytolytic differentiation factor for T-lymphocytes</a>, <a href="cope.cgi?key=FDGI">FDGI</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20growth%20inhibitor">fibroblast-derived growth inhibitor</a>, <a href="cope.cgi?key=Hybridoma%20growth%20factor">hybridoma growth factor</a>, <a href="cope.cgi?key=HPGF">HPGF</a>, <a href="cope.cgi?key=Hybridoma%2fplasmacytoma%20growth%20factor">hybridoma/plasmacytoma growth factor</a>, <a href="cope.cgi?key=HSF">HSF</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor">hepatocyte stimulating factor</a>, <a href="cope.cgi?key=HSF%2d1">HSF-1</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor%2d1">hepatocyte stimulating factor-1</a>, <a href="cope.cgi?key=ILHP1">ILHP1</a>, <a href="cope.cgi?key=Interleukin%2dhemopoietin%2d1">Interleukin-hemopoietin-1</a>, <a href="cope.cgi?key=MGI%2d2A">MGI-2A</a>, <a href="cope.cgi?key=Macrophage%2dgranulocyte%20inducer%2d2A">Macrophage-granulocyte inducer-2A</a>, <a href="cope.cgi?key=Myeloma%20GF">Myeloma GF</a>, <a href="cope.cgi?key=Myeloma%20growth%20factor">myeloma growth factor</a>, <a href="cope.cgi?key=NKAF">NKAF</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20activating%20factor">natural killer cell activating factor</a>, <a href="cope.cgi?key=TAF">TAF</a>, <a href="cope.cgi?key=T%2dcell%20activating%20factor">T-cell activating factor</a>, <a href="cope.cgi?key=Thymocyte%20growth%20factor">Thymocyte growth factor</a>, <a href="cope.cgi?key=TSF">TSF</a>, <a href="cope.cgi?key=Thymocyte%20stimulating%20factor">thymocyte stimulating factor</a>) (Fayyazi et al, 1999; Katakura et al, 2004; Hanley et al, 2004; Yamamoto et al, 1996, 1997; Khaldoyanidi et al, 1999; Van den Heuvel et al, 1999; Pruimboom et al, 1994; Sethi and Sodhi, 2004; Kamdar et al, 1997; Mathy et al, 2000; Kent et al, 2008; Lavric et al, 2008; Park et al, 2005; Mkel et al, 2009; Li et al, 2009; Song et al, 2009; Peng et al, 2007; Bai T et al, 2010; Gleissner et al, 2010; Kim SY et al, 2010; Kim DK et al, 2009; Lee GT et al, 2010; Martinez FO et al, 2006; Ogawa H et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL6">IL6</a></b> (<a href="cope.cgi?key=Interleukin%2d6">interleukin-6</a>, <a href="cope.cgi?key=26%20kDa%20protein">26 kDa protein</a>, <a href="cope.cgi?key=BSF%2d2">BSF-2</a>, <a href="cope.cgi?key=B%2dcell%20stimulating%20factor%2d2">B-cell stimulating factor-2</a>, <a href="cope.cgi?key=CDF">CDF</a>, <a href="cope.cgi?key=CAT%20development%20factor">CAT development factor</a>, <a href="cope.cgi?key=Choline%20acetyltransferase%20development%20factor">choline acetyltransferase development factor</a>, <a href="cope.cgi?key=cytolytic%20differentiation%20factor%20for%20T%2dlymphocytes">Cytolytic differentiation factor for T-lymphocytes</a>, <a href="cope.cgi?key=FDGI">FDGI</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20growth%20inhibitor">fibroblast-derived growth inhibitor</a>, <a href="cope.cgi?key=Hybridoma%20growth%20factor">hybridoma growth factor</a>, <a href="cope.cgi?key=HPGF">HPGF</a>, <a href="cope.cgi?key=Hybridoma%2fplasmacytoma%20growth%20factor">hybridoma/plasmacytoma growth factor</a>, <a href="cope.cgi?key=HSF">HSF</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor">hepatocyte stimulating factor</a>, <a href="cope.cgi?key=HSF%2d1">HSF-1</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor%2d1">hepatocyte stimulating factor-1</a>, <a href="cope.cgi?key=ILHP1">ILHP1</a>, <a href="cope.cgi?key=Interleukin%2dhemopoietin%2d1">Interleukin-hemopoietin-1</a>, <a href="cope.cgi?key=MGI%2d2A">MGI-2A</a>, <a href="cope.cgi?key=Macrophage%2dgranulocyte%20inducer%2d2A">Macrophage-granulocyte inducer-2A</a>, <a href="cope.cgi?key=Myeloma%20GF">Myeloma GF</a>, <a href="cope.cgi?key=Myeloma%20growth%20factor">myeloma growth factor</a>, <a href="cope.cgi?key=NKAF">NKAF</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20activating%20factor">natural killer cell activating factor</a>, <a href="cope.cgi?key=TAF">TAF</a>, <a href="cope.cgi?key=T%2dcell%20activating%20factor">T-cell activating factor</a>, <a href="cope.cgi?key=Thymocyte%20growth%20factor">Thymocyte growth factor</a>, <a href="cope.cgi?key=TSF">TSF</a>, <a href="cope.cgi?key=Thymocyte%20stimulating%20factor">thymocyte stimulating factor</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=IL6RA">IL6RA</a>, <a href="cope.cgi?key=IL6R%2dalpha">IL6R-alpha</a>, <a href="cope.cgi?key=IL6R">IL6R</a>, <a href="cope.cgi?key=interleukin%2d6%20receptor">interleukin-6 receptor</a>, <a href="cope.cgi?key=interleukin%2d6%20receptor%2dalpha">interleukin-6 receptor-alpha</a>, <a href="cope.cgi?key=CD126">CD126</a>, <a href="cope.cgi?key=IL6ST">IL6ST</a>, <a href="cope.cgi?key=IL6%20signal%20transducer">IL6 signal transducer</a>, <a href="cope.cgi?key=interleukin%2d6%20signal%20transducer">interleukin-6 signal transducer</a>, <a href="cope.cgi?key=IL6R%2dbeta">IL6R-beta</a>, <a href="cope.cgi?key=interleukin%2d6%20receptor%2dbeta">interleukin-6 receptor-beta</a>, <a href="cope.cgi?key=IL6RB">IL6RB</a>, <a href="cope.cgi?key=CDw130">CDw130</a>, <a href="cope.cgi?key=CD130">CD130</a>) (Coyne et al, 2001; Niemand et al, 2003; Neale and Athanasou, 1999; Ogawa H et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL7">IL7</a> </b>(<a href="cope.cgi?key=Interleukin%2d7">Interleukin-7</a>, <a href="cope.cgi?key=B%2dcell%20precursor%20growth%2dpromoting%20activity">B-cell precursor growth-promoting activity</a>, <a href="cope.cgi?key=Lpo%2d1">Lpo-1</a>, <a href="cope.cgi?key=Lymphopoietin%2d1">lymphopoietin-1</a>, <a href="cope.cgi?key=LP%2d1">LP-1</a>, <a href="cope.cgi?key=PBGF">PBGF</a>, <a href="cope.cgi?key=Pre%2dB%2dcell%20growth%20factor">Pre-B-cell growth factor</a>, <a href="cope.cgi?key=serum%20factor%20from%20patients%20with%20ulcerative%20colitis">serum factor from patients with ulcerative colitis</a>, <a href="cope.cgi?key=Thymocyte%20growth%20factor">Thymocyte growth factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL7R">IL7R</a>, <a href="cope.cgi?key=IL7RA">IL7RA</a>, <a href="cope.cgi?key=IL7R%2dalpha">IL7R-alpha</a>, <a href="cope.cgi?key=interleukin%2d7%20receptor">interleukin-7 receptor</a>, <a href="cope.cgi?key=interleukin%2d7%20receptor%2dalpha">interleukin-7 receptor-alpha</a>; <a href="cope.cgi?key=CD127">CD127</a>, <a href="cope.cgi?key=CDw127">CDw127</a>) (Tantawichien et al, 1996; Dubinett et al, 1993; Edwards JP et al, 2006; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL8">IL8</a></b> (<a href="cope.cgi?key=Interleukin%2d8">interleukin-8</a>, <a href="cope.cgi?key=SCYB8">SCYB8</a>, <a href="cope.cgi?key=3%2d10C">3-10C</a>, <a href="cope.cgi?key=9E3">9E3</a>, <a href="cope.cgi?key=ANAP">ANAP</a>, <a href="cope.cgi?key=anionic%20neutrophil%2dactivating%20peptide">anionic neutrophil-activating peptide</a>, <a href="cope.cgi?key=chemotaxin">Chemotaxin</a>, <a href="cope.cgi?key=CEF%2d4">CEF-4</a>, <a href="cope.cgi?key=CT%2fIL8">CT/IL8</a>, <a href="cope.cgi?key=CXCL8">CXCL8</a>, <a href="cope.cgi?key=CXC%20chemokine%20ligand%208">CXC chemokine ligand 8</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%208">chemokine (C-X-C motif) ligand 8</a>, <a href="cope.cgi?key=EDNAP">EDNAP</a>, <a href="cope.cgi?key=Endothelial%2dderived%20neutrophil%2dactivating%20peptide">endothelial-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=EMF%2d1">EMF-1</a>, <a href="cope.cgi?key=embryo%20fibroblast%20protein%201">embryo fibroblast protein 1</a>, <a href="cope.cgi?key=Emoctakin">Emoctakin</a>, <a href="cope.cgi?key=ENAP">ENAP</a>, <a href="cope.cgi?key=Endothelial%20cell%20neutrophil%2dactivating%20peptide">Endothelial cell neutrophil-activating peptide</a>, <a href="cope.cgi?key=FDNAP">FDNAP</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20neutrophil%2dactivating%20peptide">Fibroblast-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=FINAP">FINAP</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20neutrophil%2dactivating%20protein">fibroblast-derived neutrophil-activating protein</a>, <a href="cope.cgi?key=GCF">GCF</a>, <a href="cope.cgi?key=Granulocyte%20chemotactic%20factor">granulocyte chemotactic factor</a>, <a href="cope.cgi?key=GCP">GCP</a>, <a href="cope.cgi?key=Granulocyte%20chemotactic%20peptide">granulocyte chemotactic peptide</a>, <a href="cope.cgi?key=LAI">LAI</a>, <a href="cope.cgi?key=Leukocyte%20adhesion%20inhibitor">leukocyte adhesion inhibitor</a>, <a href="cope.cgi?key=LCF">LCF</a>, <a href="cope.cgi?key=Lymphocyte%20chemotactic%20factors">lymphocyte chemotactic factors</a>, <a href="cope.cgi?key=LDNAP">LDNAP</a>, <a href="cope.cgi?key=Leukocyte%2dderived%20neutrophil%2dactivating%20peptide">leukocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=Leukocyte%20inhibitory%20factor">leukocyte inhibitory factor</a>, <a href="cope.cgi?key=LUCT">LUCT</a>, <a href="cope.cgi?key=Lung%20carcinoma%2dderived%20chemotaxin">lung carcinoma-derived chemotaxin</a>, <a href="cope.cgi?key=LYNAP">LYNAP</a>, <a href="cope.cgi?key=Lymphocyte%2dderived%20neutrophil%2dactivating%20peptide">lymphocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=MDNAP">MDNAP</a>, <a href="cope.cgi?key=Monocyte%2dderived%20neutrophil%2dactivating%20peptide">monocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=MDNCF">MDNCF</a>, <a href="cope.cgi?key=Monocyte%2dderived%20neutrophil%20chemotactic%20factor">monocyte-derived neutrophil chemotactic factor</a>, <a href="cope.cgi?key=MOC">MOC</a>, <a href="cope.cgi?key=Monocyte%2dderived%20chemotaxin">monocyte-derived chemotaxin</a>, <a href="cope.cgi?key=MONAP">MONAP</a>, <a href="cope.cgi?key=Monocyte%2dderived%20neutrophil%2dactivating%20peptide">monocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=NAF">NAF</a>, <a href="cope.cgi?key=Neutrophil%2dactivating%20factor">neutrophil-activating factor</a>, <a href="cope.cgi?key=NAP%2d1">NAP-1</a>, <a href="cope.cgi?key=Neutrophil%2dactivating%20protein%2d1">neutrophil-activating protein-1</a>, <a href="cope.cgi?key=NCF">NCF</a>, <a href="cope.cgi?key=Neutrophil%20chemotactic%20factor">neutrophil chemotactic factor</a>, <a href="cope.cgi?key=NCP">NCP</a>, <a href="cope.cgi?key=Neutrophil%20chemotactic%20protein">neutrophil chemotactic protein</a>, <a href="cope.cgi?key=PLF">PLF</a>, <a href="cope.cgi?key=Psoriatic%20leukotactic%20factor">psoriatic leukotactic factor</a>, <a href="cope.cgi?key=TCF">TCF</a>, <a href="cope.cgi?key=T%2dcell%20chemotactic%20factor">T-cell chemotactic factor</a>, <a href="cope.cgi?key=TSG%2d1">TSG-1</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%2dstimulated%20gene%20sequence%2d1">Tumor necrosis factor-stimulated gene sequence-1</a>) (Moreno-Altamirano et al, 2004; Fadok et al, 1998; Matsuyama et al, 2004; Veckman et al, 2003; Goodman et al, 1998; Chen and Wang, 2002; Matikainen et al, 2000; Goodman et al, 1998; McKee et al, 1996; Ragno et al, 2001; Ciesielski et al, 2002; Kent et al, 2008; Jeannin et al, 2003; Sylvester et al, 1990; Fischer et al, 2007; Kim et al, 1998; Li et al, 2009; Song et al, 2009; Dahl TB et al, 2007; Curat <a href="cope.cgi?key=CA">CA</a> et al, 2006; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL8">IL8</a></b> (<a href="cope.cgi?key=Interleukin%2d8">interleukin-8</a>, <a href="cope.cgi?key=SCYB8">SCYB8</a>, <a href="cope.cgi?key=3%2d10C">3-10C</a>, <a href="cope.cgi?key=9E3">9E3</a>, <a href="cope.cgi?key=ANAP">ANAP</a>, <a href="cope.cgi?key=anionic%20neutrophil%2dactivating%20peptide">anionic neutrophil-activating peptide</a>, <a href="cope.cgi?key=chemotaxin">Chemotaxin</a>, <a href="cope.cgi?key=CEF%2d4">CEF-4</a>, <a href="cope.cgi?key=CT%2fIL8">CT/IL8</a>, <a href="cope.cgi?key=CXCL8">CXCL8</a>, <a href="cope.cgi?key=CXC%20chemokine%20ligand%208">CXC chemokine ligand 8</a>, <a href="cope.cgi?key=chemokine%20%28C%2dX%2dC%20motif%29%20ligand%208">chemokine (C-X-C motif) ligand 8</a>, <a href="cope.cgi?key=EDNAP">EDNAP</a>, <a href="cope.cgi?key=Endothelial%2dderived%20neutrophil%2dactivating%20peptide">endothelial-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=EMF%2d1">EMF-1</a>, <a href="cope.cgi?key=embryo%20fibroblast%20protein%201">embryo fibroblast protein 1</a>, <a href="cope.cgi?key=Emoctakin">Emoctakin</a>, <a href="cope.cgi?key=ENAP">ENAP</a>, <a href="cope.cgi?key=Endothelial%20cell%20neutrophil%2dactivating%20peptide">Endothelial cell neutrophil-activating peptide</a>, <a href="cope.cgi?key=FDNAP">FDNAP</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20neutrophil%2dactivating%20peptide">Fibroblast-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=FINAP">FINAP</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20neutrophil%2dactivating%20protein">fibroblast-derived neutrophil-activating protein</a>, <a href="cope.cgi?key=GCF">GCF</a>, <a href="cope.cgi?key=Granulocyte%20chemotactic%20factor">granulocyte chemotactic factor</a>, <a href="cope.cgi?key=GCP">GCP</a>, <a href="cope.cgi?key=Granulocyte%20chemotactic%20peptide">granulocyte chemotactic peptide</a>, <a href="cope.cgi?key=LAI">LAI</a>, <a href="cope.cgi?key=Leukocyte%20adhesion%20inhibitor">leukocyte adhesion inhibitor</a>, <a href="cope.cgi?key=LCF">LCF</a>, <a href="cope.cgi?key=Lymphocyte%20chemotactic%20factors">lymphocyte chemotactic factors</a>, <a href="cope.cgi?key=LDNAP">LDNAP</a>, <a href="cope.cgi?key=Leukocyte%2dderived%20neutrophil%2dactivating%20peptide">leukocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=Leukocyte%20inhibitory%20factor">leukocyte inhibitory factor</a>, <a href="cope.cgi?key=LUCT">LUCT</a>, <a href="cope.cgi?key=Lung%20carcinoma%2dderived%20chemotaxin">lung carcinoma-derived chemotaxin</a>, <a href="cope.cgi?key=LYNAP">LYNAP</a>, <a href="cope.cgi?key=Lymphocyte%2dderived%20neutrophil%2dactivating%20peptide">lymphocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=MDNAP">MDNAP</a>, <a href="cope.cgi?key=Monocyte%2dderived%20neutrophil%2dactivating%20peptide">monocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=MDNCF">MDNCF</a>, <a href="cope.cgi?key=Monocyte%2dderived%20neutrophil%20chemotactic%20factor">monocyte-derived neutrophil chemotactic factor</a>, <a href="cope.cgi?key=MOC">MOC</a>, <a href="cope.cgi?key=Monocyte%2dderived%20chemotaxin">monocyte-derived chemotaxin</a>, <a href="cope.cgi?key=MONAP">MONAP</a>, <a href="cope.cgi?key=Monocyte%2dderived%20neutrophil%2dactivating%20peptide">monocyte-derived neutrophil-activating peptide</a>, <a href="cope.cgi?key=NAF">NAF</a>, <a href="cope.cgi?key=Neutrophil%2dactivating%20factor">neutrophil-activating factor</a>, <a href="cope.cgi?key=NAP%2d1">NAP-1</a>, <a href="cope.cgi?key=Neutrophil%2dactivating%20protein%2d1">neutrophil-activating protein-1</a>, <a href="cope.cgi?key=NCF">NCF</a>, <a href="cope.cgi?key=Neutrophil%20chemotactic%20factor">neutrophil chemotactic factor</a>, <a href="cope.cgi?key=NCP">NCP</a>, <a href="cope.cgi?key=Neutrophil%20chemotactic%20protein">neutrophil chemotactic protein</a>, <a href="cope.cgi?key=PLF">PLF</a>, <a href="cope.cgi?key=Psoriatic%20leukotactic%20factor">psoriatic leukotactic factor</a>, <a href="cope.cgi?key=TCF">TCF</a>, <a href="cope.cgi?key=T%2dcell%20chemotactic%20factor">T-cell chemotactic factor</a>, <a href="cope.cgi?key=TSG%2d1">TSG-1</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%2dstimulated%20gene%20sequence%2d1">Tumor necrosis factor-stimulated gene sequence-1</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=IL8RA">IL8RA</a>, <a href="cope.cgi?key=IL8R%2dalpha">IL8R-alpha</a>, <a href="cope.cgi?key=interleukin%2d8%20receptor%2dalpha">interleukin-8 receptor-alpha</a>; <a href="cope.cgi?key=interleukin%2d8%20receptor%20type%20A">interleukin-8 receptor type A</a>, <a href="cope.cgi?key=IL8R1">IL8R1</a>, <a href="cope.cgi?key=IL8%20receptor%2d1">IL8 receptor-1</a>, <a href="cope.cgi?key=interleukin%2d8%20receptor%20type%201">interleukin-8 receptor type 1</a>, <a href="cope.cgi?key=CMKAR1">CMKAR1</a>, <a href="cope.cgi?key=chemokine%2dalpha%20receptor%201">chemokine-alpha receptor 1</a>, <a href="cope.cgi?key=CXCR1">CXCR1</a>, <a href="cope.cgi?key=CD181">CD181</a>, <a href="cope.cgi?key=IL8RB">IL8RB</a>, <a href="cope.cgi?key=IL8R%2dbeta">IL8R-beta</a>, <a href="cope.cgi?key=interleukin%2d8%20receptor%2dbeta">interleukin-8 receptor-beta</a>; <a href="cope.cgi?key=interleukin%2d8%20receptor%20type%20B">interleukin-8 receptor type B</a>, <a href="cope.cgi?key=IL8R2">IL8R2</a>, <a href="cope.cgi?key=IL8%20receptor%2d2">IL8 receptor-2</a>, <a href="cope.cgi?key=interleukin%2d8%20receptor%20type%202">interleukin-8 receptor type 2</a>, <a href="cope.cgi?key=CMKAR2">CMKAR2</a>, <a href="cope.cgi?key=chemokine%2dalpha%20receptor%202">chemokine-alpha receptor 2</a>, <a href="cope.cgi?key=CXCR2">CXCR2</a>, <a href="cope.cgi?key=CD182">CD182</a>) (Patterson et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL10">IL10</a></b> (<a href="cope.cgi?key=Interleukin%2d10">interleukin-10</a>, <a href="cope.cgi?key=B%2dTCGF">B-TCGF</a>, <a href="cope.cgi?key=B%2dcell%20derived%20T%2dcell%20growth%20factor">B-cell derived T-cell growth factor</a>, <a href="cope.cgi?key=CSIF">CSIF</a>, <a href="cope.cgi?key=Cytokine%20synthesis%20inhibitory%20factor">cytokine synthesis inhibitory factor</a>, <a href="cope.cgi?key=TGIF">TGIF</a>, <a href="cope.cgi?key=T%2dcell%20growth%20inhibitory%20factor">T-cell growth inhibitory factor</a>) (Boehringer et al, 1999; Cao et al, 2002; Dugas et al, 1996; Fadok et al, 1998; Foey et al, 2001; Mottonen et al, 2002; Katakura et al, 2004; Xu et al, 2001; Ajuebor et al, 1999; Isler et al, 1999; Lidstrom et al, 2003; Lucas et al, 2003; John et al, 1998; Sodhi and Tripathi, 2008; Kent et al, 2008; Ferlazzo et al, 2003; Moreira et al, 2008; Song et al, 2009; Peng et al, 2007; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL10">IL10</a></b> (<a href="cope.cgi?key=Interleukin%2d10">interleukin-10</a>, <a href="cope.cgi?key=B%2dTCGF">B-TCGF</a>, <a href="cope.cgi?key=B%2dcell%20derived%20T%2dcell%20growth%20factor">B-cell derived T-cell growth factor</a>, <a href="cope.cgi?key=CSIF">CSIF</a>, <a href="cope.cgi?key=Cytokine%20synthesis%20inhibitory%20factor">cytokine synthesis inhibitory factor</a>, <a href="cope.cgi?key=TGIF">TGIF</a>, <a href="cope.cgi?key=T%2dcell%20growth%20inhibitory%20factor">T-cell growth inhibitory factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL10R">IL10R</a>, <a href="cope.cgi?key=IL10R1">IL10R1</a>, <a href="cope.cgi?key=IL10RA">IL10RA</a>, <a href="cope.cgi?key=IL10%20receptor%2dalpha">IL10 receptor-alpha</a>, <a href="cope.cgi?key=IL10R%2dalpha">IL10R-alpha</a>, <a href="cope.cgi?key=interleukin%2d10%20receptor%2dalpha">interleukin-10 receptor-alpha</a>; <a href="cope.cgi?key=interleukin%2d10%20receptor">interleukin-10 receptor</a>, <a href="cope.cgi?key=CD210">CD210</a>, <a href="cope.cgi?key=CD210a">CD210a</a>, <a href="cope.cgi?key=CDw210a">CDw210a</a>; <a href="cope.cgi?key=IL10R2">IL10R2</a>, <a href="cope.cgi?key=IL10RB">IL10RB</a>, <a href="cope.cgi?key=IL10R%2dbeta">IL10R-beta</a>, <a href="cope.cgi?key=IL10%20receptor%2dbeta">IL10 receptor-beta</a>, <a href="cope.cgi?key=interleukin%2d10%20receptor%2dbeta">interleukin-10 receptor-beta</a>, <a href="cope.cgi?key=CRF2%2d4">CRF2-4</a>, <a href="cope.cgi?key=cytokine%20receptor%20family%202%20member%204">cytokine receptor family 2 member 4</a>, <a href="cope.cgi?key=CRFB4">CRFB4</a>; <a href="cope.cgi?key=CDw210b">CDw210b</a>) (Fiorentino et al, 1991; Horton et al, 1998; Flesch et al, 1998; Ancuta et al, 2001; Kim et al, 1999; Torres et al, 2001; Stumpo et al, 2003; Niemand et al, 2003; Schuetze N et al, 2005; Berlato et al, 2002; Gu et al, 2008; Mkel et al, 2009; Chang GW et al, 2007, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL11">IL11</a> </b>(<a href="cope.cgi?key=Interleukin%2d11">Interleukin-11</a>, <a href="cope.cgi?key=AGIF">AGIF</a>, <a href="cope.cgi?key=Adipogenesis%20inhibitory%20factor">adipogenesis inhibitory factor</a>, <a href="cope.cgi?key=HPAEC%20survival%20factor">HPAEC survival factor</a>, <a href="cope.cgi?key=human%20pulmonary%20artery%20endothelial%20cell%2dderived%20survival%20factor">human pulmonary artery endothelial cell-derived survival factor</a>, <a href="cope.cgi?key=Megakaryocyte%20colony%20stimulating%20factor">Megakaryocyte colony stimulating factor</a>, <a href="cope.cgi?key=Plasmacytoma%20stimulatory%20activity">Plasmacytoma stimulatory activity</a>, <a href="cope.cgi?key=Oprelvekin">Oprelvekin</a>, <a href="cope.cgi?key=Neumega">Neumega</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL11RA">IL11RA</a>, <a href="cope.cgi?key=interleukin%2d11%20receptor%2dalpha">interleukin-11 receptor-alpha</a>, <a href="cope.cgi?key=IL11R%2dalpha">IL11R-alpha</a>, <a href="cope.cgi?key=IL11RA1">IL11RA1</a>, <a href="cope.cgi?key=interleukin%2d11%20receptor%2dalpha%2d1">interleukin-11 receptor-alpha-1</a>, <a href="cope.cgi?key=Etl2">Etl2</a>, <a href="cope.cgi?key=Enhancer%20trap%20locus%202">enhancer trap locus 2</a>, <a href="cope.cgi?key=Nr1">Nr1</a>; <a href="cope.cgi?key=IL6ST">IL6ST</a>, <a href="cope.cgi?key=IL6%20signal%20transducer">IL6 signal transducer</a>, <a href="cope.cgi?key=interleukin%2d6%20signal%20transducer">interleukin-6 signal transducer</a>, <a href="cope.cgi?key=IL6R%2dbeta">IL6R-beta</a>, <a href="cope.cgi?key=IL6RB">IL6RB</a>, <a href="cope.cgi?key=CDw130">CDw130</a>, <a href="cope.cgi?key=CD130">CD130</a>) (Leng and Elias, 1997; Trepicchio et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL12">IL12</a></b> (<a href="cope.cgi?key=IL12A">IL12A</a>, <a href="cope.cgi?key=IL12%2dalpha">IL12-alpha</a> <a href="cope.cgi?key=IL12B">IL12B</a>, <a href="cope.cgi?key=IL12%2dbeta">IL12-beta</a>, <a href="cope.cgi?key=IL12%2dp35">IL12-p35</a>, <a href="cope.cgi?key=IL12%2dp40">IL12-p40</a>, <a href="cope.cgi?key=IL12%2dp70">IL12-p70</a>, <a href="cope.cgi?key=Interleukin%2d12">Interleukin-12</a>, <a href="cope.cgi?key=Interleukin%2d12A">Interleukin-12A</a>, <a href="cope.cgi?key=Interleukin%2d12B">Interleukin-12B</a>, <a href="cope.cgi?key=CLMF">CLMF</a>, <a href="cope.cgi?key=Cytotoxic%20lymphocyte%20maturation%20factor">cytotoxic lymphocyte maturation factor</a>, <a href="cope.cgi?key=NKSF">NKSF</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20stimulatory%20factor">natural killer cell stimulatory factor</a>, <a href="cope.cgi?key=NKSF1">NKSF1</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20stimulatory%20factor%2d1">natural killer cell stimulatory factor-1</a>, <a href="cope.cgi?key=NKSF2">NKSF2</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20stimulatory%20factor%2d2">natural killer cell stimulatory factor-2</a>, <a href="cope.cgi?key=TcMF">TcMF</a>, <a href="cope.cgi?key=CTL%20maturation%20factor">CTL maturation factor</a>, <a href="cope.cgi?key=TSF">TSF</a>, <a href="cope.cgi?key=T%2dcell%20stimulating%20factor">T-cell stimulating factor</a>) (Cao et al, 2002; Fernandez-Lago et al, 1999; Jiang and Dhib-Jalbut, 1998; Lawrence and Nauciel, 1998; Mottonen et al, 2002; Cappello et al, 2003; Hodge-Dufour 1997; Chen and Wang, 2002; Schuetze N et al, 2005; Xu et al, 2001; Fan et al, 1996; Isler et al, 1999; Sethi and Sodhi, 2004; Vabulas et al, 2003; Lucas et al, 2003; Aviles and Monroy, 2001; Mkel et al, 2009; Ferlazzo et al, 2003; Yawalkar et al, 2009; Ishida et al, 2008; Utsugi et al, 2009; Peng et al, 2007; Alam et al, 2010; Gleissner et al, 2010; Lifshitz et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL12%2dp40">IL12-p40</a></b> (<a href="cope.cgi?key=IL12B">IL12B</a>, <a href="cope.cgi?key=IL12%2dbeta">IL12-beta</a>, <a href="cope.cgi?key=Interleukin%2d12B">interleukin-12B</a>, <a href="cope.cgi?key=IL23%2dp40">IL23-p40</a>, <a href="cope.cgi?key=Interleukin%2d23%20p40">Interleukin-23 p40</a>) (Alleva et al, 2001; Bost and Clements, 2000; Fernandez-Lago et al, 1999; Mottonen et al, 2002; Sanjabi et al, 2000; Quesniaux et al, 2004; Luo et al, 2004; Li et al, 2001; Hasko et al, 2002; Sodhi and Tripathi, 2008; Goh F et al, 2009; Bai T et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL12">IL12</a></b> (<a href="cope.cgi?key=IL12A">IL12A</a>, <a href="cope.cgi?key=IL12%2dalpha">IL12-alpha</a> <a href="cope.cgi?key=IL12B">IL12B</a>, <a href="cope.cgi?key=IL12%2dbeta">IL12-beta</a>, <a href="cope.cgi?key=IL12%2dp35">IL12-p35</a>, <a href="cope.cgi?key=IL12%2dp40">IL12-p40</a>, <a href="cope.cgi?key=IL12%2dp70">IL12-p70</a>, <a href="cope.cgi?key=Interleukin%2d12">Interleukin-12</a>, <a href="cope.cgi?key=Interleukin%2d12A">Interleukin-12A</a>, <a href="cope.cgi?key=Interleukin%2d12B">Interleukin-12B</a>, <a href="cope.cgi?key=CLMF">CLMF</a>, <a href="cope.cgi?key=Cytotoxic%20lymphocyte%20maturation%20factor">cytotoxic lymphocyte maturation factor</a>, <a href="cope.cgi?key=NKSF">NKSF</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20stimulatory%20factor">natural killer cell stimulatory factor</a>, <a href="cope.cgi?key=NKSF1">NKSF1</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20stimulatory%20factor%2d1">natural killer cell stimulatory factor-1</a>, <a href="cope.cgi?key=NKSF2">NKSF2</a>, <a href="cope.cgi?key=Natural%20killer%20cell%20stimulatory%20factor%2d2">natural killer cell stimulatory factor-2</a>, <a href="cope.cgi?key=TcMF">TcMF</a>, <a href="cope.cgi?key=CTL%20maturation%20factor">CTL maturation factor</a>, <a href="cope.cgi?key=TSF">TSF</a>, <a href="cope.cgi?key=T%2dcell%20stimulating%20factor">T-cell stimulating factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL12RB1">IL12RB1</a>, <a href="cope.cgi?key=IL12R%2dbeta%2d1">IL12R-beta-1</a>; <a href="cope.cgi?key=interleukin%2d12%20receptor%2dbeta%2d1">interleukin-12 receptor-beta-1</a>, <a href="cope.cgi?key=IL12R">IL12R</a>, <a href="cope.cgi?key=interleukin%2d12%20receptor">interleukin-12 receptor</a>, <a href="cope.cgi?key=IL12RB">IL12RB</a>, <a href="cope.cgi?key=IL12R%2dbeta">IL12R-beta</a>, <a href="cope.cgi?key=interleukin%2d12%20receptor%2dbeta">interleukin-12 receptor-beta</a>, <a href="cope.cgi?key=CD212">CD212</a>; <a href="cope.cgi?key=IL12RB2">IL12RB2</a>, <a href="cope.cgi?key=interleukin%2d12%20receptor%2dbeta%2d2">interleukin-12 receptor-beta-2</a>; <a href="cope.cgi?key=IL12R%2dbeta%2d2">IL12R-beta-2</a>) (Munder et al, 1998; Puddu et al, 1997; Kito et al, 2003; Schindler et al, 2001; Darwich et al, 2009; Blum et al, 2008; Jana and Pahan, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL13">IL13</a> </b>(<a href="cope.cgi?key=Interleukin%2d13">Interleukin-13</a>, <a href="cope.cgi?key=NC30">NC30</a>, <a href="cope.cgi?key=P600">P600</a>)<b style="mso-bidi-font-weight:normal"> receptors</b> (<a href="cope.cgi?key=IL13RA1">IL13RA1</a>, <a href="cope.cgi?key=interleukin%2d13%20receptor%2dalpha%2d1">interleukin-13 receptor-alpha-1</a>, <a href="cope.cgi?key=IL13R%2dalpha%2d1">IL13R-alpha-1</a>, <a href="cope.cgi?key=IL13RA">IL13RA</a>, <a href="cope.cgi?key=NR4">NR4</a>, <a href="cope.cgi?key=CD213a1">CD213a1</a>) (Bogdan et al, 1997; Doherty et al, 1994; Flesch et al, 1998; Bailer et al, 2000; Mottonen et al, 2002; Rey et al, 1998, 1999; Greaves et al, 2001; Wynes and Riches, 2003; Maresz et al, 2008; Deepak et al, 2008; Gratchev A et al, 2008; Doyle et al, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL15">IL15</a> </b>(<a href="cope.cgi?key=Interleukin%2d15">Interleukin-15</a>, <a href="cope.cgi?key=IL%2dT">IL-T</a>, <a href="cope.cgi?key=Interleukin%20T">Interleukin T</a>) (Doherty et al, 1996; Mathy et al, 2000; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL15">IL15</a> </b>(<a href="cope.cgi?key=Interleukin%2d15">Interleukin-15</a>, <a href="cope.cgi?key=IL%2dT">IL-T</a>, <a href="cope.cgi?key=Interleukin%20T">Interleukin T</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL15RA">IL15RA</a>, <a href="cope.cgi?key=IL15R%2dalpha">IL15R-alpha</a>, <a href="cope.cgi?key=CD215">CD215</a>) (Liu et al, 2004; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL16">IL16</a> </b>(<a href="cope.cgi?key=Interleukin%2d16">Interleukin-16</a>, <a href="cope.cgi?key=Lymphocyte%20chemoattractant%20factor">Lymphocyte chemoattractant factor</a>, <a href="cope.cgi?key=LCF">LCF</a>) (Schwab et al, 2001; Jana and Pahan, 2009; Ghigo E et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL16">IL16</a> </b>(<a href="cope.cgi?key=Interleukin%2d16">Interleukin-16</a>, <a href="cope.cgi?key=Lymphocyte%20chemoattractant%20factor">Lymphocyte chemoattractant factor</a>, <a href="cope.cgi?key=LCF">LCF</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Krautwald, 1998; Truong et al, 1999; Mathy et al, 2000; Hermann et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL17">IL17</a> </b>(<a href="cope.cgi?key=Interleukin%2d17">Interleukin-17</a>, <a href="cope.cgi?key=IL17A">IL17A</a>, <a href="cope.cgi?key=Interleukin%2d17A">interleukin-17A</a>) (Gu et al, 2008; Song et al, 2008; Facco M et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL17">IL17</a> </b>(<a href="cope.cgi?key=Interleukin%2d17">Interleukin-17</a>, <a href="cope.cgi?key=IL17A">IL17A</a>, <a href="cope.cgi?key=Interleukin%2d17A">interleukin-17A</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL17RA">IL17RA</a>, <a href="cope.cgi?key=interleukin%2d17%20receptor%20A">interleukin-17 receptor A</a>, <a href="cope.cgi?key=IL17%20receptor%20A">IL17 receptor A</a>, <a href="cope.cgi?key=CD217">CD217</a>, <a href="cope.cgi?key=CDw217">CDw217</a>) (Jovanovic et al, 2000; Gratchev A et al, 2008; Nichols et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL17C">IL17C</a></b> (<a href="cope.cgi?key=Interleukin%2d17C">interleukin-17C</a>) (Yamaguchi et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL17RC">IL17RC</a></b> (<a href="cope.cgi?key=interleukin%2d17%20receptor%20C">interleukin-17 receptor C</a>; <a href="cope.cgi?key=IL17%20receptor%20C">IL17 receptor C</a>, <a href="cope.cgi?key=IL17RL">IL17RL</a>, <a href="cope.cgi?key=interleukin%2d17%20receptor%2dlike%20protein">interleukin-17 receptor-like protein</a>) (Nichols et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL18">IL18</a></b> (<a href="cope.cgi?key=Interleukin%2d18">interleukin-18</a>, <a href="cope.cgi?key=IGIF">IGIF</a>, <a href="cope.cgi?key=IFN%2dgamma%20inducing%20factor">IFN-gamma inducing factor</a>, <a href="cope.cgi?key=IL1%2dgamma">IL1-gamma</a>, <a href="cope.cgi?key=IL1F4">IL1F4</a>, <a href="cope.cgi?key=IL1%20family%20member%204">IL1 family member 4</a>, <a href="cope.cgi?key=Iboctadekin">Iboctadekin</a>) (Gerdes et al, 2002; Pirhonen et al, 2001; Tsutsui et al, 1999; Shimamura et al, 2004; Muneta et al, 1999; Kent et al, 2008; Rintahaka et al, 2008; Bellora F et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL18BP">IL18BP</a></b> (<a href="cope.cgi?key=IL18%20binding%20protein">IL18 binding protein</a>, <a href="cope.cgi?key=interleukin%2d18%20binding%20protein">interleukin-18 binding protein</a>, <a href="cope.cgi?key=IL18BPa">IL18BPa</a>, <a href="cope.cgi?key=IL18BPb">IL18BPb</a>, <a href="cope.cgi?key=IL18BPc">IL18BPc</a>, <a href="cope.cgi?key=IL18BPd">IL18BPd</a>, <a href="cope.cgi?key=IGIFBP">IGIFBP</a>, <a href="cope.cgi?key=IGIF%20binding%20protein">IGIF binding protein</a>, <a href="cope.cgi?key=IFN%2dgamma%20inducing%20factor%20binding%20protein">IFN-gamma inducing factor binding protein</a>, <a href="cope.cgi?key=Tadekinig%2dalpha">Tadekinig-alpha</a>) (Corbaz et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL18">IL18</a></b> (<a href="cope.cgi?key=Interleukin%2d18">interleukin-18</a>, <a href="cope.cgi?key=IGIF">IGIF</a>, <a href="cope.cgi?key=IFN%2dgamma%20inducing%20factor">IFN-gamma inducing factor</a>, <a href="cope.cgi?key=IL1%2dgamma">IL1-gamma</a>, <a href="cope.cgi?key=IL1F4">IL1F4</a>, <a href="cope.cgi?key=IL1%20family%20member%204">IL1 family member 4</a>, <a href="cope.cgi?key=Iboctadekin">Iboctadekin</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL18R1">IL18R1</a>, <a href="cope.cgi?key=interleukin%2d18%20receptor%2d1">interleukin-18 receptor-1</a>, <a href="cope.cgi?key=IL18R%2dalpha">IL18R-alpha</a>, <a href="cope.cgi?key=IL18RA">IL18RA</a>, <a href="cope.cgi?key=interleukin%2d18%20receptor%2dalpha">interleukin-18 receptor-alpha</a>, <a href="cope.cgi?key=IL1Rrp">IL1Rrp</a>, <a href="cope.cgi?key=IL1%20receptor%2drelated%20protein">IL1 receptor-related protein</a>, <a href="cope.cgi?key=IL1R5">IL1R5</a>, <a href="cope.cgi?key=Interleukin%2d1%20receptor%205">Interleukin-1 receptor 5</a>, <a href="cope.cgi?key=IL1%20receptor%20R5">IL1 receptor R5</a>, <a href="cope.cgi?key=CD218a">CD218a</a>, <a href="cope.cgi?key=CDw218a">CDw218a</a>) (Gerdes et al, 2002; Munder et al, 1998; Kito et al, 2003; Schindler et al, 2001; Darwich et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL19">IL19</a></b> (<a href="cope.cgi?key=Interleukin%2d19">interleukin-19</a>, <a href="cope.cgi?key=IL10C">IL10C</a>, <a href="cope.cgi?key=MDA1">MDA1</a>, <a href="cope.cgi?key=ZMDA1">ZMDA1</a>, <a href="cope.cgi?key=melanoma%20differentiation%20antigen%2d1">melanoma differentiation antigen-1</a>, <a href="cope.cgi?key=melanoma%20differentiation%20associated%20protein%2dlike%20protein">melanoma differentiation associated protein-like protein</a>) (Sakurai et al, 2008; Alanr T et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL20">IL20</a></b> (<a href="cope.cgi?key=Interleukin%2d20">interleukin-20</a>, <a href="cope.cgi?key=Zcyto10">Zcyto10</a>; <a href="cope.cgi?key=IL10D">IL10D</a>, <a href="cope.cgi?key=Interleukin%2d10D">interleukin-10D</a>) (Hosoi et al, 2004; Alanr T et al, 2010; Hsing et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL21">IL21</a></b> (<a href="cope.cgi?key=Interleukin%2d21">interleukin-21</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL21R">IL21R</a>, <a href="cope.cgi?key=IL21R%2dalpha">IL21R-alpha</a>, <a href="cope.cgi?key=IL21RA">IL21RA</a>, <a href="cope.cgi?key=IL21%20receptor%2dalpha">IL21 receptor-alpha</a>, <a href="cope.cgi?key=interleukin%2d21%20receptor">interleukin-21 receptor</a>, <a href="cope.cgi?key=interleukin%2d21%20receptor%2dalpha">interleukin-21 receptor-alpha</a>, <a href="cope.cgi?key=NILR">NILR</a>, <a href="cope.cgi?key=novel%20interleukin%20receptor">novel interleukin receptor</a>, <a href="cope.cgi?key=CD360">CD360</a>) (Jungel et al, 2004; Rckert et al, 2008; Pelletier et al, 2004; Pesce J et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL22">IL22</a> </b>(<a href="cope.cgi?key=Interleukin%2d22">Interleukin-22</a>, <a href="cope.cgi?key=IL%2dTIF">IL-TIF</a>, <a href="cope.cgi?key=IL10%2drelated%20T%2dcell%20derived%20inducible%20factor">IL10-related T-cell derived inducible factor</a>) (Gu et al, 2008; Alanr T et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL23">IL23</a> </b>(<a href="cope.cgi?key=Interleukin%2d23">interleukin-23</a>, <a href="cope.cgi?key=IL12B">IL12B</a>, <a href="cope.cgi?key=IL12%2dp40">IL12-p40</a>, <a href="cope.cgi?key=IL23%2dp40">IL23-p40</a>, <a href="cope.cgi?key=p19">p19</a>, <a href="cope.cgi?key=IL23%2dp19">IL23-p19</a>, <a href="cope.cgi?key=IL23A">IL23A</a>, <a href="cope.cgi?key=SGRF">SGRF</a>, <a href="cope.cgi?key=IL6%20G%2dCSF%20related%20factor">IL6 G-CSF related factor</a>) (Pirhonen et al, 2002; Yang et al, 2006; Al-Salleeh and Petro, 2008; Yawalkar et al, 2009; Mizutani et al, 2007; Shime et al, 2008; Delay et al, 2009; Schuetze N et al, 2005; Palma et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL23">IL23</a> </b>(<a href="cope.cgi?key=Interleukin%2d23">interleukin-23</a>, <a href="cope.cgi?key=IL12B">IL12B</a>, <a href="cope.cgi?key=IL12%2dp40">IL12-p40</a>, <a href="cope.cgi?key=IL23%2dp40">IL23-p40</a>, <a href="cope.cgi?key=p19">p19</a>, <a href="cope.cgi?key=IL23%2dp19">IL23-p19</a>, <a href="cope.cgi?key=IL23A">IL23A</a>, <a href="cope.cgi?key=SGRF">SGRF</a>, <a href="cope.cgi?key=IL6%20G%2dCSF%20related%20factor">IL6 G-CSF related factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL23R">IL23R</a>, <a href="cope.cgi?key=interleukin%2d23%20receptor">interleukin-23 receptor</a>) (Li et al, 2003; Blum et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL24">IL24</a></b> (<a href="cope.cgi?key=Interleukin%2d24">interleukin-24</a>, <a href="cope.cgi?key=ST16">ST16</a>, <a href="cope.cgi?key=suppression%20of%20tumorigenicity%2d16">suppression of tumorigenicity-16</a>, <a href="cope.cgi?key=MDA%2d7">MDA-7</a>, <a href="cope.cgi?key=melanoma%20differentiation%2dassociated%20gene%207">melanoma differentiation-associated gene 7</a>, <a href="cope.cgi?key=mob%2d5">mob-5</a>, <a href="cope.cgi?key=C49a">C49a</a>, <a href="cope.cgi?key=FISP">FISP</a>, <a href="cope.cgi?key=IL4%20induced%20secreted%20protein">IL4 induced secreted protein</a>) (Garn et al, 2002; Poindexter et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL27">IL27</a> </b>(<a href="cope.cgi?key=Interleukin%2d27">interleukin-27</a>, <a href="cope.cgi?key=EBI%2d3">EBI-3</a>, <a href="cope.cgi?key=EBV%20induced%20gene%2d3">EBV induced gene-3</a>, <a href="cope.cgi?key=IL27A">IL27A</a>, <a href="cope.cgi?key=IL27%2dalpha">IL27-alpha</a>, <a href="cope.cgi?key=interleukin%2d27%2dalpha">interleukin-27-alpha</a>, <a href="cope.cgi?key=IL27B">IL27B</a>; <a href="cope.cgi?key=IL27%2dbeta">IL27-beta</a>, <a href="cope.cgi?key=interleukin%2d27%2dbeta">interleukin-27-beta</a>, <a href="cope.cgi?key=p28">p28</a>, <a href="cope.cgi?key=IL27p28">IL27p28</a>, <a href="cope.cgi?key=IL30">IL30</a>, <a href="cope.cgi?key=Interleukin%2d30">interleukin-30</a>) (Larousserie F et al, 2004; Pirhonen J et al, 2007; Schuetze N et al, 2005; Hause L et al, 2007; Nelson DA et al, 2010; Robinson and Nau, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=IL27">IL27</a> </b>(<a href="cope.cgi?key=Interleukin%2d27">interleukin-27</a>, <a href="cope.cgi?key=EBI%2d3">EBI-3</a>, <a href="cope.cgi?key=EBV%20induced%20gene%2d3">EBV induced gene-3</a>, <a href="cope.cgi?key=IL27A">IL27A</a>, <a href="cope.cgi?key=IL27%2dalpha">IL27-alpha</a>, <a href="cope.cgi?key=interleukin%2d27%2dalpha">interleukin-27-alpha</a>, <a href="cope.cgi?key=IL27B">IL27B</a>; <a href="cope.cgi?key=IL27%2dbeta">IL27-beta</a>, <a href="cope.cgi?key=interleukin%2d27%2dbeta">interleukin-27-beta</a>, <a href="cope.cgi?key=p28">p28</a>, <a href="cope.cgi?key=IL27p28">IL27p28</a>, <a href="cope.cgi?key=IL30">IL30</a>, <a href="cope.cgi?key=Interleukin%2d30">interleukin-30</a>) <b style="mso-bidi-font-weight:normal">receptors </b>(<a href="cope.cgi?key=IL27RA">IL27RA</a>, <a href="cope.cgi?key=IL27%20receptor%2dalpha">IL27 receptor-alpha</a>, <a href="cope.cgi?key=interleukin%2d27%20receptor%2dalpha">interleukin-27 receptor-alpha</a>, <a href="cope.cgi?key=IL27R">IL27R</a>, <a href="cope.cgi?key=IL27R%2dalpha">IL27R-alpha</a>, <a href="cope.cgi?key=CRL1">CRL1</a>, <a href="cope.cgi?key=cytokine%20receptor%2dlike%201">Cytokine receptor-like 1</a>, <a href="cope.cgi?key=WSX%2d1">WSX-1</a>, <a href="cope.cgi?key=TCCR">TCCR</a>, <a href="cope.cgi?key=T%2dcell%20cytokine%20receptor">T-cell cytokine receptor</a>, ZCytoR1) (Ruckerl et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL29">IL29</a></b> (<a href="cope.cgi?key=IFN%2dlambda%2d1">IFN-lambda-1</a>, <a href="cope.cgi?key=interferon%2dlambda%2d1">interferon-lambda-1</a>, <a href="cope.cgi?key=IFNL1">IFNL1</a>) (Rintahaka et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL29">IL29</a></b> (<a href="cope.cgi?key=IFN%2dlambda%2d1">IFN-lambda-1</a>, <a href="cope.cgi?key=interferon%2dlambda%2d1">interferon-lambda-1</a>, <a href="cope.cgi?key=IFNL1">IFNL1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL28RA">IL28RA</a>, <a href="cope.cgi?key=interleukin%2d28%20receptor%2dalpha">interleukin-28 receptor-alpha</a>, <a href="cope.cgi?key=IL28R%2dalpha">IL28R-alpha</a>, <a href="cope.cgi?key=IL28R1">IL28R1</a>, <a href="cope.cgi?key=interleukin%2d28%20receptor%2d1">interleukin-28 receptor-1</a>, <a href="cope.cgi?key=IFN%2dlambda%2dR1">IFN-lambda-R1</a>, <a href="cope.cgi?key=IFN%2dlambda%20receptor%201">IFN-lambda receptor 1</a>; <a href="cope.cgi?key=interferon%2dlambda%20receptor%2d1">interferon-lambda receptor-1</a>, <a href="cope.cgi?key=IFNLR1">IFNLR1</a>, <a href="cope.cgi?key=IFNLR">IFNLR</a>, <a href="cope.cgi?key=interferon%2dlambda%20receptor">interferon-lambda receptor</a>, <a href="cope.cgi?key=CRF2%2d12">CRF2-12</a>, <a href="cope.cgi?key=cytokine%20receptor%20family%202%20member%2012">Cytokine receptor family 2 member 12</a>, <a href="cope.cgi?key=LICR2">LICR2</a>, <a href="cope.cgi?key=Likely%20Interleukin%20or%20Cytokine%20Receptor%2d2">Likely Interleukin or Cytokine Receptor-2</a>) (Jordan et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL31">IL31</a></b> (<a href="cope.cgi?key=Interleukin%2d31">interleukin-31</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL31RA">IL31RA</a>, <a href="cope.cgi?key=interleukin%2d31%20receptor%20A">interleukin-31 receptor A</a>; <a href="cope.cgi?key=IL31%20receptor%2dalpha">IL31 receptor-alpha</a>; <a href="cope.cgi?key=IL31R%2dalpha">IL31R-alpha</a>, <a href="cope.cgi?key=GLMR">GLMR</a>, <a href="cope.cgi?key=gp130%2dlike%20monocyte%20receptor">gp130-like monocyte receptor</a>, <a href="cope.cgi?key=GPL">GPL</a>, <a href="cope.cgi?key=gp130%2dlike%20receptor">gp130-like receptor</a>, <a href="cope.cgi?key=CRL3">CRL3</a>, <a href="cope.cgi?key=cytokine%20receptor%2dlike%203">cytokine receptor-like 3</a>; <a href="cope.cgi?key=OSMR">OSMR</a>, <a href="cope.cgi?key=oncostatin%20M%20receptor">oncostatin M receptor</a>, <a href="cope.cgi?key=OSMRB">OSMRB</a>, <a href="cope.cgi?key=Oncostatin%2dM%20receptor%2dbeta">Oncostatin-M receptor-beta</a>; <a href="cope.cgi?key=OSMR%2dbeta">OSMR-beta</a>; <a href="cope.cgi?key=Oncostatin%2dM%2dspecific%20receptor%20subunit%20beta">Oncostatin-M-specific receptor subunit beta</a>, <a href="cope.cgi?key=IL31R%2dbeta">IL31R-beta</a>, <a href="cope.cgi?key=IL31RB">IL31RB</a>, <a href="cope.cgi?key=IL31%20receptor%2dbeta">IL31 receptor-beta</a>, <a href="cope.cgi?key=Interleukin%2d31%20receptor%2dbeta">Interleukin-31 receptor-beta</a>) ( Bilsborough et al, 2006; Jawa RS et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL32">IL32</a></b> (<a href="cope.cgi?key=Interleukin%2d32">interleukin-32</a>, <a href="cope.cgi?key=IL32%2dalpha">IL32-alpha</a>, <a href="cope.cgi?key=IL32%2dbeta">IL32-beta</a>, <a href="cope.cgi?key=IL32%2ddelta">IL32-delta</a>, <a href="cope.cgi?key=IL32%2depsilon">IL32-epsilon</a>, <a href="cope.cgi?key=IL32%2dgamma">IL32-gamma</a>, <a href="cope.cgi?key=IL32%2dzeta">IL32-zeta</a>, <a href="cope.cgi?key=NK4">NK4</a>, <a href="cope.cgi?key=natural%20killer%20cell%20transcript%204">natural killer cell transcript 4</a>, <a href="cope.cgi?key=TAIF">TAIF</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%20alpha%2dinducing%20factor">tumor necrosis factor alpha-inducing factor</a>, <a href="cope.cgi?key=TAIFa">TAIFa</a>, <a href="cope.cgi?key=TAIF%2dalpha">TAIF-alpha</a>, <a href="cope.cgi?key=TAIFb">TAIFb</a>, <a href="cope.cgi?key=TAIFc">TAIFc</a>, <a href="cope.cgi?key=TAIF%2dbeta">TAIF-beta</a>, <a href="cope.cgi?key=TAIFd">TAIFd</a>, <a href="cope.cgi?key=TAIF%2ddelta">TAIF-delta</a>) (Kim et al, 2005; Calabrese et al, 2008; Sorrentino C and Di Carlo E, 2009; Netea MG et al, 2006; Keswani et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL32">IL32</a></b> (<a href="cope.cgi?key=Interleukin%2d32">interleukin-32</a>, <a href="cope.cgi?key=IL32%2dalpha">IL32-alpha</a>, <a href="cope.cgi?key=IL32%2dbeta">IL32-beta</a>, <a href="cope.cgi?key=IL32%2ddelta">IL32-delta</a>, <a href="cope.cgi?key=IL32%2depsilon">IL32-epsilon</a>, <a href="cope.cgi?key=IL32%2dgamma">IL32-gamma</a>, <a href="cope.cgi?key=IL32%2dzeta">IL32-zeta</a>, <a href="cope.cgi?key=NK4">NK4</a>, <a href="cope.cgi?key=natural%20killer%20cell%20transcript%204">natural killer cell transcript 4</a>, <a href="cope.cgi?key=TAIF">TAIF</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%20alpha%2dinducing%20factor">tumor necrosis factor alpha-inducing factor</a>, <a href="cope.cgi?key=TAIFa">TAIFa</a>, <a href="cope.cgi?key=TAIF%2dalpha">TAIF-alpha</a>, <a href="cope.cgi?key=TAIFb">TAIFb</a>, <a href="cope.cgi?key=TAIFc">TAIFc</a>, <a href="cope.cgi?key=TAIF%2dbeta">TAIF-beta</a>, <a href="cope.cgi?key=TAIFd">TAIFd</a>, <a href="cope.cgi?key=TAIF%2ddelta">TAIF-delta</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Joosten et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL33">IL33</a></b> (<a href="cope.cgi?key=Interleukin%2d33">interleukin-33</a>, <a href="cope.cgi?key=NFHEV">NFHEV</a>, <a href="cope.cgi?key=nuclear%20factor%20from%20high%20endothelial%20venules">nuclear factor from high endothelial venules</a>, <a href="cope.cgi?key=C9orf26">C9orf26</a>, <a href="cope.cgi?key=chromosome%209%20open%20reading%20frame%2026">chromosome 9 open reading frame 26</a>, <a href="cope.cgi?key=DVS27">DVS27</a>) (Ohno et al, 2009; Goh F et al, 2009; Schmitz J et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=IL33">IL33</a></b> (<a href="cope.cgi?key=Interleukin%2d33">interleukin-33</a>, <a href="cope.cgi?key=NFHEV">NFHEV</a>, <a href="cope.cgi?key=nuclear%20factor%20from%20high%20endothelial%20venules">nuclear factor from high endothelial venules</a>, <a href="cope.cgi?key=C9orf26">C9orf26</a>, <a href="cope.cgi?key=chromosome%209%20open%20reading%20frame%2026">chromosome 9 open reading frame 26</a>, <a href="cope.cgi?key=DVS27">DVS27</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=IL33R">IL33R</a>, <a href="cope.cgi?key=IL1RL1">IL1RL1</a>, <a href="cope.cgi?key=IL1%20receptor%2dlike%2d1">IL1 receptor-like-1</a>, <a href="cope.cgi?key=IL1R4">IL1R4</a>, <a href="cope.cgi?key=Interleukin%2d1%20receptor%204">interleukin-1 receptor 4</a>, <a href="cope.cgi?key=IL1%20receptor%20R4">IL1 receptor R4</a>, <a href="cope.cgi?key=T1">T1</a>, <a href="cope.cgi?key=T1%2fST2">T1/ST2</a>, <a href="cope.cgi?key=ST2">ST2</a>, <a href="cope.cgi?key=ST2L">ST2L</a>, <a href="cope.cgi?key=Fit%2d1">Fit-1</a>, <a href="cope.cgi?key=fos%2dinduced%20transcript%2d1">fos-induced transcript-1</a>, <a href="cope.cgi?key=Ly84">Ly84</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%2084">lymphocyte antigen 84</a>, <a href="cope.cgi?key=DER4">DER4</a>, <a href="cope.cgi?key=delayed%20early%20response%20gene%204">delayed early response gene 4</a>) (Espinassous Q et al, 2009; Kurowska-Stolarska M et al, 2009; Manetti et al, 2010; Ohno et al, 2011; Ogawa H et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL34">IL34</a></b> (<a href="cope.cgi?key=interleukin%2d34">interleukin-34</a>, <a href="cope.cgi?key=C16orf77">C16orf77</a>, <a href="cope.cgi?key=chromosome%2016%20open%20reading%20frame%2077">chromosome 16 open reading frame 77</a>) (Covaleda et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IL34">IL34</a></b> (<a href="cope.cgi?key=interleukin%2d34">interleukin-34</a>, <a href="cope.cgi?key=C16orf77">C16orf77</a>, <a href="cope.cgi?key=chromosome%2016%20open%20reading%20frame%2077">chromosome 16 open reading frame 77</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=CSF1R">CSF1R</a>, <a href="cope.cgi?key=fms">fms</a>, <a href="cope.cgi?key=FIM2">FIM2</a>, <a href="cope.cgi?key=CD115">CD115</a>) (Wei S et al, 2010; Chihara et al, 2010; in addition, presence inferred also from observation that <a href="cope.cgi?key=IL34">IL34</a> binds to the <a href="cope.cgi?key=M%2dCSF%20receptors">M-CSF receptor</a>, <a href="cope.cgi?key=fms">fms</a>)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=insulysin">insulysin</a></b> (<a href="cope.cgi?key=insulin%2ddegrading%20enzyme">insulin-degrading enzyme</a>, <a href="cope.cgi?key=IDE">IDE</a>, <a href="cope.cgi?key=insulin%20protease">insulin protease</a>, <a href="cope.cgi?key=insulin%20proteinase">insulin proteinase</a>, <a href="cope.cgi?key=insulinase">insulinase</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e56">EC3.4.24.56</a>, <a href="cope.cgi?key=AURA99">AURA99</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2099">augmented in rheumatoid arthritis 99</a>) (Yamamoto et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IRAK1">IRAK1</a></b> (<a href="cope.cgi?key=IL1%20receptor%2dassociated%20kinase%2d1">IL1 receptor-associated kinase-1</a>, <a href="cope.cgi?key=IRAK">IRAK</a>, <a href="cope.cgi?key=IL1%20receptor%2dassociated%20kinase">IL1 receptor-associated kinase</a>; <a href="cope.cgi?key=mPLK">mPLK</a>, <a href="cope.cgi?key=Pelle%2dlike%20protein%20kinase">Pelle-like protein kinase</a>, <a href="cope.cgi?key=Plpk">Plpk</a>) (Wells et al, 2006; Hou et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IRAK2">IRAK2</a></b> (<a href="cope.cgi?key=IL1%20receptor%2dassociated%20kinase%2d2">IL1 receptor-associated kinase-2</a>) (Wells et al, 2006; Hou et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IRAK4">IRAK4</a></b> (<a href="cope.cgi?key=IL1%20receptor%2dassociated%20kinase%2d4">IL1 receptor-associated kinase-4</a>, <a href="cope.cgi?key=REN%2d64">REN-64</a>, <a href="cope.cgi?key=NY%2dREN%2d64">NY-REN-64</a>) (Wells et al, 2006; Peng et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=IRAKM">IRAKM</a></b> (<a href="cope.cgi?key=IL1%20receptor%2dassociated%20kinase%20M">IL1 receptor-associated kinase M</a>, <a href="cope.cgi?key=IRAK3">IRAK3</a>, <a href="cope.cgi?key=IL1%20receptor%2dassociated%20kinase%2d3">IL1 receptor-associated kinase-3</a>; Zhang Y et al, 2013) (Zacharioudaki et al, 2009; Kobayashi H et al, 2011)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=JAK3">JAK3</a></b> (<a href="cope.cgi?key=Janus%20kinase%2d3">Janus kinase-3</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Jagged%2d1">jagged-1</a></b> (<a href="cope.cgi?key=JAG1">JAG1</a>, <a href="cope.cgi?key=JAGL1">JAGL1</a>, <a href="cope.cgi?key=Jagged">jagged</a>, <a href="cope.cgi?key=Serrate%2d1">Serrate-1</a>) (Nomaguchi et al, 2001; Goh F et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=JAM1">JAM1</a></b> (<a href="cope.cgi?key=Junctional%20adhesion%20molecule%201">Junctional adhesion molecule 1</a>, <a href="cope.cgi?key=JAM%2dA">JAM-A</a>, <a href="cope.cgi?key=Junctional%20adhesion%20molecule%20A">Junctional adhesion molecule A</a>, <a href="cope.cgi?key=JCAM">JCAM</a>, <a href="cope.cgi?key=Platelet%20F11%20receptor">Platelet F11 receptor</a>, <a href="cope.cgi?key=F11R">F11R</a>, <a href="cope.cgi?key=F11%20receptor">F11 receptor</a>, <a href="cope.cgi?key=platelet%20adhesion%20molecule%201">platelet adhesion molecule 1</a>, <a href="cope.cgi?key=PAM%2d1">PAM-1</a>, <a href="cope.cgi?key=Ly106">Ly106</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%20106">lymphocyte antigen 106</a>, <a href="cope.cgi?key=CD321">CD321</a>) (Gupta et al, 2001)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> kappa-opioid receptors (Alicea et al, 1999)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Lactoferrin">lactoferrin</a></b> (<a href="cope.cgi?key=LF">LF</a>, <a href="cope.cgi?key=Lactotransferrin">Lactotransferrin</a>, <a href="cope.cgi?key=LTF">LTF</a>, <a href="cope.cgi?key=CIF">CIF</a>, <a href="cope.cgi?key=Colony%20inhibitory%20factor">colony inhibitory factor</a>, <a href="cope.cgi?key=Talactoferrin">Talactoferrin</a>, <a href="cope.cgi?key=TLF">TLF</a>, <a href="cope.cgi?key=AURA19">AURA19</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2019">augmented in rheumatoid arthritis 19</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Sorimachi et al, 1997; Shimamura et al, 2004; Bartal et al, 1987)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=LBP">LBP</a></b> (<a href="cope.cgi?key=LPS%20binding%20protein">LPS binding protein</a>, <a href="cope.cgi?key=lipopolysaccharide%2dbinding%20protein">lipopolysaccharide-binding protein</a>, <a href="cope.cgi?key=BPIFD2">BPIFD2</a>, <a href="cope.cgi?key=BPI%20fold%20containing%20family%20D%20member%202">BPI fold containing family D member 2</a>) (Lee PT et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=L%2dCCR">L-CCR</a></b> (<a href="cope.cgi?key=LPS%20inducible%20C%2dC%20chemokine%20receptor%20related%20gene">LPS inducible C-C chemokine receptor related gene</a>, <a href="cope.cgi?key=Lipopolysaccharide%20inducible%20C%2dC%20chemokine%20receptor%20related%20gene">Lipopolysaccharide inducible C-C chemokine receptor related gene</a>) (Brouwer N et al, 2004; Oostendorp J et al, 2004; Shimada T et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Leptin">leptin</a></b> (<a href="cope.cgi?key=ob">ob</a>, <a href="cope.cgi?key=ob">ob/ob</a>, <a href="cope.cgi?key=obese%20protein">obese protein</a>, <a href="cope.cgi?key=obesity%20factor">obesity factor</a>, <a href="cope.cgi?key=Metreleptin">Metreleptin</a>) <b style="mso-bidi-font-weight: normal">receptors </b>(<a href="cope.cgi?key=OBR">OBR</a>, <a href="cope.cgi?key=CD295">CD295</a>, <a href="cope.cgi?key=db">db</a>, <a href="cope.cgi?key=db">db/db</a>, <a href="cope.cgi?key=fatty">fatty</a>, <a href="cope.cgi?key=fa">fa</a>, <a href="cope.cgi?key=fa">fa/fa</a>) (O'Rourke et al, 2001; Maingrette and Renier, 2003; Hongo et al, 2009; Kiguchi et al, 2009; Spiroglou SG et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=Leukocyte%20infiltration%20inducing%20factor">Leukocyte infiltration inducing factor</a><br/> <b style="mso-bidi-font-weight:normal">¥ <a href="cope.cgi?key=LGI3">LGI3</a></b> (<a href="cope.cgi?key=leucine%2drich%20glioma%20inactivated%203">leucine-rich glioma inactivated 3</a>, <a href="cope.cgi?key=LGIL4">LGIL4</a>, <a href="cope.cgi?key=LGI1%2dlike%20protein%204">LGI1-like protein 4</a>) (Kim HA et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=LIA">LIA</a></b> (<a href="cope.cgi?key=leukemia%2dassociated%20inhibitory%20activity">leukemia-associated inhibitory activity</a>, <a href="cope.cgi?key=Acidic%20isoferritin">acidic isoferritin</a>, <a href="cope.cgi?key=MDS%2dIA">MDS-IA</a>, <a href="cope.cgi?key=myelodysplastic%20syndrome%2dassociated%20inhibitory%20activity">myelodysplastic syndrome-associated inhibitory activity</a>) (Broxmeyer et al, 1982)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=LIF">LIF</a></b> (<a href="cope.cgi?key=Leukemia%20inhibitory%20factor">leukemia inhibitory factor</a>; <a href="cope.cgi?key=Myeloid%20leukemia%20inhibitory%20factor">myeloid leukemia inhibitory factor</a>, <a href="cope.cgi?key=ABAE%20cell%20growth%2dinhibitory%20activity">ABAE cell growth-inhibitory activity</a>; <a href="cope.cgi?key=CDF">CDF</a>, <a href="cope.cgi?key=Cholinergic%20differentiation%20factor">cholinergic differentiation factor</a>, <a href="cope.cgi?key=CNDF">CNDF</a>, <a href="cope.cgi?key=Cholinergic%20neuronal%20differentiation%20factor">cholinergic neuronal differentiation factor</a>, <a href="cope.cgi?key=D%2dFactor">D-Factor</a>, <a href="cope.cgi?key=Differentiation%20stimulating%20factor">differentiation stimulating factor</a>, <a href="cope.cgi?key=DIA">DIA</a>, <a href="cope.cgi?key=Differentiation%20inhibiting%20activity">differentiation inhibiting activity</a>, <a href="cope.cgi?key=DIF">DIF</a>, <a href="cope.cgi?key=Differentiation%20inducing%20factor">differentiation inducing factor</a>, <a href="cope.cgi?key=DRF">DRF</a>, <a href="cope.cgi?key=Differentiation%2dretarding%20factor">Differentiation-retarding factor</a>, <a href="cope.cgi?key=ES%20cell%20growth%20factor">ES cell growth factor</a>, <a href="cope.cgi?key=ESCGF">ESCGF</a>, <a href="cope.cgi?key=Embryonic%20stem%20cell%20growth%20factor">embryonic stem cell growth factor</a>, <a href="cope.cgi?key=GATS">GATS</a>, <a href="cope.cgi?key=Growth%20stimulatory%20activity%20for%20TS1%20cells">growth stimulatory activity for TS1 cells</a>, <a href="cope.cgi?key=HILDA">HILDA</a>, <a href="cope.cgi?key=human%20interleukin%20for%20Da%20cells">human interleukin for Da cells</a>, <a href="cope.cgi?key=HSF%2d2">HSF-2</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor%2d2">hepatocyte stimulating factor-2</a>, <a href="cope.cgi?key=HSF%2d3">HSF-3</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor%2d3">hepatocyte stimulating factor-3</a>, <a href="cope.cgi?key=Lipoprotein%20lipase%20inhibitor">Lipoprotein lipase inhibitor</a>, <a href="cope.cgi?key=M1%20differentiation%20inducing%20activity">M1 differentiation inducing activity</a>, <a href="cope.cgi?key=MCGEF">MCGEF</a>, <a href="cope.cgi?key=mast%20cell%20growth%2denhancing%20factor">mast cell growth-enhancing factor</a>, <a href="cope.cgi?key=MLPLI">MLPLI</a>, <a href="cope.cgi?key=Melanoma%2dderived%20lipoprotein%20lipase%20inhibitor">melanoma-derived lipoprotein lipase inhibitor</a>, <a href="cope.cgi?key=OAF">OAF</a>, <a href="cope.cgi?key=Osteoclast%20activating%20factor">osteoclast activating factor</a>) (Dowsing et al, 2001; Getchell et al, 2002; Vanderlocht et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=LIF">LIF</a></b> (<a href="cope.cgi?key=Leukemia%20inhibitory%20factor">leukemia inhibitory factor</a>; <a href="cope.cgi?key=Myeloid%20leukemia%20inhibitory%20factor">myeloid leukemia inhibitory factor</a>, <a href="cope.cgi?key=ABAE%20cell%20growth%2dinhibitory%20activity">ABAE cell growth-inhibitory activity</a>; <a href="cope.cgi?key=CDF">CDF</a>, <a href="cope.cgi?key=Cholinergic%20differentiation%20factor">cholinergic differentiation factor</a>, <a href="cope.cgi?key=CNDF">CNDF</a>, <a href="cope.cgi?key=Cholinergic%20neuronal%20differentiation%20factor">cholinergic neuronal differentiation factor</a>, <a href="cope.cgi?key=D%2dFactor">D-Factor</a>, <a href="cope.cgi?key=Differentiation%20stimulating%20factor">differentiation stimulating factor</a>, <a href="cope.cgi?key=DIA">DIA</a>, <a href="cope.cgi?key=Differentiation%20inhibiting%20activity">differentiation inhibiting activity</a>, <a href="cope.cgi?key=DIF">DIF</a>, <a href="cope.cgi?key=Differentiation%20inducing%20factor">differentiation inducing factor</a>, <a href="cope.cgi?key=DRF">DRF</a>, <a href="cope.cgi?key=Differentiation%2dretarding%20factor">Differentiation-retarding factor</a>, <a href="cope.cgi?key=ES%20cell%20growth%20factor">ES cell growth factor</a>, <a href="cope.cgi?key=ESCGF">ESCGF</a>, <a href="cope.cgi?key=Embryonic%20stem%20cell%20growth%20factor">embryonic stem cell growth factor</a>, <a href="cope.cgi?key=GATS">GATS</a>, <a href="cope.cgi?key=Growth%20stimulatory%20activity%20for%20TS1%20cells">growth stimulatory activity for TS1 cells</a>, <a href="cope.cgi?key=HILDA">HILDA</a>, <a href="cope.cgi?key=human%20interleukin%20for%20Da%20cells">human interleukin for Da cells</a>, <a href="cope.cgi?key=HSF%2d2">HSF-2</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor%2d2">hepatocyte stimulating factor-2</a>, <a href="cope.cgi?key=HSF%2d3">HSF-3</a>, <a href="cope.cgi?key=Hepatocyte%20stimulating%20factor%2d3">hepatocyte stimulating factor-3</a>, <a href="cope.cgi?key=Lipoprotein%20lipase%20inhibitor">Lipoprotein lipase inhibitor</a>, <a href="cope.cgi?key=M1%20differentiation%20inducing%20activity">M1 differentiation inducing activity</a>, <a href="cope.cgi?key=MCGEF">MCGEF</a>, <a href="cope.cgi?key=mast%20cell%20growth%2denhancing%20factor">mast cell growth-enhancing factor</a>, <a href="cope.cgi?key=MLPLI">MLPLI</a>, <a href="cope.cgi?key=Melanoma%2dderived%20lipoprotein%20lipase%20inhibitor">melanoma-derived lipoprotein lipase inhibitor</a>, <a href="cope.cgi?key=OAF">OAF</a>, <a href="cope.cgi?key=Osteoclast%20activating%20factor">osteoclast activating factor</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=LIFR">LIFR</a>, <a href="cope.cgi?key=leukemia%20inhibitory%20factor%20receptor">leukemia inhibitory factor receptor</a>, <a href="cope.cgi?key=LIF%20receptor">LIF receptor</a>, <a href="cope.cgi?key=LIFR%2dalpha">LIFR-alpha</a>, <a href="cope.cgi?key=leukemia%20inhibitory%20factor%20receptor%2dalpha">leukemia inhibitory factor receptor-alpha</a>, <a href="cope.cgi?key=LIF%20receptor%2dalpha">LIF receptor-alpha</a>, <a href="cope.cgi?key=LIFR%2dbeta">LIFR-beta</a>, <a href="cope.cgi?key=LIF%20receptor%2dbeta">LIF receptor-beta</a>; <a href="cope.cgi?key=leukemia%20inhibitory%20factor%20receptor%2dbeta">leukemia inhibitory factor receptor-beta</a>, <a href="cope.cgi?key=CD118">CD118</a>, <a href="cope.cgi?key=IL6ST">IL6ST</a>, <a href="cope.cgi?key=IL6%20signal%20transducer">IL6 signal transducer</a>, <a href="cope.cgi?key=IL6R%2dbeta">IL6R-beta</a>, <a href="cope.cgi?key=IL6RB">IL6RB</a>, <a href="cope.cgi?key=CDw130">CDw130</a>, <a href="cope.cgi?key=CD130">CD130</a>) (Conti et al, 1993; Sugiura et al, 2000; Meisel et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=lifeguard">lifeguard</a></b> (<a href="cope.cgi?key=LFG">LFG</a>, <a href="cope.cgi?key=NMP35">NMP35</a>, <a href="cope.cgi?key=neural%20membrane%20protein%2035">neural membrane protein 35</a>, <a href="cope.cgi?key=FAIM2">FAIM2</a>, <a href="cope.cgi?key=FAS%20apoptotic%20inhibitory%20molecule%202">FAS apoptotic inhibitory molecule 2</a>, <a href="cope.cgi?key=TMBIM2">TMBIM2</a>, <a href="cope.cgi?key=transmembrane%20BAX%20inhibitor%20motif%20containing%202">transmembrane BAX inhibitor motif containing 2</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=LIGHT">LIGHT</a></b> (<a href="cope.cgi?key=TNFSF14">TNFSF14</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2014">TNF ligand superfamily member 14</a>, <a href="cope.cgi?key=HVEM%20ligand">HVEM ligand</a>, <a href="cope.cgi?key=HVEM%2dL">HVEM-L</a>, <a href="cope.cgi?key=Herpesvirus%20entry%20mediator%20ligand">Herpesvirus entry mediator ligand</a>, <a href="cope.cgi?key=CD258">CD258</a>) (Philipps et al, 2001; Albright and Gonzalez-Scarano, 2004; Edwards et al, 2006; Harrop et al, 1998; Kim WJ et al, 2005; Lee WH et al, 2001; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Lipocalin%2d2">lipocalin-2</a></b> (<a href="cope.cgi?key=LCN2">LCN2</a>, <a href="cope.cgi?key=24p3">24p3</a>, <a href="cope.cgi?key=25%20kDa%20alpha%2d2%2dmicroglobulin%2drelated%20subunit%20of%20MMP%2d9">25 kDa alpha-2-microglobulin-related subunit of MMP-9</a>, <a href="cope.cgi?key=Alpha%2d2%2dmicroglobulin%20related%20protein">Alpha-2-microglobulin related protein</a>, <a href="cope.cgi?key=Ex%2dFABP">Ex-FABP</a>, <a href="cope.cgi?key=extracellular%20fatty%20acid%2dbinding%20protein">extracellular fatty acid-binding protein</a>, <a href="cope.cgi?key=HNL">HNL</a>, <a href="cope.cgi?key=human%20neutrophil%20lipocalin">human neutrophil lipocalin</a>, <a href="cope.cgi?key=lipocalin%2024p3">lipocalin 24p3</a>, <a href="cope.cgi?key=MSFI">MSFI</a>, <a href="cope.cgi?key=migration%20stimulating%20factor%20inhibitor">migration stimulating factor inhibitor</a>, <a href="cope.cgi?key=NGAL">NGAL</a>, <a href="cope.cgi?key=neutrophil%20gelatinase%2dassociated%20lipocalin">neutrophil gelatinase-associated lipocalin</a>, <a href="cope.cgi?key=NRL">NRL</a>, <a href="cope.cgi?key=neu%2drelated%20lipocalin">neu-related lipocalin</a>, <a href="cope.cgi?key=Scn">Scn</a>, <a href="cope.cgi?key=Siderocalin">siderocalin</a>, <a href="cope.cgi?key=SIP24">SIP24</a>, <a href="cope.cgi?key=superinducible%20protein%2024%20kDa">superinducible protein 24 kDa</a>, <a href="cope.cgi?key=SV40%2dinduced%2024P3%20protein">SV40-induced 24P3 protein</a>, <a href="cope.cgi?key=Uterocalin">Uterocalin</a>) (Meheus et al, 1993; Sunil et al, 2007; Johnson EE et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=LRRFIP1">LRRFIP1</a></b> (<a href="cope.cgi?key=leucine%20rich%20repeat%20%28in%20FLII%29%20interacting%20protein%201">leucine rich repeat (in FLII) interacting protein 1</a>; <a href="cope.cgi?key=Leucine%2drich%20repeat%20flightless%2dinteracting%20protein%201">Leucine-rich repeat flightless-interacting protein 1</a>; <a href="cope.cgi?key=LRR%20FLII%2dinteracting%20protein%201">LRR FLII-interacting protein 1</a>, <a href="cope.cgi?key=FLAP%2d1">FLAP-1</a>, <a href="cope.cgi?key=FLIIAP1">FLIIAP1</a>, <a href="cope.cgi?key=FLI%20LRR%20associated%20protein%2d1">FLI LRR associated protein-1</a>, <a href="cope.cgi?key=GCF2">GCF2</a>, <a href="cope.cgi?key=GC%2dbinding%20factor%202">GC-binding factor 2</a>, <a href="cope.cgi?key=TRIP">TRIP</a>, <a href="cope.cgi?key=TAR%20RNA%2dinteracting%20protein">TAR RNA-interacting protein</a>, <a href="cope.cgi?key=Transcription%20factor%209%2dlike">Transcription factor 9-like</a>, <a href="cope.cgi?key=HUFI%2d1">HUFI-1</a>) (Dai P et al, 2009; Suriano et al, 2005; Yang P et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=LRRK2">LRRK2</a> </b>(<a href="cope.cgi?key=leucine%2drich%20repeat%20kinase%202">leucine-rich repeat kinase 2</a>, <a href="cope.cgi?key=Dardarin">Dardarin</a>, <a href="cope.cgi?key=PARK8">PARK8</a>, <a href="cope.cgi?key=Parkinson%20disease%2d8">Parkinson disease-8</a>; <a href="cope.cgi?key=Autosomal%20Dominant%20Parkinson%20Disease%2d8">Autosomal Dominant Parkinson Disease-8</a>, <a href="cope.cgi?key=AURA17">AURA17</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2017">augmented in rheumatoid arthritis 17</a>, <a href="cope.cgi?key=RIPK%2d7">RIPK-7</a>, <a href="cope.cgi?key=receptor%2dinteracting%20serine%2fthreonine%20kinase%207">receptor-interacting serine/threonine kinase 7</a>) (Gardet et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Ly6C">Ly6C</a></b> (<a href="cope.cgi?key=lymphocyte%20antigen%206C">lymphocyte antigen 6C</a>, <a href="cope.cgi?key=Ly6C1">Ly6C1</a>, <a href="cope.cgi?key=lymphocyte%20antigen%206C1">lymphocyte antigen 6C1</a>) (Cook et al, 2003; Daley et al, 2008; Hatakeyama et al, 1994; Jutila et al, 1988; Lin <a href="cope.cgi?key=SL">SL</a> et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Lymphotoxin%2dbeta">lymphotoxin-beta</a></b> (<a href="cope.cgi?key=LT%2dbeta">LT-beta</a>, <a href="cope.cgi?key=LTB">LTB</a>, <a href="cope.cgi?key=TNFSF3">TNFSF3</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%203">TNF ligand superfamily member 3</a>, <a href="cope.cgi?key=TNF%20C">TNF C</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%20C">tumor necrosis factor C</a>) (Philipps et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Lysozyme">Lysozyme</a></b> (<a href="cope.cgi?key=LYZ">LYZ</a>, <a href="cope.cgi?key=EC3%2e2%2e1%2e17">EC3.2.1.17</a>, <a href="cope.cgi?key=1%2c4%2dbeta%2dN%2dacetylmuramidase%20C">1,4-beta-N-acetylmuramidase C</a>) (Miyauchi et al, 1985)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=LYVE%2d1">LYVE-1</a></b> (<a href="cope.cgi?key=lymphatic%20vessel%20endothelial%20hyaluronan%20receptor%2d1">lymphatic vessel endothelial hyaluronan receptor-1</a>, <a href="cope.cgi?key=CRSBP%2d1">CRSBP-1</a>, <a href="cope.cgi?key=Cell%20surface%20retention%20sequence%20binding%20protein%2d1">Cell surface retention sequence binding protein-1</a>) (Martens et al, 2006; Maruyama et al, 2005; Xu et al, 2007; Schledzewski et al, 2006; Cho et al, 2007; Schroedl et al, 2008; Martens et al, 2006)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> M150 (Agrewala et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> mannose receptors (Yamamoto et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥ <a href="cope.cgi?key=MARCO">MARCO</a></b> (<a href="cope.cgi?key=macrophage%20receptor%20with%20collagenous%20structure">macrophage receptor with collagenous structure</a>, <a href="cope.cgi?key=SCARA2">SCARA2</a>, <a href="cope.cgi?key=scavenger%20receptor%20class%20A%20member%202">scavenger receptor class A member 2</a>; <a href="cope.cgi?key=Ly112">Ly112</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%20112">lymphocyte antigen 112</a>) (<a href="cope.cgi?key=HIN%2d2">HIN-2</a> receptor) (Bin et al, 2003; Ito et al, 1999; Baqir et al, 2008; Gratchev A et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MAVS">MAVS</a> </b>(<a href="cope.cgi?key=mitochondrial%20antiviral%20signaling%20protein">mitochondrial antiviral signaling protein</a>, <a href="cope.cgi?key=KIAA1271">KIAA1271</a>, <a href="cope.cgi?key=IPS1">IPS1</a>, <a href="cope.cgi?key=Interferon%2dbeta%20promoter%20stimulator%20protein%201">Interferon-beta promoter stimulator protein 1</a>, <a href="cope.cgi?key=VISA">VISA</a>, <a href="cope.cgi?key=Virus%2dinduced%2dsignaling%20adapter">Virus-induced-signaling adapter</a>, <a href="cope.cgi?key=CARDIF">CARDIF</a>, <a href="cope.cgi?key=CARD%20adapter%20inducing%20interferon%2dbeta">CARD adapter inducing interferon-beta</a>) (Allen et al, 2010; Delaloye et al, 2009; Melchjorsen et al, 2010; Okabe et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=MBF">MBF</a> [<a href="cope.cgi?key=Macrophage%2dderived%20blastogenic%20factor">macrophage-derived blastogenic factor</a>]<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MBL">MBL</a></b> (<a href="cope.cgi?key=mannose%2dbinding%20lectin">Mannose-binding lectin</a>; <a href="cope.cgi?key=mannan%2dbinding%20lectin">mannan-binding lectin</a>, <a href="cope.cgi?key=MBL2">MBL2</a>, <a href="cope.cgi?key=mannose%2dbinding%20lectin%202">mannose-binding lectin 2</a>, <a href="cope.cgi?key=MBP">MBP</a>, <a href="cope.cgi?key=mannose%2dbinding%20protein">mannose-binding protein</a>; <a href="cope.cgi?key=Mannan%2dbinding%20protein">mannan-binding protein</a>, <a href="cope.cgi?key=MBP1">MBP1</a>, <a href="cope.cgi?key=COLEC1">COLEC1</a>, <a href="cope.cgi?key=Collectin%2d1">Collectin-1</a>; <a href="cope.cgi?key=L%2dMBP">L-MBP</a>, <a href="cope.cgi?key=liver%2dtype%20MBP">liver-type MBP</a>; <a href="cope.cgi?key=liver%2dtype%20mannan%2dbinding%20protein">liver-type mannan-binding protein</a>, <a href="cope.cgi?key=S%2dMBP">S-MBP</a>, <a href="cope.cgi?key=serum%2dtype%20MBP">serum-type MBP</a>, <a href="cope.cgi?key=serum%2dtype%20mannan%2dbinding%20protein">serum-type mannan-binding protein</a>, <a href="cope.cgi?key=MBP%2dC">MBP-C</a>, <a href="cope.cgi?key=mannan%2dbinding%20protein%20C">mannan-binding protein C</a>; <a href="cope.cgi?key=Mannose%2dbinding%20protein%20C">Mannose-binding protein C</a>, <a href="cope.cgi?key=MBP%2dA">MBP-A</a>, <a href="cope.cgi?key=mannan%2dbinding%20protein%20A">mannan-binding protein A</a>; <a href="cope.cgi?key=Mannose%2dbinding%20protein%20A">Mannose-binding protein A</a>, <a href="cope.cgi?key=MBL%2dC">MBL-C</a>, <a href="cope.cgi?key=mannan%2dbinding%20lectin%20C">mannan-binding lectin C</a>, <a href="cope.cgi?key=MBL%2dA">MBL-A</a>, <a href="cope.cgi?key=mannan%2dbinding%20lectin%20A">mannan-binding lectin A</a>, <a href="cope.cgi?key=RaRF%20p28A">RaRF p28A</a>, <a href="cope.cgi?key=Ra%2dreactive%20factor%20p28A">Ra-reactive factor p28A</a>, <a href="cope.cgi?key=CSL">CSL</a>, <a href="cope.cgi?key=core%2dspecific%20lectin">core-specific lectin</a>) (Wagner et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MCPIP">MCPIP</a></b> (<a href="cope.cgi?key=MCP%2d1%2dinduced%20protein">MCP-1-induced protein</a>; <a href="cope.cgi?key=Monocyte%20chemotactic%20protein%2dinduced%20protein">Monocyte chemotactic protein-induced protein</a>, <a href="cope.cgi?key=MCPIP1">MCPIP1</a>, <a href="cope.cgi?key=MCP%2d1%2dinduced%20protein%201">MCP-1-induced protein 1</a>; <a href="cope.cgi?key=Monocyte%20chemotactic%20protein%2d1%2dinduced%20protein%2d1">Monocyte chemotactic protein-1-induced protein-1</a>, <a href="cope.cgi?key=ZC3H12A">ZC3H12A</a>, <a href="cope.cgi?key=zinc%20finger%20CCCH%20domain%2dcontaining%20protein%2012A">zinc finger CCCH domain-containing protein 12A</a>) (Blazusiak et al, 2013; Kasza et al, 2010; Liang J et al, 2008, 2008; Mizgalska et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M%2dCSF">M-CSF</a></b> (<a href="cope.cgi?key=Macrophage%20colony%20stimulating%20factor">macrophage colony stimulating factor</a>, <a href="cope.cgi?key=CSF%2d1">CSF-1</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d1">colony stimulating factor-1</a>, <a href="cope.cgi?key=CSF%2dHU">CSF-HU</a>, <a href="cope.cgi?key=urinary%20colony%20stimulating%20factor">Urinary colony stimulating factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=Macrophage%20growth%20factor">macrophage growth factor</a>, <a href="cope.cgi?key=MGI%2d1M">MGI-1M</a>, <a href="cope.cgi?key=Macrophage%2dgranulocyte%20inducer">macrophage-granulocyte inducer</a>, <a href="cope.cgi?key=op">op</a>, <a href="cope.cgi?key=osteopetrotic">osteopetrotic</a>, <a href="cope.cgi?key=toothless">toothless</a>, <a href="cope.cgi?key=tl">tl</a>, <a href="cope.cgi?key=Lanimostim">Lanimostim</a>) (Ogawa et al, 1994; Temeles et al, 1993; Wieser et al, 1989; Seizer et al, 2010; Kim DK et al, 2009; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M%2dCSF">M-CSF</a></b> (<a href="cope.cgi?key=Macrophage%20colony%20stimulating%20factor">macrophage colony stimulating factor</a>, <a href="cope.cgi?key=CSF%2d1">CSF-1</a>, <a href="cope.cgi?key=Colony%20stimulating%20factor%2d1">colony stimulating factor-1</a>, <a href="cope.cgi?key=CSF%2dHU">CSF-HU</a>, <a href="cope.cgi?key=urinary%20colony%20stimulating%20factor">Urinary colony stimulating factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=Macrophage%20growth%20factor">macrophage growth factor</a>, <a href="cope.cgi?key=MGI%2d1M">MGI-1M</a>, <a href="cope.cgi?key=Macrophage%2dgranulocyte%20inducer">macrophage-granulocyte inducer</a>, <a href="cope.cgi?key=op">op</a>, <a href="cope.cgi?key=osteopetrotic">osteopetrotic</a>, <a href="cope.cgi?key=toothless">toothless</a>, <a href="cope.cgi?key=tl">tl</a>, <a href="cope.cgi?key=Lanimostim">Lanimostim</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=fms">fms</a>, <a href="cope.cgi?key=CSF1R">CSF1R</a>, <a href="cope.cgi?key=CSF1R">CSF-1 receptor</a>, <a href="cope.cgi?key=FIM2">FIM2</a>, <a href="cope.cgi?key=CD115">CD115</a>) (Hashimoto et al, 1997; Dello Sbarba et al, 1996; Himes et al, 2001; Suzu and Motoyoshi, 2002; Bonfield et al, 2003; Wilson et al, 1998; Alford et al, 1997; Kamdar et al, 1997; Neale and Athanasou, 1999; Yamada et al, 2005; Sakata et al, 1992; Gratchev A et al, 2008; Bellora F et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MDA%2d5">MDA-5</a></b> (<a href="cope.cgi?key=melanoma%20differentiation%2dassociated%20gene%205">melanoma differentiation-associated gene 5</a>, <a href="cope.cgi?key=IFIH1">IFIH1</a>, <a href="cope.cgi?key=interferon%2dinduced%20helicase%201">interferon-induced helicase 1</a>, <a href="cope.cgi?key=Interferon%2dinduced%20helicase%20C%20domain%2dcontaining%20protein%201">Interferon-induced helicase C domain-containing protein 1</a>, <a href="cope.cgi?key=Helicard">Helicard</a>, <a href="cope.cgi?key=Helicase%20with%202%20CARD%20domains">Helicase with 2 CARD domains</a>, <a href="cope.cgi?key=RH116">RH116</a>, <a href="cope.cgi?key=RNA%20helicase%2dDEAD%20box%20protein%20116">RNA helicase-DEAD box protein 116</a>, <a href="cope.cgi?key=IDMM19">IDMM19</a>) (Daffis et al, 2007; Maelfait et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MDAF">MDAF</a> </b>(<a href="cope.cgi?key=soluble%20macrophage%2dderived%20anti%2dHIV%20factor">soluble macrophage-derived anti-HIV factor</a>) (Mikulak et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=MD%2dECI">MD-ECI</a> [<a href="cope.cgi?key=Macrophage%2dderived%20endothelial%20cell%20inhibitor">macrophage-derived endothelial cell inhibitor</a>] (Besner and Klagsbrun, 1991)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MDGI">MDGI</a></b> (<a href="cope.cgi?key=Mammary%2dderived%20growth%20inhibitor">mammary-derived growth inhibitor</a>, <a href="cope.cgi?key=FABP3">FABP3</a>, <a href="cope.cgi?key=Fatty%20acid%2dbinding%20protein%203">Fatty acid-binding protein 3</a>, <a href="cope.cgi?key=H%2dFABP">H-FABP</a>, <a href="cope.cgi?key=Heart%2dtype%20fatty%20acid%2dbinding%20protein">Heart-type fatty acid-binding protein</a>, <a href="cope.cgi?key=M%2dFABP">M-FABP</a>, <a href="cope.cgi?key=Muscle%20fatty%20acid%2dbinding%20protein">Muscle fatty acid-binding protein</a>) (Guthmann et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=MD%2dHBGF">MD-HBGF</a> [<a href="cope.cgi?key=macrophage%2dderived%20HBGF">macrophage-derived HBGF</a>] (Besner et al, 1990)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=MECIF">MECIF</a> [<a href="cope.cgi?key=Monocyte%2dderived%20endothelial%20cell%20inhibitory%20factor">monocyte-derived endothelial cell inhibitory factor</a>] (Vilette et al, 1990)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MEDA%2d7">MEDA-7</a> </b>(mesenteric oestrogen-dependent adipose gene- 7) (Zhang H et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> melanocortin receptors (<a href="cope.cgi?key=ACTH">ACTH</a> and <a href="cope.cgi?key=Alpha%2dMSH">alpha-MSH</a> receptors) (Luger et al, 2000; Getting et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=meprin%20B">meprin B</a></b> (<a href="cope.cgi?key=meprin%2dbeta">meprin-beta</a>, <a href="cope.cgi?key=MEP1B">MEP1B</a>, <a href="cope.cgi?key=Meprin%2d1%2dbeta">Meprin-1-beta</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e63">EC3.4.24.63</a>, <a href="cope.cgi?key=endopeptidase%2d2">endopeptidase-2</a>, <a href="cope.cgi?key=endopeptidase%2d24%2e18">endopeptidase-24.18</a>, <a href="cope.cgi?key=N%2dbenzoyl%2dL%2dtyrosyl%2dp%2daminobenzoic%20acid%20hydrolase">N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase</a>, <a href="cope.cgi?key=PABA%20peptide%20hydrolase">PABA peptide hydrolase</a>, <a href="cope.cgi?key=PPH">PPH</a>) (Crisman et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Mer">mer</a></b> (<a href="cope.cgi?key=MERTK">MERTK</a>, <a href="cope.cgi?key=Eyk">eyk</a>, <a href="cope.cgi?key=East%20Lansing%20Tyrosine%20Kinase">East Lansing Tyrosine Kinase</a>, <a href="cope.cgi?key=Nyk">nyk</a>, <a href="cope.cgi?key=NCAM%2drelated%20tyrosine%20kinase">NCAM-related tyrosine kinase</a>, <a href="cope.cgi?key=RP38">RP38</a>, <a href="cope.cgi?key=retinitis%20pigmentosa%20type%2038">retinitis pigmentosa type 38</a>, <a href="cope.cgi?key=tyro12">tyro12</a>, <a href="cope.cgi?key=tyrosine%2dprotein%20kinase%2012">tyrosine-protein kinase 12</a>) (Behrens et al, 2003; Anwar et al, 2009; Galvan et al, 2012; Park HJ et al, 2012; Kazeros et al, 2008; Shao WH et al, 2009; Thorp et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Meteorin">Meteorin</a></b> (<a href="cope.cgi?key=METRN">METRN</a>, <a href="cope.cgi?key=C16orf23">C16orf23</a>, <a href="cope.cgi?key=RJD6">RJD6</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MIC1">MIC1</a></b> (<a href="cope.cgi?key=macrophage%20inhibitory%20cytokine%2d1">macrophage inhibitory cytokine-1</a>, <a href="cope.cgi?key=GDF15">GDF15</a>, <a href="cope.cgi?key=Growth%2fdifferentiation%20factor%2d15">growth/differentiation factor-15</a>, <a href="cope.cgi?key=PL74">PL74</a>, <a href="cope.cgi?key=PTGF%2dbeta">PTGF-beta</a>, <a href="cope.cgi?key=Placental%20Transforming%20Growth%20Factor%2dbeta">Placental Transforming Growth Factor-beta</a>, <a href="cope.cgi?key=PDF">PDF</a>, <a href="cope.cgi?key=prostate%2dderived%20factor">prostate-derived factor</a>, <a href="cope.cgi?key=PLAB">PLAB</a>, <a href="cope.cgi?key=Placental%20bone%20morphogenetic%20protein">Placental bone morphogenetic protein</a>, <a href="cope.cgi?key=NAG%2d1">NAG-1</a>, <a href="cope.cgi?key=NSAID%20activated%20gene%2d1">NSAID activated gene-1</a>) (Moreno-Altamirano et al, 2004; Fairlie et al, 1999; Botcov et al, 1997; Schober et al, 2001; Bottner et al, 1999; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Midkine">Midkine</a></b> (<a href="cope.cgi?key=MK">MK</a>, <a href="cope.cgi?key=Mdk">Mdk</a>, <a href="cope.cgi?key=MK1">MK1</a>, <a href="cope.cgi?key=midgestation%20and%20kidney%20protein">midgestation and kidney protein</a>, <a href="cope.cgi?key=NEGF%2d2">NEGF-2</a>, <a href="cope.cgi?key=Neurite%20growth%2dpromoting%20factor%2d2">neurite growth-promoting factor-2</a>, <a href="cope.cgi?key=ARAP">ARAP</a>, <a href="cope.cgi?key=Amphiregulin%2dassociated%20protein">Amphiregulin-associated protein</a>, <a href="cope.cgi?key=RIHB">RIHB</a>, <a href="cope.cgi?key=Retinoic%20acid%2dinducible%20heparin%20binding%20protein">retinoic acid-inducible heparin binding protein</a>) (Kodelja et al, 1997; Narita et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MIF">MIF</a></b> (<a href="cope.cgi?key=MMIF">MMIF</a>, <a href="cope.cgi?key=Macrophage%20migration%20inhibitory%20factor">macrophage migration inhibitory factor</a>, <a href="cope.cgi?key=GIF">GIF</a>, <a href="cope.cgi?key=GLIF">GLIF</a>, <a href="cope.cgi?key=Glycosylation%20inhibiting%20factor">glycosylation inhibiting factor</a>, <a href="cope.cgi?key=DER6">DER6</a>, <a href="cope.cgi?key=DER6">Delayed early response protein 6</a>, <a href="cope.cgi?key=phenylpyruvate%20tautomerase">phenylpyruvate tautomerase</a>, <a href="cope.cgi?key=PPT">PPT</a>, <a href="cope.cgi?key=EC5%2e3%2e2%2e1">EC5.3.2.1</a>, <a href="cope.cgi?key=phenylpyruvate%20keto%2denol%20isomerase">phenylpyruvate keto-enol isomerase</a>; <a href="cope.cgi?key=phenylpyruvate%20tautomerase">phenylpyruvate tautomerase</a>; <a href="cope.cgi?key=phenylpyruvate%20keto%2denol%20isomerase">phenylpyruvate keto-enol isomerase</a>; <a href="cope.cgi?key=EC5%2e3%2e2%2e1">EC5.3.2.1</a>) (Calandra et al, 1994; Martiney et al, 2000; Onodera et al, 1997; Sakamoto et al, 1998; Paiva et al, 2009; Pan X et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=MIF">MIF</a></b> (<a href="cope.cgi?key=MMIF">MMIF</a>, <a href="cope.cgi?key=Macrophage%20migration%20inhibitory%20factor">macrophage migration inhibitory factor</a>, <a href="cope.cgi?key=GIF">GIF</a>, <a href="cope.cgi?key=GLIF">GLIF</a>, <a href="cope.cgi?key=Glycosylation%20inhibiting%20factor">glycosylation inhibiting factor</a>, <a href="cope.cgi?key=DER6">DER6</a>, <a href="cope.cgi?key=DER6">Delayed early response protein 6</a>, <a href="cope.cgi?key=phenylpyruvate%20tautomerase">phenylpyruvate tautomerase</a>, <a href="cope.cgi?key=PPT">PPT</a>, <a href="cope.cgi?key=EC5%2e3%2e2%2e1">EC5.3.2.1</a>, <a href="cope.cgi?key=phenylpyruvate%20keto%2denol%20isomerase">phenylpyruvate keto-enol isomerase</a>; <a href="cope.cgi?key=phenylpyruvate%20tautomerase">phenylpyruvate tautomerase</a>; <a href="cope.cgi?key=phenylpyruvate%20keto%2denol%20isomerase">phenylpyruvate keto-enol isomerase</a>; <a href="cope.cgi?key=EC5%2e3%2e2%2e1">EC5.3.2.1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Onodera et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MINCLE">MINCLE</a> </b>(<a href="cope.cgi?key=Macrophage%2dinducible%20C%2dtype%20lectin">Macrophage-inducible C-type lectin</a>, <a href="cope.cgi?key=CLECSF9">CLECSF9</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20superfamily%20member%209">C-type lectin domain superfamily member 9</a>, <a href="cope.cgi?key=CLEC4E">CLEC4E</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%204%20member%20E">C-type lectin domain family 4 member E</a>, <a href="cope.cgi?key=AURA24">AURA24</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2024">augmented in rheumatoid arthritis 24</a>) (Ichioka et al, 2011; Matsumoto et al, 1999; Schoenen et al, 2010; Wells et al, 2008; Yamasaki et al, 2008; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MINOR">MINOR</a></b> (<a href="cope.cgi?key=mitogen%20inducible%20nuclear%20orphan%20receptor">mitogen inducible nuclear orphan receptor</a>, <a href="cope.cgi?key=NR4A3">NR4A3</a>, <a href="cope.cgi?key=nuclear%20receptor%20subfamily%204%20group%20A%20member%203">nuclear receptor subfamily 4 group A member 3</a>, <a href="cope.cgi?key=NOR1">NOR1</a>, <a href="cope.cgi?key=neuron%2dderived%20orphan%20receptor%2d1">neuron-derived orphan receptor-1</a>, <a href="cope.cgi?key=CHN">CHN</a><b style="mso-bidi-font-weight:normal">, </b><a href="cope.cgi?key=CSMF">CSMF</a>) (Bonta PI et al, 2006; Pei L et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d1">MMP-1</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d1">matrix metalloproteinase-1</a>, <a href="cope.cgi?key=Collagenase">collagenase</a>, <a href="cope.cgi?key=Collagenase%2d1">collagenase-1</a>, <a href="cope.cgi?key=CL%2d1">CL-1</a>, <a href="cope.cgi?key=CLG1">CLG1</a>, <a href="cope.cgi?key=Fibroblast%20collagenase">fibroblast collagenase</a>, <a href="cope.cgi?key=Fibroblast%2dtype%20collagenase">fibroblast-type collagenase</a>, <a href="cope.cgi?key=interstitial%20collagenase">interstitial collagenase</a>, <a href="cope.cgi?key=Tissue%20collagenase">tissue collagenase</a>, <a href="cope.cgi?key=EC3%2e4%2e23%2e7">EC3.4.23.7</a>) (Chase et al, 2002; Luan et al, 2003; Shapiro et al, 1991, 1992; Nikkari et al, 1995; Wallace et al, 2008; Ma et al, 1999; Gratchev A et al, 2005; Speidl WS et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d2">MMP-2</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d2">matrix metalloproteinase-2</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e24">EC3.4.24.24</a>, <a href="cope.cgi?key=70%20kDa%20gelatinase">70 kDa gelatinase</a>, <a href="cope.cgi?key=72%20kDa%20gelatinase">72 kDa gelatinase</a>, <a href="cope.cgi?key=72%20kDa%20metalloproteinase">72 kDa metalloproteinase</a>, <a href="cope.cgi?key=collagenase%20type%204">collagenase type 4</a>, <a href="cope.cgi?key=collagenase%20type%204A">collagenase type 4A</a>, <a href="cope.cgi?key=72%20kDa%20type%20IV%20collagenase">72 kDa type IV collagenase</a>, <a href="cope.cgi?key=Gelatinase%2072%20kDa">Gelatinase 72 kDa</a>, <a href="cope.cgi?key=Gelatinase%20A">Gelatinase A</a>, <a href="cope.cgi?key=Type%20IV%20collagenase">Type IV collagenase</a>, <a href="cope.cgi?key=Type%20IVA%20collagenase">Type IVA collagenase</a>, <a href="cope.cgi?key=neutrophils">neutrophil</a> <a href="cope.cgi?key=Gelatinase">gelatinase</a>) (Ogawa et al, 2000; Zhang et al, 2003; Death et al, 2002; Kawano et al, 1997; Ma et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d3">MMP-3</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d3">matrix metalloproteinase-3</a>, <a href="cope.cgi?key=Stromelysin%2d1">stromelysin-1</a>, <a href="cope.cgi?key=STMY1">STMY1</a>, <a href="cope.cgi?key=STR1">STR1</a>, <a href="cope.cgi?key=SL%2d1">SL-1</a>, <a href="cope.cgi?key=Transin">transin</a>, <a href="cope.cgi?key=Transin%2d1">transin-1</a>, <a href="cope.cgi?key=collagenase%20activating%20protein">collagenase activating protein</a>, <a href="cope.cgi?key=Procollagenase%20activator">procollagenase activator</a>, <a href="cope.cgi?key=proteoglycanase">proteoglycanase</a>) (Chase et al, 2002; Luan et al, 2003; Shapiro et al, 1991; Wallace et al, 2008; Unoki et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d7">MMP-7</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d7">matrix metalloproteinase-7</a>, <a href="cope.cgi?key=Matrilysin">matrilysin</a>, <a href="cope.cgi?key=Matrilysin%2d1">Matrilysin-1</a>, <a href="cope.cgi?key=PUMP">PUMP</a>, <a href="cope.cgi?key=punctuated%20metalloproteinase">punctuated metalloproteinase</a>, <a href="cope.cgi?key=pump%2d1">pump-1</a>, <a href="cope.cgi?key=putative%20metalloproteinase%2d1">putative metalloproteinase-1</a>, <a href="cope.cgi?key=Matrin">matrin</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e23">EC3.4.24.23</a>) (Halpert et al, 1996; Burke et al, 2003; Death et al, 2002; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d8">MMP-8</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d8">matrix metalloproteinase-8</a>, <a href="cope.cgi?key=neutrophil%20collagenase">neutrophil collagenase</a>, <a href="cope.cgi?key=PMNL%20collagenase">PMNL collagenase</a>, <a href="cope.cgi?key=polymorphonuclear%20leukocyte%20collagenase">polymorphonuclear leukocyte collagenase</a>, <a href="cope.cgi?key=Collagenase%2d2">collagenase-2</a>, <a href="cope.cgi?key=CLG2">CLG2</a>, <a href="cope.cgi?key=CL%2d2">CL-2</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d9">MMP-9</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d9">matrix metalloproteinase-9</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e35">EC3.4.24.35</a>, <a href="cope.cgi?key=Gelatinase%20B">gelatinase B</a>, <a href="cope.cgi?key=92%20kDa%20gelatinase">92 kDa gelatinase</a>, <a href="cope.cgi?key=92%20kDa%20type%20IV%20collagenase">92 kDa type IV collagenase</a>, or <a href="cope.cgi?key=PMNL%20gelatinase">PMNL gelatinase</a>, <a href="cope.cgi?key=polymorphonuclear%20leukocyte%20gelatinase">polymorphonuclear leukocyte gelatinase</a>, <a href="cope.cgi?key=gelatinase%20type%20IV%2dB">gelatinase type IV-B</a>, <a href="cope.cgi?key=collagenase%20type%205">collagenase type 5</a>, <a href="cope.cgi?key=Collagenase%2d5">collagenase-5</a>, <a href="cope.cgi?key=CL%2d5">CL-5</a>) (Chase et al, 2002; D'Ortho et al, 1995; Min et al, 2002; Yoo et al, 2002; Dreier et al, 2001, 2004; Ragno et al, 2001; Lee et al, 2004; Luan et al, 2003; Death et al, 2002; Shapiro et al, 1991; Wallner K et al, 1999; Wallace et al, 2008; Vaisar et al, 2009; Bourdonnay et al, 2009; Kim WJ et al, 2005; Seizer et al, 2010; Jeon ST et al, 2010; Speidl WS et al, 2011; Lee DK et al, 2012; Huang Z et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d11">MMP-11</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d11">matrix metalloproteinase-11</a>, <a href="cope.cgi?key=Stromelysin%2d3">stromelysin-3</a>, <a href="cope.cgi?key=STMY3">STMY3</a>, <a href="cope.cgi?key=SL%2d3">SL-3</a>, <a href="cope.cgi?key=ST%2d3">ST-3</a>) (Odaka and Izumiyama, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d12">MMP-12</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d12">matrix metalloproteinase-12</a>, <a href="cope.cgi?key=macrophage%20elastase">macrophage elastase</a>, <a href="cope.cgi?key=macrophage%20metalloelastase">macrophage metalloelastase</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e65">EC3.4.24.65</a>, <a href="cope.cgi?key=MME">MME</a>, <a href="cope.cgi?key=HME">HME</a>) (Vos et al, 2003; Kerkela et al, 2002; Jost et al, 2003; Raza et al, 2000; Horton et al, 1999; Monet-Kuntz et al, 1997; Toft-Hansen et al, 2004; Impola et al, 2005; Dasilva and Yong, 2008; Bourdonnay et al, 2009; Gratchev A et al, 2005; Gleissner et al, 2010; Huber J et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d13">MMP-13</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d13">matrix metalloproteinase-13</a>, <a href="cope.cgi?key=Collagenase%2d3">Collagenase-3</a>, <a href="cope.cgi?key=CLG3">CLG3</a>, <a href="cope.cgi?key=CL%2d3">CL-3</a>)<b style="mso-bidi-font-weight: normal"> </b>(Vaalamo et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d14">MMP-14</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d14">matrix metalloproteinase-14</a>, <a href="cope.cgi?key=MT1%2dMMP">MT1-MMP</a>, <a href="cope.cgi?key=Membrane%2dtype%20matrix%20metalloproteinase%2d1">Membrane-type matrix metalloproteinase-1</a>, <a href="cope.cgi?key=MT%2dMMP%2d1">MT-MMP-1</a>, <a href="cope.cgi?key=MMP%2dX1">MMP-X1</a>) (Hayashi et al, 2000; Johnson et al, 2008; Seizer et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d16">MMP-16</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d16">matrix metalloproteinase-16</a>, <a href="cope.cgi?key=MT3%2dMMP">MT3-MMP</a>, <a href="cope.cgi?key=Membrane%2dtype%20matrix%20metalloproteinase%2d3">Membrane-type matrix metalloproteinase-3</a>, <a href="cope.cgi?key=MT%2dMMP%2d3">MT-MMP-3</a>, <a href="cope.cgi?key=C8orf57">C8orf57</a>, <a href="cope.cgi?key=chromosome%208%20open%20reading%20frame%2057">chromosome 8 open reading frame 57</a>) (Uzui et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d17">MMP-17</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d17">matrix metalloproteinase-17</a>, <a href="cope.cgi?key=MT4%2dMMP">MT4-MMP</a>, <a href="cope.cgi?key=Membrane%2dtype%20matrix%20metalloproteinase%2d4">Membrane-type matrix metalloproteinase-4</a>, <a href="cope.cgi?key=MT%2dMMP%2d4">MT-MMP-4</a>) (Rikimaru et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d18">MMP-18</a></b> [<a href="cope.cgi?key=Matrix%20metalloproteinase%2d18">matrix metalloproteinase-18</a>] (<a href="cope.cgi?key=Collagenase%2d4">Collagenase-4</a>) (Krause et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MMP%2d19">MMP-19</a></b> (<a href="cope.cgi?key=Matrix%20metalloproteinase%2d19">matrix metalloproteinase-19</a>, <a href="cope.cgi?key=RASI%2d1">RASI-1</a>, <a href="cope.cgi?key=Rheumatoid%20arthritis%20synovium%20inflamed%2d1">rheumatoid arthritis synovium inflamed-1</a>) (Hieta et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=MNCC%2dSEA">MNCC-SEA</a> (Desouza et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=MNCF">MNCF</a> [<a href="cope.cgi?key=Macrophage%2dreleased%20neutrophil%20chemotactic%20factor">macrophage-released neutrophil chemotactic factor</a>]<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MNSF%2dbeta">MNSF-beta</a></b> (<a href="cope.cgi?key=Monoclonal%20nonspecific%20suppressor%20factor">monoclonal nonspecific suppressor factor</a>, hNSF, <a href="cope.cgi?key=NSF">NSF</a>, <a href="cope.cgi?key=Nonspecific%20suppressor%20factor">Nonspecific suppressor factor</a>, <a href="cope.cgi?key=MNSF%2dbeta">MNSF-beta</a>, <a href="cope.cgi?key=Fau%20protein">Fau protein</a>, <a href="cope.cgi?key=FAU">FAU</a>, <a href="cope.cgi?key=FAU1">FAU1</a>, <a href="cope.cgi?key=Ubi%2dL">Ubi-L</a>, <a href="cope.cgi?key=FBR%2dMuSV%2dassociated%20ubiquitously%20expressed%20gene">FBR-MuSV-associated ubiquitously expressed gene</a>, <a href="cope.cgi?key=Finkel%2dBiskis%2dReilly%20murine%20sarcoma%20virus%20ubiquitously%20expressed">Finkel-Biskis-Reilly murine sarcoma virus ubiquitously expressed</a>, <a href="cope.cgi?key=fox">fox</a>, dD3, <a href="cope.cgi?key=asr1">asr1</a>, <a href="cope.cgi?key=arsenite%20resistance%2d1">arsenite resistance-1</a>) (Nakamura and Omura, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MOAP1">MOAP1</a></b> (<a href="cope.cgi?key=modulator%20of%20apoptosis%201">modulator of apoptosis 1</a>, <a href="cope.cgi?key=MAP1">MAP1</a>, <a href="cope.cgi?key=PNMA4">PNMA4</a>, <a href="cope.cgi?key=paraneoplastic%20antigen%20ma4">paraneoplastic antigen ma4</a>) (Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=MPYS">MPYS</a></b> (<a href="cope.cgi?key=TMEM173">TMEM173</a>, <a href="cope.cgi?key=transmembrane%20protein%20173">transmembrane protein 173</a>, <a href="cope.cgi?key=NET23">NET23</a>, <a href="cope.cgi?key=ERIS">ERIS</a>, <a href="cope.cgi?key=endoplasmic%20reticulum%20interferon%20stimulator">endoplasmic reticulum interferon stimulator</a>, <a href="cope.cgi?key=AURA12">AURA12</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2012">augmented in rheumatoid arthritis 12</a>, <a href="cope.cgi?key=STING">STING</a>, <a href="cope.cgi?key=stimulator%20of%20interferon%20genes">stimulator of interferon genes</a>, <a href="cope.cgi?key=MITA">MITA</a>, <a href="cope.cgi?key=mediator%20of%20IRF3%20activation">mediator of IRF3 activation</a>) (Jin L et al, 2011; Koppe et al, 2012; Gratz et al, 2011; Ishikawa et al, 2009; Jin L et al, 2011; Lippmann et al 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=M%2dspondin">M-spondin</a></b> (<a href="cope.cgi?key=SPON2">SPON2</a>, <a href="cope.cgi?key=Spondin%2d2">spondin-2</a>, <a href="cope.cgi?key=DIL%2d1">DIL-1</a>, <a href="cope.cgi?key=differentially%20expressed%20in%20lung%20cells%2d1">differentially expressed in lung cells-1</a>, <a href="cope.cgi?key=differentially%20expressed%20in%20cancerous%20and%20noncancerous%20lung%20cells%201">differentially expressed in cancerous and noncancerous lung cells 1</a>, <a href="cope.cgi?key=Mindin">Mindin</a>) (Bourdonnay et al, 2009; Gleissner et al, 2010; Guleng et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Mx">Mx</a></b> (<a href="cope.cgi?key=myxovirus%20resistance%201">myxovirus resistance 1</a>, <a href="cope.cgi?key=Mx1">Mx1</a>, <a href="cope.cgi?key=MxA">MxA</a>, <a href="cope.cgi?key=IFI%2d78k">IFI-78k</a>, <a href="cope.cgi?key=Interferon%2dinducible%2078%20kDa%20protein">interferon-inducible 78 kDa protein</a>; <a href="cope.cgi?key=IFI%2d78">IFI-78</a>) (Melaine et al, 2003; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=myeloperoxidase">myeloperoxidase</a></b> (<a href="cope.cgi?key=MPO">MPO</a>, <a href="cope.cgi?key=AURA60">AURA60</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2060">augmented in rheumatoid arthritis 60</a>) (Nagra et al, 1997)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NAIP">NAIP</a> </b>(<a href="cope.cgi?key=Neuronal%20apoptosis%20inhibitor%20protein">Neuronal apoptosis inhibitor protein</a>, <a href="cope.cgi?key=NAIP1">NAIP1</a>, <a href="cope.cgi?key=Neuronal%20apoptosis%20inhibitor%20protein%201">Neuronal apoptosis inhibitor protein 1</a>, <a href="cope.cgi?key=BIRC1">BIRC1</a>, <a href="cope.cgi?key=baculoviral%20IAP%20repeat%2dcontaining%20protein%2d1">baculoviral IAP repeat-containing protein-1</a>, <a href="cope.cgi?key=BIRC1a">BIRC1a</a>, <a href="cope.cgi?key=baculoviral%20IAP%20repeat%2dcontaining%20protein%2d1a">baculoviral IAP repeat-containing protein-1a</a>, <a href="cope.cgi?key=NLRB1">NLRB1</a>, <a href="cope.cgi?key=NLRB">NLRB</a>, <a href="cope.cgi?key=Nlrb1a">Nlrb1a</a>, <a href="cope.cgi?key=NAIP%2drs1">NAIP-rs1</a>, <a href="cope.cgi?key=neuronal%20apoptosis%20inhibitory%20protein%20related%20sequence%201">neuronal apoptosis inhibitory protein related sequence 1</a>, <a href="cope.cgi?key=CLR5%2e1">CLR5.1</a>) (Diez et al, 2000; Vinzing et al, 2008; Maier et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NAIP5">NAIP5</a></b> (<a href="cope.cgi?key=Neuronal%20apoptosis%20inhibitor%20protein%205">Neuronal apoptosis inhibitor protein 5</a>, <a href="cope.cgi?key=BIRC1e">BIRC1e</a>, <a href="cope.cgi?key=baculoviral%20IAP%20repeat%2dcontaining%20protein%2d1e">baculoviral IAP repeat-containing protein-1e</a>, <a href="cope.cgi?key=NAIP%2drs3">NAIP-rs3</a>, <a href="cope.cgi?key=neuronal%20apoptosis%20inhibitory%20protein%20related%20sequence%203">neuronal apoptosis inhibitory protein related sequence 3</a>, <a href="cope.cgi?key=Nlrb1e">Nlrb1e</a>) (Akhter et al, 2009; Asare et al, 2007; Coers et al, 2007; Fortier et al, 2011; Kang et al, 2010; Losick et al, 2009; Miao et al, 2008; Molofsky et al, 2006; Whitfield et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥ <a href="cope.cgi?key=NALP1">NALP1</a></b> (<a href="cope.cgi?key=NACHT%2dLRR%2dPYD%2dcontaining%20protein%2d1">NACHT-LRR-PYD-containing protein-1</a>, <a href="cope.cgi?key=DEFCAP">DEFCAP</a>, <a href="cope.cgi?key=death%20effector%20filament%2dforming%20CED4%2dlike%20apoptosis%20protein">death effector filament-forming CED4-like apoptosis protein</a>, <a href="cope.cgi?key=CARD7">CARD7</a>, <a href="cope.cgi?key=caspase%20recruitment%20domain%2dcontaining%20protein%2d7">caspase recruitment domain-containing protein-7</a>, <a href="cope.cgi?key=KIAA0926">KIAA0926</a>, <a href="cope.cgi?key=NAC">NAC</a>, <a href="cope.cgi?key=nucleotide%2dbinding%20domain%20and%20CARD%20containing%20protein">nucleotide-binding domain and CARD containing protein</a>, <a href="cope.cgi?key=NLRP1">NLRP1</a>, <a href="cope.cgi?key=NLR%20family%2c%20pyrin%2ddomain%20containing%201">NLR family, pyrin-domain containing 1</a>, <a href="cope.cgi?key=CLR17%2e1">CLR17.1</a>) (Moayeri et al, 2010; Newman et al, 2010, 2011; Reig et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=NCP">NCP</a> (Wuyts et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=Neurokinin%20A">neurokinin A</a> receptors (D'Ortho et al, 1995; Brylla et al, 2005; Sun et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=Neurokinin%20B">neurokinin B</a> receptors (Brylla et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Neuromedin%20B">Neuromedin B</a> </b>(<a href="cope.cgi?key=NMB">NMB</a>, <a href="cope.cgi?key=Ranatensin">ranatensin</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Burke et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Neuropeptide%20Y">neuropeptide Y</a></b> (<a href="cope.cgi?key=NPY">NPY</a>, <a href="cope.cgi?key=Y%20Neuropeptide">Y Neuropeptide</a>) (Kim DK et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Neuropeptide%20Y">neuropeptide Y</a></b> (<a href="cope.cgi?key=NPY">NPY</a>, <a href="cope.cgi?key=Y%20Neuropeptide">Y Neuropeptide</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (De la Fuente et al, 1993)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Neuropilin%2d1">neuropilin-1</a></b> (<a href="cope.cgi?key=Neuropilin">Neuropilin</a>, <a href="cope.cgi?key=NPN%2d1">NPN-1</a>, <a href="cope.cgi?key=NP%2d1">NP-1</a>, <a href="cope.cgi?key=NRP1">NRP1</a>, <a href="cope.cgi?key=A5%2dantigen">A5-antigen</a>, <a href="cope.cgi?key=BDCA4">BDCA4</a>, <a href="cope.cgi?key=Blood%20dendritic%20cell%20antigen%204">Blood dendritic cell antigen 4</a>, <a href="cope.cgi?key=VEGF%2d165R">VEGF-165R</a>, <a href="cope.cgi?key=CD304">CD304</a>) (Stepanova et al, 2007; Ji et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Neuropilin%2d2">neuropilin-2</a></b> (<a href="cope.cgi?key=NPN%2d2">NPN-2</a>, <a href="cope.cgi?key=NP%2d2">NP-2</a>, <a href="cope.cgi?key=NRP2">NRP2</a>) (Stepanova et al, 2007; Ji et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Nexin%2d1">Nexin-1</a></b> (<a href="cope.cgi?key=PN%2d1%2dalpha">PN-1-alpha</a>, <a href="cope.cgi?key=Glial%2dderived%20neurite%20promoting%20factor">Glial-derived neurite promoting factor</a>, <a href="cope.cgi?key=GdNPF">GdNPF</a>, <a href="cope.cgi?key=Glia%2dderived%20nexin">Glia-derived nexin</a>, <a href="cope.cgi?key=GDN">GDN</a>, <a href="cope.cgi?key=NPF">NPF</a>, <a href="cope.cgi?key=Neurite%2dpromoting%20factor">neurite-promoting factor</a>, <a href="cope.cgi?key=Serpin%20E2">Serpin E2</a>) (Mansilla et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=NG2">NG2</a></b> (<a href="cope.cgi?key=neuronal%2fglial%202">neuronal/glial 2</a>, <a href="cope.cgi?key=AN2">AN2</a>, <a href="cope.cgi?key=MCSP">MCSP</a>, <a href="cope.cgi?key=melanoma%20chondroitin%20sulfate%20proteoglycan">melanoma chondroitin sulfate proteoglycan</a>, <a href="cope.cgi?key=mel%2dCSPG">mel-CSPG</a>, <a href="cope.cgi?key=MCSPG">MCSPG</a>, <a href="cope.cgi?key=melanoma%20chondroitin%20sulfate%20proteoglycan">melanoma chondroitin sulfate proteoglycan</a>, <a href="cope.cgi?key=HMW%2dMAA">HMW-MAA</a>,<b style="mso-bidi-font-weight: normal"> </b><a href="cope.cgi?key=high%20molecular%20weight%2dmelanoma%2dassociated%20antigen">high molecular weight-melanoma-associated antigen</a>, <a href="cope.cgi?key=CSPG4">CSPG4</a>, <a href="cope.cgi?key=chondroitin%20sulfate%20proteoglycan%204">chondroitin sulfate proteoglycan 4</a>) (Jones et al, 2002; Bu et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=NGF">NGF</a></b> (<a href="cope.cgi?key=Nerve%20growth%20factor">nerve growth factor</a>, <a href="cope.cgi?key=7S%20NGF">7S NGF</a>, <a href="cope.cgi?key=7S%20nerve%20growth%20factor">7S nerve growth factor</a>, <a href="cope.cgi?key=NGF%2dalpha">NGF-alpha</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dalpha">Nerve growth factor-alpha</a>, <a href="cope.cgi?key=kallikrein%20Klk1b4">kallikrein Klk1b4</a>, <a href="cope.cgi?key=Klk1b4">Klk1b4</a>, <a href="cope.cgi?key=NGF%2dbeta">NGF-beta</a>, <a href="cope.cgi?key=NGFB">NGFB</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dbeta">Nerve growth factor-beta</a>, <a href="cope.cgi?key=NGFG">NGFG</a>, <a href="cope.cgi?key=NGF%2dgamma">NGF-gamma</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dgamma">Nerve growth factor-gamma</a>, <a href="cope.cgi?key=kallikrein%20Klk1b3">kallikrein Klk1b3</a>, <a href="cope.cgi?key=Klk1b3">Klk1b3</a>) (Barouch et al, 2001; Caroleo et al, 2001; Kanda and Watanabe, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=NGF">NGF</a></b> (<a href="cope.cgi?key=Nerve%20growth%20factor">nerve growth factor</a>, <a href="cope.cgi?key=7S%20NGF">7S NGF</a>, <a href="cope.cgi?key=7S%20nerve%20growth%20factor">7S nerve growth factor</a>, <a href="cope.cgi?key=NGF%2dalpha">NGF-alpha</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dalpha">Nerve growth factor-alpha</a>, <a href="cope.cgi?key=kallikrein%20Klk1b4">kallikrein Klk1b4</a>, <a href="cope.cgi?key=Klk1b4">Klk1b4</a>, <a href="cope.cgi?key=NGF%2dbeta">NGF-beta</a>, <a href="cope.cgi?key=NGFB">NGFB</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dbeta">Nerve growth factor-beta</a>, <a href="cope.cgi?key=NGFG">NGFG</a>, <a href="cope.cgi?key=NGF%2dgamma">NGF-gamma</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dgamma">Nerve growth factor-gamma</a>, <a href="cope.cgi?key=kallikrein%20Klk1b3">kallikrein Klk1b3</a>, <a href="cope.cgi?key=Klk1b3">Klk1b3</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=NGFR">NGFR</a>, <a href="cope.cgi?key=p75NTR">p75NTR</a>, <a href="cope.cgi?key=p75%20neurotrophin%20receptor">p75 neurotrophin receptor</a>, <a href="cope.cgi?key=p75LNGFR">p75LNGFR</a>, <a href="cope.cgi?key=p75NGFR">p75NGFR</a>, <a href="cope.cgi?key=LNGFR">LNGFR</a>, <a href="cope.cgi?key=p75%20low%20affinity%20NGF%20receptor">p75 low affinity NGF receptor</a>, <a href="cope.cgi?key=TNFRSF16">TNFRSF16</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2016">TNF receptor superfamily member 16</a>, <a href="cope.cgi?key=CD271">CD271</a>) (Liuzzo et al, 1999; Kobayashi and Mizisin, 2001; Ricci et al, 2001; Caroleo et al, 2001; Barouch et al, 2001; Susaki et al, 1996, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NKEF%2dA">NKEF-A</a></b> (<a href="cope.cgi?key=Natural%20killer%20enhancing%20factor%20A">Natural killer enhancing factor A</a>, <a href="cope.cgi?key=Peroxiredoxin%2d1">Peroxiredoxin-1</a>, <a href="cope.cgi?key=PRDX1">PRDX1</a>, <a href="cope.cgi?key=PRX1">PRX1</a>, <a href="cope.cgi?key=PAGA">PAGA</a>, <a href="cope.cgi?key=proliferation%2dassociated%20gene%20A">proliferation-associated gene A</a>, <a href="cope.cgi?key=HBP23">HBP23</a>, <a href="cope.cgi?key=heme%2dbinding%20protein%2023%20kDa">heme-binding protein 23 kDa</a>, <a href="cope.cgi?key=MSP23">MSP23</a>, <a href="cope.cgi?key=macrophage%2023%20kDa%20stress%20protein">macrophage 23 kDa stress protein</a>, <a href="cope.cgi?key=PAG">PAG</a>, <a href="cope.cgi?key=proliferation%2dassociated%20gene">proliferation-associated gene</a>, <a href="cope.cgi?key=AURA93">AURA93</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2093">augmented in rheumatoid arthritis 93</a>) (Lavric et al, 2008; Kinnula et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NKG2D">NKG2D</a></b> (<a href="cope.cgi?key=NK%20cell%20receptor%20D">NK cell receptor D</a>, <a href="cope.cgi?key=KLR">KLR</a> <a href="cope.cgi?key=KLRK1">KLRK1</a>, <a href="cope.cgi?key=killer%20cell%20lectin%2dlike%20receptor%20subfamily%20K%20member%201">killer cell lectin-like receptor subfamily K member 1</a>, <a href="cope.cgi?key=KLRC4">KLRC4</a>, <a href="cope.cgi?key=killer%20cell%20lectin%2dlike%20receptor%20subfamily%20C%20member%204">killer cell lectin-like receptor subfamily C member 4</a>, <a href="cope.cgi?key=NKR%2dP2">NKR-P2</a>, <a href="cope.cgi?key=natural%20killer%20cell%20receptor%20P2">natural killer cell receptor P2</a>, <a href="cope.cgi?key=NK%2dcell%20receptor%20P2">NK-cell receptor P2</a>, <a href="cope.cgi?key=NK%2dcell%20receptor%20protein%2d2">NK-cell receptor protein-2</a>, <a href="cope.cgi?key=CD314">CD314</a>) (Baba et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NKLAM">NKLAM</a> </b>(<a href="cope.cgi?key=NK%20lytic%2dassociated%20molecule">NK lytic-associated molecule</a>, <a href="cope.cgi?key=IBRDC3">IBRDC3</a>, <a href="cope.cgi?key=IBR%20domain%20containing%20protein%203">IBR domain containing protein 3</a>, <a href="cope.cgi?key=RNF19B">RNF19B</a>, ring finger protein 19B) (Kozlowski et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NLRC4">NLRC4</a></b> (<a href="cope.cgi?key=NLR%20family%2c%20CARD%20domain%20containing%204">NLR family, CARD domain containing 4</a>, <a href="cope.cgi?key=IPAF">IPAF</a>, <a href="cope.cgi?key=ICE%20protease%2dactivating%20factor">ICE protease-activating factor</a>, <a href="cope.cgi?key=CARD12">CARD12</a>, <a href="cope.cgi?key=caspase%20recruitment%20domain%2dcontaining%20protein%2d12">caspase recruitment domain-containing protein-12</a>, <a href="cope.cgi?key=CLAN">CLAN</a>, <a href="cope.cgi?key=CARD%20LRR%20and%20NACHT%20domain%2dcontaining%20protein">CARD LRR and NACHT domain-containing protein</a>) (Amer et al, 2006; Arleham and Evans, 2011; Coers et al, 2007 Franchi et al, 2006; Lamkanfi et al, 2010; Miao et al, 2006, 2008; Vincing et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NLRC5">NLRC5</a> </b>(<a href="cope.cgi?key=NLR%20family%2c%20CARD%20domain%20containing%205">NLR family, CARD domain containing 5</a>, <a href="cope.cgi?key=NOD27">NOD27</a>, <a href="cope.cgi?key=caspase%20recruitment%20domain%2dcontaining%20protein%2d27">caspase recruitment domain-containing protein-27</a>, <a href="cope.cgi?key=CLR16%2e1">CLR16.1</a>) (Neerincx et al, 2010; Benko et al, 2010; Cui et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NLRP6">NLRP6</a></b> (<a href="cope.cgi?key=NLR%20family%2c%20pyrin%2ddomain%20containing%206">NLR family, pyrin-domain containing 6</a>, <a href="cope.cgi?key=PYPAF5">PYPAF5</a>, <a href="cope.cgi?key=Pyrin%2dcontaining%20APAF%2d1%2dlike%20protein%205">Pyrin-containing APAF-1-like protein 5</a>, <a href="cope.cgi?key=NALP6">NALP6</a>, <a href="cope.cgi?key=NACHT%2dLRR%2dPYD%2dcontaining%20protein%2d6">NACHT-LRR-PYD-containing protein-6</a>, <a href="cope.cgi?key=PAN3">PAN3</a>, <a href="cope.cgi?key=PAAD%20and%20NACHT%2dcontaining%20protein%203">PAAD and NACHT-containing protein 3</a>, <a href="cope.cgi?key=CLR11%2e4">CLR11.4</a>) (Meixenberger et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NLRP10">NLRP10</a></b> (<a href="cope.cgi?key=NLR%20family%2c%20pyrin%2ddomain%20containing%2010">NLR family, pyrin-domain containing 10</a>, <a href="cope.cgi?key=PYNOD">PYNOD</a>, <a href="cope.cgi?key=pyrin%20domain%20and%20nucleotide%2dbinding%20oligomerization%20domain%20containing%20protein">pyrin domain and nucleotide-binding oligomerization domain containing protein</a>, <a href="cope.cgi?key=NALP10">NALP10</a>, <a href="cope.cgi?key=NACHT%2dLRR%2dPYD%2dcontaining%20protein%2d10">NACHT-LRR-PYD-containing protein-10</a>, <a href="cope.cgi?key=NOD8">NOD8</a>, <a href="cope.cgi?key=Nucleotide%2dbinding%20oligomerization%20domain%20protein%208">Nucleotide-binding oligomerization domain protein 8</a>, <a href="cope.cgi?key=PAN5">PAN5</a>, <a href="cope.cgi?key=PAAD%20and%20NACHT%2dcontaining%20protein%205">PAAD and NACHT-containing protein 5</a>, <a href="cope.cgi?key=CLR11%2e1">CLR11.1</a>) (Imamura R et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NLRX1">NLRX1</a> </b>(<a href="cope.cgi?key=NLR%20family%20member%20X1">NLR family member X1</a>, <a href="cope.cgi?key=CLR11%2e3">CLR11.3</a>, <a href="cope.cgi?key=NOD9">NOD9</a>, <a href="cope.cgi?key=Nucleotide%2dbinding%20oligomerization%20domain%20protein%209">Nucleotide-binding oligomerization domain protein 9</a>) (Allen et al, 2010; Okabe et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Nociceptin">nociceptin</a> </b>(<a href="cope.cgi?key=PNOC">PNOC</a>, <a href="cope.cgi?key=PPNOC">PPNOC</a>, <a href="cope.cgi?key=Orphanin%20FQ">Orphanin FQ</a>, <a href="cope.cgi?key=Nociceptin%2fOrphanin%20FQ">Nociceptin/Orphanin FQ</a>, <a href="cope.cgi?key=N%2fOFQ">N/OFQ</a>, <a href="cope.cgi?key=Orphanin%20FQ%2fNociceptin">Orphanin FQ/Nociceptin</a>, <a href="cope.cgi?key=OFQ%2fN">OFQ/N</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=LC132">LC132</a>, <a href="cope.cgi?key=NOCIR">NOCIR</a>, <a href="cope.cgi?key=OPRL1">OPRL1</a>, <a href="cope.cgi?key=ORL1">ORL1</a>, <a href="cope.cgi?key=opioid%20receptor%2dlike%201">opioid receptor-like 1</a>, <a href="cope.cgi?key=opiate%20receptor%2dlike%201">opiate receptor-like 1</a>, <a href="cope.cgi?key=OP4">OP4</a>, <a href="cope.cgi?key=opioid%20receptor%204">opioid receptor 4</a>, <a href="cope.cgi?key=NOP">NOP</a>, <a href="cope.cgi?key=non%2dclassical%20opioid%20receptor">non-classical opioid receptor</a>) (Krger et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NOD1">NOD1</a></b> (<a href="cope.cgi?key=Nucleotide%2dbinding%20oligomerization%20domain%20protein%201">Nucleotide-binding oligomerization domain protein 1</a>, <a href="cope.cgi?key=CARD4">CARD4</a>, <a href="cope.cgi?key=caspase%20recruitment%20domain%2dcontaining%20protein%2d4">caspase recruitment domain-containing protein-4</a>, <a href="cope.cgi?key=NLRC1">NLRC1</a>, <a href="cope.cgi?key=NLR%20family%2c%20CARD%20domain%20containing%201">NLR family, CARD domain containing 1</a>) (Takahashi et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NOD2">NOD2</a></b> (<a href="cope.cgi?key=Nucleotide%2dbinding%20oligomerization%20domain%20protein%202">Nucleotide-binding oligomerization domain protein 2</a>, <a href="cope.cgi?key=CARD15">CARD15</a>, <a href="cope.cgi?key=caspase%20recruitment%20domain%2dcontaining%20protein%2d15">caspase recruitment domain-containing protein-15</a>, <a href="cope.cgi?key=NLRC2">NLRC2</a>, <a href="cope.cgi?key=NLR%20family%2c%20CARD%20domain%20containing%202">NLR family, CARD domain containing 2</a>, <a href="cope.cgi?key=IBD1">IBD1</a>, <a href="cope.cgi?key=inflammatory%20bowel%20disease%201">inflammatory bowel disease 1</a>, <a href="cope.cgi?key=BLAU">BLAU</a>, <a href="cope.cgi?key=CLR16%2e3">CLR16.3</a>) (Ospelt et al, 2009; Takahashi et al, 2006; Nakamura et al, 2011; Poole et al, 2011; Tsai et al, 2011; Brooks et al, 2011; Mukhopadhyay et al, 2010; Homer et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Nogo">Nogo</a></b> (<a href="cope.cgi?key=neurite%20outgrowth%20inhibitor">neurite outgrowth inhibitor</a>, <a href="cope.cgi?key=NI%2d220">NI-220</a>, <a href="cope.cgi?key=neurite%20growth%20inhibitor%20220">neurite growth inhibitor 220</a>, <a href="cope.cgi?key=KIAA0886">KIAA0886</a>, <a href="cope.cgi?key=vp20">vp20</a>, <a href="cope.cgi?key=reticulon%2d4">reticulon-4</a>, <a href="cope.cgi?key=RTN4">RTN4</a>, <a href="cope.cgi?key=IN%2d1%20antigen">IN-1 antigen</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=NgR">NgR</a>, <a href="cope.cgi?key=Nogo%20receptor">Nogo receptor</a>, <a href="cope.cgi?key=NgR1">NgR1</a>, <a href="cope.cgi?key=Nogo%20receptor%201">Nogo receptor 1</a>, <a href="cope.cgi?key=Nogo%2d66%20receptor">Nogo-66 receptor</a>, <a href="cope.cgi?key=NOGOR">NOGOR</a>, <a href="cope.cgi?key=RTN4R">RTN4R</a>, <a href="cope.cgi?key=reticulon%204%20receptor">reticulon 4 receptor</a>) (Zhu Z et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Notch%2d1">Notch-1</a></b> (<a href="cope.cgi?key=Notch">Notch</a>, <a href="cope.cgi?key=Motch">Motch</a>, <a href="cope.cgi?key=Motch%20A">Motch A</a>, <a href="cope.cgi?key=TAN%2d1">TAN-1</a>, <a href="cope.cgi?key=translocation%2dassociated%20notch%20homolog%2d1">translocation-associated notch homolog-1</a>) (Narayana Y and Balaji, 2008; Boonyatecha N et al, 2012; Wongchana W and Palaga T, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NPR3">NPR3</a> </b>(<a href="cope.cgi?key=natriuretic%20peptide%20receptor%203">natriuretic peptide receptor 3</a>, <a href="cope.cgi?key=NPR%2dC">NPR-C</a>, <a href="cope.cgi?key=natriuretic%20peptide%20receptor%2dC">natriuretic peptide receptor-C</a>, <a href="cope.cgi?key=ANPRC">ANPRC</a>, <a href="cope.cgi?key=atrial%20natriuretic%20peptide%20clearance%20receptor%20C">atrial natriuretic peptide clearance receptor C</a>, <a href="cope.cgi?key=C5ORF23">C5ORF23</a>, <a href="cope.cgi?key=chromosome%205%20open%20reading%20frame%2023">chromosome 5 open reading frame 23</a>, <a href="cope.cgi?key=osteocrin%20receptor">osteocrin receptor</a>, <a href="cope.cgi?key=musclin%20receptor">musclin receptor</a>, <a href="cope.cgi?key=longjohn">longjohn</a>, <a href="cope.cgi?key=lgj">Lgj</a>, <a href="cope.cgi?key=longjohn%2d2J">longjohn-2J</a>, <a href="cope.cgi?key=lgj%282J%29">lgj(2J)</a>, <a href="cope.cgi?key=strigosus">strigosus</a>, <a href="cope.cgi?key=stri">stri</a>)<b style="mso-bidi-font-weight:normal"> </b>(Baldini et al, 2003; Kiemer and Vollmar, 1997; Kiemer et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NT%2d3">NT-3</a></b> (<a href="cope.cgi?key=Neurotrophin%2d3">neurotrophin-3</a>, <a href="cope.cgi?key=Neuronotrophin%2d3">neuronotrophin-3</a>, <a href="cope.cgi?key=Neurotrophic%20factor%2d3">neurotrophic factor-3</a>, <a href="cope.cgi?key=NTF%2d3">NTF-3</a>, <a href="cope.cgi?key=HDNF">HDNF</a>, <a href="cope.cgi?key=Hippocampus%2dderived%20neurotrophic%20factor">hippocampus-derived neurotrophic factor</a>, <a href="cope.cgi?key=NGF%2d2">NGF-2</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2d2">Nerve growth factor-2</a>) (Barouch et al, 2001; Asami et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=NT%2d3">NT-3</a></b> (<a href="cope.cgi?key=Neurotrophin%2d3">neurotrophin-3</a>, <a href="cope.cgi?key=Neuronotrophin%2d3">neuronotrophin-3</a>, <a href="cope.cgi?key=Neurotrophic%20factor%2d3">neurotrophic factor-3</a>, <a href="cope.cgi?key=NTF%2d3">NTF-3</a>, <a href="cope.cgi?key=HDNF">HDNF</a>, <a href="cope.cgi?key=Hippocampus%2dderived%20neurotrophic%20factor">hippocampus-derived neurotrophic factor</a>, <a href="cope.cgi?key=NGF%2d2">NGF-2</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2d2">Nerve growth factor-2</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Kobayashi and Mizisin, 2001; Ricci et al, 2001; Asami et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=nur%2d77">nur-77</a></b> (<a href="cope.cgi?key=nuclear%20receptor%2d77">nuclear receptor-77</a>, <a href="cope.cgi?key=NAK1">NAK1</a>, <a href="cope.cgi?key=NGFI%2dB">NGFI-B</a>, <a href="cope.cgi?key=Nerve%20growth%20factor%2dinducible%20B">nerve growth factor-inducible B</a>, <a href="cope.cgi?key=RNR%2d1">RNR-1</a>, <a href="cope.cgi?key=regenerating%20liver%20nuclear%20receptor">regenerating liver nuclear receptor</a>, <a href="cope.cgi?key=NR4A1">NR4A1</a>,<b style="mso-bidi-font-weight:normal"> </b><a href="cope.cgi?key=nuclear%20receptor%20subfamily%204%20group%20A%20member%201">nuclear receptor subfamily 4 group A member 1</a>, <a href="cope.cgi?key=TIS1">TIS1</a>, <a href="cope.cgi?key=TPA%2dinducible%20sequence%2d1">TPA-inducible sequence-1</a>, <a href="cope.cgi?key=tetradecanoyl%20phorbol%20acetate%2dinducible%20sequence%2d1">tetradecanoyl phorbol acetate-inducible sequence-1</a>) (Bonta PI et al, 2006; Pei L et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=Nurr%2d1">Nurr-1</a> </b>(<a href="cope.cgi?key=nuclear%20receptor%2drelated%20factor%201">nuclear receptor-related factor 1</a>, <a href="cope.cgi?key=NR4A2">NR4A2</a>, <a href="cope.cgi?key=nuclear%20receptor%20subfamily%204%20group%20A%20member%202">nuclear receptor subfamily 4 group A member 2</a>, <a href="cope.cgi?key=NOT">NOT</a>, <a href="cope.cgi?key=nuclear%20receptor%20of%20T%2dcells">nuclear receptor of T-cells</a>, <a href="cope.cgi?key=TINUR">TINUR</a>, <a href="cope.cgi?key=transcriptionally%20inducible%20nuclear%20receptor">transcriptionally inducible nuclear receptor</a>) (Bonta PI et al, 2006; Pei L et al, 2005)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=OCIL">OCIL</a></b> (<a href="cope.cgi?key=osteoclast%20inhibitory%20lectin">Osteoclast inhibitory lectin</a>, <a href="cope.cgi?key=CLEC2D">CLEC2D</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%202%20member%20D">C-type lectin domain family 2 member D</a>, <a href="cope.cgi?key=CLR%2db">CLR-b</a>, <a href="cope.cgi?key=C%2dtype%20lectin%2drelated%20molecule%2db">C-type lectin-related molecule-b</a>, <a href="cope.cgi?key=LLT1">LLT1</a>, <a href="cope.cgi?key=lectin%2dlike%20transcript%201">lectin-like transcript 1</a>) (Iizuka et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=OCIL">OCIL</a></b> (<a href="cope.cgi?key=osteoclast%20inhibitory%20lectin">Osteoclast inhibitory lectin</a>, <a href="cope.cgi?key=CLEC2D">CLEC2D</a>, <a href="cope.cgi?key=C%2dtype%20lectin%20domain%20family%202%20member%20D">C-type lectin domain family 2 member D</a>, <a href="cope.cgi?key=CLR%2db">CLR-b</a>, <a href="cope.cgi?key=C%2dtype%20lectin%2drelated%20molecule%2db">C-type lectin-related molecule-b</a>, <a href="cope.cgi?key=LLT1">LLT1</a>, <a href="cope.cgi?key=lectin%2dlike%20transcript%201">lectin-like transcript 1</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Zhou et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=Oncomodulin">Oncomodulin</a></b> (<a href="cope.cgi?key=OCM">OCM</a>, <a href="cope.cgi?key=Beta%2dparvalbumin">beta-parvalbumin</a>, <a href="cope.cgi?key=parvalbumin%2dbeta">parvalbumin-beta</a>, <a href="cope.cgi?key=CBP%2d15">CBP-15</a>, <a href="cope.cgi?key=calcium%20binding%20protein%2015">calcium binding protein 15</a>) (Yin et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=Oncostatin%20M">Oncostatin M</a></b> (<a href="cope.cgi?key=OSM">OSM</a>, <a href="cope.cgi?key=OM">OM</a>, <a href="cope.cgi?key=Onco%20M">Onco M</a>, <a href="cope.cgi?key=OnM">OnM</a>) (Repovic and Benveniste, 2002; Singh and Sodhi et al, 1998; Sodhi et al, 1998; Kozlowska et al, 1998; Kastl et al, 2008, 2009; Edwards JP et al, 2006; Ganesh K et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Osteoactivin">Osteoactivin</a></b> [<a href="cope.cgi?key=HGFIN">HGFIN</a>, <a href="cope.cgi?key=hematopoietic%20growth%20factor%20inducible%20neurokinin%2d1%20type">hematopoietic growth factor inducible neurokinin-1 type</a>, <a href="cope.cgi?key=GPNMB">GPNMB</a>, <a href="cope.cgi?key=Glycoprotein%20non%2dmetastatic%20melanoma%20protein%20B">Glycoprotein non-metastatic melanoma protein B</a>, <a href="cope.cgi?key=nmb">nmb</a>, <a href="cope.cgi?key=DC%2dHIL">DC-HIL</a>, <a href="cope.cgi?key=dendritic%20cell%2dassociated%20heparan%20sulfate%20proteoglycan%2dintegrin%20ligand">dendritic cell-associated heparan sulfate proteoglycan-integrin ligand</a>] (Haralanova-Ilieva et al, 2005; Ripoll et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=Osteopontin">osteopontin</a></b> (<a href="cope.cgi?key=OPN">OPN</a>, <a href="cope.cgi?key=OP">OP</a>, <a href="cope.cgi?key=Osp">Osp</a>, <a href="cope.cgi?key=2ar">2ar</a>, <a href="cope.cgi?key=44%20kDa%20bone%20phosphoprotein">44 kDa bone phosphoprotein</a>, <a href="cope.cgi?key=66%20kDa%20bone%20phosphoprotein">66 kDa bone phosphoprotein</a>, <a href="cope.cgi?key=bone%20sialoprotein">bone sialoprotein</a>, <a href="cope.cgi?key=bone%20sialoprotein%2d1">bone sialoprotein-1</a>, <a href="cope.cgi?key=BSP">BSP</a>, <a href="cope.cgi?key=BSP1">BSP1</a>, <a href="cope.cgi?key=BSPI">BSPI</a>, <a href="cope.cgi?key=Calcium%20oxalate%20crystal%20growth%20inhibitor%20protein">Calcium oxalate crystal growth inhibitor protein</a>, <a href="cope.cgi?key=Eta%2d1">Eta-1</a>, <a href="cope.cgi?key=early%20T%2dlymphocyte%20activation%20protein%201">early T-lymphocyte activation protein 1</a>, <a href="cope.cgi?key=Nephropontin">Nephropontin</a>, <a href="cope.cgi?key=Spp%2d1">Spp-1</a>, <a href="cope.cgi?key=Secreted%20Phosphoprotein%2d1">Secreted Phosphoprotein-1</a>, <a href="cope.cgi?key=transformation%2drelated%20phosphoprotein">transformation-related phosphoprotein</a>, <a href="cope.cgi?key=tumor%2dsecreted%20phosphoprotein">tumor-secreted phosphoprotein</a>, <a href="cope.cgi?key=urinary%20stone%20protein">urinary stone protein</a>, <a href="cope.cgi?key=Uropontin">Uropontin</a>)<b style="mso-bidi-font-weight:normal"> </b>(Gao et al, 2004; Moreno-Altamirano et al, 2004; Giachelli et al, 1998; McKee and Nanci, 1996; Krause et al, 1996; Makiishi-Shimobayashi et al, 2001; Ragno et al, 2001; Khajoee et al, 2006; Kim et al, 2006; Zhao et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=Osteopontin">osteopontin</a></b> (<a href="cope.cgi?key=OPN">OPN</a>, <a href="cope.cgi?key=OP">OP</a>, <a href="cope.cgi?key=Osp">Osp</a>, <a href="cope.cgi?key=2ar">2ar</a>, <a href="cope.cgi?key=44%20kDa%20bone%20phosphoprotein">44 kDa bone phosphoprotein</a>, <a href="cope.cgi?key=66%20kDa%20bone%20phosphoprotein">66 kDa bone phosphoprotein</a>, <a href="cope.cgi?key=bone%20sialoprotein">bone sialoprotein</a>, <a href="cope.cgi?key=bone%20sialoprotein%2d1">bone sialoprotein-1</a>, <a href="cope.cgi?key=BSP">BSP</a>, <a href="cope.cgi?key=BSP1">BSP1</a>, <a href="cope.cgi?key=BSPI">BSPI</a>, <a href="cope.cgi?key=Calcium%20oxalate%20crystal%20growth%20inhibitor%20protein">Calcium oxalate crystal growth inhibitor protein</a>, <a href="cope.cgi?key=Eta%2d1">Eta-1</a>, <a href="cope.cgi?key=early%20T%2dlymphocyte%20activation%20protein%201">early T-lymphocyte activation protein 1</a>, <a href="cope.cgi?key=Nephropontin">Nephropontin</a>, <a href="cope.cgi?key=Spp%2d1">Spp-1</a>, <a href="cope.cgi?key=Secreted%20Phosphoprotein%2d1">Secreted Phosphoprotein-1</a>, <a href="cope.cgi?key=transformation%2drelated%20phosphoprotein">transformation-related phosphoprotein</a>, <a href="cope.cgi?key=tumor%2dsecreted%20phosphoprotein">tumor-secreted phosphoprotein</a>, <a href="cope.cgi?key=urinary%20stone%20protein">urinary stone protein</a>, <a href="cope.cgi?key=Uropontin">Uropontin</a>)<b style="mso-bidi-font-weight:normal"> receptors</b> (Rollo et al, 1996; Kelly et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Osteoprotegerin">osteoprotegerin</a></b> (<a href="cope.cgi?key=OPG">OPG</a>, <a href="cope.cgi?key=FDCR%2d1">FDCR-1</a>, <a href="cope.cgi?key=FDC%2dderived%20receptor%2d1">FDC-derived receptor-1</a>, <a href="cope.cgi?key=OCIF">OCIF</a>, <a href="cope.cgi?key=Osteoclastogenesis%20inhibitory%20factor">osteoclastogenesis inhibitory factor</a>, <a href="cope.cgi?key=OCIF%2fOPG">OCIF/OPG</a>, <a href="cope.cgi?key=OPG%2fOCIF">OPG/OCIF</a>, <a href="cope.cgi?key=TNFRSF11B">TNFRSF11B</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2011B">TNF receptor superfamily member 11B</a>, <a href="cope.cgi?key=TR1">TR1</a>, <a href="cope.cgi?key=TNF%20receptor%2dlike%2d1">TNF receptor-like-1</a>) (Yamada et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Oxytocin">Oxytocin</a></b> (<a href="cope.cgi?key=OT">OT</a>, <a href="cope.cgi?key=OXT">OXT</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Szeto et al, 2008)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PACAP">PACAP</a></b> (<a href="cope.cgi?key=pituitary%20adenylate%20cyclase%2dactivating%20polypeptide">pituitary adenylate cyclase-activating polypeptide</a>, <a href="cope.cgi?key=ADCYAP1">ADCYAP1</a>, <a href="cope.cgi?key=adenylate%20cyclase%2dactivating%20polypeptide%201">adenylate cyclase-activating polypeptide 1</a>, <a href="cope.cgi?key=PACAP%281%2d27%29">PACAP(1-27)</a>, <a href="cope.cgi?key=PACAP27">PACAP27</a>, <a href="cope.cgi?key=PACAP%281%2d38%29">PACAP(1-38)</a>, <a href="cope.cgi?key=PACAP38">PACAP38</a>)<b style="mso-bidi-font-weight:normal"> </b><b style="mso-bidi-font-weight:normal">receptors</b> (Soares et al, 1998; Sun et al, 2000; Delgado et al, 1999; Martinez et al, 1998; Pozo et al, 2003; Delgado and Ganea, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PAI%2d1">PAI-1</a></b> (<a href="cope.cgi?key=Plasminogen%20activator%20inhibitor%2d1">Plasminogen activator inhibitor-1</a>, <a href="cope.cgi?key=PAI">PAI</a>, <a href="cope.cgi?key=Plasminogen%20activator%20inhibitor">plasminogen activator inhibitor</a>, <a href="cope.cgi?key=endothelial%20plasminogen%20activator%20inhibitor">endothelial plasminogen activator inhibitor</a>, <a href="cope.cgi?key=Serpin%20E1">Serpin E1</a>, <a href="cope.cgi?key=MSF">MSF</a>, <a href="cope.cgi?key=Monocyte%20suppressor%20factor">monocyte suppressor factor</a>, <a href="cope.cgi?key=EIP%2d1">EIP-1</a>, <a href="cope.cgi?key=EGF%2dinducible%20protein%201">EGF-inducible protein 1</a>, <a href="cope.cgi?key=Mesosecrin">mesosecrin</a>) (Meheus et al, 1993; Wohlwend et al, 1987; Kastl et al, 2006; Thapa B et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PAI%2d2">PAI-2</a></b> (<a href="cope.cgi?key=Plasminogen%20activator%20inhibitor%2d2">Plasminogen activator inhibitor-2</a>, <a href="cope.cgi?key=placental%20plasminogen%20activator%20inhibitor">placental plasminogen activator inhibitor</a>, <a href="cope.cgi?key=epidermal%20plasminogen%20activator%20inhibitor">epidermal plasminogen activator inhibitor</a>, <a href="cope.cgi?key=monocyte%2dderived%20plasminogen%20activator%20inhibitor">monocyte-derived plasminogen activator inhibitor</a>, <a href="cope.cgi?key=Monocyte%20Arg%2dserpin">Monocyte Arg-serpin</a>, <a href="cope.cgi?key=PLANH2">PLANH2</a>, <a href="cope.cgi?key=urokinase%20inhibitor">urokinase inhibitor</a>, <a href="cope.cgi?key=PP10">PP10</a>, <a href="cope.cgi?key=placental%20protein%2010">placental protein 10</a>, <a href="cope.cgi?key=Serpin%20B2">Serpin B2</a>) (Kawata et al, 1996; Wohlwend et al, 1987; Wada et al, 1994; Costelloe et al, 1999; Gan et al, 1995; Ritchie et al, 1997; Wygrecka et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=pancreatic%20polypeptide">pancreatic polypeptide</a> </b>(<a href="cope.cgi?key=PP">PP</a>, <a href="cope.cgi?key=PPY">PPY</a>, <a href="cope.cgi?key=PNP">PNP</a>) (propancreatic polypeptide) (Throsby et al, 1998) <br/><b style="mso-bidi-font-weight:normal">¥¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=PAP%2d2">PAP-2</a></b> (<a href="cope.cgi?key=pancreatitis%2dassociated%20protein%2d2">pancreatitis-associated protein-2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Viterbo et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=par%2d4">par-4</a></b> (<a href="cope.cgi?key=prostate%20apoptosis%20response%20protein%204">prostate apoptosis response protein 4</a>, <a href="cope.cgi?key=WT1%2dinteracting%20protein">WT1-interacting protein</a>, <a href="cope.cgi?key=PAWR">PAWR</a>, PRKC <a href="cope.cgi?key=Apoptosis">apoptosis</a> <a href="cope.cgi?key=WT1">WT1</a> regulator<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=PCF">PCF</a> (<a href="cope.cgi?key=plasmacytoma%20cytotoxic%20factor">plasmacytoma cytotoxic factor</a>) (Chu and Tseng et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PDCD1">PDCD1</a></b> (<a href="cope.cgi?key=programmed%20cell%20death%2d1">programmed cell death-1</a>, <a href="cope.cgi?key=PD%2d1">PD-1</a>, <a href="cope.cgi?key=programmed%20death%2d1">programmed death-1</a>, <a href="cope.cgi?key=Ly101">Ly101</a>, <a href="cope.cgi?key=CD279">CD279</a>) (Cho et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PDCD4">PDCD4</a></b> (<a href="cope.cgi?key=programmed%20cell%20death%2d4">programmed cell death-4</a>, <a href="cope.cgi?key=MA%2d3">MA-3</a>, <a href="cope.cgi?key=TIS">TIS</a>, <a href="cope.cgi?key=topoisomerase%20inhibitor%2dsuppressed">topoisomerase inhibitor-suppressed</a>, <a href="cope.cgi?key=H731">H731</a>, <a href="cope.cgi?key=197%2f15a">197/15a</a>, <a href="cope.cgi?key=A7%2d1">A7-1</a>, <a href="cope.cgi?key=DUG">DUG</a>, <a href="cope.cgi?key=death%2dupregulated%20gene">death-upregulated gene</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PD%2dECGF">PD-ECGF</a></b> (<a href="cope.cgi?key=Platelet%2dderived%20endothelial%20cell%20growth%20factor">platelet-derived endothelial cell growth factor</a>, <a href="cope.cgi?key=ECGF%2d1">ECGF-1</a>, <a href="cope.cgi?key=Endothelial%20cell%20growth%20factor%2d1">endothelial cell growth factor-1</a>, <a href="cope.cgi?key=GLS">GLS</a>, <a href="cope.cgi?key=GLS%2fTP">GLS/TP</a>, <a href="cope.cgi?key=Gliostatin">Gliostatin</a>, <a href="cope.cgi?key=Platelet%2dderived%20endothelial%20cell%20mitogen">platelet-derived endothelial cell mitogen</a>, <a href="cope.cgi?key=EC2%2e4%2e2%2e4">EC2.4.2.4</a>, <a href="cope.cgi?key=Thymidine%20phosphorylase">thymidine phosphorylase</a>, <a href="cope.cgi?key=dThdPase">dThdPase</a>, <a href="cope.cgi?key=TYMP">TYMP</a>, <a href="cope.cgi?key=Pyrimidine%20phosphorylase">Pyrimidine phosphorylase</a>) (<a href="cope.cgi?key=fox">Fox</a> et al, 1995; Torisu-Itakura et al, 2000; Goto et al, 2001; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PDGF">PDGF</a> </b>(<a href="cope.cgi?key=Platelet%2dderived%20growth%20factor">platelet-derived growth factor</a>, <a href="cope.cgi?key=PDGF%2d1">PDGF-1</a>, <a href="cope.cgi?key=PDGF%2d2">PDGF-2</a>, <a href="cope.cgi?key=PDGF%2dA">PDGF-A</a>, <a href="cope.cgi?key=PDGF%2dAA">PDGF-AA</a>, <a href="cope.cgi?key=PDGF%2dB">PDGF-B</a>, <a href="cope.cgi?key=PDGF%2dBB">PDGF-BB</a>, <a href="cope.cgi?key=FDGF">FDGF</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20growth%20factor">fibroblast-derived growth factor</a>, <a href="cope.cgi?key=GDGF">GDGF</a>, <a href="cope.cgi?key=Glioma%2dderived%20growth%20factor%2d1">glioma-derived growth factor-1</a>, <a href="cope.cgi?key=GDGF%2d2">GDGF-2</a>, <a href="cope.cgi?key=Glioma%2dderived%20growth%20factor%2d2">glioma-derived growth factor-2</a>, <a href="cope.cgi?key=GSM">GSM</a>, <a href="cope.cgi?key=Glucocorticoid%2dsuppressible%20mitogenic%20activity">Glucocorticoid-suppressible mitogenic activity</a>, <a href="cope.cgi?key=MDF">MDF</a>, <a href="cope.cgi?key=Mesangial%20cell%20proliferating%20factor">mesangial cell proliferating factor</a>, <a href="cope.cgi?key=MDGF">MDGF</a>, <a href="cope.cgi?key=Monocyte%2dderived%20growth%20factor">monocyte-derived growth factor</a>, <a href="cope.cgi?key=OBIF">OBIF</a>, <a href="cope.cgi?key=osteoblastogenesis%20inhibitory%20factor">osteoblastogenesis inhibitory factor</a>, <a href="cope.cgi?key=ODGF">ODGF</a>, <a href="cope.cgi?key=Osteosarcoma%2dderived%20growth%20factor">osteosarcoma-derived growth factor</a>, <a href="cope.cgi?key=T47D%20factor">T47D factor</a>) (Evanko <a href="cope.cgi?key=SP">SP</a> et al, 1998; Dill et al, 1993; Ueno et al, 2001; Kodelja et al, 1997; Kovacs et al, 1994; Badgett et al, 1996; Kubota et al, 2002; Krettek et al, 1997; Bonner, 1994; Kosaka et al, 1992; Nagaoka et al, 1992; Wangoo et al, 1992; Morisaki et al, 1992; Rappolee et al, 1988; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PDGF">PDGF</a> </b>(<a href="cope.cgi?key=Platelet%2dderived%20growth%20factor">platelet-derived growth factor</a>, <a href="cope.cgi?key=PDGF%2d1">PDGF-1</a>, <a href="cope.cgi?key=PDGF%2d2">PDGF-2</a>, <a href="cope.cgi?key=PDGF%2dA">PDGF-A</a>, <a href="cope.cgi?key=PDGF%2dAA">PDGF-AA</a>, <a href="cope.cgi?key=PDGF%2dB">PDGF-B</a>, <a href="cope.cgi?key=PDGF%2dBB">PDGF-BB</a>, <a href="cope.cgi?key=FDGF">FDGF</a>, <a href="cope.cgi?key=Fibroblast%2dderived%20growth%20factor">fibroblast-derived growth factor</a>, <a href="cope.cgi?key=GDGF">GDGF</a>, <a href="cope.cgi?key=Glioma%2dderived%20growth%20factor%2d1">glioma-derived growth factor-1</a>, <a href="cope.cgi?key=GDGF%2d2">GDGF-2</a>, <a href="cope.cgi?key=Glioma%2dderived%20growth%20factor%2d2">glioma-derived growth factor-2</a>, <a href="cope.cgi?key=GSM">GSM</a>, <a href="cope.cgi?key=Glucocorticoid%2dsuppressible%20mitogenic%20activity">Glucocorticoid-suppressible mitogenic activity</a>, <a href="cope.cgi?key=MDF">MDF</a>, <a href="cope.cgi?key=Mesangial%20cell%20proliferating%20factor">mesangial cell proliferating factor</a>, <a href="cope.cgi?key=MDGF">MDGF</a>, <a href="cope.cgi?key=Monocyte%2dderived%20growth%20factor">monocyte-derived growth factor</a>, <a href="cope.cgi?key=OBIF">OBIF</a>, <a href="cope.cgi?key=osteoblastogenesis%20inhibitory%20factor">osteoblastogenesis inhibitory factor</a>, <a href="cope.cgi?key=ODGF">ODGF</a>, <a href="cope.cgi?key=Osteosarcoma%2dderived%20growth%20factor">osteosarcoma-derived growth factor</a>, <a href="cope.cgi?key=T47D%20factor">T47D factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=PDGFR">PDGFR</a>, <a href="cope.cgi?key=PDGFR1">PDGFR1</a>, <a href="cope.cgi?key=PDGFR2">PDGFR2</a>, <a href="cope.cgi?key=PDGFRA">PDGFRA</a>, <a href="cope.cgi?key=PDGFR%2dalpha">PDGFR-alpha</a>, <a href="cope.cgi?key=PDGFRB">PDGFRB</a>, <a href="cope.cgi?key=PDGFR%2dbeta">PDGFR-beta</a>, <a href="cope.cgi?key=PDGF%20receptor">PDGF receptor</a>, <a href="cope.cgi?key=PDGF%20receptor%2d1">PDGF receptor-1</a>, <a href="cope.cgi?key=PDGF%20receptor%2d2">PDGF receptor-2</a>, <a href="cope.cgi?key=PDGF%20receptor%2dalpha">PDGF receptor-alpha</a>, <a href="cope.cgi?key=PDGF%20receptor%2dbeta">PDGF receptor-beta</a>; <a href="cope.cgi?key=Patch">patch</a>; <a href="cope.cgi?key=CD140a">CD140a</a>, <a href="cope.cgi?key=CD140b">CD140b</a>, <a href="cope.cgi?key=JTK12">JTK12</a>) (Krettek et al, 2001; Kuwabara et al, 1995)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PDGF%2dC">PDGF-C</a></b> (<a href="cope.cgi?key=Platelet%2dderived%20growth%20factor%2dC">Platelet-derived growth factor-C</a>, <a href="cope.cgi?key=PDGF%2dCC">PDGF-CC</a>, <a href="cope.cgi?key=SCDGF">SCDGF</a>, <a href="cope.cgi?key=Spinal%20cord%2dderived%20growth%20factor">Spinal cord-derived growth factor</a>, <a href="cope.cgi?key=Fallotein">fallotein</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Boor et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PEDF">PEDF</a></b> (<a href="cope.cgi?key=Pigment%20epithelium%2dderived%20factor">pigment epithelium-derived factor</a>, <a href="cope.cgi?key=EPC%2d1">EPC-1</a>, <a href="cope.cgi?key=early%20population%20doubling%20level%20cDNA">early population doubling level cDNA</a>, <a href="cope.cgi?key=Caspin">Caspin</a>, <a href="cope.cgi?key=SDF%2d3">SDF-3</a>, <a href="cope.cgi?key=Stromal%20cell%2dderived%20factor%2d3">Stromal cell-derived factor-3</a>, <a href="cope.cgi?key=Serpin%20F1">Serpin F1</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Zamiri et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Pentraxin%2d3">Pentraxin-3</a></b> (<a href="cope.cgi?key=Pentaxin%2d3">Pentaxin-3</a>, <a href="cope.cgi?key=PTX3">PTX3</a>, <a href="cope.cgi?key=TNFAIP5">TNFAIP5</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%2dalpha%2dinduced%20protein%205">tumor necrosis factor-alpha-induced protein 5</a>, <a href="cope.cgi?key=pentraxin%2drelated%20gene%20rapidly%20induced%20by%20IL1%2dbeta">pentraxin-related gene rapidly induced by IL1-beta</a>, <a href="cope.cgi?key=TSG%2d14">TSG-14</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%2dstimulated%20gene%20sequence%2d14">tumor necrosis factor-stimulated gene sequence-14</a>) (Goodman et al, 2000; Alles et al, 1994; Imamura et al, 2007; Gleissner et al, 2010; Maina et al, 2009; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Pentraxin%2d3">Pentraxin-3</a></b> (<a href="cope.cgi?key=Pentaxin%2d3">Pentaxin-3</a>, <a href="cope.cgi?key=PTX3">PTX3</a>, <a href="cope.cgi?key=TNFAIP5">TNFAIP5</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%2dalpha%2dinduced%20protein%205">tumor necrosis factor-alpha-induced protein 5</a>, <a href="cope.cgi?key=pentraxin%2drelated%20gene%20rapidly%20induced%20by%20IL1%2dbeta">pentraxin-related gene rapidly induced by IL1-beta</a>, <a href="cope.cgi?key=TSG%2d14">TSG-14</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%2dstimulated%20gene%20sequence%2d14">tumor necrosis factor-stimulated gene sequence-14</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Presta et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Perforin%2d1">perforin-1</a></b> (<a href="cope.cgi?key=Pore%2dforming%20protein%2d1">pore-forming protein-1</a>, <a href="cope.cgi?key=Perforin">perforin</a>, <a href="cope.cgi?key=Pore%2dforming%20protein">pore-forming protein</a>, <a href="cope.cgi?key=PFP">PFP</a>, <a href="cope.cgi?key=PFN">PFN</a>, <a href="cope.cgi?key=PRF1">PRF1</a>, <a href="cope.cgi?key=PFN1">PFN1</a>) (Baba et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PGLYRP%2d2">PGLYRP-2</a></b> (<a href="cope.cgi?key=Peptidoglycan%20recognition%20protein%202">peptidoglycan recognition protein 2</a>, <a href="cope.cgi?key=PGRP%2dL">PGRP-L</a>, <a href="cope.cgi?key=PGRP%2dlong">PGRP-long</a>, <a href="cope.cgi?key=PGLYRPL">PGLYRPL</a>, <a href="cope.cgi?key=tagL">tagL</a>, <a href="cope.cgi?key=NAMLAA">NAMLAA</a>, <a href="cope.cgi?key=N%2dacetylmuramoyl%2dL%2dalanine%20amidase">N-acetylmuramoyl-L-alanine amidase</a>, <a href="cope.cgi?key=mucopeptide%20amidohydrolase">mucopeptide amidohydrolase</a>, <a href="cope.cgi?key=EC3%2e5%2e1%2e28">EC3.5.1.28</a>) (Hoijer et al, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PGLYRP%2d3">PGLYRP-3</a></b> (<a href="cope.cgi?key=Peptidoglycan%20recognition%20protein%203">peptidoglycan recognition protein 3</a>, <a href="cope.cgi?key=PGLYRP%2dI%2dalpha">PGLYRP-I-alpha</a>, <a href="cope.cgi?key=PGRPIA">PGRPIA</a>, <a href="cope.cgi?key=PGRP%2dI%2dalpha">PGRP-I-alpha</a>) (Mathur et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PGLYRP%2d4">PGLYRP-4</a></b> (<a href="cope.cgi?key=Peptidoglycan%20recognition%20protein%204">peptidoglycan recognition protein 4</a>, <a href="cope.cgi?key=PGLYRP%2dI%2dbeta">PGLYRP-I-beta</a>, <a href="cope.cgi?key=PGRPIB">PGRPIB</a>, <a href="cope.cgi?key=PGRP%2dI%2dbeta">PGRP-I-beta</a>) (Mathur et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Pim%2d2">Pim-2</a> </b>(<a href="cope.cgi?key=Proviral%20Integration%20of%20Moloney%20virus%202">Proviral Integration of Moloney virus 2</a>) (Narayana et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Pleiotrophin">pleiotrophin</a> </b>(<a href="cope.cgi?key=PTN">PTN</a>, <a href="cope.cgi?key=HARP">HARP</a>, <a href="cope.cgi?key=Heparin%20affin%20regulatory%20peptide">heparin affin regulatory peptide</a>, <a href="cope.cgi?key=HBBM">HBBM</a>, <a href="cope.cgi?key=Heparin%20binding%20brain%20mitogen">heparin binding brain mitogen</a>, <a href="cope.cgi?key=HB%2dGAF">HB-GAF</a>, <a href="cope.cgi?key=Heparin%20binding%20growth%2dassociated%20factor">heparin binding growth-associated factor</a>, <a href="cope.cgi?key=HB%2dGAM">HB-GAM</a>, <a href="cope.cgi?key=Heparin%20binding%20growth%2dassociated%20molecule">heparin binding growth-associated molecule</a>, <a href="cope.cgi?key=HBGF%2d8">HBGF-8</a>, <a href="cope.cgi?key=Heparin%20binding%20growth%20factor%2d8">heparin binding growth factor-8</a>, <a href="cope.cgi?key=HBNF">HBNF</a>, <a href="cope.cgi?key=Heparin%20binding%20neurotrophic%20factor">heparin binding neurotrophic factor</a>, <a href="cope.cgi?key=NEGF%2d1">NEGF-1</a>, <a href="cope.cgi?key=Neurite%20growth%2dpromoting%20factor%2d1">neurite growth-promoting factor-1</a>, <a href="cope.cgi?key=OSF%2d1">OSF-1</a>, <a href="cope.cgi?key=Osteoblast%2dspecific%20factor%2d1">osteoblast-specific factor-1</a>) (Yeh et al, 1998; Li F et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Plexin%2dA1">plexin-A1</a></b> (<a href="cope.cgi?key=PLXNA1">PLXNA1</a>, <a href="cope.cgi?key=Plexin%2d1">Plexin-1</a>, <a href="cope.cgi?key=NOV">NOV</a>) (Ji et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Plexin%2dA2">plexin-A2</a></b> (<a href="cope.cgi?key=PLXNA2">PLXNA2</a>, <a href="cope.cgi?key=Plexin%2d2">Plexin-2</a>, <a href="cope.cgi?key=OCT">OCT</a>, <a href="cope.cgi?key=KIAA0463">KIAA0463</a>) (Ji et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Plexin%2dA3">Plexin-A3</a></b> (<a href="cope.cgi?key=PLXNA3">PLXNA3</a>, <a href="cope.cgi?key=Plexin%2d4">Plexin-4</a>, <a href="cope.cgi?key=SEX">SEX</a>) (Ji et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Plexin%2dB2">Plexin-B2</a></b> (<a href="cope.cgi?key=PLXNB2">PLXNB2</a>, <a href="cope.cgi?key=MM1">MM1</a>, <a href="cope.cgi?key=KIAA0315">KIAA0315</a>) (Meda C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Plexin%2dD1">plexin-D1</a></b> (<a href="cope.cgi?key=PLXND1">PLXND1</a>, <a href="cope.cgi?key=KIAA0620">KIAA0620</a>) (Meda C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PlGF">PlGF</a> </b>(<a href="cope.cgi?key=Placenta%20growth%20factor">placenta growth factor</a>, <a href="cope.cgi?key=Placental%20growth%20factor">Placental growth factor</a>, <a href="cope.cgi?key=PGF">PGF</a>, <a href="cope.cgi?key=PlGF%2d1">PlGF-1</a>, <a href="cope.cgi?key=Placenta%20growth%20factor%2d1">placenta growth factor-1</a>, <a href="cope.cgi?key=PlGF%2d2">PlGF-2</a>, <a href="cope.cgi?key=Placenta%20growth%20factor%2d2">placenta growth factor-2</a>) (Kumazaki K et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PLIF">PLIF</a></b> (<a href="cope.cgi?key=placenta%20immunomodulatory%20ferritin">placenta immunomodulatory ferritin</a>, <a href="cope.cgi?key=placental%20isoferritin">placental isoferritin</a>, <a href="cope.cgi?key=p43%20placenta%20isoferritin">p43 placenta isoferritin</a>, <a href="cope.cgi?key=p43">p43</a>‐<a href="cope.cgi?key=PLF">PLF</a>, <a href="cope.cgi?key=C48">C48</a>, <a href="cope.cgi?key=Ferritin">ferritin</a>, <a href="cope.cgi?key=H%2dFerritin">H-Ferritin</a>, <a href="cope.cgi?key=FTH1">FTH1</a>, <a href="cope.cgi?key=FTH">FTH</a>, <a href="cope.cgi?key=CD%2dGF">CD-GF</a>, <a href="cope.cgi?key=carcinoma%2dderived%20growth%20factor">carcinoma-derived growth factor</a>) (Maymon et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=Tachykinins">preprotachykinin</a> (Killingsworth and Shore, 1997)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=prion%20protein">prion protein</a></b> (<a href="cope.cgi?key=PRP">PRP</a>, <a href="cope.cgi?key=PRNP">PRNP</a>, <a href="cope.cgi?key=PrPc">PrPc</a>, <a href="cope.cgi?key=CD230">CD230</a>) (Wang G et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=prokineticin%2d2">prokineticin-2</a></b> (<a href="cope.cgi?key=PROK2">PROK2</a>, <a href="cope.cgi?key=PK2">PK2</a>, <a href="cope.cgi?key=Bv8%20homolog">Bv8 homolog</a>) (Martucci C et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=prokineticin%2d2">prokineticin-2</a></b> (<a href="cope.cgi?key=PROK2">PROK2</a>, <a href="cope.cgi?key=PK2">PK2</a>, <a href="cope.cgi?key=Bv8%20homolog">Bv8 homolog</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=PROKR1">PROKR1</a>, <a href="cope.cgi?key=ZAQ">ZAQ</a>, <a href="cope.cgi?key=PK%2dR1">PK-R1</a>, <a href="cope.cgi?key=GPR73">GPR73</a>, <a href="cope.cgi?key=GPR73a">GPR73a</a>, <a href="cope.cgi?key=GPR73b">GPR73b</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73">G-protein-coupled receptor-73</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73a">G-protein-coupled receptor-73a</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73b">G-protein-coupled receptor-73b</a>, <a href="cope.cgi?key=PROKR2">PROKR2</a>, <a href="cope.cgi?key=I5E">I5E</a>, <a href="cope.cgi?key=PK%2dR2">PK-R2</a>, <a href="cope.cgi?key=GPR73L1">GPR73L1</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d73%2dlike%201">G-protein-coupled receptor-73-like 1</a>) (Denison FC et al, 2008; Martucci C et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Prolactin">prolactin</a> </b>(<a href="cope.cgi?key=PRL">PRL</a>, <a href="cope.cgi?key=Lactogenic%20hormone">lactogenic hormone</a>, <a href="cope.cgi?key=Lactotropin">lactotropin</a>, <a href="cope.cgi?key=Lactotropic%20hormone">lactotropic hormone</a>, <a href="cope.cgi?key=Mammotropin">mammotropin</a>, <a href="cope.cgi?key=Mammotropic%20hormone">mammotropic hormone</a>, <a href="cope.cgi?key=Luteotropic%20hormone">luteotropic hormone</a>, <a href="cope.cgi?key=LTH">LTH</a>, <a href="cope.cgi?key=Luteotropin">luteotropin</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=PRLR">PRLR</a>) (Malaguarnera et al, 2004, 2005; Zhu et al, 1997; Sodhi and Tripathi, 2008; Di Rosa et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Proopiomelanocortin">proopiomelanocortin</a></b> (<a href="cope.cgi?key=POMC">POMC</a>, <a href="cope.cgi?key=ACTH">ACTH</a>, <a href="cope.cgi?key=ACTH%5b1%2d13%5d">ACTH[1-13]</a>, <a href="cope.cgi?key=ACTH%5b18%2d39%5d">ACTH[18-39]</a>, <a href="cope.cgi?key=ACTH%5b22%2d39%5d">ACTH[22-39]</a>, <a href="cope.cgi?key=Adrenocorticotropin">adrenocorticotropin</a>, <a href="cope.cgi?key=Alpha%2dEndorphin">Alpha-Endorphin</a>, <a href="cope.cgi?key=Alpha%2dmelanocortin">alpha-melanocortin</a>, <a href="cope.cgi?key=Alpha%2dmelanotropin">alpha-melanotropin</a>, <a href="cope.cgi?key=Alpha%2dMSH">Alpha-MSH</a>, <a href="cope.cgi?key=Beta%2dcell%20trophin">Beta-cell trophin</a>, <a href="cope.cgi?key=Beta%2dEndorphin">Beta-Endorphin</a>, <a href="cope.cgi?key=Beta%2dLipotropin">Beta-Lipotropin</a>, <a href="cope.cgi?key=Beta%2dLPH">Beta-LPH</a>, <a href="cope.cgi?key=Beta%2dmelanotropin">beta-melanotropin</a>, <a href="cope.cgi?key=Beta%2dMSH">Beta-MSH</a>, <a href="cope.cgi?key=CLIP">CLIP</a>, <a href="cope.cgi?key=corticotrophin">corticotrophin</a>, <a href="cope.cgi?key=Corticotropin">corticotropin</a>, <a href="cope.cgi?key=Corticotropin%2dlike%20intermediate%20peptide">corticotropin-like intermediate peptide</a>, <a href="cope.cgi?key=Gamma%2dEndorphin">Gamma-Endorphin</a>, <a href="cope.cgi?key=Gamma%2dLipotropin">Gamma-Lipotropin</a>, <a href="cope.cgi?key=Gamma%2dLPH">Gamma-LPH</a>, <a href="cope.cgi?key=Gamma%2dMSH">Gamma-MSH</a>, <a href="cope.cgi?key=Lipotropin">Lipotropin</a>, <a href="cope.cgi?key=Melanocyte%20stimulating%20hormone%2dalpha">melanocyte stimulating hormone-alpha</a>, <a href="cope.cgi?key=Melanocyte%20stimulating%20hormone%2dbeta">melanocyte stimulating hormone-beta</a>, <a href="cope.cgi?key=Melanocyte%20stimulating%20hormone%2dgamma">melanocyte stimulating hormone-gamma</a>, <a href="cope.cgi?key=Melanotropin">melanotropin</a>, <a href="cope.cgi?key=POC">POC</a>, <a href="cope.cgi?key=pro%2dACTH%2dEndorphin">pro-ACTH-Endorphin</a>, <a href="cope.cgi?key=Proopiocortin">proopiocortin</a>) (Li et al, 1993; Lolait et al, 1986)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PSG17">PSG17</a></b> (<a href="cope.cgi?key=pregnancy%2dspecific%20glycoprotein%2017">pregnancy-specific glycoprotein 17</a>, <a href="cope.cgi?key=CEA2">CEA2</a>, <a href="cope.cgi?key=carcinoembryonic%20antigen%202">carcinoembryonic antigen 2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Ha et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PSG18">PSG18</a></b> (<a href="cope.cgi?key=pregnancy%2dspecific%20glycoprotein%2018">pregnancy-specific glycoprotein 18</a>, <a href="cope.cgi?key=CEA3">CEA3</a>, <a href="cope.cgi?key=carcinoembryonic%20antigen%203">carcinoembryonic antigen 3</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Wessells et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PSG23">PSG23</a></b> (<a href="cope.cgi?key=Pregnancy%2dspecific%20glycoprotein%2023">Pregnancy-specific glycoprotein 23</a>, <a href="cope.cgi?key=CEA11">CEA11</a>, <a href="cope.cgi?key=carcinoembryonic%20antigen%2011">carcinoembryonic antigen 11</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Wu et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PUMA%2dG">PUMA-G</a></b> (<a href="cope.cgi?key=protein%20upregulated%20in%20macrophages%20by%20IFN%2dgamma">protein upregulated in macrophages by IFN-gamma</a>, <a href="cope.cgi?key=HM74">HM74</a>, <a href="cope.cgi?key=GPR109B">GPR109B</a>, <a href="cope.cgi?key=G%2dprotein%2dcoupled%20receptor%2d109B">G-protein-coupled receptor-109B</a>) (Taggart et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PYPAF1">PYPAF1</a></b> (<a href="cope.cgi?key=Pyrin%2dcontaining%20APAF%2d1%2dlike%20protein%201">Pyrin-containing APAF-1-like protein 1</a>, <a href="cope.cgi?key=NLRP3">NLRP3</a>, <a href="cope.cgi?key=NLR%20family%2c%20pyrin%2ddomain%20containing%203">NLR family, pyrin-domain containing 3</a>, <a href="cope.cgi?key=NALP3">NALP3</a>, <a href="cope.cgi?key=NACHT%2dLRR%2dPYD%2dcontaining%20protein%2d3">NACHT-LRR-PYD-containing protein-3</a>, <a href="cope.cgi?key=CIS1">CIS1</a>, <a href="cope.cgi?key=CIAS1">CIAS1</a>, <a href="cope.cgi?key=cold%2dinduced%20auto%2dinflammatory%20syndrome">cold-induced auto-inflammatory syndrome</a>, <a href="cope.cgi?key=Cryopyrin">Cryopyrin</a>, <a href="cope.cgi?key=CLR1%2e1">CLR1.1</a>) (Ather et al, 2011; Babelova et al, 2009; Bryan et al, 2010; Chuang <a href="cope.cgi?key=YT">YT</a> et al, 2011; Guarda et al, 2011; Kankkunen et al, 2010; Reimer et al, 2010; Rosengren et al, 2005; St Pierre et al, 2010; Vandanmagsar et al, 2011; Mukhopadhyay et al, 2010; Lee HM et al, 2012; Qiao Y et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=PYPAF2">PYPAF2</a></b> (<a href="cope.cgi?key=Pyrin%2dcontaining%20APAF%2d1%2dlike%20protein%202">Pyrin-containing APAF-1-like protein 2</a>, <a href="cope.cgi?key=NALP2">NALP2</a>, <a href="cope.cgi?key=NACHT%2dLRR%2dPYD%2dcontaining%20protein%2d2">NACHT-LRR-PYD-containing protein-2</a>, <a href="cope.cgi?key=PAN1">PAN1</a>, <a href="cope.cgi?key=PAAD%20and%20NACHT%2dcontaining%20protein%201">PAAD and NACHT-containing protein 1</a>, <a href="cope.cgi?key=NLRP4">NLRP4</a>, <a href="cope.cgi?key=NLR%20family%2c%20pyrin%2ddomain%20containing%204">NLR family, pyrin-domain containing 4</a>, <a href="cope.cgi?key=NBS1">NBS1</a>, <a href="cope.cgi?key=Nucleotide%2dbinding%20site%20protein%201">Nucleotide-binding site protein 1</a>) (Bruey et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Pyrin">pyrin</a></b> (<a href="cope.cgi?key=MEFV">MEFV</a>, <a href="cope.cgi?key=FMF%20protein">FMF protein</a>, <a href="cope.cgi?key=Familial%20Mediterranenan%20fever%20protein">Familial Mediterranenan fever protein</a>, <a href="cope.cgi?key=Marenostrin">Marenostrin</a>, <a href="cope.cgi?key=TRIM20">TRIM20</a>, <a href="cope.cgi?key=tripartite%20motif%2dcontaining%20protein%2020">tripartite motif-containing protein 20</a>) (Rosengren et al, 2005; Seshadri et al, 2007; Carthagena et al, 2009)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RAGE">RAGE</a></b> (<a href="cope.cgi?key=receptor%20for%20advanced%20glycosylation%20end%20products">receptor for advanced glycosylation end products</a>, <a href="cope.cgi?key=AGER">AGER</a>, <a href="cope.cgi?key=advanced%20glycosylation%20end%20product%2dspecific%20receptor">advanced glycosylation end product-specific receptor</a>) (Xu Y et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RAMP%2d1">RAMP-1</a></b> (<a href="cope.cgi?key=receptor%20activity%2dmodifying%20protein%2d1">receptor activity-modifying protein-1</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RANK">RANK</a></b> (<a href="cope.cgi?key=receptor%20activator%20of%20NF%2dkappa%2dB">receptor activator of NF-kappa-B</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2011A">TNF receptor superfamily member 11A</a>, <a href="cope.cgi?key=TNFRSF11A">TNFRSF11A</a>, <a href="cope.cgi?key=ODAR">ODAR</a>, <a href="cope.cgi?key=osteoclast%20differentiation%20and%20activation%20receptor">osteoclast differentiation and activation receptor</a>, <a href="cope.cgi?key=ODFR">ODFR</a>, <a href="cope.cgi?key=Osteoclast%20differentiation%20factor">Osteoclast differentiation factor</a> receptor, <a href="cope.cgi?key=TRANCER">TRANCER</a>, <a href="cope.cgi?key=PDB2">PDB2</a>, <a href="cope.cgi?key=CD265">CD265</a>) (Yamada et al, 2005; Park et al, 2005; Ishii et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RBP4">RBP4</a></b> (<a href="cope.cgi?key=retinol%20binding%20protein%204">retinol binding protein 4</a>, <a href="cope.cgi?key=plasma%20retinol%2dbinding%20protein">plasma retinol-binding protein</a>, <a href="cope.cgi?key=sRBP">sRBP</a>, <a href="cope.cgi?key=serum%20retinol%20binding%20protein">serum retinol binding protein</a>) (Broch et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Reelin">Reelin</a></b> (<a href="cope.cgi?key=RELN">RELN</a>, <a href="cope.cgi?key=RL">RL</a>, <a href="cope.cgi?key=reeler">reeler</a>, <a href="cope.cgi?key=CR%2d50%20antigen">CR-50 antigen</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=VLDLR">VLDLR</a>, <a href="cope.cgi?key=very%20low%20density%20lipoprotein%20receptor">very low density lipoprotein receptor</a>) (Hiltunen et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Relaxin">Relaxin</a></b> (<a href="cope.cgi?key=RLN">RLN</a>, <a href="cope.cgi?key=RLX">RLX</a>, <a href="cope.cgi?key=RLN1">RLN1</a>, <a href="cope.cgi?key=relaxin%201">relaxin 1</a>, <a href="cope.cgi?key=relaxin%20H1">relaxin H1</a>, <a href="cope.cgi?key=H1%20relaxin">H1 relaxin</a>, <a href="cope.cgi?key=RLXH1">RLXH1</a>, <a href="cope.cgi?key=RXN1">RXN1</a>, <a href="cope.cgi?key=RLN2">RLN2</a>, <a href="cope.cgi?key=relaxin%202">relaxin 2</a>, <a href="cope.cgi?key=relaxin%20H2">relaxin H2</a>, <a href="cope.cgi?key=H2%20relaxin">H2 relaxin</a>, <a href="cope.cgi?key=RLXH2">RLXH2</a>, <a href="cope.cgi?key=RXN2">RXN2</a>, <a href="cope.cgi?key=relaxin%201%2f2">relaxin 1/2</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Figueiredo et al, 2009; Dschietzig et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> Renin (Iwai et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Resistin">resistin</a> </b>(<a href="cope.cgi?key=RSTN">RSTN</a>, <a href="cope.cgi?key=RETN">RETN</a>, <a href="cope.cgi?key=RETN1">RETN1</a>, <a href="cope.cgi?key=ADSF">ADSF</a>, <a href="cope.cgi?key=adipose%20tissue%2dspecific%20secretory%20factor">adipose tissue-specific secretory factor</a>, <a href="cope.cgi?key=FIZZ%2d3">FIZZ-3</a>, <a href="cope.cgi?key=found%20in%20inflammatory%20zone%2d3">found in inflammatory zone-3</a>, <a href="cope.cgi?key=XCP4">XCP4</a>, <a href="cope.cgi?key=ten%2dcysteine%20protein%204">ten-cysteine protein 4</a>) (Patel et al, 2003; Curat <a href="cope.cgi?key=CA">CA</a> et al, 2006; Broch et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RGMa">RGMa</a></b> (<a href="cope.cgi?key=repulsive%20guidance%20molecule%20A">Repulsive guidance molecule A</a>; <a href="cope.cgi?key=RGM%20domain%20family%20member%20A">RGM domain family member A</a>) (Schnichels et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RGMb">RGMb</a></b> (<a href="cope.cgi?key=repulsive%20guidance%20molecule%20B">Repulsive guidance molecule B</a>; <a href="cope.cgi?key=RGM%20domain%20family%20member%20B">RGM domain family member B</a>; <a href="cope.cgi?key=DRAGON">DRAGON</a>; <a href="cope.cgi?key=DRG11%2dresponsive%20axonal%20guidance%20and%20outgrowth%20of%20neurite">DRG11-responsive axonal guidance and outgrowth of neurite</a>) (Xia Y et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> RGS1 (regulator of G-protein signaling 1) (Gratchev A et al, 2008; Gleissner et al, 2010; Cho Y et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RIG%2dI">RIG-I</a></b> (<a href="cope.cgi?key=Retinoic%20acid%20inducible%20gene%2dI">Retinoic acid inducible gene-I</a>, <a href="cope.cgi?key=DDX58">DDX58</a>, <a href="cope.cgi?key=DEAD%20box%20polypeptide%2058">DEAD box polypeptide 58</a>, <a href="cope.cgi?key=DEAD%2fH%20BOX%2058">DEAD/H BOX 58</a>) (Hou J et al, 2009; Kong et al, 2009; Rintahaka et al, 2008; Wang et al, 2008; Ohman et al, 2009; Wilden et al, 2009; Imaizumi et al, 2007; Daffis et al, 2007; Kim and Yoo, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=RTF">RTF</a></b> (<a href="cope.cgi?key=regeneration%20and%20tolerance%20factor">Regeneration and tolerance factor</a>, <a href="cope.cgi?key=TJ6">TJ6</a>, <a href="cope.cgi?key=ATP6V0A2">ATP6V0A2</a>, <a href="cope.cgi?key=H%28%2b%29%20transporting%20lysosomal%20ATPase%20V0%20subunit%20A2">H(+) transporting lysosomal ATPase V0 subunit A2</a>, <a href="cope.cgi?key=A2V%2dATPase">A2V-ATPase</a>, <a href="cope.cgi?key=V%2dATPase">V-ATPase</a>, <a href="cope.cgi?key=vacuolar%2dtype%20proton%20pump%20H%28%2b%29%2dATPase">vacuolar-type proton pump H(+)-ATPase</a>) (Derks and Beaman, 2004)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=S1PR1">S1PR1</a></b> (<a href="cope.cgi?key=Sphingosine%2d1%2dphosphate%20receptor%201">sphingosine-1-phosphate receptor 1</a>, <a href="cope.cgi?key=S1P%20receptor%201">S1P receptor 1</a>, <a href="cope.cgi?key=S1P1">S1P1</a>, <a href="cope.cgi?key=Endothelial%20differentiation%20G%2dprotein%20coupled%20receptor%201">Endothelial differentiation G-protein coupled receptor 1</a>, <a href="cope.cgi?key=EDG1">EDG1</a>, <a href="cope.cgi?key=endothelial%20differentiation%20gene%201">endothelial differentiation gene 1</a>, <a href="cope.cgi?key=CD363">CD363</a>) (Durafourt BA et al, 2011; Hornuss C et al, 2001; Hughes <a href="cope.cgi?key=JE">JE</a> et al, 2008; Jiang <a href="cope.cgi?key=LI">LI</a> et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=S100A4">S100A4</a></b> (<a href="cope.cgi?key=S100%20calcium%20binding%20protein%20A4">S100 calcium binding protein A4</a>, <a href="cope.cgi?key=CAPL">CAPL</a>, <a href="cope.cgi?key=calcium%20placental%20protein">calcium placental protein</a>, <a href="cope.cgi?key=Calvasculin">Calvasculin</a>, <a href="cope.cgi?key=metastasin">metastasin</a>, <a href="cope.cgi?key=metastasin%2d1">metastasin-1</a>, <a href="cope.cgi?key=mts%2d1">mts-1</a>, <a href="cope.cgi?key=18A2">18A2</a>, <a href="cope.cgi?key=42A">42A</a>, <a href="cope.cgi?key=p9Ka">P9Ka</a>, <a href="cope.cgi?key=pEL98">pEL98</a>, <a href="cope.cgi?key=fibroblast%2dspecific%20protein%201">fibroblast-specific protein 1</a>, <a href="cope.cgi?key=fibroblast%20secretory%20protein%2d1">fibroblast secretory protein-1</a>, <a href="cope.cgi?key=FSP%2d1">FSP-1</a>) (Takenaga et al, 1994; Klingelhofer et al, 1997; Gleissner et al, 2010; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=S100A8">S100A8</a></b> (<a href="cope.cgi?key=S100%20calcium%20binding%20protein%20A8">S100 calcium binding protein A8</a>, <a href="cope.cgi?key=MRP%2d8">MRP-8</a>, <a href="cope.cgi?key=Migration%20inhibition%20factor%2drelated%20protein%2d8">migration inhibition factor-related protein-8</a>, <a href="cope.cgi?key=Myeloid%2drelated%20protein%2d8">myeloid-related protein-8</a>, <a href="cope.cgi?key=CP%2d10">CP-10</a>, <a href="cope.cgi?key=chemotactic%20protein%2010">chemotactic protein 10</a>, <a href="cope.cgi?key=CAGA">CAGA</a>, <a href="cope.cgi?key=Calgranulin%20A">Calgranulin A</a>, <a href="cope.cgi?key=CGLA">CGLA</a>, <a href="cope.cgi?key=CFAG">CFAG</a>, <a href="cope.cgi?key=Cystic%20fibrosis%20antigen">cystic fibrosis antigen</a>, <a href="cope.cgi?key=CF%20antigen">CF antigen</a>) (<a href="cope.cgi?key=hu">Hu</a> et al, 1996; Xu et al, 2000; Engel et al, 2000; Goebeler et al, 1994; Wu and Davidson, 2004; Bhardwaj et al, 1992; Altwegg et al, 2007; Kawasaki et al, 2009; Gleissner et al, 2010; Ban JY et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=S100A9">S100A9</a></b> (<a href="cope.cgi?key=S100%20calcium%20binding%20protein%20A9">S100 calcium binding protein A9</a>, <a href="cope.cgi?key=MRP%2d14">MRP-14</a>, <a href="cope.cgi?key=Migration%20inhibition%20factor%2drelated%20protein%2d14">migration inhibition factor-related protein-14</a>, <a href="cope.cgi?key=Myeloid%2drelated%20protein%2d14">myeloid-related protein-14</a>, <a href="cope.cgi?key=Calgranulin%20B">Calgranulin B</a>, <a href="cope.cgi?key=CAGB">CAGB</a>, <a href="cope.cgi?key=CGLB">CGLB</a>, <a href="cope.cgi?key=Calprotectin">Calprotectin</a>, <a href="cope.cgi?key=CFAG">CFAG</a>, <a href="cope.cgi?key=Cystic%20fibrosis%20antigen">cystic fibrosis antigen</a>, <a href="cope.cgi?key=CF%20antigen">CF antigen</a>) (Engel et al, 2000; Goebeler et al, 1994; Wu and Davidson, 2004; Bhardwaj et al, 1992; Altwegg et al, 2007; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=S100A10">S100A10</a></b> (<a href="cope.cgi?key=S100%20calcium%20binding%20protein%20A10">S100 calcium binding protein A10</a>, <a href="cope.cgi?key=Calpactin%2d1%20light%20chain">Calpactin-1 light chain</a>, <a href="cope.cgi?key=CAL1L">CAL1L</a>, <a href="cope.cgi?key=Calpactin%20p11">Calpactin p11</a>, <a href="cope.cgi?key=CLP11">CLP11</a>, <a href="cope.cgi?key=p11">p11</a>, <a href="cope.cgi?key=42C">42C</a>, <a href="cope.cgi?key=NGF%2dinduced%20protein%2042C">NGF-induced protein 42C</a>, <a href="cope.cgi?key=Annexin%2d2%20ligand">Annexin-2 ligand</a>, <a href="cope.cgi?key=ANX2LG">ANX2LG</a>) (Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=S100P">S100P</a></b> (<a href="cope.cgi?key=S100%2dE">S100-E</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SAA3">SAA3</a> </b>(<a href="cope.cgi?key=serum%20amyloid%20A3">serum amyloid A3</a>) (Meheus et al, 1993; Rokita et al, 1987)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Salusin%2dalpha">Salusin-alpha</a></b> (<a href="cope.cgi?key=TOR2A">TOR2A</a>, <a href="cope.cgi?key=torsin%20family%202%20member%20A">torsin family 2 member A</a>, <a href="cope.cgi?key=torsin%202A">torsin 2A</a>, <a href="cope.cgi?key=TORP1">TORP1</a>, <a href="cope.cgi?key=torsin%2drelated%20protein%2d1">torsin-related protein-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Watanabe et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Salusin%2dbeta">Salusin-beta</a></b> (<a href="cope.cgi?key=TOR2A">TOR2A</a>, <a href="cope.cgi?key=torsin%20family%202%20member%20A">torsin family 2 member A</a>, <a href="cope.cgi?key=torsin%202A">torsin 2A</a>, <a href="cope.cgi?key=TORP1">TORP1</a>, <a href="cope.cgi?key=torsin%2drelated%20protein%2d1">torsin-related protein-1</a>) (Sato et al, 2010; Suzuki et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Salusin%2dbeta">Salusin-beta</a></b> (<a href="cope.cgi?key=TOR2A">TOR2A</a>, <a href="cope.cgi?key=torsin%20family%202%20member%20A">torsin family 2 member A</a>, <a href="cope.cgi?key=torsin%202A">torsin 2A</a>, <a href="cope.cgi?key=TORP1">TORP1</a>, <a href="cope.cgi?key=torsin%2drelated%20protein%2d1">torsin-related protein-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Watanabe et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SCF">SCF</a></b> (<a href="cope.cgi?key=Stem%20cell%20factor">stem cell factor</a>, <a href="cope.cgi?key=HLGF%2d1">HLGF-1</a>, <a href="cope.cgi?key=Hemolymphopoietic%20growth%20factor%2d1">hemolymphopoietic growth factor-1</a>), <a href="cope.cgi?key=Kit%20ligand">kit ligand</a>, <a href="cope.cgi?key=KITL">KITL</a>, <a href="cope.cgi?key=KITLG">KITLG</a>, <a href="cope.cgi?key=Mast%2fstem%20cell%20growth%20factor">Mast/stem cell growth factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20factor">mast cell growth factor</a>, <a href="cope.cgi?key=SLF">SLF</a>, <a href="cope.cgi?key=Steel%20factor">steel factor</a>) (Temeles et al, 1993; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=SCF">SCF</a></b> (<a href="cope.cgi?key=Stem%20cell%20factor">stem cell factor</a>, <a href="cope.cgi?key=HLGF%2d1">HLGF-1</a>, <a href="cope.cgi?key=Hemolymphopoietic%20growth%20factor%2d1">hemolymphopoietic growth factor-1</a>), <a href="cope.cgi?key=Kit%20ligand">kit ligand</a>, <a href="cope.cgi?key=KITL">KITL</a>, <a href="cope.cgi?key=KITLG">KITLG</a>, <a href="cope.cgi?key=Mast%2fstem%20cell%20growth%20factor">Mast/stem cell growth factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=Mast%20cell%20growth%20factor">mast cell growth factor</a>, <a href="cope.cgi?key=SLF">SLF</a>, <a href="cope.cgi?key=Steel%20factor">steel factor</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=kit">kit</a>, <a href="cope.cgi?key=SCFR">SCFR</a>, <a href="cope.cgi?key=CD117">CD117</a>) (Neale and Athanasou, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Semaphorin%203A">Semaphorin 3A</a></b> (<a href="cope.cgi?key=SEMA3A">SEMA3A</a>, <a href="cope.cgi?key=SEMA1">SEMA1</a>, <a href="cope.cgi?key=Semaphorin%203">Semaphorin 3</a>, <a href="cope.cgi?key=sema%20III">sema III</a>, <a href="cope.cgi?key=Collapsin%2d1">collapsin-1</a>, <a href="cope.cgi?key=coll%2d1">coll-1</a>, <a href="cope.cgi?key=Hsema%2dI">Hsema-I</a>, <a href="cope.cgi?key=Semaphorin%20D">Semaphorin D</a>, <a href="cope.cgi?key=Sem%20D">Sem D</a>, <a href="cope.cgi?key=SEMAD">SEMAD</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Ji et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Semaphorin%204A">Semaphorin 4A</a></b> (<a href="cope.cgi?key=SEMA4A">SEMA4A</a>, <a href="cope.cgi?key=Semaphorin%20B">Semaphorin B</a>, <a href="cope.cgi?key=SEMAB">SEMAB</a>, <a href="cope.cgi?key=Sem%20B">Sem B</a>) (Li et al, 2004; Meda C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Semaphorin%204A">Semaphorin 4A</a></b> (<a href="cope.cgi?key=SEMA4A">SEMA4A</a>, <a href="cope.cgi?key=Semaphorin%20B">Semaphorin B</a>, <a href="cope.cgi?key=SEMAB">SEMAB</a>, <a href="cope.cgi?key=Sem%20B">Sem B</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Meda C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Semaphorin%204D">Semaphorin 4D</a></b> (<a href="cope.cgi?key=SEMA4D">SEMA4D</a>, <a href="cope.cgi?key=Semaphorin%20J">Semaphorin J</a>, <a href="cope.cgi?key=SEMAJ">SEMAJ</a>, <a href="cope.cgi?key=CD100">CD100</a>, <a href="cope.cgi?key=M%2dsema%20G">M-sema G</a>, <a href="cope.cgi?key=collapsin%2d4">collapsin-4</a>, <a href="cope.cgi?key=coll%2d4">coll-4</a>, <a href="cope.cgi?key=BB18">BB18</a>, <a href="cope.cgi?key=A8">A8</a>, <a href="cope.cgi?key=GR3">GR3</a>, <a href="cope.cgi?key=C9orf164">C9orf164</a>, <a href="cope.cgi?key=chromosome%209%20open%20reading%20frame%20164">chromosome 9 open reading frame 164</a>) (Sierra et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Semaphorin%204D">Semaphorin 4D</a></b> (<a href="cope.cgi?key=SEMA4D">SEMA4D</a>, <a href="cope.cgi?key=Semaphorin%20J">Semaphorin J</a>, <a href="cope.cgi?key=SEMAJ">SEMAJ</a>, <a href="cope.cgi?key=CD100">CD100</a>, <a href="cope.cgi?key=M%2dsema%20G">M-sema G</a>, <a href="cope.cgi?key=collapsin%2d4">collapsin-4</a>, <a href="cope.cgi?key=coll%2d4">coll-4</a>, <a href="cope.cgi?key=BB18">BB18</a>, <a href="cope.cgi?key=A8">A8</a>, <a href="cope.cgi?key=GR3">GR3</a>, <a href="cope.cgi?key=C9orf164">C9orf164</a>, <a href="cope.cgi?key=chromosome%209%20open%20reading%20frame%20164">chromosome 9 open reading frame 164</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (<a href="cope.cgi?key=CD72">CD72</a>) (Schwarting et al, 1992)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Semaphorin%204D">Semaphorin 4D</a></b> (<a href="cope.cgi?key=SEMA4D">SEMA4D</a>, <a href="cope.cgi?key=Semaphorin%20J">Semaphorin J</a>, <a href="cope.cgi?key=SEMAJ">SEMAJ</a>, <a href="cope.cgi?key=CD100">CD100</a>, <a href="cope.cgi?key=M%2dsema%20G">M-sema G</a>, <a href="cope.cgi?key=collapsin%2d4">collapsin-4</a>, <a href="cope.cgi?key=coll%2d4">coll-4</a>, <a href="cope.cgi?key=BB18">BB18</a>, <a href="cope.cgi?key=A8">A8</a>, <a href="cope.cgi?key=GR3">GR3</a>, <a href="cope.cgi?key=C9orf164">C9orf164</a>, <a href="cope.cgi?key=chromosome%209%20open%20reading%20frame%20164">chromosome 9 open reading frame 164</a>) (Sierra et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Semaphorin%207A">Semaphorin 7A</a></b> (<a href="cope.cgi?key=SEMA7A">SEMA7A</a>, <a href="cope.cgi?key=Semaphorin%20L">Semaphorin L</a>, <a href="cope.cgi?key=SEMAL">SEMAL</a>, <a href="cope.cgi?key=H%2dSema%2dL">H-Sema-L</a>, <a href="cope.cgi?key=H%2dSema%20K1">H-Sema K1</a>, <a href="cope.cgi?key=Semaphorin%20K1">Semaphorin K1</a>, <a href="cope.cgi?key=CD108">CD108</a>, <a href="cope.cgi?key=CDw108">CDw108</a>, <a href="cope.cgi?key=JMH%20human%20blood%20group%20antigen">JMH human blood group antigen</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Suzuki et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Serglycin">serglycin</a></b> (<a href="cope.cgi?key=SRGN">SRGN</a>, <a href="cope.cgi?key=PRG1">PRG1</a>, <a href="cope.cgi?key=PRG">PRG</a>, <a href="cope.cgi?key=PPG">PPG</a>, <a href="cope.cgi?key=platelet%20proteoglycan%20protein%20core">platelet proteoglycan protein core</a>) (Toyama-Sorimachi et al, 1997; Kolsetet al, 1996; Zernichow et al, 2006; Uhlin-Hansen et al, 1993)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Serpin%20B1">Serpin B1</a></b> (<a href="cope.cgi?key=LEI">LEI</a>, <a href="cope.cgi?key=Leukocyte%20elastase%20inhibitor">Leukocyte elastase inhibitor</a>, <a href="cope.cgi?key=MNEI">MNEI</a>, <a href="cope.cgi?key=monocyte%20neutrophil%20elastase%20inhibitor">monocyte neutrophil elastase inhibitor</a>, <a href="cope.cgi?key=ELANH2">ELANH2</a>, <a href="cope.cgi?key=Monocyte%2fneutrophil%20elastase%20inhibitor%2d2">Monocyte/neutrophil elastase inhibitor-2</a>, <a href="cope.cgi?key=EI">EI</a>, <a href="cope.cgi?key=elastase%20inhibitor">elastase inhibitor</a>, <a href="cope.cgi?key=L%2dDNase%20II">L-DNase II</a>, <a href="cope.cgi?key=LEI%2dderived%20DNase%20II">LEI-derived DNase II</a>) (Remold-O'Donnell et al, 1989; Yasumatsu et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d1">SIGLEC-1</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%201">sialic acid binding immunoglobulin-like lectin 1</a>, <a href="cope.cgi?key=SLG">SLG</a>, <a href="cope.cgi?key=SIGLEC%2dlike%20gene">SIGLEC-like gene</a>, <a href="cope.cgi?key=sialoadhesin">sialoadhesin</a>, <a href="cope.cgi?key=SER">SER</a>, <a href="cope.cgi?key=sheep%20erythrocyte%20receptor">sheep erythrocyte receptor</a>, <a href="cope.cgi?key=CD169">CD169</a>, <a href="cope.cgi?key=MOMA%2d1">MOMA-1</a>, <a href="cope.cgi?key=C19orf75">C19orf75</a>, <a href="cope.cgi?key=chromosome%2019%20open%20reading%20frame%2075">chromosome 19 open reading frame 75</a>) (McWilliam et al, 1992; Hartnell et al, 2001; van den Berg et al, 2001, 1996; Martens et al, 2006; Ducreux et al, 2009; Martens et al, 2006; Barral et al, 2010; van den Berg et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d5">SIGLEC-5</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%205">sialic acid binding immunoglobulin-like lectin 5</a>, <a href="cope.cgi?key=SIGLEC%2dF">SIGLEC-F</a>, <a href="cope.cgi?key=CD33L2">CD33L2</a>, <a href="cope.cgi?key=CD33%2dlike%2d2">CD33-like-2</a>, <a href="cope.cgi?key=OBBP2">OBBP2</a>, <a href="cope.cgi?key=Ob%20binding%20protein%202">Ob binding protein 2</a>, <a href="cope.cgi?key=CD170">CD170</a>) (Munday et al, 1999; Feng YH and Mao H, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d9">SIGLEC-9</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%209">sialic acid binding immunoglobulin-like lectin 9</a>, <a href="cope.cgi?key=OBBP%2dlike">OBBP-like</a>, <a href="cope.cgi?key=Ob%20binding%20protein%2dlike">Ob binding protein-like</a>, <a href="cope.cgi?key=CDw329">CDw329</a>, <a href="cope.cgi?key=CD329">CD329</a>, <a href="cope.cgi?key=FOAP%2d9">FOAP-9</a>, <a href="cope.cgi?key=SIGLEC%2dE">SIGLEC-E</a>) (Zhang et al, 2004; Ando et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d10">SIGLEC-10</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%2010">sialic acid binding immunoglobulin-like lectin 10</a>, <a href="cope.cgi?key=CD330">CD330</a>, <a href="cope.cgi?key=SLG2">SLG2</a>, <a href="cope.cgi?key=SIGLEC%2dlike%20gene%202">SIGLEC-like gene 2</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d11">SIGLEC-11</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%2011">sialic acid binding immunoglobulin-like lectin 11</a>) (Angata et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d12">SIGLEC-12</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%2012">sialic acid binding immunoglobulin-like lectin 12</a>, <a href="cope.cgi?key=SLG">SLG</a>, <a href="cope.cgi?key=SIGLEC%2dlike%20gene">SIGLEC-like gene</a>, <a href="cope.cgi?key=S2V">S2V</a>, <a href="cope.cgi?key=SIGLECL1">SIGLECL1</a>, <a href="cope.cgi?key=SIGLEC%2dlike%201">SIGLEC-like 1</a>, <a href="cope.cgi?key=SLGS">SLGS</a>, <a href="cope.cgi?key=SLGL">SLGL</a>) (Yu et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d15">SIGLEC-15</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%2015">sialic acid binding immunoglobulin-like lectin 15</a>, <a href="cope.cgi?key=CD33L3">CD33L3</a>, <a href="cope.cgi?key=CD33%2dlike%2d3">CD33-like-3</a>, <a href="cope.cgi?key=CD33%20antigen%2dlike%2d3">CD33 antigen-like-3</a>) (Angata et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2d16">SIGLEC-16</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%2016">sialic acid binding immunoglobulin-like lectin 16</a>, <a href="cope.cgi?key=SIGLECP16">SIGLECP16</a>) (Cao et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIGLEC%2dH">SIGLEC-H</a></b> (<a href="cope.cgi?key=sialic%20acid%20binding%20immunoglobulin%2dlike%20lectin%20H">sialic acid binding immunoglobulin-like lectin H</a>) (Zhang et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SIMPL">SIMPL</a></b> [<a href="cope.cgi?key=signaling%20molecule%20that%20associates%20with%20the%20mouse%20pelle%2dlike%20kinase">signaling molecule that associates with the mouse pelle-like kinase</a>] (Conner et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=sirtuin%2d1">sirtuin-1</a></b> (<a href="cope.cgi?key=SIRT1">SIRT1</a>, <a href="cope.cgi?key=SIR2L1">SIR2L1</a>, <a href="cope.cgi?key=Sir2%2dlike%201">Sir2-like 1</a>, <a href="cope.cgi?key=SIR2%2dalpha">SIR2-alpha</a>) (Gratchev A et al, 2008; Yoshizaki T et al, 2010; Zhang R et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Slit%2d3">Slit-3</a></b> (<a href="cope.cgi?key=slit%20homolog%2d3">slit homolog-3</a>, <a href="cope.cgi?key=MEGF5">MEGF5</a>, <a href="cope.cgi?key=multiple%20epidermal%20growth%20factor%2dlike%20domains%205">multiple epidermal growth factor-like domains 5</a>) (Tanno et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SLPI">SLPI</a></b> (<a href="cope.cgi?key=secretory%20leukocyte%20protease%20inhibitor">secretory leukocyte protease inhibitor</a>, <a href="cope.cgi?key=Antileukoproteinase">antileukoproteinase</a>, <a href="cope.cgi?key=BLPI">BLPI</a>, <a href="cope.cgi?key=Bronchial%20leukocyte%20proteinase%20inhibitor">Bronchial leukocyte proteinase inhibitor</a>, <a href="cope.cgi?key=BMI">BMI</a> <a href="cope.cgi?key=bronchial%20mucus%20inhibitor">bronchial mucus inhibitor</a>, <a href="cope.cgi?key=CUSI">CUSI</a>, <a href="cope.cgi?key=cervical%20mucus%20inhibitor">cervical mucus inhibitor</a>, <a href="cope.cgi?key=HUSI%2dI">HUSI-I</a>, <a href="cope.cgi?key=Human%20seminal%20plasma%20inhibitor%2dI">human seminal plasma inhibitor-I</a>, <a href="cope.cgi?key=MPI">MPI</a>, <a href="cope.cgi?key=Mucus%20proteinase%20inhibitor">Mucus proteinase inhibitor</a>, <a href="cope.cgi?key=seminal%20plasma%20inhibitor">seminal plasma inhibitor</a>) (Odaka et al, 2003; Jin et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=SLPI">SLPI</a></b> (<a href="cope.cgi?key=secretory%20leukocyte%20protease%20inhibitor">secretory leukocyte protease inhibitor</a>, <a href="cope.cgi?key=Antileukoproteinase">antileukoproteinase</a>, <a href="cope.cgi?key=BLPI">BLPI</a>, <a href="cope.cgi?key=Bronchial%20leukocyte%20proteinase%20inhibitor">Bronchial leukocyte proteinase inhibitor</a>, <a href="cope.cgi?key=BMI">BMI</a> <a href="cope.cgi?key=bronchial%20mucus%20inhibitor">bronchial mucus inhibitor</a>, <a href="cope.cgi?key=CUSI">CUSI</a>, <a href="cope.cgi?key=cervical%20mucus%20inhibitor">cervical mucus inhibitor</a>, <a href="cope.cgi?key=HUSI%2dI">HUSI-I</a>, <a href="cope.cgi?key=Human%20seminal%20plasma%20inhibitor%2dI">human seminal plasma inhibitor-I</a>, <a href="cope.cgi?key=MPI">MPI</a>, <a href="cope.cgi?key=Mucus%20proteinase%20inhibitor">Mucus proteinase inhibitor</a>, <a href="cope.cgi?key=seminal%20plasma%20inhibitor">seminal plasma inhibitor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Sano et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SLURP%2d2">SLURP-2</a></b> (<a href="cope.cgi?key=Secreted%20Ly%2d6%2fuPAR%2drelated%20protein%202">Secreted Ly-6/uPAR-related protein 2</a>; <a href="cope.cgi?key=secreted%20Ly%2d6%2fPLAUR%20domain%2dcontaining%20protein%202">secreted Ly-6/PLAUR domain-containing protein 2</a>, <a href="cope.cgi?key=GC26">GC26</a>, <a href="cope.cgi?key=LYNX1">LYNX1</a>, <a href="cope.cgi?key=Ly%2d6%2fneurotoxin%2dlike%20protein%201">Ly-6/neurotoxin-like protein 1</a>) (Kawashima et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SMAD2">SMAD2</a></b> (<a href="cope.cgi?key=Sma%20and%20Mad%20related%20protein%2d2">Sma and Mad related protein-2</a>, <a href="cope.cgi?key=JV18%2d1">JV18-1</a>, <a href="cope.cgi?key=MADR2">MADR2</a>, <a href="cope.cgi?key=Mad%2drelated%20protein%202">Mad-related protein 2</a>, <a href="cope.cgi?key=MADH2">MADH2</a>, <a href="cope.cgi?key=Mothers%20against%20DPP%20homolog%202">Mothers against DPP homolog 2</a>, <a href="cope.cgi?key=Mothers%20against%20DPP%20homolog%202">Mothers against DPP homolog 2</a>) (Gratchev A et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SMAD3">SMAD3</a></b> (<a href="cope.cgi?key=Sma%20and%20Mad%20related%20protein%2d3">Sma and Mad related protein-3</a>, <a href="cope.cgi?key=MADH3">MADH3</a>, <a href="cope.cgi?key=Mothers%20against%20decapentaplegic%20homolog%203">Mothers against decapentaplegic homolog 3</a>, <a href="cope.cgi?key=Mothers%20against%20DPP%20homolog%203">Mothers against DPP homolog 3</a>, <a href="cope.cgi?key=JV15%2d2">JV15-2</a>) (Lee HJ et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SOCS3">SOCS3</a></b> (<a href="cope.cgi?key=Suppressor%20of%20cytokine%20signaling%2d3">Suppressor of cytokine signaling-3</a>, <a href="cope.cgi?key=CIS3">CIS3</a>, <a href="cope.cgi?key=Cytokine%20inducible%20SH2%2dcontaining%20protein%2d3">Cytokine inducible SH2-containing protein-3</a>, <a href="cope.cgi?key=SSI3">SSI3</a>, <a href="cope.cgi?key=STAT%20induced%20STAT%20inhibitor%2d3">STAT induced STAT inhibitor-3</a>) (Huang et al, 2003; Niemand et al, 2003; Berlato et al, 2002; Folco et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Somatostatin">somatostatin</a> </b>(<a href="cope.cgi?key=SST">SST</a>, <a href="cope.cgi?key=Somatotropin%20release%20inhibiting%20hormone">Somatotropin release inhibiting hormone</a>, <a href="cope.cgi?key=SIH">SIH</a>, <a href="cope.cgi?key=Somatotropin%20release%20inhibiting%20factor">Somatotropin release inhibiting factor</a>, <a href="cope.cgi?key=SRIF">SRIF</a>, <a href="cope.cgi?key=growth%20hormone%2dinhibiting%20hormone">growth hormone-inhibiting hormone</a>, <a href="cope.cgi?key=GIH">GIH</a>, <a href="cope.cgi?key=growth%20hormone%20release%20inhibitory%20hormone">growth hormone release inhibitory hormone</a>, <a href="cope.cgi?key=GH%2dRIH">GH-RIH</a>) (Ryu et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Somatostatin">somatostatin</a> </b>(<a href="cope.cgi?key=SST">SST</a>, <a href="cope.cgi?key=Somatotropin%20release%20inhibiting%20hormone">Somatotropin release inhibiting hormone</a>, <a href="cope.cgi?key=SIH">SIH</a>, <a href="cope.cgi?key=Somatotropin%20release%20inhibiting%20factor">Somatotropin release inhibiting factor</a>, <a href="cope.cgi?key=SRIF">SRIF</a>, <a href="cope.cgi?key=growth%20hormone%2dinhibiting%20hormone">growth hormone-inhibiting hormone</a>, <a href="cope.cgi?key=GIH">GIH</a>, <a href="cope.cgi?key=growth%20hormone%20release%20inhibitory%20hormone">growth hormone release inhibitory hormone</a>, <a href="cope.cgi?key=GH%2dRIH">GH-RIH</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Dalm et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=SPARC">SPARC</a></b> (<a href="cope.cgi?key=secreted%20protein%20acidic%20and%20rich%20in%20cysteine">secreted protein acidic and rich in cysteine</a>, <a href="cope.cgi?key=osteonectin">osteonectin</a>, <a href="cope.cgi?key=BM%2d40">BM-40</a>, <a href="cope.cgi?key=Basement%2dmembrane%20protein%2040">basement-membrane protein 40</a>, <a href="cope.cgi?key=43K%20glycoprotein">43K glycoprotein</a> ) (Puolakkainen et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=stanniocalcin%201">stanniocalcin 1</a></b> (<a href="cope.cgi?key=STC1">STC1</a>, <a href="cope.cgi?key=STC">STC</a>, <a href="cope.cgi?key=STC50">STC50</a>, <a href="cope.cgi?key=stanniocalcin">stanniocalcin</a>, <a href="cope.cgi?key=hypocalcin">hypocalcin</a>, <a href="cope.cgi?key=teleocalcin">teleocalcin</a>) (Kanellis et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=stanniocalcin%201">stanniocalcin 1</a></b> (<a href="cope.cgi?key=STC1">STC1</a>, <a href="cope.cgi?key=STC">STC</a>, <a href="cope.cgi?key=STC50">STC50</a>, <a href="cope.cgi?key=stanniocalcin">stanniocalcin</a>, <a href="cope.cgi?key=hypocalcin">hypocalcin</a>, <a href="cope.cgi?key=teleocalcin">teleocalcin</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Kanellis et al, 2004; Sheikh-Hamad, 2010; WangY et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=STAT1">STAT1</a></b> (<a href="cope.cgi?key=signal%20transducer%20and%20activator%20of%20transcription%2d1">signal transducer and activator of transcription-1</a>, <a href="cope.cgi?key=STAT1%2dalpha">STAT1-alpha</a>, <a href="cope.cgi?key=STAT1%2dbeta">STAT1-beta</a>, <a href="cope.cgi?key=p91">p91</a>, <a href="cope.cgi?key=Stat91">Stat91</a>, <a href="cope.cgi?key=p84">p84</a>) (Wells et al, 2006; Li F et al, 2009; Goh F et al, 2009; Lifshitz et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=STAT3">STAT3</a></b> (<a href="cope.cgi?key=signal%20transducer%20and%20activator%20of%20transcription%2d3">signal transducer and activator of transcription-3</a>, <a href="cope.cgi?key=APRF">APRF</a>, <a href="cope.cgi?key=Acute%20phase%20response%20factor">acute phase response factor</a>, <a href="cope.cgi?key=STAT3%2dalpha">STAT3-alpha</a>, <a href="cope.cgi?key=STAT3%2dbeta">STAT3-beta</a>, <a href="cope.cgi?key=STAT3%2dgamma">STAT3-gamma</a>, <a href="cope.cgi?key=STAT3%2ddelta">STAT3-delta</a>) (Kiguchi et al, 2009; Li F et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=STAT5">STAT5</a></b> (<a href="cope.cgi?key=signal%20transducer%20and%20activator%20of%20transcription%2d5">signal transducer and activator of transcription-5</a>, <a href="cope.cgi?key=STAT5a">STAT5a</a>, <a href="cope.cgi?key=STAT5b">STAT5b</a>) (Lifshitz et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=STAT6">STAT6</a></b> (<a href="cope.cgi?key=signal%20transducer%20and%20activator%20of%20transcription%2d6">signal transducer and activator of transcription-6</a>, <a href="cope.cgi?key=IL4%2dSTAT">IL4-STAT</a>, <a href="cope.cgi?key=IL4%20induced%20nuclear%2dactivating%20factor">IL4 induced nuclear-activating factor</a>, <a href="cope.cgi?key=IL4%2dNAF">IL4-NAF</a>) (Jang et al, 2009; Tomita K et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Substance%20P">substance P</a> </b>(<a href="cope.cgi?key=Neurokinin%2d1">Neurokinin-1</a>, <a href="cope.cgi?key=NK1">NK1</a>, <a href="cope.cgi?key=NKA">NKA</a>, <a href="cope.cgi?key=Neurokinin%20A">Neurokinin A</a>, <a href="cope.cgi?key=Tac1">Tac1</a>, <a href="cope.cgi?key=Tachykinin%2d1">tachykinin-1</a>) (Ho et al, 1998; Ryu et al, 2000; Blum et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Substance%20P">substance P</a> </b>(<a href="cope.cgi?key=Neurokinin%2d1">Neurokinin-1</a>, <a href="cope.cgi?key=NK1">NK1</a>, <a href="cope.cgi?key=NKA">NKA</a>, <a href="cope.cgi?key=Neurokinin%20A">Neurokinin A</a>, <a href="cope.cgi?key=Tac1">Tac1</a>, <a href="cope.cgi?key=Tachykinin%2d1">tachykinin-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Chancellor-Freeland et al, 1995, 1996; D'Ortho et al, 1995; Ho et al, 1998; Rameshwar et al, 1994; Marriott and Bost, 2001; Jeon et al, 1999; Zhu et al, 1996; Brylla et al, 2005; Amoruso et al, 2008; Sun et al, 2008; Siebenhaar et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=suppressin">suppressin</a></b> (<a href="cope.cgi?key=SPN">SPN</a>) (Ban and LeBoeuf, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=surfactant%20protein%20A">surfactant protein A</a></b> (<a href="cope.cgi?key=SP%2dA">SP-A</a>, <a href="cope.cgi?key=SFTPA1">SFTPA1</a>, <a href="cope.cgi?key=surfactant%20protein%20A1">surfactant protein A1</a>, <a href="cope.cgi?key=collectin%2d4">collectin-4</a>, <a href="cope.cgi?key=SFTP1">SFTP1</a>, <a href="cope.cgi?key=surfactant%2dassociated%20protein%2c%20pulmonary%201">surfactant-associated protein, pulmonary 1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Alcorn and Wright, 2004; Guillot et al, 2002; Gil et al, 2009; Lopez et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥ <a href="cope.cgi?key=syndecan%2d1">Syndecan-1</a></b> (<a href="cope.cgi?key=syndecan">syndecan</a>, <a href="cope.cgi?key=syndecan%20proteoglycan%201">syndecan proteoglycan 1</a>, <a href="cope.cgi?key=SDC1">SDC1</a>, <a href="cope.cgi?key=Synd1">Synd1</a>, <a href="cope.cgi?key=SD%2d1">SD-1</a>, <a href="cope.cgi?key=104%2d9%20antigen">104-9 antigen</a>, <a href="cope.cgi?key=1D4%20antigen">1D4 antigen</a>, <a href="cope.cgi?key=B%2dB2%20antigen">B-B2 antigen</a>, <a href="cope.cgi?key=B%2dB4%20antigen">B-B4 antigen</a>, <a href="cope.cgi?key=Mi15">Mi15</a>, <a href="cope.cgi?key=CD138">CD138</a>) (Slimani et al, 2003; Yeaman and Rapraeger, 1993; Brule et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=syndecan%2d2">syndecan-2</a></b> (<a href="cope.cgi?key=syndecan%20proteoglycan%202">syndecan proteoglycan 2</a>, <a href="cope.cgi?key=SDC2">SDC2</a>, <a href="cope.cgi?key=SYND2">SYND2</a>, <a href="cope.cgi?key=HSPG">HSPG</a>, <a href="cope.cgi?key=Heparan%20sulfate%20proteoglycan%20core%20protein">Heparan sulfate proteoglycan core protein</a>, <a href="cope.cgi?key=HSPG1">HSPG1</a>, <a href="cope.cgi?key=Heparan%20sulfate%20proteoglycan%20core%20protein%2d1">Heparan sulfate proteoglycan core protein-1</a>, <a href="cope.cgi?key=fibroglycan">fibroglycan</a>, <a href="cope.cgi?key=CD362">CD362</a>) (Clasper et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=syndecan%2d3">syndecan-3</a> </b>(<a href="cope.cgi?key=SDC3">SDC3</a>, <a href="cope.cgi?key=Synd3">Synd3</a>, <a href="cope.cgi?key=N%2dSyndecan">N-Syndecan</a>, <a href="cope.cgi?key=neural%20syndecan">neural syndecan</a>, <a href="cope.cgi?key=neural%20syndecan">neural-type syndecan</a>, <a href="cope.cgi?key=SDCN">SDCN</a>) (Patterson et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥ </b><b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Syndecan%2d4">Syndecan-4</a></b> (<a href="cope.cgi?key=SDC4">SDC4</a>, <a href="cope.cgi?key=SYND4">SYND4</a>, <a href="cope.cgi?key=amphiglycan">amphiglycan</a>, <a href="cope.cgi?key=ryudocan">ryudocan</a>) (Brule et al, 2006; Smith et al, 2006; McLaren et al, 2011; Slimani et al, 2003; Tanino et al, 2012)<br/> <b style="mso-bidi-font-weight:normal"><br/> ¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TCTP">TCTP</a></b> (<a href="cope.cgi?key=translationally%20controlled%20tumor%20protein">translationally controlled tumor protein</a>, <a href="cope.cgi?key=TPT1">TPT1</a>, <a href="cope.cgi?key=tumor%20protein%20translationally%2dcontrolled%2d1">tumor protein translationally-controlled-1</a>, <a href="cope.cgi?key=Fortilin">fortilin</a>, <a href="cope.cgi?key=p23">p23</a>, <a href="cope.cgi?key=IgE%2dHRF">IgE-HRF</a>, <a href="cope.cgi?key=IgE%2ddependent%20histamine%20releasing%20factor">IgE-dependent histamine releasing factor</a>) (Sanchez et al, 1997; Guillaume et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=tenascin%2dC">tenascin-C</a></b> (<a href="cope.cgi?key=TN%2dC">TN-C</a>, <a href="cope.cgi?key=Tenascin">Tenascin</a>, <a href="cope.cgi?key=TN">TN</a>, <a href="cope.cgi?key=TNC220">TNC220</a>, <a href="cope.cgi?key=TNS">TNS</a>, <a href="cope.cgi?key=TNC320">TNC320</a>, <a href="cope.cgi?key=TNL">TNL</a>, <a href="cope.cgi?key=Cytotactin">Cytotactin</a>, <a href="cope.cgi?key=hexabrachion">hexabrachion</a>, <a href="cope.cgi?key=HXB">HXB</a>, <a href="cope.cgi?key=myotendinous%20antigen">myotendinous antigen</a>, <a href="cope.cgi?key=M1%20antigen">M1 antigen</a>, <a href="cope.cgi?key=GMEM">GMEM</a>, <a href="cope.cgi?key=Glioma%2dassociated%2dextracellular%20matrix%20antigen">Glioma-associated-extracellular matrix antigen</a>, <a href="cope.cgi?key=neuronectin">neuronectin</a>, <a href="cope.cgi?key=J1%20Glycoprotein">J1 Glycoprotein</a>, <a href="cope.cgi?key=J1%2ftenascin">J1/tenascin</a>, <a href="cope.cgi?key=tenascin%2dJ1">tenascin-J1</a>) (Kim DK et al, 2009; Gratchev A et al, 2005; Pkk P et al, 2000; Wallner K et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TFF%2d2">TFF-2</a></b> (<a href="cope.cgi?key=Trefoil%20factor%2d2">Trefoil factor-2</a>, <a href="cope.cgi?key=Spasmolytic%20protein">spasmolytic protein</a>, <a href="cope.cgi?key=SML%2d1">SML-1</a>, <a href="cope.cgi?key=Spasmolysin">spasmolysin</a>) (Kurt-Jones et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TFPI">TFPI</a></b> (<a href="cope.cgi?key=tissue%20factor%20pathway%20inhibitor">tissue factor pathway inhibitor</a>, <a href="cope.cgi?key=TFPI%2d1">TFPI-1</a>, <a href="cope.cgi?key=tissue%20factor%20pathway%20inhibitor%2d1">tissue factor pathway inhibitor-1</a>, <a href="cope.cgi?key=EPI">EPI</a>, <a href="cope.cgi?key=extrinsic%20pathway%20inhibitor">extrinsic pathway inhibitor</a>, <a href="cope.cgi?key=LACI">LACI</a>, <a href="cope.cgi?key=lipoprotein%2dassociated%20coagulation%20inhibitor">lipoprotein-associated coagulation inhibitor</a>) (Petit et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TGF%2dalpha">TGF-alpha</a></b> (<a href="cope.cgi?key=transforming%20growth%20factor%2dalpha">transforming growth factor-alpha</a>, <a href="cope.cgi?key=TGFA">TGFA</a>, <a href="cope.cgi?key=TGF%2dA">TGF-A</a>, <a href="cope.cgi?key=MDGF%2d2">MDGF-2</a>, <a href="cope.cgi?key=Milk%2dderived%20growth%20factor%2d2">milk-derived growth factor-2</a>, <a href="cope.cgi?key=TCGF">TCGF</a>, <a href="cope.cgi?key=transformed%20cell%20growth%20factor">transformed cell growth factor</a>, <a href="cope.cgi?key=wa%2d1">wa-1</a>, <a href="cope.cgi?key=waved%2d1">waved-1</a>) (Kodelja et al, 1997; Zhu et al, 1991; Rappolee et al, 1988; Rappolee et al, 1988)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TGF%2dbeta">TGF-beta</a></b> (<a href="cope.cgi?key=transforming%20growth%20factor%2dbeta">transforming growth factor-beta</a>, <a href="cope.cgi?key=TGFB">TGFB</a>, <a href="cope.cgi?key=B%2dTGF">B-TGF</a>, <a href="cope.cgi?key=Aqueous%20humor%20lymphocyte%20inhibitory%20activity">Aqueous humor lymphocyte inhibitory activity</a>, <a href="cope.cgi?key=DIF">DIF</a>, <a href="cope.cgi?key=Differentiation%2dinhibiting%20factor">differentiation-inhibiting factor</a>, <a href="cope.cgi?key=EGI">EGI</a>, <a href="cope.cgi?key=epithelial%20cell%2dspecific%20growth%20inhibitor">epithelial cell-specific growth inhibitor</a>; <a href="cope.cgi?key=epithelial%20growth%20inhibitor">epithelial growth inhibitor</a>, <a href="cope.cgi?key=EIF">EIF</a>, <a href="cope.cgi?key=Epstein%2dBarr%20virus%20inducing%20factor">Epstein-Barr virus inducing factor</a>, <a href="cope.cgi?key=epithelial%20cell%20growth%20inhibiting%20factor">Epithelial cell growth inhibiting factor</a>, <a href="cope.cgi?key=G%2dTsF">G-TsF</a>, <a href="cope.cgi?key=Glioma%2dderived%20T%2dcell%20suppressor%20factor">glioma-derived T-cell suppressor factor</a>, <a href="cope.cgi?key=MDGF">MDGF</a>, <a href="cope.cgi?key=Milk%2dderived%20growth%20factor">milk-derived growth factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=Milk%20growth%20factor">milk growth factor</a>, <a href="cope.cgi?key=Polyergin">Polyergin</a>, <a href="cope.cgi?key=Simian%20BSC%2d1%20cell%20growth%20inhibitor">Simian BSC-1 cell growth inhibitor</a>, <a href="cope.cgi?key=SP%20factor">SP factor</a>, <a href="cope.cgi?key=TCGF">TCGF</a>, <a href="cope.cgi?key=transformed%20cell%20growth%20factor">transformed cell growth factor</a>, <a href="cope.cgi?key=TGI">TGI</a>, <a href="cope.cgi?key=Tissue%2dderived%20growth%20inhibitor">tissue-derived growth inhibitor</a>, <a href="cope.cgi?key=TIF%2d1">TIF-1</a>, <a href="cope.cgi?key=Tumor%20inducing%20factor%2d1">tumor inducing factor-1</a>) (Yagnik et al, 2004; Chong et al, 1999; Corradin et al, 1993; Dhanani et al, 1994; Katakura et al, 2004; Smith and Hale, 1997; Wu et al, 1997; Fadok et al, 1998; Xing et al, 1997; Nelson et al, 1994; Kodelja et al, 1997; Kovacs et al, 1994; Ueno et al, 2001; Lucas et al, 2003; Rappolee et al, 1988; Cheng et al, 2003; Wickenhauser et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TGF%2dbeta">TGF-beta</a></b> (<a href="cope.cgi?key=transforming%20growth%20factor%2dbeta">transforming growth factor-beta</a>, <a href="cope.cgi?key=TGFB">TGFB</a>, <a href="cope.cgi?key=B%2dTGF">B-TGF</a>, <a href="cope.cgi?key=Aqueous%20humor%20lymphocyte%20inhibitory%20activity">Aqueous humor lymphocyte inhibitory activity</a>, <a href="cope.cgi?key=DIF">DIF</a>, <a href="cope.cgi?key=Differentiation%2dinhibiting%20factor">differentiation-inhibiting factor</a>, <a href="cope.cgi?key=EGI">EGI</a>, <a href="cope.cgi?key=epithelial%20cell%2dspecific%20growth%20inhibitor">epithelial cell-specific growth inhibitor</a>; <a href="cope.cgi?key=epithelial%20growth%20inhibitor">epithelial growth inhibitor</a>, <a href="cope.cgi?key=EIF">EIF</a>, <a href="cope.cgi?key=Epstein%2dBarr%20virus%20inducing%20factor">Epstein-Barr virus inducing factor</a>, <a href="cope.cgi?key=epithelial%20cell%20growth%20inhibiting%20factor">Epithelial cell growth inhibiting factor</a>, <a href="cope.cgi?key=G%2dTsF">G-TsF</a>, <a href="cope.cgi?key=Glioma%2dderived%20T%2dcell%20suppressor%20factor">glioma-derived T-cell suppressor factor</a>, <a href="cope.cgi?key=MDGF">MDGF</a>, <a href="cope.cgi?key=Milk%2dderived%20growth%20factor">milk-derived growth factor</a>, <a href="cope.cgi?key=MGF">MGF</a>, <a href="cope.cgi?key=Milk%20growth%20factor">milk growth factor</a>, <a href="cope.cgi?key=Polyergin">Polyergin</a>, <a href="cope.cgi?key=Simian%20BSC%2d1%20cell%20growth%20inhibitor">Simian BSC-1 cell growth inhibitor</a>, <a href="cope.cgi?key=SP%20factor">SP factor</a>, <a href="cope.cgi?key=TCGF">TCGF</a>, <a href="cope.cgi?key=transformed%20cell%20growth%20factor">transformed cell growth factor</a>, <a href="cope.cgi?key=TGI">TGI</a>, <a href="cope.cgi?key=Tissue%2dderived%20growth%20inhibitor">tissue-derived growth inhibitor</a>, <a href="cope.cgi?key=TIF%2d1">TIF-1</a>, <a href="cope.cgi?key=Tumor%20inducing%20factor%2d1">tumor inducing factor-1</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=TGFBR1">TGFBR1</a>, <a href="cope.cgi?key=TbetaRI">TbetaRI</a>, <a href="cope.cgi?key=TbetaRI">TbetaR1</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%20receptor%201">transforming growth factor-beta receptor 1</a>, <a href="cope.cgi?key=TGF%2dbeta%20receptor%201">TGF-beta receptor 1</a>; <a href="cope.cgi?key=TGF%2dbeta%20receptor%20type%201">TGF-beta receptor type 1</a>, <a href="cope.cgi?key=type%201%20TGF%2dbeta%20receptors">type 1 TGF-beta receptors</a>, <a href="cope.cgi?key=ALK5">ALK5</a>, <a href="cope.cgi?key=Activin%20receptor%2dlike%20kinase%205">Activin receptor-like kinase 5</a>, <a href="cope.cgi?key=activin%20A%20receptor%20type%202%2dlike%20kinase">activin A receptor type 2-like kinase</a>, <a href="cope.cgi?key=ACVRLK4">ACVRLK4</a>, <a href="cope.cgi?key=Activin%20receptor%2dlike%20kinase%204">activin receptor-like kinase 4</a> ; <a href="cope.cgi?key=TGFBR2">TGFBR2</a>, <a href="cope.cgi?key=TbetaRII">TbetaRII</a>, <a href="cope.cgi?key=TbetaRII">TbetaR2</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%20receptor%202">transforming growth factor-beta receptor 2</a>, <a href="cope.cgi?key=TGF%2dbeta%20receptor%202">TGF-beta receptor 2</a>, <a href="cope.cgi?key=TGF%2dbeta%20receptor%20type%202">TGF-beta receptor type 2</a>, <a href="cope.cgi?key=type%201%20TGF%2dbeta%20receptors">type 1 TGF-beta receptors</a>, <a href="cope.cgi?key=MFS2">MFS2</a>, <a href="cope.cgi?key=Marfan%20syndrome%20type%202">Marfan syndrome type 2</a>) (Ma et al, 1999; Corradin et al, 1993; Chong et al, 1999; Falcone et al, 1993; Krettek et al, 2001; Yoon et al, 2000; Kim et al, 2008; Gratchev A et al, 2008; Gleissner et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TGF%2dbeta%2d1">TGF-beta-1</a></b> (<a href="cope.cgi?key=TGFB1">TGFB1</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%2d1">transforming growth factor-beta-1</a>, <a href="cope.cgi?key=CIF%2dA">CIF-A</a>, <a href="cope.cgi?key=Cartilage%20inducing%20factor%20A">cartilage inducing factor A</a>, <a href="cope.cgi?key=ISF">ISF</a>, <a href="cope.cgi?key=Immunosuppressive%20factor">immunosuppressive factor</a>, <a href="cope.cgi?key=MGF%2db">MGF-b</a>, <a href="cope.cgi?key=Milk%20growth%20factor">milk growth factor</a>, <a href="cope.cgi?key=PDGI">PDGI</a>, <a href="cope.cgi?key=Platelet%2dderived%20endothelial%20cell%20growth%20inhibitor">platelet-derived endothelial cell growth inhibitor</a>) (Evanko <a href="cope.cgi?key=SP">SP</a> et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=TGF%2dbeta%2d1">TGF-beta-1</a></b> (<a href="cope.cgi?key=TGFB1">TGFB1</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%2d1">transforming growth factor-beta-1</a>, <a href="cope.cgi?key=CIF%2dA">CIF-A</a>, <a href="cope.cgi?key=Cartilage%20inducing%20factor%20A">cartilage inducing factor A</a>, <a href="cope.cgi?key=ISF">ISF</a>, <a href="cope.cgi?key=Immunosuppressive%20factor">immunosuppressive factor</a>, <a href="cope.cgi?key=MGF%2db">MGF-b</a>, <a href="cope.cgi?key=Milk%20growth%20factor">milk growth factor</a>, <a href="cope.cgi?key=PDGI">PDGI</a>, <a href="cope.cgi?key=Platelet%2dderived%20endothelial%20cell%20growth%20inhibitor">platelet-derived endothelial cell growth inhibitor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=TGFBR1">TGFBR1</a>, <a href="cope.cgi?key=TbetaRI">TbetaRI</a>, <a href="cope.cgi?key=TbetaRI">TbetaR1</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%20receptor%201">transforming growth factor-beta receptor 1</a>, <a href="cope.cgi?key=TGF%2dbeta%20receptor%201">TGF-beta receptor 1</a>; <a href="cope.cgi?key=TGF%2dbeta%20receptor%20type%201">TGF-beta receptor type 1</a>, <a href="cope.cgi?key=type%201%20TGF%2dbeta%20receptors">type 1 TGF-beta receptors</a>, <a href="cope.cgi?key=ALK5">ALK5</a>, <a href="cope.cgi?key=Activin%20receptor%2dlike%20kinase%205">Activin receptor-like kinase 5</a>, <a href="cope.cgi?key=activin%20A%20receptor%20type%202%2dlike%20kinase">activin A receptor type 2-like kinase</a>, <a href="cope.cgi?key=ACVRLK4">ACVRLK4</a>, <a href="cope.cgi?key=Activin%20receptor%2dlike%20kinase%204">activin receptor-like kinase 4</a> ; <a href="cope.cgi?key=TGFBR2">TGFBR2</a>, <a href="cope.cgi?key=TbetaRII">TbetaRII</a>, <a href="cope.cgi?key=TbetaRII">TbetaR2</a>, <a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%20receptor%202">transforming growth factor-beta receptor 2</a>, <a href="cope.cgi?key=TGF%2dbeta%20receptor%202">TGF-beta receptor 2</a>, <a href="cope.cgi?key=TGF%2dbeta%20receptor%20type%202">TGF-beta receptor type 2</a>, <a href="cope.cgi?key=type%201%20TGF%2dbeta%20receptors">type 1 TGF-beta receptors</a>, <a href="cope.cgi?key=MFS2">MFS2</a>, <a href="cope.cgi?key=Marfan%20syndrome%20type%202">Marfan syndrome type 2</a>) (Gratchev A et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TGF%2dbeta%2d2">TGF-beta-2</a></b> (<a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%2d2">transforming growth factor-beta-2</a>, <a href="cope.cgi?key=TGFB2">TGFB2</a>, <a href="cope.cgi?key=G%2dTsF">G-TsF</a>, <a href="cope.cgi?key=Glioblastoma%2dderived%20T%2dcell%20suppressor%20factor">Glioblastoma-derived T-cell suppressor factor</a>, <a href="cope.cgi?key=CIF%2dB">CIF-B</a>, <a href="cope.cgi?key=Cartilage%20inducing%20factor%20B">cartilage inducing factor B</a>, <a href="cope.cgi?key=Corneal%20epithelial%20inhibitor%20of%20stromal%20cell%20collagenase%20synthesis">Corneal epithelial inhibitor of stromal cell collagenase synthesis</a>, <a href="cope.cgi?key=DSF">DSF</a>, <a href="cope.cgi?key=Decidual%20suppressor%20factor">decidual suppressor factor</a>, <a href="cope.cgi?key=MGF%2da">MGF-a</a>, <a href="cope.cgi?key=Milk%20growth%20factor">milk growth factor</a>) (Evanko <a href="cope.cgi?key=SP">SP</a> et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TGF%2dbeta%2d3">TGF-beta-3</a></b> (<a href="cope.cgi?key=transforming%20growth%20factor%2dbeta%2d3">transforming growth factor-beta-3</a>, <a href="cope.cgi?key=TGFB3">TGFB3</a>, <a href="cope.cgi?key=ARVD1">ARVD1</a>, <a href="cope.cgi?key=Arrhythmogenic%20right%20ventricular%20cardiomyopathy%20type%201">Arrhythmogenic right ventricular cardiomyopathy type 1</a>) (Evanko <a href="cope.cgi?key=SP">SP</a> et al, 1998)<br/> <b>¥</b> <b><a href="cope.cgi?key=Thimet%20oligopeptidase">Thimet oligopeptidase</a></b> (<a href="cope.cgi?key=THOP1">THOP1</a>, <a href="cope.cgi?key=Thimet%20oligopeptidase%201">Thimet oligopeptidase 1</a>, <a href="cope.cgi?key=EC3%2e4%2e24%2e15">EC3.4.24.15</a>, <a href="cope.cgi?key=Endopeptidase%2024%2e15">Endopeptidase 24.15</a>, <a href="cope.cgi?key=EP24%2e15">EP24.15</a>, <a href="cope.cgi?key=MP24%2e15">MP24.15</a>, <a href="cope.cgi?key=metalloendopeptidase%2024%2e15">metalloendopeptidase 24.15</a>, <a href="cope.cgi?key=TOP">TOP</a>, <a href="cope.cgi?key=thiol%2dactivated%20metallo%2doligopeptidase">thiol-activated metallo-oligopeptidase</a>, <a href="cope.cgi?key=BIE">BIE</a>, <a href="cope.cgi?key=bradykinin%20inactivating%20endopeptidase">bradykinin inactivating endopeptidase</a>, <a href="cope.cgi?key=MP78">MP78</a>, <a href="cope.cgi?key=Pz%2dpeptidase">Pz-peptidase</a>, <a href="cope.cgi?key=endo%2doligopeptidase%20A">endo-oligopeptidase A</a>) (Lesser et al, 1992; Choi <a href="cope.cgi?key=HS">HS</a> et al, 1990; Portaro et al, 2001; Vietinghoff and Paegelow, 2000; Yang X et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Thrombin">Thrombin</a> </b>(<a href="cope.cgi?key=coagulation%20factor%2d2">coagulation factor-2</a>, <a href="cope.cgi?key=factor%20IIa">factor IIa</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Kobayashi et al, 1997; Tani et al, 1997; Kastl et al, 2009; Lo et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Thrombin%20receptor">Thrombin receptor</a></b> (<a href="cope.cgi?key=TR">TR</a>, <a href="cope.cgi?key=CF2R">CF2R</a>, <a href="cope.cgi?key=coagulation%20factor%202%20receptor">coagulation factor 2 receptor</a>, <a href="cope.cgi?key=F2R">F2R</a>, <a href="cope.cgi?key=PAR%2d1">PAR-1</a>, <a href="cope.cgi?key=Proteinase%2dactivated%20receptor%201">Proteinase-activated receptor 1</a>) (Colognato et al, 2003; D'Andrea et al, 2001; Raza et al, 2000; roche et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Thrombospondin%2d1">Thrombospondin-1</a> </b>(<a href="cope.cgi?key=Thrombospondin">Thrombospondin</a>, <a href="cope.cgi?key=TSP1">TSP1</a>, <a href="cope.cgi?key=TSP">TSP</a>, <a href="cope.cgi?key=THBS1">THBS1</a>) (Dagtekin et al, 2003; De Nichilo and Burns, 1995; <a href="cope.cgi?key=Lu">Lu</a> et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Thymopoietin">thymopoietin</a></b> (<a href="cope.cgi?key=Tpo">Tpo</a>, <a href="cope.cgi?key=TP">TP</a>, <a href="cope.cgi?key=TMPO">TMPO</a>, <a href="cope.cgi?key=TP%2d5">TP-5</a>, <a href="cope.cgi?key=Thymopentin">thymopentin</a>, <a href="cope.cgi?key=Thymopoietin%2032%2d36">thymopoietin 32-36</a>, <a href="cope.cgi?key=Lamina%2dassociated%20polypeptide%202">Lamina-associated polypeptide 2</a>, <a href="cope.cgi?key=LAP2">LAP2</a>) (Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Thymosin%2dalpha%2d1">thymosin-alpha-1</a></b> (<a href="cope.cgi?key=Prothymosin%2dalpha">Prothymosin-alpha</a>, <a href="cope.cgi?key=PTMA">PTMA</a>, <a href="cope.cgi?key=Thymalfasin">Thymalfasin</a>, <a href="cope.cgi?key=Zadaxin">Zadaxin</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Tzehoval et al, 1989; Shrivastava et al, 2004, 2005; Paul et al, 2000; Tzehoval et al, 1989; Peng et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Thymosin%2dbeta%2d4">thymosin-beta-4</a></b> (<a href="cope.cgi?key=TMSB4">TMSB4</a>, <a href="cope.cgi?key=TMSB4X">TMSB4X</a>, <a href="cope.cgi?key=Tb4">Tb4</a>, <a href="cope.cgi?key=Tbeta%2d4">Tbeta-4</a>, <a href="cope.cgi?key=6%2d26">6-26</a>, <a href="cope.cgi?key=Fx">Fx</a>, <a href="cope.cgi?key=PTMB4">PTMB4</a>, <a href="cope.cgi?key=THYB4">THYB4</a>) (Xu et al, 1982; Dalakas and Trapp, 1986; Larsson and Holck, 2007; Hannappel E and Leibold, 1985; Yu et al, 1994; Hannappel et al, 1982; Kannan et al, 2007)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Thymosin%2dbeta%2d4">thymosin-beta-4</a></b> (<a href="cope.cgi?key=TMSB4">TMSB4</a>, <a href="cope.cgi?key=TMSB4X">TMSB4X</a>, <a href="cope.cgi?key=Tb4">Tb4</a>, <a href="cope.cgi?key=Tbeta%2d4">Tbeta-4</a>, <a href="cope.cgi?key=6%2d26">6-26</a>, <a href="cope.cgi?key=Fx">Fx</a>, <a href="cope.cgi?key=PTMB4">PTMB4</a>, <a href="cope.cgi?key=THYB4">THYB4</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Tzehoval et al, 1989)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Thymosin%2dbeta%2d10">Thymosin-beta-10</a> </b>(<a href="cope.cgi?key=TMSB10">TMSB10</a>, <a href="cope.cgi?key=Tbeta%2d10">Tbeta-10</a>, <a href="cope.cgi?key=Tb10">Tb10</a>, <a href="cope.cgi?key=PTMB10">PTMB10</a>, <a href="cope.cgi?key=THYB10">THYB10</a>) (Gutirrez-Pabello JA et al, 2002; Yu et al, 1994; Tsuji et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Tim%2d2">Tim-2</a> </b>(<a href="cope.cgi?key=T%2dcells">T-cell</a> immunoglobulin and mucin <a href="cope.cgi?key=domain">domain</a> containing 2; <a href="cope.cgi?key=T%2dcell%20immunoglobulin%20and%20mucin%20domain%2dcontaining%20protein%202">T-cell immunoglobulin and mucin domain-containing protein 2</a>; <a href="cope.cgi?key=T%2dcell%20membrane%20protein%202">T-cell membrane protein 2</a>, <a href="cope.cgi?key=Timd2">Timd2</a>) (Smith <a href="cope.cgi?key=EP">EP</a> et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥ <a href="cope.cgi?key=Tim%2d3">Tim-3</a></b> (<a href="cope.cgi?key=T%2dcell%20immunoglobulin%20and%20mucin%20domain%2dcontaining%20protein%203">T-cell immunoglobulin and mucin domain-containing protein 3</a>; <a href="cope.cgi?key=T%2dcell%20membrane%20protein%203">T-cell membrane protein 3</a>, <a href="cope.cgi?key=T%2dcell%20immunoglobulin%20mucin%203">T-cell immunoglobulin mucin 3</a>, <a href="cope.cgi?key=T%2dcell%20Ig%20mucin%203">T-cell Ig mucin 3</a>, <a href="cope.cgi?key=Timd3">Timd3</a>, <a href="cope.cgi?key=HAVCR2">HAVCR2</a>, <a href="cope.cgi?key=hepatitis%20A%20virus%20cellular%20receptor%202">hepatitis A virus cellular receptor 2</a>) (Oikawa et al, 2006; Mengshol et al, 2010; Nakayama et al, 2009; Dorfman et al, 2010; Zhang Y et al, 2011; Frisanch-Kiss et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Tim%2d4">Tim-4</a></b> (<a href="cope.cgi?key=T%2dcell%20membrane%20protein%204">T-cell membrane protein 4</a>, <a href="cope.cgi?key=TIMD4">TIMD4</a>, <a href="cope.cgi?key=T%2dcells">T-cell</a> immunoglobulin and mucin <a href="cope.cgi?key=domain">domain</a> containing 4; <a href="cope.cgi?key=T%2dcell%20immunoglobulin%20and%20mucin%20domain%2dcontaining%20protein%204">T-cell immunoglobulin and mucin domain-containing protein 4</a>, <a href="cope.cgi?key=SMUCKLER">SMUCKLER</a>) (Kobayashi et al, 2007; Xu L et al, 2010, 2011; Rodriguez-Manzanet et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TIMP%2d1">TIMP-1</a></b> (<a href="cope.cgi?key=Tissue%20inhibitor%20of%20metalloproteinases%2d1">tissue inhibitor of metalloproteinases-1</a>, <a href="cope.cgi?key=TIMP%20metallopeptidase%20inhibitor%201">TIMP metallopeptidase inhibitor 1</a>, <a href="cope.cgi?key=TIMP">TIMP</a>, <a href="cope.cgi?key=Tissue%20inhibitor%20of%20metalloproteinases">tissue inhibitor of metalloproteinases</a>, <a href="cope.cgi?key=HCI">HCI</a>, <a href="cope.cgi?key=human%20collagenase%20inhibitor">human collagenase inhibitor</a>, <a href="cope.cgi?key=CLGI">CLGI</a>, <a href="cope.cgi?key=3%2f10">3/10</a>, <a href="cope.cgi?key=16C8">16C8</a>, <a href="cope.cgi?key=Fibroblast%20elongation%20factor">Fibroblast elongation factor</a>, <a href="cope.cgi?key=fibroblast%20collagenase%20inhibitor">fibroblast collagenase inhibitor</a>, <a href="cope.cgi?key=B1%20anticollagenase">B1 anticollagenase</a>, <a href="cope.cgi?key=Beta%2d1%20anticollagenase">Beta-1 anticollagenase</a>, <a href="cope.cgi?key=EPA">EPA</a>, <a href="cope.cgi?key=Erythroid%20promoting%20activity">erythroid promoting activity</a>, <a href="cope.cgi?key=Embryogenin%2d1">embryogenin-1</a>, <a href="cope.cgi?key=TPA%2dS1">TPA-S1</a>, <a href="cope.cgi?key=TPA%2dinduced%20protein%20S1">TPA-induced protein S1</a>) (Death et al, 2002; Shapiro et al, 1991, 1992; Toft-Hansen et al, 2004; Ma et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TIMP%2d2">TIMP-2</a></b> (<a href="cope.cgi?key=Tissue%20inhibitor%20of%20metalloproteinases%2d2">tissue inhibitor of metalloproteinases-2</a>, <a href="cope.cgi?key=TIMP%20metallopeptidase%20inhibitor%202">TIMP metallopeptidase inhibitor 2</a>, <a href="cope.cgi?key=CSC%2d21K">CSC-21K</a>, <a href="cope.cgi?key=MI">MI</a>, <a href="cope.cgi?key=CHIAMP">CHIAMP</a>, <a href="cope.cgi?key=Chondrocyte%2dderived%20inhibitor%20of%20angiogenesis%20and%20metalloproteinase%20activity">Chondrocyte-derived inhibitor of angiogenesis and metalloproteinase activity</a>) (Kawano et al, 1997; Shapiro et al, 1992; Ma et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TIMP%2d3">TIMP-3</a></b> (<a href="cope.cgi?key=Tissue%20inhibitor%20of%20metalloproteinases%2d3">tissue inhibitor of metalloproteinases-3</a>, <a href="cope.cgi?key=TIMP%20metallopeptidase%20inhibitor%203">TIMP metallopeptidase inhibitor 3</a>, <a href="cope.cgi?key=mitogen%2dinducible%20gene%205">mitogen-inducible gene 5</a>, <a href="cope.cgi?key=mig%2d5">mig-5</a>; <a href="cope.cgi?key=SFD">SFD</a>, <a href="cope.cgi?key=Sorsby%20fundus%20dystrophy">Sorsby fundus dystrophy</a>) (Johnson et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TIMP%2d4">TIMP-4</a></b> (<a href="cope.cgi?key=tissue%20inhibitor%20of%20metalloproteinases%2d4">tissue inhibitor of metalloproteinases-4</a>, <a href="cope.cgi?key=TIMP%20metallopeptidase%20inhibitor%204">TIMP metallopeptidase inhibitor 4</a>) (Koskivirta et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TIS10">TIS10</a></b> (<a href="cope.cgi?key=TPA%2dinducible%20sequence%2d10">TPA-inducible sequence-10</a>, <a href="cope.cgi?key=tetradecanoyl%20phorbol%20acetate%2dinducible%20sequence%2d10">tetradecanoyl phorbol acetate-inducible sequence-10</a>, <a href="cope.cgi?key=p71%2f73">p71/73</a>) (Reddy and Herschman, 1994)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=tissue%20factor">Tissue factor</a></b> (<a href="cope.cgi?key=TF">TF</a>, <a href="cope.cgi?key=TFA">TFA</a>, <a href="cope.cgi?key=Thromboplastin">thromboplastin</a>, <a href="cope.cgi?key=Tissue%20thromboplastin">tissue thromboplastin</a>, <a href="cope.cgi?key=CD142">CD142</a>, <a href="cope.cgi?key=factor%20III">factor III</a>, <a href="cope.cgi?key=factor%203">factor 3</a>, <a href="cope.cgi?key=F3">F3</a>, <a href="cope.cgi?key=FIII">FIII</a>, <a href="cope.cgi?key=coagulation%20factor%20III">coagulation factor III</a>) (Bea et al, 2003; Neve et al, 2001; Ovanesov et al, 2005; Hutter et al, 2004; Wada et al, 1994; Meisel et al, 1999; Edwards JP et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d1">TLR-1</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d1">Toll-like receptor-1</a>, <a href="cope.cgi?key=rsc786">rsc786</a>, <a href="cope.cgi?key=randomly%20sequenced%20cDNA%20786">randomly sequenced cDNA 786</a>, <a href="cope.cgi?key=TIL">TIL</a>, <a href="cope.cgi?key=Toll%2dinterleukin%2d1%20receptor%2dlike">Toll-interleukin-1 receptor-like</a>, <a href="cope.cgi?key=CD281">CD281</a>) (Sweet et al, 2001; Ruiperez et al, 2009; House et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d2">TLR-2</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d2">Toll-like receptor-2</a>, <a href="cope.cgi?key=TIL%2d4">TIL-4</a>, <a href="cope.cgi?key=Toll%2dinterleukin%2d1%20receptor%2dlike%2d4">Toll-interleukin-1 receptor-like-4</a>, <a href="cope.cgi?key=Ly105">Ly105</a>, <a href="cope.cgi?key=Lymphocyte%20antigen%20105">lymphocyte antigen 105</a>, <a href="cope.cgi?key=CD282">CD282</a>) (Droemann et al, 2003; Toshchakov et al, 2003; Medvedev et al, 2000; Sethi and Sodhi, 2004; Zhang and Bliska, 2003; Quesniaux et al, 2004; Lucas et al, 2003; Han et al, 2003; Gehring et al, 2003; Ropert et al, 2003; Dobrovolskaia et al, 2003; Haehnel et al, 2002; Park et al, 2004; Ebert et al, 2007; Miettinen et al, 2007; Herrera et al, 2009; Ruiperez et al, 2009; Moreira et al, 2008; House et al, 2008; Austin et al, 2005; Liang et al, 2009; Juarez et al, 2010; Gleissner et al, 2010; Babelova et al, 2009; Layoun A and Santos MM, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d3">TLR-3</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d3">Toll-like receptor-3</a>, <a href="cope.cgi?key=CD283">CD283</a>) (Pirhonen J et al, 2007; Hause L et al, 2007; Miettinen et al, 2007; Mkel et al, 2009; Ruiperez et al, 2009; Meng L et al, 2010; Yagi Y et al, 2010; Maelfait et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d4">TLR-4</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d4">Toll-like receptor-4</a>, <a href="cope.cgi?key=human%20toll">human Toll</a>, <a href="cope.cgi?key=TOLL">TOLL</a>, <a href="cope.cgi?key=Ly87">Ly87</a>, <a href="cope.cgi?key=Rasl2%2d8">Rasl2-8</a>, <a href="cope.cgi?key=CD284">CD284</a>) (Zhang and Bliska, 2003; Sweet et al, 2001; Hsu et al, 2004; Lucas et al, 2003; Han et al, 2003; Ropert et al, 2003; Mizel et al, 2003; Royle et al, 2003; Toshchakov et al, 2003; Roger et al, 2003; Schilling et al, 2002; Medvedev et al, 2000; Sethi and Sodhi, 2004; Gao et al, 2003; Dobrovolskaia et al, 2003; Guillot et al, 2002; Park et al, 2004; Takahashi et al, 2006; Ebert et al, 2007; Tachado et al, 2005; Necela et al, 2008; Arranz et al, 2008; Pirhonen J et al, 2007; Mkel et al, 2009; Herrera et al, 2009; Ruiperez et al, 2009; Pan et al, 2006; House et al, 2008; Austin et al, 2005; Vink et al, 2002; Liang et al, 2009; Rettew et al, 2009; Wu et al, 2009; Swisher JF et al, 2010; Eissmann P et al, 2010; Juarez E et al, 2010; Kim SY et al, 2010; Gleissner et al, 2010; Babelova et al, 2009; Maelfait et al, 2008; Mukhopadhyay et al, 2010; Wells et al, 2006; Rettew et al, 2010; Smith et al, 2011; Layoun A and Santos MM, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d5">TLR-5</a></b> [<a href="cope.cgi?key=Toll%2dlike%20receptor%2d5">Toll-like receptor-5</a>, <a href="cope.cgi?key=TIL%2d3">TIL-3</a>, <a href="cope.cgi?key=Toll%2dinterleukin%2d1%20receptor%2dlike%2d3">Toll-interleukin-1 receptor-like-3</a>) (Mizel et al, 2003; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d6">TLR-6</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d6">toll-like receptor-6</a>, <a href="cope.cgi?key=CD286">CD286</a>) (Ruiperez et al, 2009; House et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d7">TLR-7</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d7">Toll-like receptor-7</a>) (Hause L et al, 2007; Pirhonen J et al, 2007; Miettinen et al, 2007; Ruiperez et al, 2009; Eissmann P et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d8">TLR-8</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d8">Toll-like receptor-8</a>, <a href="cope.cgi?key=CD288">CD288</a>) (Pirhonen J et al, 2007; Mkel et al, 2009; Eissmann P et al, 2010; Gleissner et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d9">TLR-9</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d9">Toll-like receptor-9</a>, <a href="cope.cgi?key=A6RP">A6RP</a>, <a href="cope.cgi?key=A6%2drelated%20protein">A6-related protein</a>, <a href="cope.cgi?key=CD289">CD289</a>) (Gao et al, 2003; Lucas et al, 2003; Ebert et al, 2007; House et al, 2008; Ravindran et al, 2010; Juarez E et al, 2010; Ravindran C et al, 2010; Barlan et al, 2011; Dibra D et al, 2012; Thapa B et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d11">TLR-11</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d11">Toll-like receptor-11</a>) (Zhang et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TLR%2d13">TLR-13</a></b> (<a href="cope.cgi?key=Toll%2dlike%20receptor%2d13">Toll-like receptor-13</a>) (Tabeta et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TNFAIP8L2">TNFAIP8L2</a></b> (<a href="cope.cgi?key=TNFAIP8%2dlike%20protein%2d2">TNFAIP8-like protein-2</a>; <a href="cope.cgi?key=TNFAIP8%2dlike%2d2">TNFAIP8-like-2</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%2dalpha%2dinduced%20protein%208%2dlike%2d2">tumor necrosis factor-alpha-induced protein 8-like-2</a>; <a href="cope.cgi?key=TNF%2dalpha%2dinduced%20protein%208%2dlike%2d2">TNF-alpha-induced protein 8-like-2</a>, <a href="cope.cgi?key=TIPE2">TIPE2</a>, <a href="cope.cgi?key=Inflammation%20factor%20protein%2020">Inflammation factor protein 20</a>, <a href="cope.cgi?key=Oxi%2dc">Oxi-c</a>, <a href="cope.cgi?key=Oxidative%20stress%20regulated%20gene%2dc">Oxidative stress regulated gene-c</a>) (Zhang G et al, 2010; Sun H et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TNF%2dalpha">TNF-alpha</a> </b>(<a href="cope.cgi?key=Tumor%20necrosis%20factor%2dalpha">tumor necrosis factor-alpha</a>, <a href="cope.cgi?key=TNFSF2">TNFSF2</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%202">TNF ligand superfamily member 2</a>, <a href="cope.cgi?key=Cachectin">Cachectin</a>, <a href="cope.cgi?key=CF">CF</a>, <a href="cope.cgi?key=Cytotoxic%20factor">cytotoxic factor</a>, <a href="cope.cgi?key=CTX">CTX</a>, <a href="cope.cgi?key=cytotoxin">cytotoxin</a>, <a href="cope.cgi?key=DIF">DIF</a>, <a href="cope.cgi?key=Differentiation%20inducing%20factor">differentiation inducing factor</a>, <a href="cope.cgi?key=EP">EP</a>, <a href="cope.cgi?key=endogenous%20pyrogens">endogenous pyrogens</a>, <a href="cope.cgi?key=Hemorrhagic%20factor">Hemorrhagic factor</a>, <a href="cope.cgi?key=Macrophage%2dderived%20cytotoxic%20factor">Macrophage-derived cytotoxic factor</a>, <a href="cope.cgi?key=J774%2dderived%20cytotoxic%20factor">J774-derived cytotoxic factor</a>, <a href="cope.cgi?key=MCF">MCF</a>, <a href="cope.cgi?key=Macrophage%20cytotoxic%20factor">macrophage cytotoxic factor</a>, <a href="cope.cgi?key=MCT">MCT</a>, <a href="cope.cgi?key=Macrophage%20cytotoxin">macrophage cytotoxin</a>, <a href="cope.cgi?key=MD%2dFGF">MD-FGF</a>, <a href="cope.cgi?key=monocyte%2dderived%20fibroblast%20growth%20factor">monocyte-derived fibroblast growth factor</a>, <a href="cope.cgi?key=PCF">PCF</a>, <a href="cope.cgi?key=Peritoneal%20cytotoxic%20factor">peritoneal cytotoxic factor</a>, <a href="cope.cgi?key=RCF">RCF</a>, <a href="cope.cgi?key=Released%20cytotoxic%20factor">Released cytotoxic factor</a>) (Aviles and Monroy, 2001; Bai T et al, 2010; Boehringer et al, 1999; Branch and Guilbert, 1996; Chaudhry, 1997; Chen and Wang, 2002; Dahl TB et al, 2007; Fadok et al, 1998; Foey et al, 2001; Gleissner et al, 2010; Ishida et al, 2008; Kodelja et al, 1997; Kop EN et al, 2005; Leeper NJ et al, 2009; Li et al, 2009; Lucas et al, 2003; Major et al, 2002; Mkel et al, 2009; Mathy et al, 2000; Meheus et al, 1993; Philipps et al, 2001; Pope et al, 2000; Pruimboom et al, 1994; Ragno et al, 2001; Riches et al, 1996; Rodenburg et al, 1998; Sethi and Sodhi, 2004; Song et al, 2009; Taylor et al, 1993; Weghofer et al, 2001; Wu et al, 2009; Xu et al, 2001; Martinez FO et al, 2006; Ogawa H et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TNF%2dalpha">TNF-alpha</a> </b>(<a href="cope.cgi?key=Tumor%20necrosis%20factor%2dalpha">tumor necrosis factor-alpha</a>, <a href="cope.cgi?key=TNFSF2">TNFSF2</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%202">TNF ligand superfamily member 2</a>, <a href="cope.cgi?key=Cachectin">Cachectin</a>, <a href="cope.cgi?key=CF">CF</a>, <a href="cope.cgi?key=Cytotoxic%20factor">cytotoxic factor</a>, <a href="cope.cgi?key=CTX">CTX</a>, <a href="cope.cgi?key=cytotoxin">cytotoxin</a>, <a href="cope.cgi?key=DIF">DIF</a>, <a href="cope.cgi?key=Differentiation%20inducing%20factor">differentiation inducing factor</a>, <a href="cope.cgi?key=EP">EP</a>, <a href="cope.cgi?key=endogenous%20pyrogens">endogenous pyrogens</a>, <a href="cope.cgi?key=Hemorrhagic%20factor">Hemorrhagic factor</a>, <a href="cope.cgi?key=Macrophage%2dderived%20cytotoxic%20factor">Macrophage-derived cytotoxic factor</a>, <a href="cope.cgi?key=J774%2dderived%20cytotoxic%20factor">J774-derived cytotoxic factor</a>, <a href="cope.cgi?key=MCF">MCF</a>, <a href="cope.cgi?key=Macrophage%20cytotoxic%20factor">macrophage cytotoxic factor</a>, <a href="cope.cgi?key=MCT">MCT</a>, <a href="cope.cgi?key=Macrophage%20cytotoxin">macrophage cytotoxin</a>, <a href="cope.cgi?key=MD%2dFGF">MD-FGF</a>, <a href="cope.cgi?key=monocyte%2dderived%20fibroblast%20growth%20factor">monocyte-derived fibroblast growth factor</a>, <a href="cope.cgi?key=PCF">PCF</a>, <a href="cope.cgi?key=Peritoneal%20cytotoxic%20factor">peritoneal cytotoxic factor</a>, <a href="cope.cgi?key=RCF">RCF</a>, <a href="cope.cgi?key=Released%20cytotoxic%20factor">Released cytotoxic factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=CD120a">CD120a</a>, <a href="cope.cgi?key=TNFRSF1A">TNFRSF1A</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%201A">TNF receptor superfamily member 1A</a>, <a href="cope.cgi?key=FPF">FPF</a>, <a href="cope.cgi?key=TNFAR">TNFAR</a>, <a href="cope.cgi?key=TNFR">TNFR</a>, <a href="cope.cgi?key=TNFR1">TNFR1</a>, <a href="cope.cgi?key=TNFR55">TNFR55</a>, <a href="cope.cgi?key=TNFR60">TNFR60</a>, <a href="cope.cgi?key=TNFR%2dalpha">TNFR-alpha</a>, <a href="cope.cgi?key=TNF%20receptor%201">TNF receptor 1</a>; <a href="cope.cgi?key=CD120b">CD120b</a>, <a href="cope.cgi?key=TNFRSF1B">TNFRSF1B</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%201B">TNF receptor superfamily member 1B</a>, <a href="cope.cgi?key=p75TNFR">p75TNFR</a>, <a href="cope.cgi?key=TNFR2">TNFR2</a>, <a href="cope.cgi?key=TNFR75">TNFR75</a>, <a href="cope.cgi?key=TNFR80">TNFR80</a>, <a href="cope.cgi?key=TNFR%2dbeta">TNFR-beta</a>) (Bailer et al, 2000; Fournier et al, 1995; Galve-de Rochemonteix et al, 1996; Coyne et al, 1999; Ciesielski et al, 2002; Neale and Athanasou, 1999; Park et al, 2005)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=TNF%2dalpha%2dinhibiting%20factor">TNF-alpha-inhibiting factor</a> (Baer et al, 1998)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TNF%2dbeta">TNF-beta</a></b> (<a href="cope.cgi?key=Tumor%20necrosis%20factor%2dbeta">tumor necrosis factor-beta</a>, <a href="cope.cgi?key=TNFB">TNFB</a>, <a href="cope.cgi?key=Coley%27s%20toxin">Coley's toxin</a>, <a href="cope.cgi?key=LT">LT</a>, <a href="cope.cgi?key=Lymphotoxin">lymphotoxin</a>, <a href="cope.cgi?key=Lymphotoxin%2dalpha">lymphotoxin-alpha</a>, <a href="cope.cgi?key=LT%2dalpha">LT-alpha</a>, <a href="cope.cgi?key=LTA">LTA</a>, <a href="cope.cgi?key=Necrosin">Necrosin</a>, <a href="cope.cgi?key=NKCF">NKCF</a>, <a href="cope.cgi?key=Natural%20killer%20cytotoxic%20factor">natural killer cytotoxic factor</a>, <a href="cope.cgi?key=NK%2dCIA">NK-CIA</a>, <a href="cope.cgi?key=Natural%20killer%20colony%2dinhibiting%20activity">Natural killer colony-inhibiting activity</a>, <a href="cope.cgi?key=TNFSF1">TNFSF1</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%201">TNF ligand superfamily member 1</a>) (Philipps et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TNFRSF25">TNFRSF25</a></b> (<a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2025">TNF receptor superfamily member 25</a>, <a href="cope.cgi?key=TNFRSF12">TNFRSF12</a>, <a href="cope.cgi?key=DR3">DR3</a>, <a href="cope.cgi?key=death%20receptor%2d3">death receptor-3</a>, <a href="cope.cgi?key=TR3">TR3</a>, <a href="cope.cgi?key=TNF%20receptor%2dlike%2d3">TNF receptor-like-3</a>, <a href="cope.cgi?key=LARD">LARD</a>, <a href="cope.cgi?key=Lymphocyte%2dassociated%20receptor%20of%20death">lymphocyte-associated receptor of death</a>, <a href="cope.cgi?key=APO%2d3">APO-3</a>, <a href="cope.cgi?key=apoptosis%20antigen%2d3">apoptosis antigen-3</a>, <a href="cope.cgi?key=TRAMP">TRAMP</a>, <a href="cope.cgi?key=TNF%20receptor%20apoptosis%2dmediating%20protein">TNF receptor apoptosis-mediating protein</a>, <a href="cope.cgi?key=wsl%2d1">wsl-1</a>) (Philipps et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥ </b><b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TOLLIP">TOLLIP</a> </b>(<a href="cope.cgi?key=Toll%2dinteracting%20protein">Toll-interacting protein</a>)<b style="mso-bidi-font-weight:normal"> </b>(Wells et al, 2006; Chakraborty et al, 2011; Hong Byun et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRAF1">TRAF1</a></b> (<a href="cope.cgi?key=TNF%20receptor%20associated%20factor%2d1">TNF receptor associated factor-1</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%20receptor%2dassociated%20factor%2d1">Tumor necrosis factor receptor-associated factor-1</a>, <a href="cope.cgi?key=EBI%2d6">EBI-6</a>, <a href="cope.cgi?key=EBV%20induced%20gene%2d6">EBV induced gene-6</a>) (Folco et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRAF6">TRAF6</a></b> (<a href="cope.cgi?key=TNF%20receptor%20associated%20factor%2d6">TNF receptor associated factor-6</a>, <a href="cope.cgi?key=Tumor%20necrosis%20factor%20receptor%2dassociated%20factor%2d6">Tumor necrosis factor receptor-associated factor-6</a>, <a href="cope.cgi?key=RNF85">RNF85</a>, <a href="cope.cgi?key=RING%20finger%20protein%2085">RING finger protein 85</a>) (Hou et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRAIL">TRAIL</a></b> (<a href="cope.cgi?key=TNF%2drelated%20apoptosis%20inducing%20ligand">TNF-related apoptosis inducing ligand</a>, <a href="cope.cgi?key=APO%2d2%20ligand">APO-2 ligand</a>, <a href="cope.cgi?key=APO%2d2L">APO-2L</a>, <a href="cope.cgi?key=TL2">TL2</a>, <a href="cope.cgi?key=TNF%2dlike%2d2">TNF-like-2</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2010">TNF ligand superfamily member 10</a>, <a href="cope.cgi?key=TNFSF10">TNFSF10</a>, <a href="cope.cgi?key=Ly81">Ly81</a>, <a href="cope.cgi?key=CD253">CD253</a>) (Halaas et al, 2000; Philipps et al, 2001; Gleissner et al, 2010; Martinez FO et al, 2006; Liu L et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRAIL">TRAIL</a></b> (<a href="cope.cgi?key=TNF%2drelated%20apoptosis%20inducing%20ligand">TNF-related apoptosis inducing ligand</a>, <a href="cope.cgi?key=APO%2d2%20ligand">APO-2 ligand</a>, <a href="cope.cgi?key=APO%2d2L">APO-2L</a>, <a href="cope.cgi?key=TL2">TL2</a>, <a href="cope.cgi?key=TNF%2dlike%2d2">TNF-like-2</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2010">TNF ligand superfamily member 10</a>, <a href="cope.cgi?key=TNFSF10">TNFSF10</a>, <a href="cope.cgi?key=Ly81">Ly81</a>, <a href="cope.cgi?key=CD253">CD253</a>) <b style="mso-bidi-font-weight: normal">receptor-1</b> (<a href="cope.cgi?key=TRAIL%20receptor%2d1">TRAIL receptor-1</a>, <a href="cope.cgi?key=TRAIL%2dR1">TRAIL-R1</a>, <a href="cope.cgi?key=TRAIL%2dR">TRAIL-R</a>, <a href="cope.cgi?key=TRAIL%20receptor">TRAIL receptor</a>, <a href="cope.cgi?key=DR4">DR4</a>, <a href="cope.cgi?key=death%20receptor%2d4">death receptor-4</a>, <a href="cope.cgi?key=APO%2d2">APO-2</a>, <a href="cope.cgi?key=TNFRSF10A">TNFRSF10A</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2010A">TNF receptor superfamily member 10A</a>, <a href="cope.cgi?key=CD261">CD261</a>) (Philipps et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRAIL">TRAIL</a></b> (<a href="cope.cgi?key=TNF%2drelated%20apoptosis%20inducing%20ligand">TNF-related apoptosis inducing ligand</a>, <a href="cope.cgi?key=APO%2d2%20ligand">APO-2 ligand</a>, <a href="cope.cgi?key=APO%2d2L">APO-2L</a>, <a href="cope.cgi?key=TL2">TL2</a>, <a href="cope.cgi?key=TNF%2dlike%2d2">TNF-like-2</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2010">TNF ligand superfamily member 10</a>, <a href="cope.cgi?key=TNFSF10">TNFSF10</a>, <a href="cope.cgi?key=Ly81">Ly81</a>, <a href="cope.cgi?key=CD253">CD253</a>) <b style="mso-bidi-font-weight: normal">receptor-2</b> (<a href="cope.cgi?key=TRAIL%20receptor%2d2">TRAIL receptor-2</a>, <a href="cope.cgi?key=TRAIL%2dR2">TRAIL-R2</a>, <a href="cope.cgi?key=death%20receptor%2d5">death receptor-5</a>, <a href="cope.cgi?key=DR5">DR5</a>, <a href="cope.cgi?key=KILLER">KILLER</a>, <a href="cope.cgi?key=TRICK2">TRICK2</a>, <a href="cope.cgi?key=TRAIL%20receptor%20inducer%20of%20cell%20killing%2d2">TRAIL receptor inducer of cell killing-2</a>, <a href="cope.cgi?key=TNFRSF10B">TNFRSF10B</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2010B">TNF receptor superfamily member 10B</a>, <a href="cope.cgi?key=CD262">CD262</a>, <a href="cope.cgi?key=Ly98">Ly98</a>) (Perlman et al, 2003; Philipps et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRAIL">TRAIL</a></b> (<a href="cope.cgi?key=TNF%2drelated%20apoptosis%20inducing%20ligand">TNF-related apoptosis inducing ligand</a>, <a href="cope.cgi?key=APO%2d2%20ligand">APO-2 ligand</a>, <a href="cope.cgi?key=APO%2d2L">APO-2L</a>, <a href="cope.cgi?key=TL2">TL2</a>, <a href="cope.cgi?key=TNF%2dlike%2d2">TNF-like-2</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2010">TNF ligand superfamily member 10</a>, <a href="cope.cgi?key=TNFSF10">TNFSF10</a>, <a href="cope.cgi?key=Ly81">Ly81</a>, <a href="cope.cgi?key=CD253">CD253</a>) <b style="mso-bidi-font-weight: normal">receptor-3</b> (<a href="cope.cgi?key=TRAIL%20receptor%2d3">TRAIL receptor-3</a>, <a href="cope.cgi?key=TRAIL%2dR3">TRAIL-R3</a>, <a href="cope.cgi?key=TRID">TRID</a>, <a href="cope.cgi?key=TRAIL%20receptor%20without%20an%20intracellular%20domain">TRAIL receptor without an intracellular domain</a>, <a href="cope.cgi?key=DcR%2d1">DcR-1</a>, <a href="cope.cgi?key=Decoy%20receptor%2d1">Decoy receptor-1</a>, <a href="cope.cgi?key=LIT">LIT</a>, <a href="cope.cgi?key=Lymphocyte%20inhibitor%20of%20TRAIL">lymphocyte inhibitor of TRAIL</a>, <a href="cope.cgi?key=TNFRSF10C">TNFRSF10C</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2010C">TNF receptor superfamily member 10C</a>, <a href="cope.cgi?key=CD263">CD263</a>) (Perlman et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Transferrin">transferrin</a></b> (<a href="cope.cgi?key=TRF">TRF</a>, <a href="cope.cgi?key=Serotransferrin">serotransferrin</a>, <a href="cope.cgi?key=Siderophilin">siderophilin</a>, <a href="cope.cgi?key=DF%2d77">DF-77</a>, <a href="cope.cgi?key=GPBP">GPBP</a>, <a href="cope.cgi?key=Granulocyte%2fpollen%2dbinding%20protein">granulocyte/pollen-binding protein</a>, <a href="cope.cgi?key=Lung%2dderived%20growth%20factor">Lung-derived growth factor</a>) (Djeha et al, 1995; Ryu et al, 2000; Haurani et al, 1973)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Transferrin">transferrin</a></b> (<a href="cope.cgi?key=TRF">TRF</a>, <a href="cope.cgi?key=DF%2d77">DF-77</a>, <a href="cope.cgi?key=GPBP">GPBP</a>, <a href="cope.cgi?key=Granulocyte%2fpollen%2dbinding%20protein">granulocyte/pollen-binding protein</a>, <a href="cope.cgi?key=Lung%2dderived%20growth%20factor">Lung-derived growth factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=CD71">CD71</a>, <a href="cope.cgi?key=TFR">TFR</a>, <a href="cope.cgi?key=TFR1">TFR1</a>, <a href="cope.cgi?key=TRFR">TRFR</a>, <a href="cope.cgi?key=TFRC">TFRC</a>, <a href="cope.cgi?key=OKT9">OKT9</a>, <a href="cope.cgi?key=T9">T9</a>, <a href="cope.cgi?key=OX26">OX26</a>) (Carcamo et al, 1996; Scheuerer et al, 2000; Schaberg et al, 1992; Taylor et al, 2000; Ryu et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TREM1">TREM1</a></b> (<a href="cope.cgi?key=triggering%20receptor%20expressed%20on%20myeloid%20cells%201">triggering receptor expressed on myeloid cells 1</a>, <a href="cope.cgi?key=CD354">CD354</a>) (Gustafsson et al, 2008; Ornatowska et al, 2007; Schenk et al, 2007; Gmez-Pia et al, 2007; Zeng et al, 2007; Murakami et al, 2007; Richeldi et al, 2004; Zanzinger et al,, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TREM2">TREM2</a></b> (<a href="cope.cgi?key=triggering%20receptor%20expressed%20on%20myeloid%20cells%202">triggering receptor expressed on myeloid cells 2</a>, <a href="cope.cgi?key=TREM2a">TREM2a</a>, <a href="cope.cgi?key=TREM2b">TREM2b</a>) (Daws et al, 2001; Gustafsson et al, 2008; Charles et al, 2008; Turnbull et al, 2006; Hamerman et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TREM3">TREM3</a></b> (<a href="cope.cgi?key=triggering%20receptor%20expressed%20on%20myeloid%20cells%203">triggering receptor expressed on myeloid cells 3</a>) (Chung et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TREML2">TREML2</a> </b>(<a href="cope.cgi?key=Trem%2dlike%20transcript%202%20protein">Trem-like transcript 2 protein</a>; <a href="cope.cgi?key=triggering%20receptor%20expressed%20on%20myeloid%20cells%2dlike%202">triggering receptor expressed on myeloid cells-like 2</a>; <a href="cope.cgi?key=TREM%2dlike%20protein%202">TREM-like protein 2</a>, <a href="cope.cgi?key=TLT%2d2">TLT-2</a>, <a href="cope.cgi?key=C6orf76">C6orf76</a>, <a href="cope.cgi?key=chromosome%206%20open%20reading%20frame%2076">chromosome 6 open reading frame 76</a>) (King RG et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRIM5">TRIM5</a></b> (<a href="cope.cgi?key=tripartite%20motif%2dcontaining%20protein%205">tripartite motif-containing protein 5</a>, <a href="cope.cgi?key=TRIM5%2dalpha">TRIM5-alpha</a>, <a href="cope.cgi?key=tripartite%20motif%2dcontaining%20protein%205%2dalpha">tripartite motif-containing protein 5-alpha</a>, <a href="cope.cgi?key=RNF88">RNF88</a>, <a href="cope.cgi?key=RING%20finger%20protein%2088">RING finger protein 88</a>, <a href="cope.cgi?key=Lv1">Lv1</a>, <a href="cope.cgi?key=lentivirus%20susceptibility%20factor%201">lentivirus susceptibility factor 1</a>; <a href="cope.cgi?key=Ref1">Ref1</a>, <a href="cope.cgi?key=restriction%20factor%201">restriction factor 1</a>) (Carthagena et al, 2009; Battivelli et al, 2011)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TRIM56">TRIM56</a></b> (<a href="cope.cgi?key=Tripartite%20motif%2dcontaining%20protein%2056">Tripartite motif-containing protein 56</a>, <a href="cope.cgi?key=RNF109">RNF109</a>, <a href="cope.cgi?key=RING%20finger%20protein%20109">RING finger protein 109</a>) (Carthagena et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Tristetraprolin">tristetraprolin</a></b> (<a href="cope.cgi?key=TTP">TTP</a>, <a href="cope.cgi?key=nup475">Nup475</a>, <a href="cope.cgi?key=Nuclear%20protein%2d475">nuclear protein-475</a>, <a href="cope.cgi?key=TIS11">TIS11</a>, <a href="cope.cgi?key=TPA%2dinducible%20sequence%2d11">TPA-inducible sequence-11</a>, <a href="cope.cgi?key=tetradecanoyl%20phorbol%20acetate%2dinducible%20sequence%2d11">tetradecanoyl phorbol acetate-inducible sequence-11</a>, <a href="cope.cgi?key=TIS11a">TIS11a</a>, <a href="cope.cgi?key=TPA%2dinducible%20sequence%2d11">TPA-inducible sequence-11</a>, <a href="cope.cgi?key=tetradecanoyl%20phorbol%20acetate%2dinducible%20sequence%2d11a">tetradecanoyl phorbol acetate-inducible sequence-11a</a>, <a href="cope.cgi?key=Zfp36">Zfp36</a>, <a href="cope.cgi?key=Zinc%20finger%20protein%2036">Zinc finger protein 36</a>, <a href="cope.cgi?key=GOS%2d24">GOS-24</a>, <a href="cope.cgi?key=G0%2fG1%20switch%20gene%2024">G0/G1 switch gene 24</a>) (Leppnen T et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=trkA">trkA</a></b> (<a href="cope.cgi?key=tropomyosin%2drelated%20kinase%20A">tropomyosin-related kinase A</a>, <a href="cope.cgi?key=NTRK1">NTRK1</a>, <a href="cope.cgi?key=neurotrophic%20tyrosine%20kinase%20receptor%201">neurotrophic tyrosine kinase receptor 1</a>) (Ricci et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=trkB">trkB</a></b> (<a href="cope.cgi?key=tropomyosin%2drelated%20kinase%20B">tropomyosin-related kinase B</a>, <a href="cope.cgi?key=NTRK2">NTRK2</a>, <a href="cope.cgi?key=neurotrophic%20tyrosine%20kinase%20receptor%202">neurotrophic tyrosine kinase receptor 2</a>) (Garcia-Suarez et al, 1998; Perez-Perez et al, 1999; Ricci et al, 2001; Barouch et al, 2001; Asami et al, 2006; Garca-Surez O et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b><b style="mso-bidi-font-weight:normal"> <a href="cope.cgi?key=trkC">trkC</a></b> (<a href="cope.cgi?key=tropomyosin%2drelated%20kinase%20C">tropomyosin-related kinase C</a>, <a href="cope.cgi?key=NTRK3">NTRK3</a>, <a href="cope.cgi?key=neurotrophic%20tyrosine%20kinase%20receptor%203">neurotrophic tyrosine kinase receptor 3</a>) (Ricci et al, 2001; Barouch et al, 2001; Asami et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Tryptophanyl%2dtRNA%20synthetase">Tryptophanyl-tRNA synthetase</a></b> (<a href="cope.cgi?key=TrpRS">TrpRS</a>, <a href="cope.cgi?key=WARS">WARS</a>, <a href="cope.cgi?key=Tryptophan%2dtRNA%20Ligase">Tryptophan-tRNA Ligase</a>) (Krause et al, 1996)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TSG%2d6">TSG-6</a></b> (<a href="cope.cgi?key=Tumor%20necrosis%20factor%2dstimulated%20gene%20sequence%2d6">tumor necrosis factor-stimulated gene sequence-6</a>, <a href="cope.cgi?key=TNFAIP6">TNFAIP6</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%2dalpha%2dinduced%20protein%206">tumor necrosis factor-alpha-induced protein 6</a>, <a href="cope.cgi?key=TNFIP6">TNFIP6</a>, <a href="cope.cgi?key=tumor%20necrosis%20factor%2dinduced%20protein%206">tumor necrosis factor-induced protein 6</a>, <a href="cope.cgi?key=PS4">PS4</a>) (Maina et al, 2009)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TSLP">TSLP</a></b> (<a href="cope.cgi?key=Thymic%20stromal%20derived%20lymphopoietin">thymic stromal derived lymphopoietin</a>, <a href="cope.cgi?key=Thymic%20stromal%20lymphopoietin">Thymic stromal lymphopoietin</a>) (Ying S et al, 2008)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TWEAK">TWEAK</a></b> (<a href="cope.cgi?key=TNF%2dlike%20weak%20inducer%20of%20apoptosis">TNF-like weak inducer of apoptosis</a>, <a href="cope.cgi?key=APO%2d3L">APO-3L</a>, <a href="cope.cgi?key=APO%2d3%20ligand">APO-3 ligand</a>, <a href="cope.cgi?key=DR3LG">DR3LG</a>, <a href="cope.cgi?key=DR3%20ligand">DR3 ligand</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2012">TNF ligand superfamily member 12</a>, <a href="cope.cgi?key=TNFSF12">TNFSF12</a>) (Philipps et al, 2001; Muoz-Garca et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=TWEAK">TWEAK</a> </b>(<a href="cope.cgi?key=TNF%2dlike%20weak%20inducer%20of%20apoptosis">TNF-like weak inducer of apoptosis</a>, <a href="cope.cgi?key=APO%2d3L">APO-3L</a>, <a href="cope.cgi?key=APO%2d3%20ligand">APO-3 ligand</a>, <a href="cope.cgi?key=DR3LG">DR3LG</a>, <a href="cope.cgi?key=DR3%20ligand">DR3 ligand</a>, <a href="cope.cgi?key=TNF%20ligand%20superfamily%20member%2012">TNF ligand superfamily member 12</a>, <a href="cope.cgi?key=TNFSF12">TNFSF12</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (<a href="cope.cgi?key=TWEAKR">TWEAKR</a>, <a href="cope.cgi?key=TNFRSF12A">TNFRSF12A</a>, <a href="cope.cgi?key=TNF%20receptor%20superfamily%20member%2012A">TNF receptor superfamily member 12A</a>, <a href="cope.cgi?key=Fn%2d14">Fn-14</a>, <a href="cope.cgi?key=fibroblast%20growth%20factor%2dinducible%2d14">fibroblast growth factor-inducible-14</a>, <a href="cope.cgi?key=CD266">CD266</a>) (Kim et al, 2004; Muoz-Garca et al, 2004; Gleissner et al, 2010)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <a href="cope.cgi?key=ubiquicidin">Ubiquicidin</a> (Hiemstra et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> Urokinase-type plasminogen activator (uPA) (Oka et al, 2000)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=vasohibin%2d2">vasohibin-2</a></b> (<a href="cope.cgi?key=VASH2">VASH2</a>, <a href="cope.cgi?key=VASHL">VASHL</a>, <a href="cope.cgi?key=vasohibin%2dlike%20protein">vasohibin-like protein</a>) (Shen Z et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Vasopressin">Vasopressin</a> </b>(<a href="cope.cgi?key=Arginine%20vasopressin">Arginine vasopressin</a>, <a href="cope.cgi?key=Arg%2dVasopressin">Arg-Vasopressin</a>, <a href="cope.cgi?key=AVP">AVP</a>, <a href="cope.cgi?key=ARVP">ARVP</a>, <a href="cope.cgi?key=VP">VP</a>, <a href="cope.cgi?key=Antidiuretic%20hormone">Antidiuretic hormone</a>, <a href="cope.cgi?key=ADH">ADH</a>, <a href="cope.cgi?key=Adiuretin">Adiuretin</a>, <a href="cope.cgi?key=Vasotocin">Vasotocin</a>, <a href="cope.cgi?key=Pituitrin%20P">Pituitrin P</a>, <a href="cope.cgi?key=Pitressin">Pitressin</a>, <a href="cope.cgi?key=arginine%2dvasopressin%2dneurophysin%20II">arginine-vasopressin-neurophysin II</a>, <a href="cope.cgi?key=vasopressin%2dneurophysin%202%2dcopeptin">vasopressin-neurophysin 2-copeptin</a>, <a href="cope.cgi?key=AVP%2dNpII">AVP-NpII</a>) <b style="mso-bidi-font-weight: normal">receptors</b> (Bell et al, 1993)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Vaspin">Vaspin</a></b> (<a href="cope.cgi?key=Visceral%20adipose%2dspecific%20serpin">Visceral adipose-specific serpin</a>, <a href="cope.cgi?key=Serpin%20A12">Serpin A12</a>, <a href="cope.cgi?key=OL%2d64">OL-64</a>) (Spiroglou SG et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGF%2dA">VEGF-A</a></b> (<a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%20A">Vascular endothelial growth factor A</a>; <a href="cope.cgi?key=VEGF%2d1">VEGF-1</a>, <a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%2d1">vascular endothelial growth factor-1</a>, <a href="cope.cgi?key=VEGF">VEGF</a>, <a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor">vascular endothelial growth factor</a>; <a href="cope.cgi?key=vasculo%2dendothelial%20growth%20factor">vasculo-endothelial growth factor</a>, <a href="cope.cgi?key=VEG%2fPF">VEG/PF</a>, <a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor">vascular endothelial growth factor</a>/<a href="cope.cgi?key=Vascular%20permeability%20factor">vascular permeability factor</a>, <a href="cope.cgi?key=GD%2dVEGF">GD-VEGF</a>, <a href="cope.cgi?key=Glioma%2dderived%20vascular%20endothelial%20growth%20factor">glioma-derived vascular endothelial growth factor</a>, <a href="cope.cgi?key=VAS">VAS</a>, <a href="cope.cgi?key=Vasculotropin">Vasculotropin</a>, <a href="cope.cgi?key=Vascular%20endothelial%20cell%20proliferation%20factor">Vascular endothelial cell proliferation factor</a>; <a href="cope.cgi?key=VPF">VPF</a>, <a href="cope.cgi?key=Vascular%20permeability%20factor">vascular permeability factor</a>, <a href="cope.cgi?key=Mouse%20sarcoma%20180%2dderived%20growth%20factor">Mouse sarcoma 180-derived growth factor</a>; <a href="cope.cgi?key=FSdGF">FSdGF</a>, <a href="cope.cgi?key=Folliculo%20stellate%20cell%2dderived%20growth%20factor">Folliculo stellate cell-derived growth factor</a>) (Burke et al, 2003; Cejudo-Martin et al, 2000; Constant et al, 2000; Dagtekin et a. 2003; Ernens I et al, 2010; Esposito I et al, 2004; Granata F et al, 2010; Itaya et al, 2001; Kataru RP et al, 2009; Kiriakidis et al, 2003; Kumazaki K et al, 2002; Lee et al, 2008; Malaguarnera et al, 2005; McLaren et al, 1996; Ragno et al, 2001; Stepanova et al, 2007; Walczak et al, 2004; Xiong et al, 1998; Meda C et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGF%2dB">VEGF-B</a></b> (<a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%20B">vascular endothelial growth factor B</a>, <a href="cope.cgi?key=VEGF%2dB%28167%29">VEGF-B(167)</a>, <a href="cope.cgi?key=VEGF%2dB%28186%29">VEGF-B(186)</a>, <a href="cope.cgi?key=VRF">VRF</a>, <a href="cope.cgi?key=VEGF%20related%20factor">VEGF related factor</a>, <a href="cope.cgi?key=VRP">VRP</a>, <a href="cope.cgi?key=VEGF%20related%20protein">VEGF related protein</a>) (Granata F et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGF%2dC">VEGF-C</a></b> (<a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%20C">vascular endothelial growth factor C</a>, <a href="cope.cgi?key=VEGF%2d2">VEGF-2</a>, <a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%2d2">Vascular endothelial growth factor-2</a>, <a href="cope.cgi?key=flt%2d4%20ligand">flt-4 ligand</a>, <a href="cope.cgi?key=flt%2d4L">flt-4L</a>) (Baluk P et al, 2005; Cursiefen C et al, 2004; Esposito I et al, 2004; Granata F et al, 2010; Kataru RP et al, 2009; Machnik A et al, 2009; Nakano T et al, 2005; Schmeisser A et al, 2006; Schoppmann et al, 2002; Stepanova et al, 2007; Stojakovic et al, 2007; Ding M et al, 2012)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGF%2dD">VEGF-D</a> </b>(<a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%20D">vascular endothelial growth factor D</a>, <a href="cope.cgi?key=FIGF">FIGF</a>, <a href="cope.cgi?key=fos%20induced%20growth%20factor">fos induced growth factor</a>) (Baluk P et al, 2005; Cursiefen C et al, 2004; Granata F et al, 2010; Kataru RP et al, 2009; Nakano T et al, 2005; Rutanen J et al, 2003; Schmeisser A et al, 2006; Schoppmann <a href="cope.cgi?key=SF">SF</a> et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGF%2dD">VEGF-D</a> </b>(<a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%20D">vascular endothelial growth factor D</a>, <a href="cope.cgi?key=FIGF">FIGF</a>, <a href="cope.cgi?key=fos%20induced%20growth%20factor">fos induced growth factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Schmeisser A et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGFR1">VEGFR1</a></b> (<a href="cope.cgi?key=VEGF%20receptor%2d1">VEGF receptor-1</a>, <a href="cope.cgi?key=flt">flt</a>, <a href="cope.cgi?key=fms%2dlike%20tyrosine%20kinase">fms-like tyrosine kinase</a>, <a href="cope.cgi?key=flt%2d1">flt-1</a>, <a href="cope.cgi?key=fms%2dlike%20tyrosine%20kinase%2d1">fms-like tyrosine kinase-1</a>; <a href="cope.cgi?key=FRT">FRT</a>, <a href="cope.cgi?key=fms%2drelated%20tyrosine%20kinase">fms-related tyrosine kinase</a>) (Woodside et al, 2003; Stepanova et al, 2007<b style="mso-bidi-font-weight:normal">; </b>Lee et al, 2008; Kumazaki K et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGFR2">VEGFR2</a></b> (<a href="cope.cgi?key=VEGF%20receptor%2d2">VEGF receptor-2</a>, <a href="cope.cgi?key=KDR">KDR</a>, <a href="cope.cgi?key=Kinase%20insert%20domain%20receptor">kinase insert domain receptor</a>, <a href="cope.cgi?key=flk%2d1">flk-1</a>, <a href="cope.cgi?key=Fetal%20liver%20kinase%2d1">fetal liver kinase-1</a>, <a href="cope.cgi?key=CD309">CD309</a>, <a href="cope.cgi?key=Quek%2d1">Quek-1</a>, <a href="cope.cgi?key=quail%20endothelial%20kinase%2d1">quail endothelial kinase-1</a>) (Woodside et al, 2003; Stepanova et al, 2007; Ragno et al, 2001)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGFR3">VEGFR3</a></b> (<a href="cope.cgi?key=VEGF%20receptor%2d3">VEGF receptor-3</a>, <a href="cope.cgi?key=flt%2d4">flt-4</a>, <a href="cope.cgi?key=fms%2dlike%20tyrosine%20kinase%2d4">fms-like tyrosine kinase-4</a>) (Stepanova et al, 2007; Schoppmann et al, 2002; Schmeisser A et al, 2006; )<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VEGF%2dA">VEGF-A</a></b> (<a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%20A">Vascular endothelial growth factor A</a>; <a href="cope.cgi?key=VEGF%2d1">VEGF-1</a>, <a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor%2d1">vascular endothelial growth factor-1</a>, <a href="cope.cgi?key=VEGF">VEGF</a>, <a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor">vascular endothelial growth factor</a>; <a href="cope.cgi?key=vasculo%2dendothelial%20growth%20factor">vasculo-endothelial growth factor</a>, <a href="cope.cgi?key=VEG%2fPF">VEG/PF</a>, <a href="cope.cgi?key=Vascular%20endothelial%20growth%20factor">vascular endothelial growth factor</a>/<a href="cope.cgi?key=Vascular%20permeability%20factor">vascular permeability factor</a>, <a href="cope.cgi?key=GD%2dVEGF">GD-VEGF</a>, <a href="cope.cgi?key=Glioma%2dderived%20vascular%20endothelial%20growth%20factor">glioma-derived vascular endothelial growth factor</a>, <a href="cope.cgi?key=VAS">VAS</a>, <a href="cope.cgi?key=Vasculotropin">Vasculotropin</a>, <a href="cope.cgi?key=Vascular%20endothelial%20cell%20proliferation%20factor">Vascular endothelial cell proliferation factor</a>; <a href="cope.cgi?key=VPF">VPF</a>, <a href="cope.cgi?key=Vascular%20permeability%20factor">vascular permeability factor</a>, <a href="cope.cgi?key=Mouse%20sarcoma%20180%2dderived%20growth%20factor">Mouse sarcoma 180-derived growth factor</a>; <a href="cope.cgi?key=FSdGF">FSdGF</a>, <a href="cope.cgi?key=Folliculo%20stellate%20cell%2dderived%20growth%20factor">Folliculo stellate cell-derived growth factor</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Salomonsson et al, 2003; McLaren et al, 1996; Ragno et al, 2001; Akuzawa et al, 2000)<br/> <b style="mso-bidi-font-weight:normal">¥</b> Vimentin (secreted) (Mor-Vaknin et al, 2003)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VIP">VIP</a> </b>(<a href="cope.cgi?key=Vasoactive%20intestinal%20peptide">vasoactive intestinal peptide</a>) (Metwali et al, 2002)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=VIP">VIP</a> </b>(<a href="cope.cgi?key=Vasoactive%20intestinal%20peptide">vasoactive intestinal peptide</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (de la Fuente et al, 1994; Delgado et al, 1999; Sun et al, 2000; Pozo et al, 1997; Goetzl et al, 1998; Martinez et al, 1998; Arranz et al, 2008; Herrera et al, 2009; Burian B et al, 2010)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Visfatin">Visfatin</a></b> (<a href="cope.cgi?key=VF">VF</a>, <a href="cope.cgi?key=PBEF">PBEF</a>, <a href="cope.cgi?key=pre%20B%2dcell%20colony%20enhancing%20factor">pre B-cell colony enhancing factor</a>, <a href="cope.cgi?key=PBEF1">PBEF1</a>, <a href="cope.cgi?key=pre%20B%2dcell%20colony%20enhancing%20factor%2d1">pre B-cell colony enhancing factor-1</a>, <a href="cope.cgi?key=EC2%2e4%2e2%2e12">EC2.4.2.12</a>, <a href="cope.cgi?key=Nicotinamide%20phosphoribosyltransferase">Nicotinamide phosphoribosyltransferase</a>, <a href="cope.cgi?key=NMN%20diphosphorylase">NMN diphosphorylase</a>, <a href="cope.cgi?key=NMN%20pyrophosphorylase">NMN pyrophosphorylase</a>, <a href="cope.cgi?key=NAmPRTase">NAmPRTase</a>, <a href="cope.cgi?key=Nampt">Nampt</a>, <a href="cope.cgi?key=AURA94">AURA94</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2094">augmented in rheumatoid arthritis 94</a>) (Curat <a href="cope.cgi?key=CA">CA</a> et al, 2006; Dahl TB et al, 2007; Spiroglou SG et al, 2010; Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥¥</b> <b style="mso-bidi-font-weight: normal"><a href="cope.cgi?key=Visfatin">Visfatin</a></b> (<a href="cope.cgi?key=VF">VF</a>, <a href="cope.cgi?key=PBEF">PBEF</a>, <a href="cope.cgi?key=pre%20B%2dcell%20colony%20enhancing%20factor">pre B-cell colony enhancing factor</a>, <a href="cope.cgi?key=PBEF1">PBEF1</a>, <a href="cope.cgi?key=pre%20B%2dcell%20colony%20enhancing%20factor%2d1">pre B-cell colony enhancing factor-1</a>, <a href="cope.cgi?key=EC2%2e4%2e2%2e12">EC2.4.2.12</a>, <a href="cope.cgi?key=Nicotinamide%20phosphoribosyltransferase">Nicotinamide phosphoribosyltransferase</a>, <a href="cope.cgi?key=NMN%20diphosphorylase">NMN diphosphorylase</a>, <a href="cope.cgi?key=NMN%20pyrophosphorylase">NMN pyrophosphorylase</a>, <a href="cope.cgi?key=NAmPRTase">NAmPRTase</a>, <a href="cope.cgi?key=Nampt">Nampt</a>, <a href="cope.cgi?key=AURA94">AURA94</a>, <a href="cope.cgi?key=augmented%20in%20rheumatoid%20arthritis%2094">augmented in rheumatoid arthritis 94</a>) <b style="mso-bidi-font-weight:normal">receptors</b> (Dahl TB et al, 2007; Li Y et al, 2008)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Wnt%2d2">Wnt-2</a> </b>(<a href="cope.cgi?key=IRP">IRP</a>, <a href="cope.cgi?key=int%2d1%2drelated%20protein">int-1-related protein</a>, <a href="cope.cgi?key=INT1L1">INT1L1</a>, <a href="cope.cgi?key=int%2d1%2dlike%201">int-1-like 1</a>) (Smith et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Wnt%2d5a">Wnt-5a</a></b> (Smith et al, 1999)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Wnt%2d7b">Wnt-7b</a></b> (Lobov et al, 2005)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=XAF1">XAF1</a></b> (<a href="cope.cgi?key=X%2dlinked%20inhibitor%20of%20apoptosis%2dassociated%20factor%2d1">X-linked inhibitor of apoptosis-associated factor-1</a>, <a href="cope.cgi?key=XIAP%20associated%20factor%2d1">XIAP associated factor-1</a>, <a href="cope.cgi?key=BIRC4BP">BIRC4BP</a>, <a href="cope.cgi?key=BIRC4%20binding%20protein">BIRC4 binding protein</a>) (Martinez FO et al, 2006)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=XCL1">XCL1</a></b> (<a href="cope.cgi?key=chemokine%20C%20motif%20ligand%2d1">chemokine C motif ligand-1</a>, <a href="cope.cgi?key=CL1">CL1</a>, <a href="cope.cgi?key=Lymphotactin">lymphotactin</a>, <a href="cope.cgi?key=Ltn">Ltn</a>, <a href="cope.cgi?key=Lptn">Lptn</a>, <a href="cope.cgi?key=SCM%2d1%2dalpha">SCM-1-alpha</a>, <a href="cope.cgi?key=Single%20C%20motif%2d1%2dalpha">Single C motif-1-alpha</a>, <a href="cope.cgi?key=ATAC">ATAC</a>, <a href="cope.cgi?key=activation%20induced%20T%2dcell%20derived%20and%20chemokine%20related">activation induced T-cell derived and chemokine related</a>, <a href="cope.cgi?key=SCYC1">SCYC1</a>) (Kim et al, 2004)<br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=XCL2">XCL2</a></b> (<a href="cope.cgi?key=chemokine%20C%20motif%20ligand%2d2">chemokine C motif ligand-2</a>, <a href="cope.cgi?key=CL2">CL2</a>, <a href="cope.cgi?key=SCM%2d1%2dbeta">SCM-1-beta</a>, <a href="cope.cgi?key=Single%20C%20motif%2d1%2dbeta">Single C motif-1-beta</a>, <a href="cope.cgi?key=SCYC2">SCYC2</a>) (Cao et al, 2008)<br/> <br/> <b style="mso-bidi-font-weight:normal">¥</b> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=ZBP1">ZBP1</a> </b>(<a href="cope.cgi?key=Z%2dDNA%20binding%20protein%201">Z-DNA binding protein 1</a>, <a href="cope.cgi?key=C20orf183">C20orf183</a>, <a href="cope.cgi?key=chromosome%2020%20open%20reading%20frame%20183">chromosome 20 open reading frame 183</a>, <a href="cope.cgi?key=DLM%2d1">DLM-1</a>, <a href="cope.cgi?key=Tumor%20stroma%20and%20activated%20macrophage%20protein">Tumor stroma and activated macrophage protein</a>, <a href="cope.cgi?key=DAI">DAI</a>, <a href="cope.cgi?key=DNA%2ddependent%20activator%20of%20interferon%20regulatory%20factors">DNA-dependent activator of interferon regulatory factors</a>; <a href="cope.cgi?key=DNA%2ddependent%20activator%20of%20IRFs">DNA-dependent activator of IRFs</a>) (<a href="cope.cgi?key=fu">Fu</a> et al, 1999)<br/> <br/> For related information of interest see also: <a href="cope.cgi?key=cell%20types">Cell types</a>, <a href="cope.cgi?key=Cell%20lines%20in%20Cytokine%20Research">Cell lines in Cytokine Research</a>, <a href="cope.cgi?key=cell%20culture">Cell culture</a>. <br/><p>For other entries pertaining to <a href="cope.cgi?key=Hematopoiesis">hematopoiesis</a> see also the <a href="cope.cgi?key=Hematology%20MiniCOPE%20Dictionary">Hematology Dictionary</a> section of this encyclopedia. </p><p><br/> <b style="mso-bidi-font-weight:normal"><a href="cope.cgi?key=Copyright">Copyright</a> © 2012 by H IBELGAUFTS. All rights reserved.</b><b style="mso-bidi-font-weight: normal"><br/> </b>ENTRY LAST MODIFIED: December 2012 </p><p><br/></p><hr/><table bgcolor="#8FBC8F" cellpadding="4" cellspacing="4"><tr><td><!-- REFERENCES section --><p> </p><p>See <a href="cope.cgi?key=macrophages__REFERENCES"><b>REFERENCES</b></a> for entry <b>macrophages</b>.</p><p>Click <a href="cope.cgi?key=macrophages__BACKLINKS"><b>BACKLINKS</b></a> to see which COPE entries contain the term <b> macrophages </b>.</p><p><br/></p></td></tr></table><hr/><br/>
<center>
<table border="" cellpadding="5" cellspacing="0">
<tr>
<td><a href="cope.cgi">COPE Homepage</a></td>
<td><a href="#TOP_OF_PAGE">Top of Page</a></td>
</tr>
</table>
</center>
<br/>
<hr/>
<!-- Top of ./alphatab.htm -->
<font size="1"> </font><br/>
<center>
<a href="http://www.myriadrbm.com/scientific-literature/application-notes/inflammation-app-notes/" target="_new"><img alt="www.myriadrbm.com" src="myriadrbminflamm.jpg"/></a>
</center>
<font size="1"> </font><br/>
<center><a name="END_OF_PAGE"></a></center>
<center>
<table bgcolor="#FFDEAD" cellpadding="0" cellspacing="0">
<font face="Helvetica,Verdana"> <font color="red"> <font size="2">
<tr align="center"><td><font size="3"><a href="cope.cgi?key=HELP REQUEST"><b>SUPPORT COPE </b></a> <b>|</b>
<a href="cope.cgi?key=Santa Claus"><b>Santa Claus </b></a> <b>|</b>
<a href="cope.cgi?key=COPE"><b>Intro </b></a> <b>|</b>
<a href="cope.cgi?key=MiniCOPE Dictionaries"><b> Subdictionaries</b></a> <b>|</b>
<a href="cope.cgi?key=COPEAlert"><b>New Entries</b></a> <b>|</b>
<a href="cope.cgi?key=CALL FOR CONTRIBUTIONS"><b> Contribute data </b></a> <b>|</b>
<a href="cope.cgi?key=COPE Reviews"><b> COPE Credentials</b></a>
</font></td>
</tr></font></font></font></table>
</center>
<center>
<table bgcolor="#FFDEAD" cellpadding="4" cellspacing="4">
<tr>
<td><a href="cope.cgi?lex_0"><font size="5"><b>#</b></font></a></td>
<td><a href="cope.cgi?lex_a"><font size="5"><b>A</b></font></a></td>
<td><a href="cope.cgi?lex_b"><font size="5"><b>B</b></font></a></td>
<td><a href="cope.cgi?lex_c"><font size="5"><b>C</b></font></a></td>
<td><a href="cope.cgi?lex_d"><font size="5"><b>D</b></font></a></td>
<td><a href="cope.cgi?lex_e"><font size="5"><b>E</b></font></a></td>
<td><a href="cope.cgi?lex_f"><font size="5"><b>F</b></font></a></td>
<td><a href="cope.cgi?lex_g"><font size="5"><b>G</b></font></a></td>
<td><a href="cope.cgi?lex_h"><font size="5"><b>H</b></font></a></td>
<td><a href="cope.cgi?lex_i"><font size="5"><b>I</b></font></a></td>
<td><a href="cope.cgi?lex_j"><font size="5"><b>J</b></font></a></td>
<td><a href="cope.cgi?lex_k"><font size="5"><b>K</b></font></a></td>
<td><a href="cope.cgi?lex_l"><font size="5"><b>L</b></font></a></td>
<!--
<td><form action="https://www.paypal.com/cgi-bin/webscr" method="post"> 
<input type="hidden" name="cmd" value="_s-xclick"> 
<input type="hidden" name="encrypted" value="-----BEGIN PKCS7-----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-----END PKCS7----- 
"> 
<input type="image" src="https://www.paypalobjects.com/en_US/i/btn/btn_donateCC_LG.gif" border="0" name="submit" alt="PayPal - The safer, easier way to pay online!"> 
<img alt="" border="0" src="https://www.paypalobjects.com/en_US/i/scr/pixel.gif" width="1" height="1"> 
</form> </td>
-->
<td><!-- Top of paypalbutton.htm -->
<form action="https://www.paypal.com/cgi-bin/webscr" method="post">
<input name="cmd" type="hidden" value="_s-xclick"/>
<input name="encrypted" type="hidden" value="-----BEGIN PKCS7-----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 
VoXDTM1MDIxMzEwMTMxNVowgY4xCzAJBgNVBAYTAlVTMQswCQYDVQQIEwJDQTEWMBQGA1UEBxMNTW91bnRhaW4gVmlldzEUMBIGA1UEChMLUGF5UGFsIEluYy4xEzARBgNVBAsUCmxpdmVfY2VydHMxETAPBgNVBAMUCGxpdmVfYXBpMRwwGgYJKoZIhvcNAQkBFg1yZUBwYXlwYWwuY29tMIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQDBR07d/ETMS1ycjtkpkvjXZe9k+6CieLuLsPumsJ7QC1odNz3sJiCbs2wC0nLE0uLGaEtXynIgRqIddYCHx88pb5HTXv4SZeuv0Rqq4+axW9PLAAATU8w04qqjaSXgbGLP3NmohqM6bV9kZZwZLR/klDaQGo1u9uDb9lr4Yn+rBQIDAQABo4HuMIHrMB0GA1UdDgQWBBSWn3y7xm8XvVk/UtcKG+wQ1mSUazCBuwYDVR0jBIGzMIGwgBSWn3y7xm8XvVk/UtcKG+wQ1mSUa6GBlKSBkTCBjjELMAkGA1UEBhMCVVMxCzAJBgNVBAgTAkNBMRYwFAYDVQQHEw1Nb3VudGFpbiBWaWV3MRQwEgYDVQQKEwtQYXlQYWwgSW5jLjETMBEGA1UECxQKbGl2ZV9jZXJ0czERMA8GA1UEAxQIbGl2ZV9hcGkxHDAaBgkqhkiG9w0BCQEWDXJlQHBheXBhbC5jb22CAQAwDAYDVR0TBAUwAwEB/zANBgkqhkiG9w0BAQUFAAOBgQCBXzpWmoBa5e9fo6ujionW1hUhPkOBakTr3YCDjbYfvJEiv/2P+IobhOGJr85+XHhN0v4gUkEDI8r2/rNk1m0GA8HKddvTjyGw/XqXa+LSTlDYkqI8OwR8GEYj4efEtcRpRYBxV8KxAW93YDWzFGvruKnnLbDAF6VR5w/cCMn5hzGCAZowggGWAgEBMIGUMIGOMQswCQYDVQQGEwJVUzELMAkGA1UE 
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-----END PKCS7----- 
"/>
<input alt="PayPal - The safer, easier way to pay online!" border="0" name="submit" src="https://www.paypalobjects.com/en_US/i/btn/btn_donateCC_LG.gif" type="image"/>
<img alt="" border="" bottom="" of="" paypalbutton.htm=""/>
</form></td>
<td><a href="cope.cgi?lex_m"><font size="5"><b>M</b></font></a></td>
<td><a href="cope.cgi?lex_n"><font size="5"><b>N</b></font></a></td>
<td><a href="cope.cgi?lex_o"><font size="5"><b>O</b></font></a></td>
<td><a href="cope.cgi?lex_p"><font size="5"><b>P</b></font></a></td>
<td><a href="cope.cgi?lex_q"><font size="5"><b>Q</b></font></a></td>
<td><a href="cope.cgi?lex_r"><font size="5"><b>R</b></font></a></td>
<td><a href="cope.cgi?lex_s"><font size="5"><b>S</b></font></a></td>
<td><a href="cope.cgi?lex_t"><font size="5"><b>T</b></font></a></td>
<td><a href="cope.cgi?lex_u"><font size="5"><b>U</b></font></a></td>
<td><a href="cope.cgi?lex_v"><font size="5"><b>V</b></font></a></td>
<td><a href="cope.cgi?lex_w"><font size="5"><b>W</b></font></a></td>
<td><a href="cope.cgi?lex_x"><font size="5"><b>X</b></font></a></td>
<td><a href="cope.cgi?lex_y"><font size="5"><b>Y</b></font></a></td>
<td><a href="cope.cgi?lex_z"><font size="5"><b>Z</b></font></a></td>
</tr>
</table>
</center>
<!-- <center><TABLE width="100%" CELLPADDING=2 bgcolor= "maroon" > 

<center><TABLE width="90%" CELLPADDING=2 bgcolor=maroon>
<TR ALIGN=CENTER><TD>
 
<P>
<font face="Helvetica,Verdana"> <font color=white> <font size=5>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B>Space for your banner or text advertisement</B>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</FONT>
</TD></TR>
</FONT>
</TABLE>
</center>  -->
<!--
<center>
<A HREF="http://www.immunotools.de/html/promotion.pdf"><IMG SRC="immunotools-ef-3.gif" width="688" height="56" ALT="http://www.immunotools.de/html/promotion.pdf"></a>
</center>
-->
<!--
<center><TABLE width="100%" CELLPADDING=2 >
<TR ALIGN=CENTER><TD>
 
<P>
<font face="Helvetica,Verdana"> <font color=white> <font size=5>
</FONT>
</TD></TR>
</FONT>
</TABLE>
</center>
-->
<!--
<HR SIZE=5>
<center>
<B> <a target="_new" HREF="http://www.cellsciences.com/"><IMG SRC="cela.gif" width="144" height="34" ALT="Cell Sciences Inc"></A> <font face="Verdana"> <font color=red> supports COPE with an unrestricted educational grant.  Please inquire. </B></FONT> 
</center>
<HR SIZE=5>
-->
<hr size="5"/>
<center>
<table>
<tr>
<td><a href="cope.cgi?key=COPE Contact Information"><img alt="Please inquire." src="edugrantbanner.png"/></a></td>
<td><font face="Verdana"> <font color="red"><b><a href="cope.cgi?key=COPE Contact Information"> Support COPE with an educational grant. Please inquire</a></b></font> </font></td>
</tr>
</table>
</center>
<hr size="5"/>
<!-- Bottom of ./alphatab.htm -->
<!-- Top of ./topicbot.htm -->
<center><table bgcolor="#FFCC66" cellpadding="2" width="100%">
<tr align="CENTER"><td>
<p>
<font face="Helvetica,Verdana"> <font color="maroon"> <font size="4">
      
      
<b>Created, developed, and maintained by Prof Dr H Ibelgaufts</b>
      
      <br/>
<a href="cope.cgi?key=Horst Ibelgaufts">About the author of COPE</a> </font>   <b>|</b>   
<a href="cope.cgi?key=Contact information">Contact COPE</a>     <b>|</b>   
<a href="cope.cgi?key=postcard and stampware"> postcard and stampware </a> 
  <b>|</b>   
<a href="cope.cgi?key=COPE Site Usage Agreement and Disclaimer and Copyright Notice">Terms &amp; Conditions </a>
</font>
</font></p></td></tr>
</table>
</center>
<hr/>
<center><font color="black" size="3"><b>
</b></font><center>
<table width="100%">
<tr>
<td align="middle" bgcolor="#FFFF99"><b> Access to COPE is free only for academic institutions and non-profit organizations. <br/>
<font color="RED"> OTHER USERS: </font> <a href="cope.cgi?key=Contact information">must contact COPE and pay a site licence fee.</a></b>
</td></tr>
</table>
<table width="100%">
<tr>
<p>
</p><p><font color="green"><b>U L T R A   P O S S E   N E M O   O B L I G A T U R</b></font>
</p></tr>
</table>
</center>
</center></body></html><!-- Bottom of ./topicbot.htm -->